,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,174.94137573242188,2023-01-15,168.32223510742188,-0.037836335728399506,D4,[],"{""assetTurnoverTTM"": 0.4662, ""bookValue"": 76804, ""cashRatio"": 0.18447367477868176, ""currentRatio"": 0.9909, ""ebitPerShare"": 1.5835, ""eps"": 1.3268, ""ev"": 491213, ""fcfMargin"": 0.1587, ""fcfPerShareTTM"": 6.5742, ""grossMargin"": 0.6747, ""inventoryTurnoverTTM"": 2.2932, ""longtermDebtTotalAsset"": 0.1435, ""longtermDebtTotalCapital"": 0.2309, ""longtermDebtTotalEquity"": 0.3501, ""netDebtToTotalCapital"": 0.2521, ""netDebtToTotalEquity"": 0.3823, ""netMargin"": 0.1485, ""operatingMargin"": 0.1772, ""payoutRatioTTM"": 0.6511, ""pb"": 6.0133, ""peTTM"": 25.7426, ""pfcfTTM"": 26.8751, ""pretaxMargin"": 0.1772, ""psTTM"": 5.5141, ""ptbv"": 16.2171, ""quickRatio"": 0.7111, ""receivablesTurnoverTTM"": 5.3275, ""roaTTM"": 0.0999, ""roeTTM"": 0.2373, ""roicTTM"": 0.1631, ""rotcTTM"": 0.1793, ""salesPerShare"": 8.9355, ""sgaToSale"": 0.3253, ""tangibleBookValue"": 28479, ""totalDebtToEquity"": 0.5164, ""totalDebtToTotalAsset"": 0.2117, ""totalDebtToTotalCapital"": 0.3405, ""totalRatio"": 1.6946, ""period"": ""2023-01-01""}"
1,2023-01-15,168.32223510742188,2023-01-22,163.77037048339844,-0.027042562862348407,D3,[],"{""assetTurnoverTTM"": 0.4662, ""bookValue"": 76804, ""cashRatio"": 0.18447367477868176, ""currentRatio"": 0.9909, ""ebitPerShare"": 1.5835, ""eps"": 1.3268, ""ev"": 491213, ""fcfMargin"": 0.1587, ""fcfPerShareTTM"": 6.5742, ""grossMargin"": 0.6747, ""inventoryTurnoverTTM"": 2.2932, ""longtermDebtTotalAsset"": 0.1435, ""longtermDebtTotalCapital"": 0.2309, ""longtermDebtTotalEquity"": 0.3501, ""netDebtToTotalCapital"": 0.2521, ""netDebtToTotalEquity"": 0.3823, ""netMargin"": 0.1485, ""operatingMargin"": 0.1772, ""payoutRatioTTM"": 0.6511, ""pb"": 6.0133, ""peTTM"": 25.7426, ""pfcfTTM"": 26.8751, ""pretaxMargin"": 0.1772, ""psTTM"": 5.5141, ""ptbv"": 16.2171, ""quickRatio"": 0.7111, ""receivablesTurnoverTTM"": 5.3275, ""roaTTM"": 0.0999, ""roeTTM"": 0.2373, ""roicTTM"": 0.1631, ""rotcTTM"": 0.1793, ""salesPerShare"": 8.9355, ""sgaToSale"": 0.3253, ""tangibleBookValue"": 28479, ""totalDebtToEquity"": 0.5164, ""totalDebtToTotalAsset"": 0.2117, ""totalDebtToTotalCapital"": 0.3405, ""totalRatio"": 1.6946, ""period"": ""2023-01-01""}"
2,2023-01-22,163.77037048339844,2023-01-29,163.275390625,-0.0030224017747374488,D1,[],{}
3,2023-01-29,163.275390625,2023-02-05,159.76199340820312,-0.021518228824000896,D3,"[{""date"": ""2023-01-29"", ""headline"": ""Are You Seeking Passive Income? Try These 2 Dividend Kings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-29"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-29"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Legend Biotech: CARTITUDE-4 Study A Success"", ""summary"": ""Legend Biotech and partner JNJ announced positive topline results from the CARTITUDE-4 trial of Carvykti last week. See why LEGN stock is a Buy.""}, {""date"": ""2023-01-30"", ""headline"": ""Top 5 4th Quarter Trades of WAFRA INC."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""J&J\u2019s Talc Bankruptcy Case Thrown Out by Appeals Court"", ""summary"": ""A federal appeals court said Johnson & Johnson\u2019s LTL Management can\u2019t use bankruptcy to resolve numerous talc-injury lawsuits.""}, {""date"": ""2023-01-30"", ""headline"": ""Court rejects Johnson & Johnson bankruptcy protection from talcum powder lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson Shares Drop as Court Rejects Use of Bankruptcy in Talc Lawsuits"", ""summary"": ""The opinion raises questions about the future of the more than 40,000 lawsuits claiming that J&J's talc products caused cancer.""}, {""date"": ""2023-01-30"", ""headline"": ""J&J's LTL unit's bankruptcy dismissed by U.S. appeals court - filing"", ""summary"": ""The bankruptcy petition of Johnson & Johnson unit LTL Management, which was assigned talc liabilities, was dismissed by the 3rd U.S. Circuit Court of Appeals on Monday, according to a court ruling. (Reporting by Tom Hals in Wilmington, Delaware)""}, {""date"": ""2023-01-30"", ""headline"": ""U.S. court dismisses bankruptcy petition by J&J's talc unit"", ""summary"": ""An appeals court in the United States on Monday dismissed a bankruptcy petition by Johnson & Johnson's talc unit.""}, {""date"": ""2023-01-30"", ""headline"": ""Third Circuit Ruling Reopens Courthouse Doors for Talc-Asbestos Claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Hot Stocks: JNJ, MMM fall on legal decision; GEHC rises on earnings; PHG climbs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Legal Trouble Hits JNJ Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson stock takes a dive after WSJ report that federal appeals court rejected talc bankruptcy case"", ""summary"": ""Shares of Johnson & Johnson took a dive in midday trading Monday, after The Wall Street Journal reported that a federal appeals court rejected the consumer...""}, {""date"": ""2023-01-30"", ""headline"": ""J&J falls after appeals court rules company can`t use bankruptcy to end cancer suits (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson to challenge federal appeals court ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Pfizer Stock Falls on Downbeat Guidance as Company Braces for Covid Vaccine Drop-Off"", ""summary"": ""The pharmaceutical company is bracing for a top-line dip. Pfizer said it expects Covid-19 vaccine sales to drop to $13.5 billion in 2023.""}, {""date"": ""2023-01-30"", ""headline"": ""These 2 dividend-stock ETFs are more like growth funds in disguise. Can either still work in your income portfolio?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""J&J falls after appeals court rules company can`t use bankruptcy to end cancer suits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""3M declines suddenly after Johnson & Johnson loses appeal on talc litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""J&J falls after losing appeals court ruling in talc litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""J&J drops 3% after court rejects bankruptcy plan for talc lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Johnson & Johnson Becomes Oversold"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Dividends for Stability, Safety in a Mixed Market"", ""summary"": ""This week, we'll discuss one way to navigate this kind of market scenario\u2014including a few defensive stocks to consider.""}, {""date"": ""2023-01-30"", ""headline"": ""WHO maintains public health emergency on COVID but sees `inflexion point` ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Johnson & Johnson: Starting To Look Interesting Again"", ""summary"": ""Johnson & Johnson continues to grow, albeit at a very modest GDP + pace. JNJ closed the Abiomed deal while maintaining balance sheet integrity. Read more here.""}, {""date"": ""2023-01-31"", ""headline"": ""U.S. court rejects J&J bankruptcy strategy for thousands of talc lawsuits"", ""summary"": ""A U.S. appeals court on Monday shot down Johnson & Johnson's attempt to offload tens of thousands of lawsuits over its talc products into bankruptcy court. The ruling marked the first major repudiation of an emerging legal strategy with the potential to upend U.S. corporate...""}, {""date"": ""2023-01-31"", ""headline"": ""Tracking Yacktman Asset Management Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""5 Dividend King Stocks Gurus Are Feasting On"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV Buys 4, Sells 1 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Top 5 4th Quarter Trades of VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Time Heals All Wounds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Wells sees J&J talc settlement reaching a `manageable` $10B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Haleon said to evaluate potential deals to increase its size - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Top 5 4th Quarter Trades of Alterity Financial Group, LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""J&J talc bankruptcy case dismissal impact to be determined, says BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Johnson & Johnson put buyer realizes 135% same-day gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Wall Street Breakfast Podcast: IMF: U.S. Could Avoid Recession In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Core Alternative Capital`s Top 5 Buys of the 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Genmab: High-Quality Biotech Darling, But Lacks Meaningful Catalysts In The Near Term"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""The 7 Best Climate Change Stocks to Buy for 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""My 26 Stock ~$384k Portfolio Sports Double-Digit Returns To Start The New Year"", ""summary"": ""My portfolio, built specifically for my retirement, features growth, dividend, and risk stocks for a happy retirement. Click here to see my strategy.""}, {""date"": ""2023-02-01"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.92% higher to $164.92 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-02-01"", ""headline"": ""Novavax refuses to refund $700M for COVID shots never delivered, NY Times says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""The most overbought and oversold S&P 500 stocks to start February"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""J&J bankruptcy ruling an `incremental negative` for 3M, says BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""SCHMIDT P J INVESTMENT MANAGEMENT INC Buys 2, Sells 3 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-02"", ""headline"": ""COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst"", ""summary"": ""Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.""}, {""date"": ""2023-02-02"", ""headline"": ""COLUMN-3M foes act fast to capitalize on J&J\u2019s talc bankruptcy defeat"", ""summary"": ""When a U.S. appeals court ruled on Monday that Johnson & Johnson can\u2019t use the U.S. bankruptcy system to offload vast litigation exposure from product liability claims, the people who reacted most quickly were undoubtedly J&J investors.  Within hours of the 3rd U.S. Circuit Court of Appeals decision, investors drove J&J\u2019s share price down by nearly 4% -- its biggest one-day decline in years.  But another, albeit much smaller, group of people was also roiled by Monday\u2019s ruling from the 3rd Circuit: appellate lawyers who were finishing up friend-of-the-court briefs due on Wednesday in a 7th Circuit appeal by 3M Co that presents issues similar to those in the J&J case.""}, {""date"": ""2023-02-02"", ""headline"": ""Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference"", ""summary"": ""NEW BRUNSWICK, N.J., February 02, 2023--Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 43rd Annual HealthCare Conference on Tuesday, March 7th, at the Boston Marriott Copley Place, Boston, MA. Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).""}, {""date"": ""2023-02-02"", ""headline"": ""Corporate lawsuit dodge imperiled after court rejects J&J bankruptcy tactic"", ""summary"": ""Attorney Greg Gordon, a partner at the Jones Day law firm, offered an innovative solution to Johnson & Johnson and other major companies that faced mountains of lawsuits alleging their products sickened or killed people: They could use the bankruptcy system to force all...""}, {""date"": ""2023-02-02"", ""headline"": ""What\u2019s Ailing the Dow This Year? UnitedHealth, Chevron, J&J, Amgen."", ""summary"": ""The blue-chip index is up just 2.7% year to date, behind the S&P 500's 8.9% gain""}, {""date"": ""2023-02-02"", ""headline"": ""3 Defensive Stocks to Buy If You Think the Market Is Headed Lower"", ""summary"": ""As we kick off a new year, investing in defensive stocks certainly appears to be in focus for many investors. Following a brutal 2022, many aggressive investors were taught a lesson by Mr. Market\u2013 namely, what happens when a portfolio lacks diversification and low-beta assets. In risk-on momentum-driven bull market rallies, growth stocks outperform to an incredible degree. However, when valuations start to matter and money isn\u2019t free anymore, defensive stocks outperform. Defensive stocks are typ""}, {""date"": ""2023-02-02"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.38% higher to $165.54 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-02-03"", ""headline"": ""Johnson & Johnson unit plots job cuts; James Merson to depart"", ""summary"": ""The company last year moved into nearly 200,000 square feet in Brisbane \u2014 enough space for 400 people.""}, {""date"": ""2023-02-03"", ""headline"": ""U.S. military members suing 3M seek dismissal of subsidiary's bankruptcy"", ""summary"": ""Current and former U.S. military members suing 3M over allegedly defective military earplugs have asked a U.S. judge to dismiss 3M subsidiary Aearo Technologies' bankruptcy, accusing the company of using bankruptcy to shield itself from litigation, which has grown into the...""}, {""date"": ""2023-02-03"", ""headline"": ""13 Best Value Dividend Stocks to Buy"", ""summary"": ""In this article, we take a look at 13 best value dividend stocks to buy. If you want to see more best value dividend stocks to buy, go directly to 5 Best Value Dividend Stocks to Buy. Value stocks are stocks of companies generally considered trading below what many investors think they are worth. Because [\u2026]""}, {""date"": ""2023-02-03"", ""headline"": ""Veterans Suing Over 3M Earplugs Want Bankruptcy Case Tossed"", ""summary"": ""Plaintiffs say a ruling on the Johnson & Johnson talc case supports their opposition to 3M\u2019s plan for settling claims.""}, {""date"": ""2023-02-03"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.56% to $164.61 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-03"", ""headline"": ""3 Dow Stocks That Make for Screaming Buys in February"", ""summary"": ""Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.""}, {""date"": ""2023-02-04"", ""headline"": ""2 Stocks Down More Than 6% to Buy Right Now"", ""summary"": ""In fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV)..  Motley Fool contributors Adria Cimino and Keith Speights talk about why these two stocks actually make great buys right now.  Adria Cimino (Johnson & Johnson): J&J may have disappointed investors when it reported fourth-quarter earnings on Jan. 24.""}, {""date"": ""2023-02-04"", ""headline"": ""3 Unstoppable Dividend Stocks to Buy in February"", ""summary"": ""Any time is a good time to buy solid dividend stocks.  Here's why they chose Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Johnson & Johnson (NYSE: JNJ).  David Jagielski\u00a0(Abbott Laboratories):\u00a0 One dividend stock that should be attractive to long-term investors is Abbott Laboratories.""}, {""date"": ""2023-02-04"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - February 2023"", ""summary"": ""This is part of our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying, and offer discounts. Click here for more.""}, {""date"": ""2023-02-05"", ""headline"": ""Dividend Challengers List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend challengers by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Challengers List Ranked By Yield: Top 10. Dividend Challengers are companies that have raised their dividends for five years or more. These companies [\u2026]""}, {""date"": ""2023-02-05"", ""headline"": ""2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell"", ""summary"": ""There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare businesses.  With the company's impressive track record of dividend payments and its pipeline's massive throughput of new medicines, it's clear that this stock will be around for the foreseeable future.  Johnson & Johnson's product mix makes it worth buying in times like now when inflation is higher than average.""}, {""date"": ""2023-02-05"", ""headline"": ""12 Safe Stocks to Buy For Long-Term"", ""summary"": ""In this article, we take a look at 12 safe stocks to buy for the long-term according to hedge funds. You can skip our detailed analysis of safe stocks and go directly to read 5 Safe Stocks to Buy According to Hedge Funds. Even if there are many indications that the macro environment will remain [\u2026]""}, {""date"": ""2023-02-05"", ""headline"": ""1 Resilient Blue Chip Stock to Buy on the Dip"", ""summary"": ""Johnson & Johnson is facing issues that are causing investors to look elsewhere (more on those below).  Let's look into why opportunistic investors should seriously consider buying shares of Johnson & Johnson as they sink.  On Jan. 24, Johnson & Johnson released its fourth-quarter and full-year 2022 financial results.""}]",{}
4,2023-02-05,159.76199340820312,2023-02-12,157.37445068359375,-0.014944372398440486,D2,"[{""date"": ""2023-02-05"", ""headline"": ""Biogen: What To Do Ahead Of Q4 2022 Financial Report"", ""summary"": ""Biogen's business focuses on developing and commercializing drugs aimed at treating patients living with neurological and neurodegenerative diseases. Find out why BIIB stock is a Hold.""}, {""date"": ""2023-02-05"", ""headline"": ""Dividend Challengers List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend challengers by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Challengers List Ranked By Yield: Top 10. Dividend Challengers are companies that have raised their dividends for five years or more. These companies [\u2026]""}, {""date"": ""2023-02-05"", ""headline"": ""2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell"", ""summary"": ""There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare businesses.  With the company's impressive track record of dividend payments and its pipeline's massive throughput of new medicines, it's clear that this stock will be around for the foreseeable future.  Johnson & Johnson's product mix makes it worth buying in times like now when inflation is higher than average.""}, {""date"": ""2023-02-05"", ""headline"": ""12 Safe Stocks to Buy For Long-Term"", ""summary"": ""In this article, we take a look at 12 safe stocks to buy for the long-term according to hedge funds. You can skip our detailed analysis of safe stocks and go directly to read 5 Safe Stocks to Buy According to Hedge Funds. Even if there are many indications that the macro environment will remain [\u2026]""}, {""date"": ""2023-02-05"", ""headline"": ""1 Resilient Blue Chip Stock to Buy on the Dip"", ""summary"": ""Johnson & Johnson is facing issues that are causing investors to look elsewhere (more on those below).  Let's look into why opportunistic investors should seriously consider buying shares of Johnson & Johnson as they sink.  On Jan. 24, Johnson & Johnson released its fourth-quarter and full-year 2022 financial results.""}, {""date"": ""2023-02-06"", ""headline"": ""The 3 Best Forever Stocks to Buy for February 2023"", ""summary"": ""The past year has not been particularly kind to investors who suffered through an interest-rate-driven bear market. However, long-term investors know that bears are a normal part of the investing cycle. According to S&P Dow Jones Indices, since 1932, bear markets have occurred about every four years and eight months on average. Long-term investors also know that market downturns are a great time to load up on forever stocks at a discount. Forever stocks are established companies with great track""}, {""date"": ""2023-02-06"", ""headline"": ""Johnson & Johnson's Drug Acquired Via Momenta Deal Shows Encouraging Data In Fetal Disorder"", ""summary"": ""Janssen, a unit of Johnson & Johnson (NYSE: JNJ), announced topline results from the proof-of-concept Phase 2 open-label UNITY trial for pregnant adults at high risk for severe hemolytic disease of the fetus and newborn. In 2020, Johnson & Johnson shelled out $6.5 billion to acquire Momenta Pharmaceuticals Inc, gaining access to its lead product, nipocalimab. HDFN is a rare condition that can cause life-threatening anemia in the fetus. It occurs when the blood types of a pregnant individual and""}, {""date"": ""2023-02-06"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson shed 0.76% to $163.36 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-06"", ""headline"": ""Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL"", ""summary"": ""Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.""}, {""date"": ""2023-02-06"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term"", ""summary"": ""Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.""}, {""date"": ""2023-02-06"", ""headline"": ""Catalent Stock Surges on Report of Danaher Interest. M&A May Be Back."", ""summary"": ""After two major healthcare and life sciences deals at the end of 2022, M&A in the industry could be about to rebound.""}, {""date"": ""2023-02-06"", ""headline"": ""Johnson & Johnson's Latest Talcum Powder Development Could Be Costly"", ""summary"": ""Healthcare conglomerate Johnson & Johnson's (NYSE: JNJ) ongoing litigation over the alleged health effects of its talc-based baby powder continues to hang over the company's head.  Recently, an appeals court ruled against Johnson & Johnson's attempt at using bankruptcy protection to shield itself from claims.  An analyst from JPMorgan estimated that Johnson & Johnson's potential talc liabilities could approach $8 billion to $10 billion, which is no small pill to swallow.""}, {""date"": ""2023-02-06"", ""headline"": ""VONV: Lagging Other Value ETFs"", ""summary"": ""Vanguard Russell 1000 Value ETF has beaten its parent index in the last 12 months, but it has lagged several large cap value ETFs. Click for my take on VONV.""}, {""date"": ""2023-02-06"", ""headline"": ""10 Monthly Dividend Stocks with Over 5% Yield"", ""summary"": ""In this article, we discuss 10 monthly dividend stocks with over 5% yield. If you want to see more stocks in this selection, check out 5 Monthly Dividend Stocks with Over 5% Yield. During a difficult time for the capital markets in 2022, dividend-paying stocks proved to be a strong investment, outperforming both non-dividend stocks [\u2026]""}, {""date"": ""2023-02-06"", ""headline"": ""Catalent stock rockets 21% premarket on report of takeover interest from Danaher"", ""summary"": ""Life Sciences Company Danaher Corp. is interested in taking over contract manufacturer Catalent Inc. and is willing to pay a significant premium for the...""}, {""date"": ""2023-02-06"", ""headline"": ""Tracking Ken Fisher's Fisher Asset Management Portfolio - Q4 2022 Update"", ""summary"": ""Fisher\u00e2\u0080\u0099s 13F portfolio value increased from ~$133B to ~$148B in Q4 2022. Click here to read a full update of the portfolio.""}, {""date"": ""2023-02-06"", ""headline"": ""Talc ruling a blow to J&J and the \u2018Texas two-step\u2019 bankruptcy jig"", ""summary"": ""Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits""}, {""date"": ""2023-02-07"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst-Performing January Stocks?"", ""summary"": ""Taking a cue from the Dogs of the Dow strategy, let's see if any of the Dow's weakest performers in January are worth buying today.  Johnson & Johnson\u00a0(NYSE: JNJ) is as stable of a blue chip stock as they come, but the healthcare giant faced several negative headlines in January that pushed its shares lower, and its earnings report failed to impress the market.  Along with partners, it also canceled its phase 3 Mosaico clinical HIV vaccine trial, because the drug was not effective in preventing HIV infection.""}, {""date"": ""2023-02-07"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.02% higher to $163.40 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-02-07"", ""headline"": ""12 Dividend Stocks to Buy According to Billionaire Ken Fisher"", ""summary"": ""In this article, we will discuss the 12 dividend stocks to buy according to billionaire Ken Fisher. If you want to explore some of Ken Fisher\u2019s top dividend stock picks, you can go to 5 Dividend Stocks to Buy According to Billionaire Ken Fisher. Ken Fisher is an American billionaire investor, author, and philanthropist. He [\u2026]""}, {""date"": ""2023-02-07"", ""headline"": ""Catalent (CTLT) Surges on Rumors of Acquisition by Danaher"", ""summary"": ""Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.""}, {""date"": ""2023-02-07"", ""headline"": ""Dividend Capture Strategy: 10 High-Yield Stocks to Buy in February"", ""summary"": ""In this article, we discuss 10 high-yield stocks to buy in February. You can skip our detailed analysis on dividend capture strategy and past performance of high dividend stocks, and go directly to read Dividend Capture Strategy: 5 High-Yield Stocks to Buy in February. Dividend capture strategy is one of the most popular techniques employed [\u2026]""}, {""date"": ""2023-02-07"", ""headline"": ""The jig is up for the Texas two-step"", ""summary"": ""Today is Tuesday, February 7th, and this is your FT News Briefing.  Johnson & Johnson can no longer sidestep certain liability lawsuits.  Google is playing catch-up with its artificial intelligence technology.""}, {""date"": ""2023-02-08"", ""headline"": ""A Look at Pharma ETFs Post Q4 Earnings"", ""summary"": ""Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.""}, {""date"": ""2023-02-08"", ""headline"": ""This Could Cost Johnson & Johnson Billions in Profit"", ""summary"": ""The talc lawsuits create some risk for the business -- but is it enough of a reason to stay away from the stock?""}, {""date"": ""2023-02-08"", ""headline"": ""ARWR: Catalyst-Rich 2023\u2026"", ""summary"": ""By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Multiple Catalysts Ahead in 2023 Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is developing medicines that cause gene silencing using RNA interference (RNAi), a specific means of inhibiting the expression of genes and stopping the production of a specific protein. The company has a deep and diverse pipeline that""}, {""date"": ""2023-02-08"", ""headline"": ""3 Dividend Stocks That Will Hold Up No Matter the Market Conditions"", ""summary"": ""All three major indexes have started the year off on the right foot. After touching bear territory last year, they're now posting gains for 2023 so far. Will the next step be a bull market? It's possible -- but it's too early to say whether the market is truly ready to fully recover and thrive.""}, {""date"": ""2023-02-08"", ""headline"": ""4 Dividend Aristocrat Buys For February"", ""summary"": ""Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. Here are 4 stock picks for February.""}, {""date"": ""2023-02-09"", ""headline"": ""AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales"", ""summary"": ""AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.""}, {""date"": ""2023-02-09"", ""headline"": ""Wall Street\u2019s frozen IPO market is thawing as companies take advantage of stock rally"", ""summary"": ""Wall Street's so-called IPO window, allowing companies to readily tap investors for new stock, has been mostly shut for the past year. ""}, {""date"": ""2023-02-09"", ""headline"": ""7 Dividend Stocks to Buy for a Reliable Income Stream"", ""summary"": ""With 2022 featuring a deluge of red ink, the temptation this year centers on scooping up popular names for cheap. Though investors shouldn\u2019t ignore the relatively boring option of dividend stocks to buy. True, companies that provide reliable passive income don\u2019t generate much excitement. However, with so many variables ahead of the markets, a dull but dependable route may be more prudent. For this list of dividend stocks to buy, every company features a payout ratio \u2013 or the proportion of earnin""}, {""date"": ""2023-02-09"", ""headline"": ""How To Allocate $5,000 Among 5 Dividend Income And Dividend Growth Stocks And ETFs"", ""summary"": ""In this article, I will show you a portfolio that consists of 5 picks that provide you with Dividend Income and Dividend Growth. Read more here.""}, {""date"": ""2023-02-10"", ""headline"": ""Compounders And Dividends: February 2023 Watch List Update"", ""summary"": ""Three companies have been removed from my watchlist and added to the active portfolio. I added four new companies to my watchlist. Read more here.""}, {""date"": ""2023-02-10"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-02-10"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q4 2022 Update"", ""summary"": ""Tweedy, Browne\u00e2\u0080\u0099s 13F portfolio value decreased from $2.27B to $1.88B this quarter. They increased Ionis Pharmaceuticals while reducing most of the other stakes. Read more here.""}, {""date"": ""2023-02-10"", ""headline"": ""2 Top Stocks to Buy Without Hesitation in 2023"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is one of the world's largest healthcare companies, soon to be split into two separate entities.  The company is in the process of spinning off its consumer health business into a new company called Kenvue, while its medical device and pharmaceutical businesses will remain under the umbrella of the Johnson & Johnson name.  CEO Joaquin Duato noted in the company's recent 2022 earnings call that \""we filed our form S-1 with the SEC, giving us the option to pursue an IPO as a potential step in the separation.\""""}, {""date"": ""2023-02-10"", ""headline"": ""BME: Well-Positioned Healthcare CEF For Monthly Income"", ""summary"": ""BlackRock Health Sciences Trust is a top healthcare CEF with long tenure that offers monthly distributions and an average yield. See why I'm bullish on BME CEF.""}, {""date"": ""2023-02-11"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""2023-02-11"", ""headline"": ""10 Set-It-and-Forget-It Stocks to Buy According to Financial Media"", ""summary"": ""In this article, we take a look at 10 set-it-and-forget-it stocks to buy according to financial media. If you want to see more set-it-and-forget-it stocks to buy according to financial media, go directly to 5 Set-It-and-Forget-It Stocks to Buy According to Financial Media. Some stocks of leading companies are forever stocks in the eyes of many [\u2026]""}, {""date"": ""2023-02-11"", ""headline"": ""3 Warren Buffett Stocks to Buy and Hold"", ""summary"": ""Adding shares of Berkshire Hathaway's top stocks to your equity portfolio could do wonders for your own performance.""}, {""date"": ""2023-02-11"", ""headline"": ""The Dividend Aristocrats Ranked By Quality Scores"", ""summary"": """"}, {""date"": ""2023-02-11"", ""headline"": ""How This Income Method Could Lead To Financial Freedom"", ""summary"": ""We will go over our thesis as to how a diversified income method with low volatility could make you financially independent. Click here for our strategy.""}, {""date"": ""2023-02-11"", ""headline"": ""Better Passive Income Buy: VYM Vs. JEPI"", ""summary"": ""VYM offers income investors easy access to a well-diversified, low-cost portfolio. JEPI costs more. Find out which is the better buy at the moment.""}, {""date"": ""2023-02-12"", ""headline"": ""Connor, Clark & Lunn Investment Management Ltd. Buys 4, Sells 1 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Ten Stocks to Buy Before Their Ex-Dividend Dates Arrive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of AMALGAMATED BANK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Globus And NuVasive Take Spinal Fusion To A New Level"", ""summary"": ""Globus and NuVasive's merger deal will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share. Read what investors need to know.""}]",{}
5,2023-02-12,157.37445068359375,2023-02-19,156.78590393066406,-0.003739785907897919,D1,"[{""date"": ""2023-02-11"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""2023-02-12"", ""headline"": ""JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics."", ""summary"": ""The company more than doubled an investment in MeiraGTx, and more than halved its stake in surgical robotics firm Procept in the fourth quarter.""}, {""date"": ""2023-02-12"", ""headline"": ""OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Connor, Clark & Lunn Investment Management Ltd. Buys 4, Sells 1 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Ten Stocks to Buy Before Their Ex-Dividend Dates Arrive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of AMALGAMATED BANK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Globus And NuVasive Take Spinal Fusion To A New Level"", ""summary"": ""Globus and NuVasive's merger deal will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share. Read what investors need to know.""}, {""date"": ""2023-02-13"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Mettler-Toledo (MTD) and Bioxcel Therapeutics (BTAI)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""J&J faces dismissal in talc unit bankruptcy filing after appeals court ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president"", ""summary"": ""Johnson & Johnson said on Monday John Reed will take the role of executive vice president of pharmaceuticals, research and development, effective April 3.""}, {""date"": ""2023-02-13"", ""headline"": ""Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D"", ""summary"": ""NEW BRUNSWICK, N.J., February 13, 2023--Johnson & Johnson (NYSE: JNJ) (the Company) today announced the appointment of John Reed, M.D., Ph.D., to the Company\u2019s Executive Committee as Executive Vice President of Pharmaceuticals, R&D. Dr. Reed previously served as Executive Vice President, Global Head of Research and Development for Sanofi and brings more than 35 years of biomedical research leadership to the Company.""}, {""date"": ""2023-02-13"", ""headline"": ""Thousands of J&J talc lawsuits in New Jersey get new judge"", ""summary"": ""A new judge has been assigned to oversee tens of thousands of lawsuits in New Jersey federal court against Johnson & Johnson over its talc products, two weeks after an appeals court rejected the company's plan to offload the claims into bankruptcy.""}, {""date"": ""2023-02-13"", ""headline"": ""Hepatitis B Foundation calls reports J&J is deprioritizing its hepatitis therapy efforts 'disappointing'"", ""summary"": ""\""We entered 2023 with a robust and diverse pipeline of potential treatments for hepatitis B, but this news demonstrates the precarious nature of the pipeline.\""""}, {""date"": ""2023-02-13"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.37% higher to $162.75 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-02-13"", ""headline"": ""What Stocks To Buy Today? 2 Defensive Stocks To Know"", ""summary"": ""Do you have these defensive stocks on your radar right now?""}, {""date"": ""2023-02-13"", ""headline"": ""Wainwright initiates Arcellx with a buy on CAR-T pipeline, partnership with Gilead`s Kite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Opioid Settlement Money Is Coming, and Two Ohio Counties Differ on Ways to Use It"", ""summary"": ""The local government officials must decide how to make the most of funds to treat drug addiction.""}, {""date"": ""2023-02-14"", ""headline"": ""Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2022 Update"", ""summary"": ""Berkshire Hathaway's 13F stock portfolio value increased from ~$296B to ~$299B. Click here to see the Q4 update on Warren Buffett's portfolio.""}, {""date"": ""2023-02-14"", ""headline"": ""Tracking Warren Buffett`s Berkshire Hathaway Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Top 5 4th Quarter Trades of OLD POINT TRUST & FINANCIAL SERVICES N A"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""PARADIGM ASSET MANAGEMENT CO LLC Buys 3, Sells 2 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""3 ETFs Investors Can Buy to Weather a Recession"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson, Chevron share losses contribute to Dow`s nearly 50-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors"", ""summary"": ""NEW BRUNSWICK, N.J., February 14, 2023--Johnson & Johnson (NYSE: JNJ) announced today that Paula A. Johnson, MD, MPH, President of Wellesley College, has been appointed to its Board of Directors.""}, {""date"": ""2023-02-14"", ""headline"": ""J&J Must Face Baby Powder Suit by 24-Year-Old Dying of Cancer"", ""summary"": ""(Bloomberg) -- Johnson & Johnson can no longer use bankruptcy to block a trial in California over claims its baby powder caused the deadly cancer of a 24-year-old man, a federal judge ruled Tuesday.Most Read from BloombergUS Says 3 Mystery Objects Likely Private, With No China LinkNew Cars Are Only for the Rich Now as Automakers Rake In ProfitsGunman Kills Three at Michigan State; Suspect Found DeadAmerica's Priciest Neighborhoods Are Changing as the Ultra-Rich Move to FloridaUS Inflation Stays""}, {""date"": ""2023-02-14"", ""headline"": ""US Judge Intends To Dismiss Johnson & Johnson's Talc Subsidiary Bankruptcy"", ""summary"": ""A three-judge panel of the Philadelphia-based 3rd U.S. Circuit Court of Appeals ruled to dismiss Johnson & Johnson's (NYSE: JNJ) subsidiary's bankruptcy case regarding talc-related claims. The panel said it had no legitimate claim to Chapter 11 protection because it did not face financial distress. U.S. Bankruptcy Judge Michael Kaplan said during a hearing in Trenton, New Jersey, that he intends to toss the Chapter 11 case once the Philadelphia-based 3rd U.S. Circuit Court of Appeals issues a fo""}, {""date"": ""2023-02-14"", ""headline"": ""Ray Dalio Stock Portfolio: Top 15 Stock Picks"", ""summary"": ""In this piece, we will take a look at Ray Dalio Stock Portfolio: Top 15 Stock Picks. For more stocks, head on over to Ray Dalio Stock Portfolio: Top 5 Stock Picks. Ray Dalio\u2019s Bridgewater Associates is one of the biggest investment management firms in the world. In fact, as of December 2022, the firm [\u2026]""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.44% to $162.04 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-14"", ""headline"": ""Judge indicates intention to dismiss J&J talc unit bankruptcy"", ""summary"": ""The bankruptcy case filed by Johnson & Johnson's subsidiary shouldering talc-related lawsuits will soon be dismissed unless a U.S appeals court agrees to reconsider its decision to nix the company's attempt to offload the litigation into Chapter 11 proceedings, a federal...""}, {""date"": ""2023-02-14"", ""headline"": ""UPDATE 2-Judge indicates intention to dismiss J&J talc unit bankruptcy"", ""summary"": ""The bankruptcy case filed by Johnson & Johnson's subsidiary shouldering talc-related lawsuits will soon be dismissed unless a U.S appeals court agrees to reconsider its decision to nix the company's attempt to offload the litigation into Chapter 11 proceedings, a federal judge said on Tuesday.  U.S. Bankruptcy Judge Michael Kaplan said during a hearing in Trenton, New Jersey that he intends to toss the Chapter 11 case once the Philadelphia-based 3rd U.S. Circuit Court of Appeals issues a formal mandate to carry out a Jan. 30 ruling by a three-judge panel to dismiss the matter.  The 3rd Circuit panel ruled that the J&J subsidiary, called LTL Management, had no legitimate claim to Chapter 11 protection because it did not face financial distress.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson to Participate in the Barclays Global HealthCare Conference"", ""summary"": ""NEW BRUNSWICK, N.J., February 14, 2023--Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global HealthCare Conference on Tuesday, March 14th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Aldo Denti, Company Group Chairman DePuy Synthes and Peter Menziuso, Company Group Chairman, Vision will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).""}, {""date"": ""2023-02-14"", ""headline"": ""Better Buy: Johnson & Johnson or AbbVie?"", ""summary"": ""The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead.""}, {""date"": ""2023-02-14"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts` Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""J&J talc unit faces bankruptcy judge after tactic rejected"", ""summary"": ""Johnson & Johnson's subsidiary shouldering talc-related lawsuits goes before a bankruptcy judge on Tuesday for the first time since a U.S. appeals court last month nixed the company's attempt to offload the litigation into Chapter 11 proceedings.  A three-judge panel of the Philadelphia-based 3rd U.S. Circuit Court of Appeals on Jan. 30 ruled that the J&J subsidiary's bankruptcy case should be dismissed, finding it had no legitimate claim to Chapter 11 protection because it did not face financial distress.  Absent a reversal, the decision would force J&J back into trial courts to battle nearly 40,000 lawsuits alleging the company's Baby Powder and other cosmetic products containing talc cause cancer.""}, {""date"": ""2023-02-14"", ""headline"": ""4 Stock Market Sweethearts You'll Want to Call Your Own"", ""summary"": ""Valentine's Day is known for chocolates, heart-shaped gifts, and showing your significant other how much you care for them.  Although all three major stock indexes plunged into a bear market last year, patience has been the lure that's brought investors and equities together for decades.  It makes the current bear market for equities the perfect time for opportunistic investors to pounce.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson poaches Sanofi R&D head"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Johnson & Johnson appoints Dr. John Reed as EVP of Pharmaceuticals, R&D"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Top 5 4th Quarter Trades of Deseret Mutual Benefit Administrators"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Competition Coming For AbbVie's Blockbuster Humira"", ""summary"": ""It\u00e2\u0080\u0099s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper \u00e2\u0080\u009cbiosimilar\u00e2\u0080\u009d copycats. Read how price relief is on the way for Humira.""}, {""date"": ""2023-02-15"", ""headline"": ""Early Retirement Portfolio: 15 Stocks to Live Off Dividends Revisited"", ""summary"": ""In this article, we discuss 15 best dividend stocks for retirement. You can skip our detailed analysis of the early retirement phenomenon and dividend stocks, and go directly to read Early Retirement Portfolio: 5 Stocks to Live Off Dividends. Due to the onset of the pandemic in 2020, early retirement gained a steady pace among [\u2026]""}, {""date"": ""2023-02-15"", ""headline"": ""Value Investor Joel Greenblatt\u2019s Top 12 Dividend Picks"", ""summary"": ""In this article, we will discuss value investor Joel Greenblatt\u2019s top 12 dividend picks. You can skip our detailed analysis of Greenblatt\u2019s investment philosophy and his hedge fund\u2019s performance over the years, and go directly to read Value Investor Joel Greenblatt\u2019s Top 5 Dividend Picks. Joe Greenblatt is one of Wall Street\u2019s most famous value [\u2026]""}, {""date"": ""2023-02-15"", ""headline"": ""Stryker: Typically Excellent, Typically Expensive"", ""summary"": ""Stryker posted impressive top-line growth in Q4, driven by mid-teens growth in the MedSurg and Neuro operations. Read more to see my thoughts on SYK stock.""}, {""date"": ""2023-02-15"", ""headline"": ""15 Most Profitable Dividend Stocks"", ""summary"": ""In this article, we take a look at 15 most profitable dividend stocks. If you want to see more most profitable dividend stocks, go directly to 5 Most Profitable Dividend Stocks. Dividend stocks are stocks of companies that pay dividends. Many dividend stocks pay a dividend quarterly as a way to return excess capital back [\u2026]""}, {""date"": ""2023-02-15"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 1.65% to $159.37 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-15"", ""headline"": ""JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals"", ""summary"": ""Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) received written notice from Janssen, a unit of Johnson & Johnson (NYSE: JNJ), to terminate their rights to JNJ-75220795, now called ARO-PNPLA3, under the October 2018 research collaboration and option agreement. The companies are working to transition the program and associated data to Arrowhead. ARO-PNPLA3 is an investigational RNA interference (RNAi) therapeutic developed using Arrowhead's proprietary TRiM platform and designed to reduce liver expr""}, {""date"": ""2023-02-15"", ""headline"": ""5 Stocks In The Dividend Growth Sweet Spot"", ""summary"": ""Finding companies with a high initial yield and rapid dividend growth is difficult. Here's my criteria for finding such companies.""}, {""date"": ""2023-02-15"", ""headline"": ""Johnson & Johnson (JNJ) Presents at SVB Securities Global Biopharma Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) SVB Securities Global Biopharma Conference February 15, 2023 1:00 PM ETCompany ParticipantsBiljana Naumovic - Worldwide President, Global OncologyPeter...""}, {""date"": ""2023-02-15"", ""headline"": ""3 Resilient Stocks to Help Solidify Your Portfolio in 2023"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has a vast presence in the global market with popular brands under its consumer and health segments.  With this separation, J&J intends to focus solely on its core pharmaceutical business.""}, {""date"": ""2023-02-15"", ""headline"": ""Boston Scientific Stands Out With Strong, Diversified Growth Profile"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Medicare mulls limiting per month costs for generic drugs at $2"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Panel backs moving opioid antidote Narcan over the counter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Top 5 4th Quarter Trades of MAR VISTA INVESTMENT PARTNERS LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Worried About 2023? Park Your Money in These 2 Low-Volatility Dividend Stocks"", ""summary"": ""If you're not sure where to invest this year and don't want to take a risk with your money, consider buying shares of dividend stocks.  An even better option may be to hold dividend stocks that are low in volatility.  You can see how volatile a stock is by looking at its beta value.""}, {""date"": ""2023-02-15"", ""headline"": ""Ex-Dividend Reminder: Johnson & Johnson, Primerica and CNA Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Ray Dalio Buys 1, Sells 4 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""S&P 500, Dow, Nasdaq finish mixed as Fed debate continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Billionaire Ken Fisher\u2019s Top 15 Dividend Growth Stock Picks"", ""summary"": ""In this article, we discuss billionaire Ken Fisher\u2019s top 15 dividend growth stock picks. You can skip our detailed analysis of Ken Fisher\u2019s investment strategy and his hedge fund\u2019s performance over the years, and go directly to read Billionaire Ken Fisher\u2019s Top 5 Dividend Growth Stock Picks. In an interview with Fox Business, Ken Fisher [\u2026]""}, {""date"": ""2023-02-16"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slipped 0.71% to $158.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-16"", ""headline"": ""10 Best Stocks to Buy for Investment"", ""summary"": ""In this article, we take a look at 10 best stocks to buy for investment. If you want to see more best stocks to buy for investment, go directly to 5 Best Stocks to Buy for Investment. While different people have different opinions on what the best stocks for investment are, a decent number of [\u2026]""}, {""date"": ""2023-02-16"", ""headline"": ""10 Best Stocks to Buy for an 18 Year Old"", ""summary"": ""In this article, we take a look at 10 best stocks to buy for an 18 year old. If you want to see more best stocks to buy for an 18 year old, go directly to 5 Best Stocks to Buy for an 18 Year Old. The broader stock market has declined substantially in bear [\u2026]""}, {""date"": ""2023-02-16"", ""headline"": ""Competition Coming For AbbVie`s Blockbuster Humira"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""October 20th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Renaissance Technologies Top Trades This Quarter Included Apple, Amazon, Taiwan Semiconductor And More Released Here"", ""summary"": """"}, {""date"": ""2023-02-16"", ""headline"": ""Top 5 4th Quarter Trades of Ray Dalio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Johnson & Johnson files for debt securities offering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Cancer patient asks court to end Georgia-Pacific asbestos bankruptcy"", ""summary"": ""A cancer patient on Friday asked a U.S. bankruptcy court to dismiss the long-running bankruptcy of a Georgia-Pacific subsidiary, arguing that it serves no purpose other than to prevent asbestos-related lawsuits from proceeding in other courts.  The bankruptcy case began in 2017, when Georgia-Pacific, a unit of industrial conglomerate Koch Industries, spun off its liabilities for asbestos litigation into a new company, Bestwall, which then filed for bankruptcy.""}, {""date"": ""2023-02-17"", ""headline"": ""Novavax Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Novavax Inc. inched 0.30% higher to $10.02 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-02-17"", ""headline"": ""Merck & Co. Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Merck & Co. Inc. advanced 2.83% to $109.52 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-02-17"", ""headline"": ""Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. rallied 1.32% to $1.53 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-02-17"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. advanced 2.04% to $15.52 Friday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2023-02-17"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rallied 2.09% to $160.39 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-02-17"", ""headline"": ""Dow's 60-point jump led by gains for Amgen, Merck stocks"", ""summary"": ""Shares of Amgen and Merck are trading higher Friday afternoon, sending the Dow Jones Industrial Average into positive territory. Shares of Amgen and Merck...""}, {""date"": ""2023-02-17"", ""headline"": ""2 Warren Buffett Stocks to Buy Hand Over Fist and Hold for 30 Years or More"", ""summary"": ""Owning shares of reliably growing businesses means getting the advantage of their success for as long as you're willing to hold them.  Two companies in the Berkshire Hathaway portfolio that fit that description and are worth buying hand over fist today are Johnson & Johnson (NYSE: JNJ) and Apple (NASDAQ: AAPL) -- especially if you can hold them for the many decades that Warren Buffett would.  Johnson & Johnson is a relatively minor Berkshire holding, but it's a great example of some elements of Buffett's investing style.""}, {""date"": ""2023-02-17"", ""headline"": ""3 Exceptional Dividend Stocks to Buy Right Now"", ""summary"": ""These stocks can add to your returns -- no matter what the stock itself or the general market is doing.""}, {""date"": ""2023-02-17"", ""headline"": ""10 Sectors Likely To Generate Good Returns In The Next Decade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Will Johnson & Johnson Remain A Top Dividend Aristocrat Stock Going Forward?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-18"", ""headline"": ""IYH: Destiny's Favorite Child"", ""summary"": ""IYH exhibits low volatility, a low beta, and is extremely resilient in recessionary periods. It sports a 10-year annualized return of 13.56%. Read more here.""}, {""date"": ""2023-02-18"", ""headline"": ""IYH: Destiny`s Favorite Child"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-18"", ""headline"": ""Top 5 4th Quarter Trades of CITIZENS & NORTHERN CORP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-19"", ""headline"": ""2 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Warren Buffett is undoubtedly one of the best investors of the past half-century.  Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) chairman and chief executive officer has built it into the largest investment holding company in the world.  Here are two businesses in which Berkshire Hathaway owns stakes that could be good picks for dividend growth investors.""}, {""date"": ""2023-02-19"", ""headline"": ""3 Dow Stocks You Can Confidently Buy Now and Hold Forever"", ""summary"": ""These highly profitable, time-tested companies can make their shareholders significantly richer over time.""}]",{}
6,2023-02-19,156.78590393066406,2023-02-26,152.46524047851562,-0.027557729003872544,D3,"[{""date"": ""2023-02-19"", ""headline"": ""2 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Warren Buffett is undoubtedly one of the best investors of the past half-century.  Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) chairman and chief executive officer has built it into the largest investment holding company in the world.  Here are two businesses in which Berkshire Hathaway owns stakes that could be good picks for dividend growth investors.""}, {""date"": ""2023-02-19"", ""headline"": ""3 Dow Stocks You Can Confidently Buy Now and Hold Forever"", ""summary"": ""These highly profitable, time-tested companies can make their shareholders significantly richer over time.""}, {""date"": ""2023-02-20"", ""headline"": ""VIGI Has A Quality Portfolio But We Prefer Other Alternatives"", ""summary"": ""Vanguard International Dividend Appreciation's long-term growth potential appears to be inferior to its U.S. peers and has more downside risk. Find out why VIGI is a Hold.""}, {""date"": ""2023-02-20"", ""headline"": ""The 3 Best Dividend Stocks for Beginner Investors"", ""summary"": ""The stock market bloodbath of 2022 has left investors wondering whether they should choose safety over aggressive growth. While many investors are still sitting out and waiting for the market to recover, smart investors know that this is the time to bag solid, long-term stocks at a discount. The stock market has been off to a good start this year but the Federal Reserve still has a lot of work to do. With the concerns about rising interest rates, and looming recession, it is ideal to consider di""}, {""date"": ""2023-02-20"", ""headline"": ""Is This Supercharged Growth Stock a Buy?"", ""summary"": ""A $10,000 investment in pharmaceutical stalwart Eli Lilly (NYSE: LLY) made 10 years ago would now be worth $79,000 with dividends reinvested.  Putting this into perspective, that is leaps and bounds ahead of the $32,000 that the same investment amount put into the S&P 500 index 10 years ago would have turned into with dividends reinvested.  With more than 38,000 employees around the world and its products marketed in 120 countries, Eli Lilly is a dominant drugmaker.""}, {""date"": ""2023-02-20"", ""headline"": ""3 Top Dividend Kings to Buy for the Long Haul"", ""summary"": ""For long-term investors, there are not many things better than finding a profitable company paying you to hold shares.  If a company in the S&P 500 can pay and raise its dividend annually for 50 consecutive years, it earns a designation as a Dividend King.  Here are three Dividend Kings in the healthcare industry that you can own and sleep well at night while building wealth simultaneously.""}, {""date"": ""2023-02-20"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q4 2022 Update"", ""summary"": ""Jeremy Grantham\u00e2\u0080\u0099s 13F portfolio value increased from $17.33B to $18.77B this quarter. Click here to read the full update of the portfolio for Q4 2022.""}, {""date"": ""2023-02-20"", ""headline"": ""What To Expect From Bristol-Myers Squibb In 2023"", ""summary"": ""Bristol-Myers Squibb's primary focus is developing and commercializing innovative products in various therapeutic areas. Click here to read why BMY stock is a Buy.""}, {""date"": ""2023-02-20"", ""headline"": ""Tracking Jeremy Grantham`s GMO Capital Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Relative Strength Alert For Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""US Supreme Court Refuses To Reject $302M Judgment Against Johnson & Johnson Over Pelvic Mesh Marketing"", ""summary"": ""The U.S. Supreme Court refused to hear Johnson & Johnson's (NYSE: JNJ) regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products. J&J had argued to the Supreme Court that state consumer protection laws like California's are too vague, exposing companies to unpredictable state lawsuits, Reuters reported JNJ said the Supreme Court's rejection of the case will lead to continued \""uneven, unclear, and unfair enforcem""}, {""date"": ""2023-02-21"", ""headline"": ""J&J loses challenge to $302 million judgment over pelvic mesh marketing"", ""summary"": ""The U.S. Supreme Court on Tuesday let stand a $302 million judgment against Johnson & Johnson in a lawsuit brought by the state of California accusing the company of concealing the risks of its pelvic mesh products.""}, {""date"": ""2023-02-21"", ""headline"": ""UPDATE 1-J&J loses challenge to $302 mln judgment over pelvic mesh marketing"", ""summary"": ""The U.S. Supreme Court on Tuesday let stand a $302 million judgment against Johnson & Johnson in a lawsuit brought by the state of California accusing the company of concealing the risks of its pelvic mesh products.  The court, following its usual practice, did not give any reason for refusing to hear J&J's appeal.  J&J had argued to the Supreme Court that state consumer protection laws like California's are too vague, exposing companies to unpredictable state lawsuits.""}, {""date"": ""2023-02-21"", ""headline"": ""Novavax Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Novavax Inc. slid 6.29% to $9.39 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-02-21"", ""headline"": ""Merck & Co. Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. slumped 0.41% to $109.07 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-21"", ""headline"": ""Inovio Pharmaceuticals Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. slipped 7.84% to $1.41 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-02-21"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. shed 1.74% to $15.25 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-02-21"", ""headline"": ""J&J loses challenge to $302 mln judgment over pelvic mesh marketing"", ""summary"": ""The U.S. Supreme Court on Tuesday let stand a $302 million judgment against Johnson & Johnson in a lawsuit brought by the state of California accusing the company of concealing the risks of its pelvic mesh products.""}, {""date"": ""2023-02-21"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 1.49% to $158.00 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-21"", ""headline"": ""15 Highest Yielding Dividend Stocks You Can Buy"", ""summary"": ""In this article, we discuss 15 highest-yielding dividend stocks you can buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Highest Yielding Dividend Stocks You Can Buy. After delivering a record-breaking performance in 2022, dividend stocks are grabbing the spotlight this year as [\u2026]""}, {""date"": ""2023-02-21"", ""headline"": ""3 Healthcare Stocks to Buy and Hold for the Next 10 Years"", ""summary"": ""The healthcare industry has long proven itself to be a resilient place for investors to park their cash.  Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to report explosive financial growth from its core portfolio of products, all while expanding its pipeline into new disease areas ripe for disruption.  It's delivered a total return of 24% over the past year, compared to the S&P 500's negative return of 7% in that same period.""}, {""date"": ""2023-02-21"", ""headline"": ""This Is the Greatest Dividend Stock on the Planet, and Virtually No One Even Knows It Exists"", ""summary"": ""This practically unknown company has been paying a consecutive dividend for more than two centuries.""}, {""date"": ""2023-02-21"", ""headline"": ""Johnson & Johnson fails in bid to overturn $302M vaginal-mesh award \ufffd\ufffd\ufffd Bloomberg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""3 Foundational Dividend Stocks To Build A Portfolio Around"", ""summary"": ""Dividend investing is something that takes time to build through the process of compounding. Check out three dividend stocks that pay safe and growing dividends.""}, {""date"": ""2023-02-21"", ""headline"": ""Where To Invest $10,000 Right Now?"", ""summary"": ""This article is built around the question of where would you put $10,000 right now. Read why dividend growth investing is a smart way to go.""}, {""date"": ""2023-02-21"", ""headline"": ""Top 5 4th Quarter Trades of PROSPECTOR PARTNERS LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Top Trades of Ray Dalio`s Bridgewater in the 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Top 5 4th Quarter Trades of BERKSHIRE ASSET MANAGEMENT LLC/PA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Highlander Capital Management, LLC Buys 1, Sells 4 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""My dividend income rose by 9.56% on a y/y basis during January. My portfolio's value rose by approximately 6.9%. Here's a review of my portfolio for January 2023.""}, {""date"": ""2023-02-22"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.14%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $157.78, moving -0.14% from the previous trading session.""}, {""date"": ""2023-02-22"", ""headline"": ""12 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this piece, we will take a look at 12 most profitable pharmaceutical stocks now. For more stocks, head on over to 5 Most Profitable Pharmaceutical Stocks Now. The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living. As [\u2026]""}, {""date"": ""2023-02-22"", ""headline"": ""Selecting Dividend Aristocrats Using SCHD Methodology - Falling Behind"", ""summary"": ""Check out the proposal leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats.""}, {""date"": ""2023-02-22"", ""headline"": ""Novavax Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Novavax Inc. slipped 3.09% to $9.10 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-22"", ""headline"": ""Inovio Pharmaceuticals Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. dropped 0.71% to $1.40 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2023-02-22"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. inched 0.85% higher to $15.38 Wednesday, on what proved to be an all-around mixed trading session for the stock...""}, {""date"": ""2023-02-22"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.14% to $157.78 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-22"", ""headline"": ""Want to Get to $1 Million by Retirement? Here's How Much You Should Invest Today."", ""summary"": ""When you're in your 20s, you might think you don't have enough money to start putting away for retirement, whereas when you're in your 40s or 50s, you might worry that it's too late to start.  People normally make more money as they get older, and so it could be easier to put aside a big lump sum into an investment at that stage of your life.  Billionaire investor Warren Buffett says the first rule of investing is to not lose money; his second rule is to not forget the first one.""}, {""date"": ""2023-02-22"", ""headline"": ""What To Expect From Viatris In 2023"", ""summary"": ""Viatris' gross margin reached its highest level since its inception in Q4 2020. Read more to see my recommendation on VTRS stock.""}, {""date"": ""2023-02-22"", ""headline"": ""3 More Stocks Raising Their Dividends for Over 60 Years"", ""summary"": ""In periods of rising inflation and slowing economic growth, one constant investors can count on is the reliability of dividend stocks to see them through.  The asset managers at Hartford Funds looked at the performance of the benchmark S&P 500 going all the way back to 1930, and they found that dividends contributed 40% to the total return of the index over that 91-year period.  Dividend stocks in the S&P 500, however, returned a positive 1.8%.""}, {""date"": ""2023-02-22"", ""headline"": ""Smith & Nephew: Progress, But More Work Ahead In Ortho"", ""summary"": ""Smith & Nephew plc has the technology to be more competitive in ortho and gain share in major joints and extremities. Click here to know more on SNN stock.""}, {""date"": ""2023-02-23"", ""headline"": ""Treasury yields little changed as investors assess Fed minutes, data"", ""summary"": ""U.S. Treasury yields fell slightly on Friday morning as investors reacted to the Fed's latest meeting minutes and awaited key inflation and consumer data.""}, {""date"": ""2023-02-23"", ""headline"": ""Johnson & Johnson wins EU nod for prostate cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Novavax Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Novavax Inc. slumped 0.33% to $9.07 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-23"", ""headline"": ""Inovio Pharmaceuticals Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. shed 5.71% to $1.32 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-02-23"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. dropped 0.65% to $15.28 Thursday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-02-23"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson dropped 0.03% to $157.73 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-23"", ""headline"": ""Johnson & Johnson (JNJ) Down 6.9% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-02-23"", ""headline"": ""Arrowhead Pharmaceuticals Requires Caution"", ""summary"": ""Arrowhead Pharmaceuticals is a company with strong potential. Click here to read why we think ARWR stock may become a behemoth, in time.""}, {""date"": ""2023-02-23"", ""headline"": ""April 6th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Zhongchao renews partnership with Johnson & Johnson China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $1,690.50K"", ""summary"": """"}, {""date"": ""2023-02-24"", ""headline"": ""Buy the Dip in Johnson & Johnson and Its Near-3% Dividend Yield"", ""summary"": ""Johnson & Johnson stock has fallen in seven straight weeks, trades at less than 15 times earnings and pays a near-3% dividend yield. Plus, support is nearby.""}, {""date"": ""2023-02-24"", ""headline"": ""10 Best Stocks to Buy and Hold for a Lifetime"", ""summary"": ""In this article, we take a look at 10 best stocks to buy and hold for a lifetime. If you want to see more best stocks to buy and hold for a lifetime, go directly to 5 Best Stocks to Buy and Hold for a Lifetime. If the investment timeline is greater than 10 years, [\u2026]""}, {""date"": ""2023-02-24"", ""headline"": ""Novavax Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Novavax Inc. slipped 2.76% to $8.82 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-24"", ""headline"": ""Merck & Co. Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Merck & Co. Inc. shed 0.63% to $109.89 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-24"", ""headline"": ""Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. slid 3.03% to $1.28 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-02-24"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock falls Friday, still outperforms market"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. shed 0.13% to $15.26 Friday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-02-24"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.12% to $155.97 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-24"", ""headline"": ""All 30 Dow stocks are falling, led by Boeing, Salesforce and Disney"", ""summary"": ""Shares of all 30 components of the Dow Jones Industrial Average are trading lower in Friday\u2019s premarket, as Dow futures took a hit after strong consumer...""}, {""date"": ""2023-02-25"", ""headline"": ""PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route"", ""summary"": ""There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Read more to see why PSIL ETF is my choice.""}]",{}
7,2023-02-26,152.46524047851562,2023-03-05,150.55905151367188,-0.012502449468883126,D2,"[{""date"": ""2023-02-25"", ""headline"": ""PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route"", ""summary"": ""There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Read more to see why PSIL ETF is my choice.""}, {""date"": ""2023-02-26"", ""headline"": ""Treasury yields rise slightly to start the week"", ""summary"": ""U.S. Treasury yields were marginally lower on Monday morning as investors continue to monitor the outlook for inflation and the economy.""}, {""date"": ""2023-02-27"", ""headline"": ""The 20 worst U.S. stocks in February: the biggest loser dropped 35%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Johnson & Johnson initiated with a Neutral at Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Fate Therapeutics reports Q4 EPS (58c), consensus (86c)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Treasury prices fall slightly to close out bumper month for yields"", ""summary"": ""U.S. Treasury prices fell slightly on Tuesday to close out a bumper month for government bond yields.""}, {""date"": ""2023-02-27"", ""headline"": ""Top 10 Drug Companies in USA and Their China Reliance"", ""summary"": ""In this article, we will be taking a look at the top 10 drug companies in USA and their China reliance. To skip our detailed analysis of the pharmaceutical sector, you can go directly to see the Top 5 Drug Companies in USA and Their China Reliance. The US has long been reliant on China [\u2026]""}, {""date"": ""2023-02-27"", ""headline"": ""25 Freest Countries In the World"", ""summary"": ""\u00adIn this article, we will be taking a look at the 25 freest countries in the world. To skip our detailed analysis of the freest countries in the world, you can go directly to see the 5 Freest Countries In the World. Economists, including those working at the United Nations Development Programme, have established that [\u2026]""}, {""date"": ""2023-02-27"", ""headline"": ""22 Most Profitable Stocks of the Last 20 Years"", ""summary"": ""In this article, we will take a look at the 22 most profitable stocks of the last 20 years. If you want to explore similar stocks, you can also take a look at 5 Most Profitable Stocks of the Last 20 Years. On February 24, the Bureau of Economic Analysis released the Personal Income and Outlays [\u2026]""}, {""date"": ""2023-02-27"", ""headline"": ""Novavax Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Novavax Inc. slipped 1.70% to $8.67 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-27"", ""headline"": ""Merck & Co. Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Merck & Co. Inc. sank 0.48% to $109.36 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-27"", ""headline"": ""5 Stocks With Major Passive Income Potential"", ""summary"": ""Stocks are typically thought of as vehicles for capital appreciation. However, some stocks offer the potential for both capital gains and ongoing income via their dividends. Find Out: How Much...""}, {""date"": ""2023-02-27"", ""headline"": ""Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Inovio Pharmaceuticals Inc. shed 3.13% to $1.24 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-02-27"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-02-27"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.22% to $155.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-27"", ""headline"": ""2 Forever Stocks to Buy and Hold for Long-Term Growth"", ""summary"": ""Whereas other investments might keep you up at night, forever stocks are stable enough and dish out enough cash to your account from their dividends that they might even help you to sleep soundly.  If a financial terms dictionary provided examples along with its definitions, \""forever stock\"" would list Johnson & Johnson (NYSE: JNJ) as the first example.  The healthcare juggernaut sells everything from coronavirus vaccines to prescription drugs to operating room tools to shampoo and Tylenol, and it's done so profitably each year for decades on end, without fail.""}, {""date"": ""2023-02-27"", ""headline"": ""12 Best Affordable Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 best affordable dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Best Affordable Dividend Stocks to Buy. In February 2023, the Federal Reserve announced its eighth consecutive interest rate hike in a year, [\u2026]""}, {""date"": ""2023-02-27"", ""headline"": ""10 Most Promising Psychedelic Stocks According To Analysts"", ""summary"": ""In this article, we discuss 10 most promising psychedelic stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Psychedelic Stocks According To Analysts. Psychedelic drugs encompass a range of chemicals, including lysergic acid diethylamide (LSD) and plant-derived compounds. Psychedelics can be divided into two categories [\u2026]""}, {""date"": ""2023-02-28"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $153.26, moving -1.52% from the previous trading session.""}, {""date"": ""2023-02-28"", ""headline"": ""Why Emergent BioSolutions Stock Tumbled by Almost 12% Today"", ""summary"": ""Emergent BioSolutions (NYSE: EBS) probably wishes it had stayed in bed on Tuesday.  For its fourth quarter of 2022, Emergent booked revenue of just under $331 million, which was 54% below the same quarter of the previous year.  Of its two business divisions, Emergent's services unit was a real problem area.""}, {""date"": ""2023-02-28"", ""headline"": ""25 Most Profitable Companies in the World"", ""summary"": ""In this article, we will be taking a look at the 25 most profitable companies in the world. To skip our detailed analysis, you can go directly to see the 5 most profitable companies in the world. There is a great divide in the finance world between revenue, growth and profit. Often times, the focus [\u2026]""}, {""date"": ""2023-02-28"", ""headline"": ""March Dividend Kings: 5 Buys, 4 To Watch"", ""summary"": ""The 47 Dividend Kings screened as of February 24, 2023, represented eight of eleven Morningstar Sectors. Here are 5 of my picks to buy and 4 to watch.""}, {""date"": ""2023-02-28"", ""headline"": ""Jim Cramer says these three things can help you see through the market madness"", ""summary"": ""\""Put your emotions to the side and try to make reasonable decisions...without letting the irrational action infuriate you,\"" said CNBC's Jim Cramer. ""}, {""date"": ""2023-02-28"", ""headline"": ""Merck & Co. Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Merck & Co. Inc. slid 2.85% to $106.24 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-28"", ""headline"": ""Emergent's (EBS) Q4 Earnings Miss, Sales Beat Estimates"", ""summary"": ""Emergent (EBS) reported mixed fourth-quarter 2022 results. While the company significantly misses the mark on earnings, it beat sales estimates.""}, {""date"": ""2023-02-28"", ""headline"": ""11 Most Promising Cancer Stocks According to Analysts"", ""summary"": ""In this article, we discuss 11 most promising cancer stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Cancer Stocks According to Analysts. The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 [\u2026]""}, {""date"": ""2023-02-28"", ""headline"": ""Catalyst Pharmaceuticals Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Catalyst Pharmaceuticals Inc. slumped 0.78% to $15.26 Tuesday, on what proved to be an all-around poor trading session for the stock market, with...""}, {""date"": ""2023-02-28"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.52% to $153.26 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-28"", ""headline"": ""Dow drops 200 points on losses for shares of Goldman Sachs, Merck"", ""summary"": ""Shares of Goldman Sachs and Merck are seeing declines Tuesday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of Goldman...""}, {""date"": ""2023-02-28"", ""headline"": ""Goldman Sachs, Merck share losses contribute to Dow's 200-point drop"", ""summary"": ""Behind negative returns for shares of Goldman Sachs and Merck, the Dow Jones Industrial Average is declining Tuesday morning. The Dow was most recently...""}, {""date"": ""2023-02-28"", ""headline"": ""Dow down 118 points on losses for Goldman Sachs, Merck stocks"", ""summary"": ""Shares of Goldman Sachs and Merck are trading lower Tuesday morning, sending the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""2023-02-28"", ""headline"": ""Microsoft Stock Is Not Worth Buying Just Because Of ChatGPT"", ""summary"": ""There are plenty of speculations around the newly introduced ChatGPT, backed by Microsoft. See why I wouldn't invest in MSFT stock at the current price.""}, {""date"": ""2023-03-01"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $1,677.00K"", ""summary"": """"}, {""date"": ""2023-03-01"", ""headline"": ""Guggenheim Initiates Coverage of Johnson & Johnson (JNJ) with Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-03-01"", ""headline"": ""Johnson & Johnson-Backed Antiviral Candidate Effectively Prevents Influenza Infection"", ""summary"": ""Cidara Therapeutics Inc (NASDAQ: CDTX) announced efficacy and safety data from a planned interim analysis of the ongoing Phase 2a trial evaluating the pre-exposure prophylactic activity of CD388 against the H3N2 influenza A virus strain. As evidenced by animal efficacy studies, CD388 has the potential to be a long-acting antiviral drug designed to deliver universal prevention of seasonal and pandemic influenza A and B strains. A single dose of CD388 decreased influenza viral replication in the u""}, {""date"": ""2023-03-01"", ""headline"": ""S.Africa's Aspen set for deals to revive idled production lines"", ""summary"": ""South African drugmaker Aspen Pharmacare is close to signing four partnerships to revive its COVID-19 vaccine production lines that are generating no revenues, its CEO said, sending its shares up almost 10% in the day.""}, {""date"": ""2023-03-01"", ""headline"": ""FATE's Q4 Loss Narrower Than Expected, Pipeline in Focus"", ""summary"": ""FATE reports a narrower loss and higher collaboration revenues for the fourth quarter.""}, {""date"": ""2023-03-01"", ""headline"": ""7 Stocks to Protect Against the Massive Inflation Shock of 2023"", ""summary"": ""Last year has proven to be one of the most challenging years for the U.S. economy. An inflation shock took hold, driving the annualized inflation rate from 1.4% in January 2021 to 7% to close out the year. Moreover, the recently released inflation data suggest that inflation will continue to weigh down the economy for the better half of 2023. Therefore, I wouldn\u2019t blame investors for looking at some of the best stocks to buy to battle what could be yet another inflation shock this year. Perhaps""}, {""date"": ""2023-03-01"", ""headline"": ""Is Medtronic Still a Great Dividend Stock?"", ""summary"": ""A stock with a great dividend yield and lousy financials is a house of cards waiting to become a dividend trap.  Great dividend companies are those whose distributions are in no danger of being cut because their businesses are growing and they have plenty of free cash flow to cover their dividends.  Medtronic (NYSE: MDT) offers a dividend that yields roughly 3.23%, nearly twice that of the S&P 500 average dividend yield.""}, {""date"": ""2023-03-01"", ""headline"": ""Get a Dividend Every Month With These 3 Healthcare Stocks"", ""summary"": ""There are companies that deliver a monthly dividend, but the better move, at least for diversity and safety's sake, is to get a monthly dividend check each month by finding dependable dividend payers that deliver in different months.  Using that logic, I picked Johnson & Johnson (NYSE: JNJ), AbbVie (NYSE: ABBV), and Medtronic (NYSE: MDT).  All three healthcare companies have raised their dividends for 25 consecutive years or more and their dividends have a yield of 2.9% or more, well above the S&P 500 average of 1.7%.""}, {""date"": ""2023-03-01"", ""headline"": ""2 Buffett-Approved Stocks to Ride Out the Next Recession"", ""summary"": ""According to some data, there have been eight recessions in the U.S. since 1965.  Interestingly enough, 1965 was also the year Warren Buffett took over Berkshire Hathaway.  Despite facing an more than a few economic downturns, the legendary investor has beat the market in that time period.""}, {""date"": ""2023-03-01"", ""headline"": ""My $394k Portfolio Outperforms The Market Again In A Dreary February"", ""summary"": ""My portfolio, built specifically for my retirement ~20+ years from now, features growth, dividends, and risk stocks for a happy retirement. Click to read more.""}, {""date"": ""2023-03-01"", ""headline"": ""This Dividend Growth Stock Seemed Stable, But Just Suspended Its Payouts"", ""summary"": ""It can be tempting to think that because a company has a strong track record of paying and increasing dividends the trend will continue.  A great example of that is what happened with Healthcare Services Group\u00a0(NASDAQ: HCSG) in February.  Healthcare Services' business centers around housekeeping and dining services it offers to healthcare facilities.""}, {""date"": ""2023-03-01"", ""headline"": ""3 Warren Buffett Stocks Are Begging to Be Bought in March"", ""summary"": ""These three stocks stand out as the best buys right now in Berkshire Hathaway's 49-security investment portfolio.""}, {""date"": ""2023-03-01"", ""headline"": ""J&J initiated at neutral at Guggenheim on need for pharma, medtech growth visibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""Johnson & Johnson At 52-Week Lows: Is It Attractive?"", ""summary"": ""Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment.""}, {""date"": ""2023-03-01"", ""headline"": ""3 Dividend Kings So You Can Sleep Well At Night"", ""summary"": ""JNJ, SWK, and FRT are dividend kings that are trading with a wide margin of safety. Click here for a detailed analysis.""}, {""date"": ""2023-03-01"", ""headline"": ""Cidara Therapeutics announces interim Phase 2a data of CD388"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""Retail Earnings Indicate Unclear Outlook. Why the Fed Needs Consumers to Cut Back."", ""summary"": ""China growth, a U.S. TikTok ban?, Pfizer clears FDA vaccine hurdle, and other news to start your day.""}, {""date"": ""2023-03-01"", ""headline"": ""FBI Director says novel coronavirus likely originated from China lab leak"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""Johnson & Johnson initiated with a Neutral, $161 price target at Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 0.08% to $152.45 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-02"", ""headline"": ""Three-Stock Lunch: JNJ, CVS & D"", ""summary"": ""Victoria Green of G Squared Private Wealth joins 'Power Lunch' to discuss stocks hitting new lows, including Johnson & Johnson, CVS Health and Dominion Energy.""}, {""date"": ""2023-03-02"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-03-02"", ""headline"": ""April 14th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Merck and AstraZeneca to face FDA AdCom meeting for prostate cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""The $3 Million Dividend Growth Portfolio That Could Secure Your Retirement"", ""summary"": ""High retirement expectations data shows that the average investor is far from prepared. Click here to find out what makes dividend growth investing so powerful.""}, {""date"": ""2023-03-02"", ""headline"": ""Bristol-Myers, Janssen launch late-stage Librexia program evaluating milvexian"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Bristol Myers, Janssen launch late-stage Librexia program evaluating milvexian"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""Bristol-Myers and Johnson & Johnson launch Phase 3 trial of milvexian"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""My Dividend Growth Portfolio February Update: Cash Is Not Trash"", ""summary"": ""Cash is yielding over 4%, so a dividend growth investor can afford to be patient. Click here to read the February Update on my dividend growth portfolio.""}, {""date"": ""2023-03-03"", ""headline"": ""The Final Call: JNJ, PFE & OC"", ""summary"": ""The final trades this week. With CNBC's Melissa Lee and the Options Action traders, Carter Worth, Mike Khouw and Brian Stutland.""}, {""date"": ""2023-03-03"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.03% to $154.02 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-03"", ""headline"": ""Kenvue IPO Still Leaves Johnson & Johnson With Most Of The Talc Liabilities - An Update"", ""summary"": ""Johnson & Johnson stock is now trading at 15 times earnings, due to renewed legal concerns. Click here to read my analysis of JNJ stock.""}, {""date"": ""2023-03-03"", ""headline"": ""How Dividend Investors Can Pick the Right Companies"", ""summary"": ""Investors have been gravitating toward dividend-paying stocks and the mutual funds and exchange-traded funds that buy them.  Over the past three years, many of them have resumed dividend payments\u2014but some haven\u2019t, and according to the latest Global Dividend Index from Janus Henderson, overall dividend growth is expected to slow to 2.3% in 2023.  Now, even as the economy continues to emerge from the worst of the pandemic disruptions, persistent inflation and higher interest rates are stressing companies\u2019 balance sheets, which can discourage dividend payments.""}, {""date"": ""2023-03-03"", ""headline"": ""The Dividend Pyramid: Potentially Beat The Market With This 12-Stock Portfolio"", ""summary"": ""There is a good case to be made to buy a huge basket of stocks via an ETF. Find out why there is tremendous value in the behavioral approach.""}, {""date"": ""2023-03-04"", ""headline"": ""Lexicon Pharma: Advancing A Worthwhile Pipeline But Commercialization Remains A Key Risk"", ""summary"": ""Lexicon is getting closer to FDA approval for sotagliflozin. Click here to read my analysis of LXRX stock.""}, {""date"": ""2023-03-04"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""2023-03-04"", ""headline"": ""Johnson & Johnson`s Stelara demonstrates long-term efficacy in Crohn`s disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-04"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023"", ""summary"": ""In this article, we highlight 5 large-cap, relatively safe, dividend stocks that are offering large discounts to their historical norms. Click here to learn more.""}, {""date"": ""2023-03-04"", ""headline"": ""ILCV: There Are Better Options Among Large Cap Value ETFs"", ""summary"": ""iShares Morningstar Large-Cap Value ETF implements a strategy similar to the S&P 500 Value Index. Click here to see whether ILCV is a Buy.""}, {""date"": ""2023-03-05"", ""headline"": ""My Favorite Dividend Stocks for 2023"", ""summary"": ""Dividend stocks can provide resilience and growth to your portfolio in a wide variety of market environments.  Here are two fantastic dividend stocks that fit that bill and are no-brainer buys as investors kick off a new month in 2023.  Johnson & Johnson (NYSE: JNJ) has raised its dividend for 60 years in a row and counting.""}, {""date"": ""2023-03-05"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""3 Ideal Dividend Buys From Fortune's World's Most Admired All Stars 2023"", ""summary"": ""Fortune Magazine February/March 2023 Issue listed 50 World's Most Admired companies. Click here for an analysis of the top dividend stocks on the list.""}, {""date"": ""2023-03-05"", ""headline"": ""3 Ideal Dividend Buys From Fortune`s World`s Most Admired All Stars 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""Run Don't Walk: This Bull Trap Is About To End"", ""summary"": ""While inflation has hurt overall economic prosperity, various sectors fared better than feared, holding up major indices. Click here to read more.""}]",{}
8,2023-03-05,150.55905151367188,2023-03-12,148.20318603515625,-0.01564745164658332,D2,"[{""date"": ""2023-03-04"", ""headline"": ""Lexicon Pharma: Advancing A Worthwhile Pipeline But Commercialization Remains A Key Risk"", ""summary"": ""Lexicon is getting closer to FDA approval for sotagliflozin. Click here to read my analysis of LXRX stock.""}, {""date"": ""2023-03-04"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""2023-03-05"", ""headline"": ""Uncertainty Looms Over Immunovant`s Future As Batoclimab Faces Dim Prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""5 Stocks ChatGPT Says Will Make Me Rich in 20 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""My Favorite Dividend Stocks for 2023"", ""summary"": ""Dividend stocks can provide resilience and growth to your portfolio in a wide variety of market environments.  Here are two fantastic dividend stocks that fit that bill and are no-brainer buys as investors kick off a new month in 2023.  Johnson & Johnson (NYSE: JNJ) has raised its dividend for 60 years in a row and counting.""}, {""date"": ""2023-03-05"", ""headline"": ""3 Ideal Dividend Buys From Fortune's World's Most Admired All Stars 2023"", ""summary"": ""Fortune Magazine February/March 2023 Issue listed 50 World's Most Admired companies. Click here for an analysis of the top dividend stocks on the list.""}, {""date"": ""2023-03-05"", ""headline"": ""3 Ideal Dividend Buys From Fortune`s World`s Most Admired All Stars 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""Run Don't Walk: This Bull Trap Is About To End"", ""summary"": ""While inflation has hurt overall economic prosperity, various sectors fared better than feared, holding up major indices. Click here to read more.""}, {""date"": ""2023-03-06"", ""headline"": ""Protagonist Therapeutics Surges 52% after Successful Phase 2 Trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Johnson & Johnson AAA Rated 3% Dividend Yield Good Value: Buy, Sell Or Hold?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $155.56, marking a +1% move from the previous day.""}, {""date"": ""2023-03-06"", ""headline"": ""7 Stocks to Buy for the Worrying Climate Change Crisis"", ""summary"": ""Although the topic of climate change generates intense debate, its growing reality dictates that investors consider modifying their portfolios to target certain stocks to buy. As NASA\u2019s website states, \u201c[t]here is unequivocal evidence that Earth is warming at an unprecedented rate. Further, human activity represents the principal catalyst. Fortunately, several public enterprises have stepped up to the plate, ready to deliver tangible solutions. A major component of the underlying proposals cente""}, {""date"": ""2023-03-06"", ""headline"": ""7 Dividend Kings to Buy for an Uncertain Market Environment"", ""summary"": ""Though the term dividend aristocrats generate plenty of interest for the underlying elite status, another even more rarefied category exists called dividend kings to buy. Rather than 25 years of consecutive payout growth, the kings command at least 50 years. As we head into uncertain times, investors should pay close attention to this rare group of enterprises. Fundamentally, of course, companies that can afford to provide passive income to their stakeholders tend to be deeply established busine""}, {""date"": ""2023-03-06"", ""headline"": ""Talc supplier hit with $29 mln verdict in South Carolina trial"", ""summary"": ""A South Carolina jury has ordered former talc supplier Whittaker, Clark & Daniels to pay $29.14 million to a woman who said she developed mesothelioma from being exposed to asbestos-tainted talc in cosmetic products.  The jury in Columbia on Friday also found that talc manufacturer IMI Fabi was not responsible for plaintiff Sarah Plant's illness, clearing it of liability, according to Jessica Dean, a lawyer for the plaintiff.  Cosmetics company Mary Kay and makeup pigment maker Color Techniques were also defendants but were dropped mid-trial after reaching confidential agreements with Plant.""}, {""date"": ""2023-03-06"", ""headline"": ""J&J Kenvue spinoff adds slew of banks to its initial public offering roster"", ""summary"": ""MARKET PULSE Kenvue Inc., the consumer products spinoff from Johnson & Johnson (JNJ) has grown the roster of banks underwriting its initial public offering beyond the two original leads . Goldman Sachs & Co.""}, {""date"": ""2023-03-06"", ""headline"": ""Uncertainty Looms Over Immunovant's Future As Batoclimab Faces Dim Prospects"", ""summary"": ""Immunovant's lead drug, batoclimab, is one of many treatments, either approved or in development, for autoimmune diseases. Find out why IMVT stock is a sell.""}, {""date"": ""2023-03-06"", ""headline"": ""Johnson & Johnson stock rises Monday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 1.00% higher to $155.56 Monday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-03-06"", ""headline"": ""How To Use Covered Calls To Get 17% Annualized Return On JNJ Stock"", ""summary"": ""Selling the May 155 call option generates an income of 3.42% in just over two months, equaling around 17% annualized.""}, {""date"": ""2023-03-06"", ""headline"": ""Grade my trade: JNJ, ACN, ULTA & AMZN"", ""summary"": ""CNBC\u2019s \u2018Halftime Report\u2019 investment committee, Jason Snipe, Shannon Saccocia, Joe Terranova and Sarat Sethi, weigh in on the Johnson & Johnson, Accenture, Ulta Beauty and Amazon trades.""}, {""date"": ""2023-03-06"", ""headline"": ""Dow's 170-point jump highlighted by gains in shares of Apple, Merck"", ""summary"": ""Behind positive momentum for shares of Apple and Merck, the Dow Jones Industrial Average is climbing Monday afternoon. The Dow is trading 170 points (0.5%)...""}, {""date"": ""2023-03-06"", ""headline"": ""Dow`s 170-point jump highlighted by gains in shares of Apple, Merck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Apple, Merck share gains contribute to Dow's 75-point jump"", ""summary"": ""The Dow Jones Industrial Average is climbing Monday morning with shares of Apple and Merck delivering the strongest returns for the price-weighted average....""}, {""date"": ""2023-03-06"", ""headline"": ""Janssen`s macitentan, tadalafil combo improves pulmonary hemodynamics vs. monotherapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Apple, Merck share gains contribute to Dow`s 75-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Johnson & Johnson says A DUE study met co-primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Wall Street Breakfast Podcast: Bill To Ban Senior Federal Officials From Stock Trading"", ""summary"": ""Hawley expected to introduce a bill to ban senior federal officials from stock trading. More cost cuts? Amazon is shuttering Go stores after HQ2 construction halt. Tesla slashes prices.""}, {""date"": ""2023-03-07"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The March 2023 Heat Map"", ""summary"": ""We are only interested in those targets that are attractively valued in historical comparison. Click here for our 3-step process that focuses on wide-moat stocks.""}, {""date"": ""2023-03-07"", ""headline"": ""3 Value Stocks on Sale Now"", ""summary"": ""Growth stocks have clearly led the market thus far in 2023, but will that continue?""}, {""date"": ""2023-03-07"", ""headline"": ""Why Protagonist Therapeutics Shares Are Trading Higher Today"", ""summary"": ""Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from its collaboration with Janssen Biotech Inc, a part of Johnson & Johnson (NYSE: JNJ), in the FRONTIER 1 Phase 2b trial of oral Interleukin-23 receptor (IL-23R) antagonist peptide JNJ-2113 in patients with moderate-to-severe plaque psoriasis. Data from the 255-patient study showed that JNJ-2113 achieved the study's primary efficacy endpoint, with a statistically significant greater proportion of patients achieving PASI-75 (""}, {""date"": ""2023-03-07"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.94% to $154.09 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-07"", ""headline"": ""Johnson & Johnson (JNJ) Presents at Cowen 43rd Annual HealthCare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Cowen 43rd Annual HealthCare Conference March 7, 2023 11:10 AM ETCompany ParticipantsJoe Wolk - EVP and CFOJessica Moore - VP, IRConference Call...""}, {""date"": ""2023-03-07"", ""headline"": ""10 Mad Money Stock Picks This Week"", ""summary"": ""In this article, we will take a look at the 10 Mad Money stock picks this week. To see more such companies, go directly to 5 Mad Money Stock Picks This Week. All indicators show that the Federal Reserve is ready to continue raising interest rates as it has more than enough reasons to stick [\u2026]""}, {""date"": ""2023-03-07"", ""headline"": ""Hot Stocks: BB, THO drop on earnings news; SQSP rallies; PTGX surges on clinical data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-07"", ""headline"": ""DSTL Efficiently Combines Value And Quality Styles"", ""summary"": ""Distillate Fundamental Stability & Value ETF selects and weights stocks based on cash flow, stability and debt. Click here for my review of DSTL.""}, {""date"": ""2023-03-07"", ""headline"": ""3 Dow Stocks That Are Screaming Buys in March"", ""summary"": ""Among the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.""}, {""date"": ""2023-03-07"", ""headline"": ""My Dividend Stock Portfolio: New February Record - 99 Holdings With 32 Buys And 4 Sales"", ""summary"": ""Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Click here to read more about the dividend stocks.""}, {""date"": ""2023-03-07"", ""headline"": ""Protagonist Therapeutics Sees Positive Topline Results in JNJ-2113 Trial"", ""summary"": ""By Chris Wack Protagonist Therapeutics Inc. said Tuesday it saw positive topline results from its collaboration with Janssen Biotech Inc. in a Phase 2b...""}, {""date"": ""2023-03-07"", ""headline"": ""Protagonist Therapeutics reports `positive` results from FRONTIER 1 Phase 2b"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-07"", ""headline"": ""Biden to announce plan to keep Medicare solvent beyond 2050"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Kenvue prices $7.75B offering in a series of senior unsecured notes to fund separation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""How to Invest in 2023 If You Are Looking To Avoid Losses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Interesting JNJ Put And Call Options For April 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., March 08, 2023--Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (\""Kenvue\""), a wholly owned subsidiary of Johnson & Johnson, priced an offering of the following series of senior unsecured notes in an aggregate principal amount of $7.75 billion (each series of notes collectively, the \""Notes\""):""}, {""date"": ""2023-03-08"", ""headline"": ""7 Stocks at 52-Week Lows and Highly Attractive From Here"", ""summary"": ""Although public companies that suffer staggering losses often do so for good reason, sometimes, it might be worthwhile to take a shot with stocks at 52-week lows. Some of the justification comes down to the mechanics of contrarianism. Essentially, traders who shorted troubled securities need to exit their positions. For the bears, this exiting necessitates buying back borrowed shares, thus sparking bullish momentum. In other cases, certain enterprises may be overlooked and/or undervalued. With s""}, {""date"": ""2023-03-08"", ""headline"": ""Protagonist (PTGX) Up on Positive Results From FRONTIER Study"", ""summary"": ""Protagonist (PTGX) gains as the phase II study, conducted by Janssen, achieves its primary goal.""}, {""date"": ""2023-03-08"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.73% to $152.96 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-08"", ""headline"": ""3 Must-Buy Income Champs as Fed Rates Head to 5%"", ""summary"": ""When the U.S. central bank raises interest rates and keeps them elevated, investors should position toward must-buy income stocks to buy. Risk-free cash invested in various funds will pay close to the Fed Funds rate. When the next set of economic data confirm that inflation is persistent, yet the job markets are strong, it will keep borrowing costs high. Investors should accumulate companies that pay a dividend income. That income, plus the upside from these stocks\u2019 potentially rising price, sho""}, {""date"": ""2023-03-08"", ""headline"": ""Musk: \u2018Berkshire Hathaway high on Coke.' Warren Buffett earned $704M in dividends from Coca-Cola in 2022 \u2014 here are 3 more income stocks in the portfolio"", ""summary"": ""Even the world\u2019s richest man is impressed.""}, {""date"": ""2023-03-08"", ""headline"": ""15 Dividend Zombies and Kings With Longest Dividend Payouts"", ""summary"": ""In this article, we will discuss 15 dividend zombies and dividend kings with the longest dividend payouts. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Dividend Zombies and Kings With Longest Dividend Payouts. Dividend zombies are companies with century-long dividend payouts, whereas [\u2026]""}, {""date"": ""2023-03-08"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Zacks Investment Ideas feature highlights: Procter and Gamble, Johnson & Johnson and Abbott Labs"", ""summary"": ""Procter and Gamble, Johnson & Johnson and Abbott Labs have been highlighted in this Investment Ideas article.""}, {""date"": ""2023-03-08"", ""headline"": ""2 March Dogs Of The Dow To Buy, 4 More To Watch"", ""summary"": ""The highest-yield 10 are March\u00e2\u0080\u0099s Dogs of the Dow: JNJ, KO, CSCO, AMGN, CVX, DOW, IBM, WBA, MMM, and VZ, averaging a 4.41% annual yield.""}, {""date"": ""2023-03-08"", ""headline"": ""Wall Street Analysts Are Neutral on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Johnson & Johnson in pact with Biocytogen for antibody-based therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Sleep-at-night stocks for those hedging or risk averse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-09"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 1.12% to $151.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-09"", ""headline"": ""3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off"", ""summary"": ""Dividend stocks offer something for every type of investor.  Whether you're risk-averse or prefer a more aggressive style of putting your cash to work in the market, companies with a lengthy track record of paying and elevating their dividends in a variety of economic landscapes can improve your compounded returns over the years.  Innovative Industrial Properties (NYSE: IIPR) remains an increasingly unique example of a profitable business operating within the fast-growing cannabis space.""}, {""date"": ""2023-03-09"", ""headline"": ""5 Large Drug Stocks to Watch as Sector Picks Up in 2023"", ""summary"": ""Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sanofi (SNY) are worth retaining in your portfolio.""}, {""date"": ""2023-03-09"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-09"", ""headline"": ""3 Top Guru Favorites Trading Near 52-Week Lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $151.61 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-03-10"", ""headline"": ""The 4 Dividend Aristocrat Buys For March"", ""summary"": ""Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. Click here for our top picks for March.""}, {""date"": ""2023-03-10"", ""headline"": ""11 Best Long-term Growth Stocks for Strong Returns"", ""summary"": ""In this article, we take a look at 11 best long-term growth stocks for strong returns. If you want to see more best long-term growth stocks for strong returns, go directly to 5 Best Long-term Growth Stocks for Strong Returns. It is impossible to know the future. As such, it isn\u2019t possible to know stocks [\u2026]""}, {""date"": ""2023-03-10"", ""headline"": ""Why I'm Convinced That SCHD Will Outperform"", ""summary"": ""In this article, we start with a discussion of a very tricky macro environment, consisting of a rapidly falling equity risk premium and growth challenges. Read more here.""}, {""date"": ""2023-03-10"", ""headline"": ""Why I`m Convinced That SCHD Will Outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Halted Stocks Alert: Nasdaq Halts Trading in SVB Financial (SIVB) Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi"", ""summary"": ""J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article.""}, {""date"": ""2023-03-10"", ""headline"": ""Zimmer Biomet upgraded at Piper Sandler citing conservative guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""If You Like Johnson & Johnson, You'll Love These Higher-Yielding SWANs"", ""summary"": ""Johnson & Johnson's business model is as defensive as they come. Click here to read on two superior low-volatility SWAN alternatives to JNJ stock.""}, {""date"": ""2023-03-10"", ""headline"": ""If You Like Johnson & Johnson, You`ll Love These Higher-Yielding SWANs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch in 2023"", ""summary"": ""Kellogg, Johnson & Johnson, Crane, and BorgWarner are planning to hive off a chunk of their businesses in 2023. What investors need to know.""}, {""date"": ""2023-03-10"", ""headline"": ""3 of the Best Dividend Stocks, According to Analysts\ufffd\ufffd\ufffd3/10/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-11"", ""headline"": ""3 No-Brainer Dividend Stocks to Buy in March"", ""summary"": ""Choosing from the thousands of dividend stocks on the market can fall into the former category.  Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).  Keith Speights (AbbVie): I don't think anyone would seriously challenge AbbVie's credentials as a solid dividend stock.""}, {""date"": ""2023-03-11"", ""headline"": ""The Near-Perfect Portfolio: Sleep Well During Turbulent Times"", ""summary"": ""With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. Read more here.""}, {""date"": ""2023-03-11"", ""headline"": ""Dividend Stock Watch List: Lanny's March 2023 Edition"", ""summary"": ""Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers.""}, {""date"": ""2023-03-11"", ""headline"": ""Dividend Stock Watch List: Lanny`s March 2023 Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""S&P 500 futures give up earlier gains as investors weigh government's backstop of SVB: Live updates"", ""summary"": ""Investors were monitoring developments out of Washington for details on next steps in the Silicon Valley Bank crisis.""}, {""date"": ""2023-03-12"", ""headline"": ""10 Best Psychedelic Stocks to Buy According to Hedge Funds"", ""summary"": ""In this article, we discuss 10 best psychedelic stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy According to Hedge Funds. Data Bridge Market Research predicts that the psychedelic drugs market will expand at a compound annual growth rate [\u2026]""}, {""date"": ""2023-03-12"", ""headline"": ""These 7 Dividend Stocks Pay $96 Billion a Year, Combined, to Their Shareholders"", ""summary"": ""These widely owned, brand-name income stocks are parsing out between $11 billion and $20.2 billion annually to their shareholders.""}, {""date"": ""2023-03-12"", ""headline"": ""7 Blue-Chip Stocks to Buy in March"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
9,2023-03-12,148.20318603515625,2023-03-19,148.95590209960938,0.005078946577265597,U1,"[{""date"": ""2023-03-12"", ""headline"": ""Arcellx initiated with a Buy at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""7 Blue-Chip Stocks to Buy in March"", ""summary"": ""The concept of buy and hold may seem out of fashion given the state of the market in 2023. But if the threat of higher interest rates hasn\u2019t sent you to the sidelines, blue-chip stocks offer an opportunity to get a total return that can beat inflation. Today, we\u2019ll look at seven of the best blue-chip stocks to buy this month. Blue-chip stocks are defined as companies that have reliable business models and a history of delivering long-term total returns for shareholders. One characteristic that h""}, {""date"": ""2023-03-12"", ""headline"": ""Notable Monday Option Activity: JNJ, FITB, V"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""S&P 500 futures give up earlier gains as investors weigh government's backstop of SVB: Live updates"", ""summary"": ""Investors were monitoring developments out of Washington for details on next steps in the Silicon Valley Bank crisis.""}, {""date"": ""2023-03-12"", ""headline"": ""10 Best Psychedelic Stocks to Buy According to Hedge Funds"", ""summary"": ""In this article, we discuss 10 best psychedelic stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy According to Hedge Funds. Data Bridge Market Research predicts that the psychedelic drugs market will expand at a compound annual growth rate [\u2026]""}, {""date"": ""2023-03-12"", ""headline"": ""These 7 Dividend Stocks Pay $96 Billion a Year, Combined, to Their Shareholders"", ""summary"": ""These widely owned, brand-name income stocks are parsing out between $11 billion and $20.2 billion annually to their shareholders.""}, {""date"": ""2023-03-13"", ""headline"": ""CNBC Daily Open: Banks got hammered by SVB's collapse. But the Fed might still raise rates "", ""summary"": ""Bank stocks had a very rough Monday in the aftermath of Silicon Valley Bank\u2019s implosion. The 2-year Treasury yield plummeted. ""}, {""date"": ""2023-03-13"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $153.06, marking a +0.96% move from the previous day.""}, {""date"": ""2023-03-13"", ""headline"": ""CNBC Daily Open: The bank rout continues. The Fed might still raise rates anyway"", ""summary"": ""Bank stocks had a very rough Monday in the aftermath of Silicon Valley Bank\u2019s implosion. The 2-year Treasury yield plummeted. ""}, {""date"": ""2023-03-13"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.96% higher to $153.06 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-03-13"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow`s nearly 100-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation"", ""summary"": ""The blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and AbbVie's leukemia treatment Imbruvica are likely to be among 10 big-selling medicines subject to U.S. price negotiations for 2026, according to five Wall Street and academic analyses shared with Reuters.  Last year Congress passed the Inflation Reduction Act (IRA), giving the U.S. government power to start the first price negotiations over prescription drugs for its Medicare health program covering more than 60 million Americans, most over age 65.  The government will launch the negotiation process in September by naming the first drugs it plans to target.""}, {""date"": ""2023-03-13"", ""headline"": ""3 Reliable Dividend Stocks to Buy and Hold for Decades of Passive Income"", ""summary"": ""These healthcare-focused businesses should be able to raise their quarterly payouts for many years to come.""}, {""date"": ""2023-03-13"", ""headline"": ""These 3 Dow Stocks Are the Cheapest They've Been in Over a Decade"", ""summary"": ""While its 9% decline did represent its worst performance since 2008, it was markedly better than the Nasdaq Composite, which lost a whopping 33% last year.  Because the Dow's 30 components have a rich history of profitability, they're just the type of businesses investors turn to when stock market volatility and uncertainty pick up.  While most Dow components are well off their all-time highs, some are truly screaming values.""}, {""date"": ""2023-03-13"", ""headline"": ""Unusually active option classes on open March 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-14"", ""headline"": ""Johnson & Johnson oral dengue therapy enters mid-stage trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-14"", ""headline"": ""Johnson & Johnson: Creating Shareholder Value"", ""summary"": ""The diversified health care company has a strong pharmaceutical pipeline""}, {""date"": ""2023-03-14"", ""headline"": ""SXSW 2023: How medical companies have begun adopting AI, VR technology"", ""summary"": ""Yahoo Finance\u2019s Brad Smith joins the Live show from the 2023 SXSW Conference in Austin, Texas with a look at some of the innovation being unveiled there.""}, {""date"": ""2023-03-14"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.56% higher to $153.92 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-03-14"", ""headline"": ""Johnson & Johnson (JNJ) management presents at Barclays Global Healthcare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Barclays Global Healthcare Conference March 14, 2023 10:15 AM ETCompany ParticipantsAldo Denti - Company Group Chairman, DePuy Synthes The Orthopedic...""}, {""date"": ""2023-03-15"", ""headline"": ""Medicare publishes initial guidance on drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on First-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., March 15, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 18th to review first-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson\u2019s executive team.""}, {""date"": ""2023-03-15"", ""headline"": ""Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies"", ""summary"": ""New data published in the journal Nature shows that Johnson & Johnson's (NYSE: JNJ) experimental dengue pill proved effective against all four virus types in mice and prevented infection from two types in monkeys. The first-in-class antiviral, shown to be safe and well tolerated in Phase 1 first-in-human clinical study, is now progressing into Phase 2 clinical studies to prevent and treat dengue. Reuters writes that early animal results add hope for what could become the first antiviral treatmen""}, {""date"": ""2023-03-15"", ""headline"": ""Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study"", ""summary"": ""Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the blinded, placebo-controlled, randomized withdrawal portion of REVIVE of rusfertide for polycythemia vera, causing the bone marrow to make too many red blood cells. Subjects receiving rusfertide achieved highly statistically significant improvements versus placebo in the primary endpoint. More subjects receiving rusfertide during the blinded randomized withdrawal portion of the REVIVE study were responders compared wit""}, {""date"": ""2023-03-15"", ""headline"": ""J&J's experimental dengue pill prevents infection in mice, monkeys"", ""summary"": ""An experimental pill for dengue developed by Johnson & Johnson proved effective against all four types of the virus in mice and prevented infection from two types in monkeys, according to data published on Wednesday.""}, {""date"": ""2023-03-15"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.28% higher to $154.35 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-03-15"", ""headline"": ""7 Blue-Chip Stocks to Buy and Hold for Decades"", ""summary"": ""High uncertainty may continue to loom over the stock market, but that doesn\u2019t mean you need to stay on the sidelines. Instead, keep your eyes on the long-term, with solid additions to your portfolio, such as the best blue-chip stocks to buy and hold. These high-quality names have historically provided investors with solid total returns. First, through steady dividend payouts that grow over time. Most of these top blue-chips are \u201cdividend aristocrats,\u201d with over 25 years of consecutive dividend g""}, {""date"": ""2023-03-15"", ""headline"": ""Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature"", ""summary"": ""BEERSE, Belgium, March 15, 2023--The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today the publication of new data in the journal Nature showing that an early-stage clinical candidate (JNJ-1802) provides strong protection against dengue in non-human primates and mice. The first-in-class antiviral, which was shown to be safe and well tolerated in a Phase 1 first-in-human clinical study, is now progressing into Phase 2 clinical studies for the prevention and treatment""}, {""date"": ""2023-03-15"", ""headline"": ""Are You Looking for a High-Growth Dividend Stock?"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-03-15"", ""headline"": ""3 Blue-Chip Dividend Stocks to Buy on the Dip Now"", ""summary"": ""Now more than ever, investors are looking for high-quality companies to invest in. There were some rumblings that we\u2019re in a new bull market, but the latest developments have been concerning. As such, investors are looking for blue-chip dividend stocks to buy. The collapse of SVB Financial (NASDAQ:SIVB) has rattled global markets. Stock prices have been under pressure \u2014 particularly in financial stocks \u2014 while other asset prices have made some large moves too. Bonds, gold, global stocks, and mor""}, {""date"": ""2023-03-15"", ""headline"": ""15 Best Dividend Paying Stocks To Buy Now"", ""summary"": ""In this article, we will discuss 15 best dividend-paying dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend stocks provide several advantages to income investors, including regular income, the potential [\u2026]""}, {""date"": ""2023-03-15"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-03-15"", ""headline"": ""3M fights a growing legal battle over combat-grade earplugs"", ""summary"": ""More than 200,000 military service members and veterans are suing 3M claiming its Combat Arms earplugs failed to protect them. ""}, {""date"": ""2023-03-15"", ""headline"": ""Janssen announces publication of data on dengue antiviral candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""5 Forever Dividend Stocks To Build A Portfolio Around"", ""summary"": ""All 5 of these stocks prioritize returning money to shareholders. These firms have each paid growing dividends between 10 years and 60 years. Click for my list.""}, {""date"": ""2023-03-16"", ""headline"": ""VYM: Offers High-Dividend Stocks With Stable Income Stream"", ""summary"": ""The Vanguard High Dividend Yield ETF offers a stable income stream as well as potential growth in stock prices. Read more to learn why I rate VYM ETF a Buy.""}, {""date"": ""2023-03-16"", ""headline"": ""26 Companies that Donate to Nonprofits"", ""summary"": ""In this piece, we will take a look at the 26 companies that donate to nonprofits. For more companies, head on over to 5 Companies that Donate to Nonprofits. Corporate greed is always a popular topic in the press. And, firms are to blame for some extent as well. There are well known examples of [\u2026]""}, {""date"": ""2023-03-16"", ""headline"": ""15 Best US Stocks for Foreigners"", ""summary"": ""In this article, we take a look at 15 best US stocks for foreigners. If you want to see more best US stocks for foreigners, go directly to 5 Best US Stocks for Foreigners. Given the United States has the largest economy in the world, many foreigners invest in American stocks. Furthermore, many leading American companies [\u2026]""}, {""date"": ""2023-03-16"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson sank 0.21% to $154.03 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-16"", ""headline"": ""10 Best Stocks to Buy for Medium Term"", ""summary"": ""In this article, we will be taking a look at the 10 best stocks to buy for medium term. To skip our detailed analysis of the current stock market dynamics, you can go directly to see the 5 Best Stocks to Buy for Medium Term. While some investors prefer to hold long-term positions in the [\u2026]""}, {""date"": ""2023-03-16"", ""headline"": ""CMS releases 'bombshell' guidance draft of Medicare drug price negotiations"", ""summary"": ""Medicare issues draft guidance for drug price negotiation""}, {""date"": ""2023-03-16"", ""headline"": ""10 Stocks ChatGPT Says Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will be taking a look at 10 stocks recommended by ChatGPT. To skip our detailed analysis of ChatGPT and developments in artificial intelligence, you can go directly to see the 5 Stocks ChatGPT Says Will Make Me Rich in 10 Years. One of the biggest developments in artificial intelligence (AI) seen [\u2026]""}, {""date"": ""2023-03-17"", ""headline"": ""Top Stock Reports for Johnson & Johnson, Toyota Motor & Infosys"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Toyota Motor Corporation (TM) and Infosys Limited (INFY).""}, {""date"": ""2023-03-17"", ""headline"": ""Johnson & Johnson stock falls Friday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 1.07% to $152.38 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-17"", ""headline"": ""IN BRIEF: Johnson & Johnson notes positive data for psoriasis drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-17"", ""headline"": ""Needham med tech analyst to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-18"", ""headline"": ""Top 8 Stocks To Profit From Rising Interest Rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-18"", ""headline"": ""Why Nick Jonas is raising awareness for diabetes at SXSW"", ""summary"": ""Superstar recording artist Nick Jonas shares his experience with diabetes and why he's using his platform to improve access to diabetes care. Nick joins Yahoo Finance Senior Reporter Allie Garfinkle from SXSW in Austin, TX to discuss how health technology like continuous glucose monitoring (CGM) is easing the burden of managing diabetes.\u00a0 Watch as Nick opens up about his partnership with DexCom (DXCM), fatherhood, and his struggle with diabetes.""}, {""date"": ""2023-03-18"", ""headline"": ""Ready to Buy the Dip? Johnson & Johnson Stock Is a Smart Buy"", ""summary"": ""Shares of healthcare giant Johnson & Johnson (NYSE: JNJ) are down more than 13% this year even as the S&P 500 is up 4%.  Johnson & Johnson has long been one of the favored stocks for income-oriented investors.  Here are five reasons why Johnson & Johnson could be a smart buy now.""}, {""date"": ""2023-03-18"", ""headline"": ""5 Stocks You Can Confidently Invest $500 in Right Now"", ""summary"": ""These companies have the balance sheets and growth prospects to continue growing shareholder value in the coming years.""}, {""date"": ""2023-03-19"", ""headline"": ""Pfizer CEO pockets $33M for 2022 after 36% pay hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-19"", ""headline"": ""3 Retirement Investing Moves to Help Get You Back on Track"", ""summary"": ""If you've fallen behind on funding your retirement, it's important to do what you can to get yourself on a path to recovery.""}, {""date"": ""2023-03-19"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-03-19,148.95590209960938,2023-03-26,149.21983337402344,0.0017718752375288638,U1,"[{""date"": ""2023-03-18"", ""headline"": ""Top 8 Stocks To Profit From Rising Interest Rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-19"", ""headline"": ""Pfizer CEO pockets $33M for 2022 after 36% pay hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-19"", ""headline"": ""3 Retirement Investing Moves to Help Get You Back on Track"", ""summary"": ""If you've fallen behind on funding your retirement, it's important to do what you can to get yourself on a path to recovery.""}, {""date"": ""2023-03-19"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-20"", ""headline"": ""Banks Failing, Interest Rates Rising - Keep Buying Assets"", ""summary"": ""The stock market is still up year-to-date in 2023, despite the banking crisis/economic turmoil.""}, {""date"": ""2023-03-20"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $153.89 in the latest trading session, marking a +0.99% move from the prior day.""}, {""date"": ""2023-03-20"", ""headline"": ""Johnson & Johnson stock rises Monday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.99% higher to $153.89 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-03-20"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix"", ""summary"": ""Johnson & Johnson, Toyota Motor, Infosys, Novartis and Equinix are part of the Zacks top Analyst Blog.""}, {""date"": ""2023-03-20"", ""headline"": ""3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now"", ""summary"": ""The past 15 months have been disastrous for the major stock market indexes, but one has fared better than its peers.  The Dow Jones Industrial Average has fallen around 12% since the end of 2021.  While traditionally filled with industrial and financial stocks, there aren't any specific rules that determine which companies become one of the Dow's 30 components.""}, {""date"": ""2023-03-21"", ""headline"": ""J&J turns to Supreme Court to OK unit bankruptcy plan for talc lawsuits - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""J&J turns to Supreme Court to OK unit bankruptcy plan for tac lawsuits - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""Johnson & Johnson stock remains steady Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson were unchanged Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-21"", ""headline"": ""Johnson & Johnson`s (NYSE:JNJ) Decade-Low P/E Ratio Deserves Your Attention"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""JNJ Dividend Yield Pushes Past 3%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""J&J Fails to Win Rehearing of Talc Unit\u2019s Bankruptcy Case"", ""summary"": ""Johnson & Johnson will seek the Supreme Court\u2019s review after an appeals court declined to revive the company\u2019s bid to use chapter 11 bankruptcy to freeze nearly 40,000 lawsuits linking its talc products to cancer.""}, {""date"": ""2023-03-22"", ""headline"": ""J&J to seek U.S. Supreme Court review on unit's bankruptcy"", ""summary"": ""Johnson & Johnson said on Wednesday that it would ask the U.S. Supreme Court to revive its effort to resolve tens of thousands of lawsuits over its talc products through the bankruptcy of a subsidiary, after an appeals court refused to reconsider its ruling that the bankruptcy...""}, {""date"": ""2023-03-22"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.85% to $151.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-22"", ""headline"": ""Talc Plaintiffs Will Press to Reopen Courthouse Doors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""UPDATE 2-J&J to seek U.S. Supreme Court review on unit's bankruptcy"", ""summary"": ""Johnson & Johnson said on Wednesday that it would ask the U.S. Supreme Court to revive its effort to resolve tens of thousands of lawsuits over its talc products through the bankruptcy of a subsidiary, after an appeals court refused to reconsider its ruling that the bankruptcy was improper.  J&J sought to use the bankruptcy of its subsidiary company, LTL Management, to halt more than 38,000 lawsuits alleging the company\u2019s Baby Powder and other talc products are contaminated with asbestos, which J&J denies.  J&J maintains its consumer talc products are safe and confirmed through thousands of tests to be asbestos-free.""}, {""date"": ""2023-03-22"", ""headline"": ""J&J to seek US Supreme Court review on unit's bankruptcy"", ""summary"": ""Johnson & Johnson said on Wednesday that it would seek U.S. Supreme Court review on its strategy to address tens of thousands of lawsuits over its talc products in bankruptcy court, after a U.S. appeals court rejected its request for rehearing. (Reporting by Manas Mishra...""}, {""date"": ""2023-03-22"", ""headline"": ""Why 200,000-plus servicemembers and veterans are suing 3M"", ""summary"": ""More than 200,000 military servicemembers and veterans are suing 3M claiming its Combat Arms earplugs failed to protect them.""}, {""date"": ""2023-03-22"", ""headline"": ""Think the Bear Market Is Over? Here's How to Invest $5,000"", ""summary"": ""One of the features of bear markets, in comparison to bull markets, is that the former tend to be shorter, lasting a little less than 10 months on average compared to the latter's 2.7 years.  For investors who have $5,000 handy that isn't earmarked for emergencies, let's go over one of the many possible combinations of equities you could buy with that cash to generate solid returns over the long run.  Exchange-traded funds (ETFs) are a good place to begin investing in any market environment, including bull markets.""}, {""date"": ""2023-03-22"", ""headline"": ""Johnson & Johnson issues statement on Third Circuit review petition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""2 Stocks That Should Be Better Buys After Their Spinoffs This Year"", ""summary"": ""Two companies that are planning spinoffs this year that could become better businesses after that happens are\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Kellogg\u00a0(NYSE: K).  Johnson & Johnson has been a safe stock to own over the years.""}, {""date"": ""2023-03-22"", ""headline"": ""Johnson & Johnson put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""GLOBAL BRIEFING: Growth in Japan's private sector strengthens"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Tracking Al Gore's Generation Investment Management Portfolio - Q4 2022 Update"", ""summary"": ""Generation Investment Management\u00e2\u0080\u0099s 13F portfolio value increased from $16.86B to $17.32B this quarter. Click here to see an update on the portfolio for Q4 2022.""}, {""date"": ""2023-03-23"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.05% higher to $151.13 Thursday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-03-23"", ""headline"": ""Johnson & Johnson loses key tuberculosis drug patent in India"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Have $1,000? 2 Smart Stocks to Buy This Month"", ""summary"": ""While a volatile market continues to keep some investors on the sidelines, if you're putting your money into wonderful businesses in both good times and bad, you can prime your portfolio for more consistent returns over the long term.  Johnson & Johnson (NYSE: JNJ) has a lengthy history of delivering returns to shareholders over a wide range of markets and economic environments through its faithful dividend payments.  The last five years alone have seen J&J's dividend jump by more than 25%.""}, {""date"": ""2023-03-23"", ""headline"": ""My Top 10 Dividend Growth Stocks For March 2023"", ""summary"": ""In today\u00e2\u0080\u0099s article, I will present 10 dividend growth companies that I currently consider to be particularly attractive.""}, {""date"": ""2023-03-23"", ""headline"": ""3 Safe Dow Dividend Stocks to Buy Now"", ""summary"": ""You may have heard words like \""safe\"" or \""reliable\"" used to describe low-growth, stodgy dividend stocks.  The Dow Jones Industrial Average is chock-full of industry-leading companies that provide a pulse on the overall economy.  All but three of the 30 components pay a dividend, making the Dow a good place to look for prospective investments.""}, {""date"": ""2023-03-23"", ""headline"": ""'Oh my God': This secretary in Illinois built a $7M fortune starting with $180. Here's the one powerful technique that made Grace Groner rich \u2014 and can change your life too"", ""summary"": ""No lotto tickets required.""}, {""date"": ""2023-03-23"", ""headline"": ""Tracking Al Gore`s Generation Investment Management Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Wall Street Breakfast Podcast: Federal Reserve: Rate Hike, 'Additional Policy Firming'"", ""summary"": ""Nasdaq, S&P futures rebound from post-Fed slump as markets price in no more hikes. J&J turns to Supreme Court to OK unit bankruptcy plan for talc lawsuits. Coinbase receives Wells notice.""}, {""date"": ""2023-03-23"", ""headline"": ""Wall Street Breakfast Podcast: Federal Reserve: Rate Hike, `Additional Policy Firming`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""J&J, Abbvie`s Imbruvica gets expanded blood cancer indication in Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.01% to $152.65 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-24"", ""headline"": ""2 Dow Stocks To Watch Today"", ""summary"": ""Are these two dow stocks on your radar today?""}, {""date"": ""2023-03-24"", ""headline"": ""What young TikTok creators think about a possible ban: 'People will freak out'"", ""summary"": ""It\u2019s not just TikTok as a company that has a lot at stake right now. The people who are on TikTok the most, the influencers \u2014 also called creators \u2014 are also in the crosshairs.""}, {""date"": ""2023-03-24"", ""headline"": ""Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic Players"", ""summary"": ""The Indian Patent Office rejected Johnson and Johnson's (NYSE: JNJ) application to extend its patent on tuberculosis treatment, bedaquiline, beyond July 2023. The decision paves the way for the entry of cheaper generics by domestic players. Many such manufacturers have already expressed an interest in supplying the drug at more affordable prices under the WHO's pre-qualification program. Janssen, a subsidiary of J&J, filed for multiple patents on bedaquiline in India, not limiting itself to the""}, {""date"": ""2023-03-24"", ""headline"": ""U.S. Executives to Keep Low Profile at China Forum Amid Tensions"", ""summary"": ""Ahead of this weekend\u2019s high-level conference in Beijing, the mood among the global CEOs and senior executives expected to attend was a mix of anxiety and caution.""}, {""date"": ""2023-03-24"", ""headline"": ""Study Shows 186 Banks Are On The Brink Of Failure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""TD Cowen medical devices analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Fate Therapeutics: If You Are Comparing With Geron, Do It Thoroughly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-25"", ""headline"": ""Who Are Pfizer's (PFE) Main Competitors?"", ""summary"": ""Pfizer's biggest competitors in the global pharmaceutical industry are Johnson & Johnson, Roche, Eli Lilly, AbbVie, Novo Nordisk, and Merck.""}, {""date"": ""2023-03-25"", ""headline"": ""Better Buy: AbbVie vs. Johnson & Johnson"", ""summary"": ""AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year.  After all, these stocks offer a track record of earnings growth and dividend increases.  The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.""}]",{}
11,2023-03-26,149.21983337402344,2023-04-02,151.51702880859375,0.015394705801690112,U2,"[{""date"": ""2023-03-27"", ""headline"": ""Top 5 \""Forever\"" Stocks To Buy In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-27"", ""headline"": ""3 Blue-Chip Stocks to Buy for Stability and Safety"", ""summary"": ""An excellent way to find stocks to buy is by examining the holdings of exchange-traded funds (ETFs) that focus on the subject matter you\u2019re interested in. In this case, safe blue-chip stocks. Investopedia defines blue-chip stocks as follows: \u201cThese are typically large, well-established, and financially sound companies that have operated for many years and that have dependable earnings, often paying dividends to investors.\u201d So, if you want to invest in a blue-chip healthcare company, Johnson & Jo""}, {""date"": ""2023-03-27"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $153.30, marking a +0.43% move from the previous day.""}, {""date"": ""2023-03-27"", ""headline"": ""UPDATE 1-Caligan pushes ahead with board challenge at Anika, nominates two directors"", ""summary"": ""Activist investor Caligan Partners has nominated two director candidates to Anika Therapeutics' seven member board, according to a regulatory filing on Monday, signaling plans to push ahead with a board challenge at the biotechnology company.  The investment firm, which owns a roughly 4% stake and is one of Anika's 10 biggest shareholders, named former Johnson & Johnson executive Gary Fischetti and former healthcare technology executive and experienced board member James Hogan as its candidates, according to the filing.""}, {""date"": ""2023-03-27"", ""headline"": ""Caligan pushes ahead with board challenge at Anika, nominates two directors"", ""summary"": ""Activist investor Caligan Partners has nominated two director candidates to Anika Therapeutics' seven member board, according to a regulatory filing on Monday, signaling plans to push ahead with a board challenge at the biotechnology company.  The investment firm, which owns a roughly 4% stake and is one of Anika's 10 biggest shareholders, named former Johnson & Johnson executive Gary Fischetti and former healthcare technology executive and experienced board member James Hogan as its candidates, according to the filing.""}, {""date"": ""2023-03-27"", ""headline"": ""Johnson & Johnson stock rises Monday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.43% higher to $153.30 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-03-27"", ""headline"": ""11 Best Counter Cyclical Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best counter cyclical stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Counter Cyclical Stocks To Buy Now. A counter cyclical stock is a term used to describe the shares of a company that operates in an industry or sector [\u2026]""}, {""date"": ""2023-03-27"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2023-03-27"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Eli Lilly & Co (LLY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""J&J unveils long-term data on Rybrevant for non-small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Diversity And Inclusion - An Investor`s Handbook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""7 Dividend Aristocrats to Buy for Consistent Income Growth"", ""summary"": ""I\u2019d argue there\u2019s never been a better time to consider investing in dividend aristocrats. Volatility remains very high in the overall market, with a destabilized banking sector. Additionally, inflation has proven to be anything but transitory. In short, dividend aristocrats, with their larger size and liquidity requirements and 25+ years of successive increasing payments, are generally about as solid as investments can be. Investors who buy into this group will receive consistent income growth,""}, {""date"": ""2023-03-28"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.97% to $151.82 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-28"", ""headline"": ""Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?"", ""summary"": ""These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.""}, {""date"": ""2023-03-28"", ""headline"": ""WHO updates COVID vaccine guidance; low priority for children and adolescents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Selecting Dividend Aristocrats Using SCHD Methodology - Mounting A Comeback"", ""summary"": ""I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. Read more here.""}, {""date"": ""2023-03-28"", ""headline"": ""It's a Mistake to Ignore the Growth Potential of These 3 Dividend Stocks"", ""summary"": ""Many dividend stocks have fallen out of favor over the past year as rising interest rates made certificates of deposit, bonds, and T-bills more attractive options for income investors.  Many dividend investors love Coca-Cola for three reasons: It runs an evergreen business; it's a Dividend King, having raised its payout annually for 61 consecutive years, and it pays an attractive forward dividend yield of about 3.1%.""}, {""date"": ""2023-03-28"", ""headline"": ""Virtual Incision Expands Leadership Team as it Prepares for New Market Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Inverse Jim Cramer Strategy - Q1 2023"", ""summary"": ""We provide an update on our Inverse Jim Cramer strategy by taking a look at results of his top stock picks for first three months of 2023. Click here to read more.""}, {""date"": ""2023-03-28"", ""headline"": ""argenx sells global rights for cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Johnson & Johnson initiated with a Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $2,226.00K"", ""summary"": """"}, {""date"": ""2023-03-29"", ""headline"": ""J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out"", ""summary"": ""Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.""}, {""date"": ""2023-03-29"", ""headline"": ""Best Blue Chip Stocks To Invest In Right Now? 3 To Know"", ""summary"": ""Three blue chip stocks to watch today.""}, {""date"": ""2023-03-29"", ""headline"": ""J&J bows out of RSV vaccine race after scrapping trial"", ""summary"": ""Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.""}, {""date"": ""2023-03-29"", ""headline"": ""FHLC: Aging U.S. Demographics Should Boost This Health Care ETF"", ""summary"": ""Healthcare is considered a defensive sector that should outperform during times of high inflation, weak economic growth, and challenging markets. Read more about FHLC ETF here.""}, {""date"": ""2023-03-29"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $153.31 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-03-29"", ""headline"": ""UPDATE 4-J&J bows out of RSV vaccine race after scrapping trial"", ""summary"": ""Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.  J&J made the decision in order \""to focus on medicines with the greatest potential benefit to patients,\"" the company said on Wednesday.  The drugmaker, which started the global study in 2021 in more than 27,000 adults aged 60 years and older, did not provide any further details about the trial.""}, {""date"": ""2023-03-29"", ""headline"": ""UPDATE 3-J&J bows out of RSV vaccine race after scrapping trial"", ""summary"": ""Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.""}, {""date"": ""2023-03-29"", ""headline"": ""J&J to stop late-stage RSV vaccine trial"", ""summary"": ""Johnson & Johnson's pharmaceutical unit said on Wednesday it will discontinue its late-stage study of its experimental respiratory syncytial virus (RSV) adult vaccine as part its strategic choice for its research and development investments. (Reporting by Leroy Leo in Bengaluru...""}, {""date"": ""2023-03-29"", ""headline"": ""J&J backs out of RSV vaccine race with rivals Pfizer and GSK "", ""summary"": ""J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month. ""}, {""date"": ""2023-03-29"", ""headline"": ""UBS Initiates Coverage of Johnson & Johnson (JNJ) with Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-03-29"", ""headline"": ""Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows"", ""summary"": ""Blue chip stocks can be ideal investments to buy and hold for decades.  A couple of stocks that have been falling recently and that are near multi-year lows are Johnson & Johnson (NYSE: JNJ) and Home Depot (NYSE: HD).  If you have enough in savings and can afford to invest $5,000, here's why you should consider buying shares of one or even both of these stocks.""}, {""date"": ""2023-03-29"", ""headline"": ""J&J`s Janssen discontinues RSV adult vaccine program"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?"", ""summary"": ""Curious about the \""dogs of the Dow\"" in 2023? Here's what's happening in the darkest corner of Wall Street's most exclusive club.""}, {""date"": ""2023-03-29"", ""headline"": ""Johnson & Johnson drops RSV vaccine program"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Johnson & Johnson assumed with a Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""STAAR Surgical names Warren Foust COO, Magda Michna, as chief of medical affairs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Diversity And Inclusion - An Investor's Handbook"", ""summary"": ""DEI is sometimes viewed as a 'softer' policy topic that doesn\u00e2\u0080\u0099t factor into investor outcomes. We think that\u00e2\u0080\u0099s a mistake.""}, {""date"": ""2023-03-30"", ""headline"": ""Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.08% higher to $153.43 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-03-30"", ""headline"": ""The 3 Best Stocks to Buy if You Want to Retire Early"", ""summary"": ""There are many ways to retire early, but the easiest path starts with finding the best stocks for early retirement. The magic of compound interest means those who want their golden years to start a little earlier just need to get their money into the market as soon as possible, and let time do the rest. The S&P 500\u2019s annual return comes in at 8.5% when adjusted for inflation, meaning investors could dump their money into an index fund and call it a day. But picking the right stocks can bump that""}, {""date"": ""2023-03-30"", ""headline"": ""2 Unstoppable Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has garnered a few distinctions over the years that have set it aside from many fellow healthcare stocks, not to mention stocks in general.  It has an extremely long-standing track record of not only paying out but raising its dividend, which currently yields around 3%.  In fact, the company has raised its dividend every single year for six decades and counting, a period in which it's seen more than a few economic storms and cycles.""}, {""date"": ""2023-03-30"", ""headline"": ""Equity Income Funds See Outflows as Bond Yields Rise"", ""summary"": ""For the week ended March 22, U.S. Lipper equity income funds had a net outflow of $1.5 billion, the largest move in that direction since December 2021,...""}, {""date"": ""2023-03-30"", ""headline"": ""11 Best Dow Jones Dividend Stocks According to Hedge Funds"", ""summary"": ""In this article, we discuss 11 best Dow Jones dividend stocks according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Dow Jones Dividend Stocks According to Hedge Funds. The Dow Jones Industrial Average, or DJIA, is a stock market [\u2026]""}, {""date"": ""2023-03-30"", ""headline"": ""JNJ September 15th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""8 Defensive Dividend Stars That Could Help You Retire Rich"", ""summary"": ""This article presents 8 stocks having fantastic conservative dividend growth characteristics suitable to help one to reach financial goals. Read more here.""}, {""date"": ""2023-03-30"", ""headline"": ""11 Stocks: 9 Dividend Payers 2 For Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-31"", ""headline"": ""Johnson & Johnson, Procter & Gamble Among 11 Companies To Continue Dividend Growth In Early April"", ""summary"": ""Eleven companies announced annual dividend increases in March. Colgate-Palmolive started its 7th decade of dividend growth in March with a 2% boost. Read more here.""}, {""date"": ""2023-03-31"", ""headline"": ""Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal"", ""summary"": ""A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolve tens of thousands of lawsuits over its talc products.""}, {""date"": ""2023-03-31"", ""headline"": ""3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio"", ""summary"": ""The start of a bull market is a good time to look for dividend stocks to buy. Is this the start of a new one? It could be, but we still have plenty of issues to sort through. For that reason, among many others, investors are still going to be on the hunt for the best dividend stocks to buy. Specifically, they\u2019ll constantly be looking for names to build an income-based portfolio with. Whether they consider themselves growth investors, tech investors, value investors or income-oriented investors,""}, {""date"": ""2023-03-31"", ""headline"": ""UPDATE 2-Johnson & Johnson unit loses bid to stay in bankruptcy during Supreme Court appeal"", ""summary"": ""A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the company's planned Supreme Court appeal to use bankruptcy to resolve tens of thousands of lawsuits over its talc products.  J&J sought to use the bankruptcy of its subsidiary company, LTL Management, to halt more than 38,000 lawsuits alleging the company's Baby Powder and other talc products are contaminated with asbestos.  J&J maintains its consumer talc products are safe and asbestos-free.""}, {""date"": ""2023-03-31"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.02% to $155.00 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-31"", ""headline"": ""Buy Johnson & Johnson Stock and Its 3% Dividend Yield?"", ""summary"": ""Johnson & Johnson stock in Q1 declined for nine straight weeks. Is that the selloff that long investors had been waiting for?""}, {""date"": ""2023-03-31"", ""headline"": ""Johnson & Johnson (JNJ) Could Be a Great Choice"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-03-31"", ""headline"": ""My Top 10 High Dividend Yield Stocks To Invest In April 2023"", ""summary"": ""In today\u00e2\u0080\u0099s article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. Read more here.""}, {""date"": ""2023-04-01"", ""headline"": ""3 Surprisingly Underrated Stocks to Buy in April"", ""summary"": ""Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out.  Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use.  The company's stock is down by 19% since the start of the year.""}, {""date"": ""2023-04-01"", ""headline"": ""Confounded's Complete All-Weather Portfolio Revealed"", ""summary"": ""Most readers follow my work for the extensive writing I have done referencing my aggressive growth portfolio. Read more here.""}, {""date"": ""2023-04-01"", ""headline"": ""Confounded`s Complete All-Weather Portfolio Revealed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-02"", ""headline"": ""Could This Move by Johnson & Johnson Equal Billions for Moderna?"", ""summary"": ""What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)?  Last week, however, Johnson & Johnson said it would discontinue its adult RSV program.  Could the J&J news eventually translate into billions of dollars for Moderna?""}]",{}
12,2023-04-02,151.51702880859375,2023-04-09,161.43893432617188,0.06548376506321363,U5+,"[{""date"": ""2023-04-02"", ""headline"": ""Noteworthy Monday Option Activity: JNJ, OKTA, IBM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-02"", ""headline"": ""Could This Move by Johnson & Johnson Equal Billions for Moderna?"", ""summary"": ""What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)?  Last week, however, Johnson & Johnson said it would discontinue its adult RSV program.  Could the J&J news eventually translate into billions of dollars for Moderna?""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson spikes over 3% after nearly $9B settlement on talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson Offers to Pay $8.9B in Bankruptcy Filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson stock up 3% as company sets aside $8.9 billion to settle talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""J&J unit refiles for bankruptcy over talc litigation; offers to pay $8.9B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""J&J to pay $8.9B to resolve current and future talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""9 Upcoming Dividend Increases In April 2023"", ""summary"": ""Dividends are the foundation of our goal to reach financial freedom. We continuously invest in dividend growth stocks to grow our passive income.""}, {""date"": ""2023-04-03"", ""headline"": ""JNJ weighs second bankruptcy to halt talc-related cancer suits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval"", ""summary"": ""Novartis (NVS) receives a positive opinion from the CHMP for Entresto (sacubitril/valsartan) for a new indication in pediatric patients.""}, {""date"": ""2023-04-03"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?"", ""summary"": ""The Dow Jones Industrial Average managed to post a small gain in the first quarter of 2023.  Let's take a closer look at the three worst-performing stocks in the Dow Jones Industrials through the end of March (in reverse order of performance) to see if any of them are worth buying.  Honeywell\u00a0(NASDAQ: HON), like other industrial companies, has struggled on both sides of the income statement, facing weakening demand and rising costs due to inflation.""}, {""date"": ""2023-04-03"", ""headline"": ""6 Reasons To Consider Johnson & Johnson Stock"", ""summary"": ""The Abiomed acquisition enhances Johnson & Johnson\u00e2\u0080\u0099s positioning and could be earnings accretive next year. Click here to read my analysis of JNJ stock.""}, {""date"": ""2023-04-03"", ""headline"": ""Tesla, Disney and Nvidia Join 7 Others Showing Unusual Options Activity"", ""summary"": """"}, {""date"": ""2023-04-03"", ""headline"": ""3 Dow Stocks With Above-Average Dividends Yields to Buy in April"", ""summary"": ""Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.""}, {""date"": ""2023-04-03"", ""headline"": ""3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now"", ""summary"": ""Now that it's down 14% from a highwater mark it set way back in 2021, a strong recovery for the S&P 500 could be in the cards for later this spring.  Then again, the next big market recovery might not get started until 2024 or even later.  Nobody can predict when the market will reach its next major upswing, but investors who buy the benchmark index's top stocks when they're trading at depressed prices could realize market-beating gains once market conditions improve.""}, {""date"": ""2023-04-03"", ""headline"": ""J&J launches once-daily Erleada for prostate cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""3 Warren Buffett Stocks That Are No-Brainer Buys in April"", ""summary"": ""Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now.""}, {""date"": ""2023-04-03"", ""headline"": ""OUSA: An ETF Focused On Capital Preservation"", ""summary"": ""O\u00e2\u0080\u0099Shares FTSE U.S. Quality Dividend ETF's low yield can\u00e2\u0080\u0099t satisfy income-seeking investors, but high quality and low volatility may help preserve the capital in a bear market""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson: Don't Run As It's Time To Be Greedy"", ""summary"": ""Johnson & Johnson's fundamental thesis remains sound, and its business model generates significant FCF profitability. Read why I assign a buy rating to JNJ stock.""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson: Don`t Run As It`s Time To Be Greedy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Surviving Inflation: 5 Perfect Dividend Stocks To Get The Job Done"", ""summary"": ""Inflation will remain sticky causing policymakers in the US and EU to prepare the market for more hikes. Read about five dividend stocks to beat inflation when it matters most.""}, {""date"": ""2023-04-03"", ""headline"": ""Morgan Stanley Keeps Their Hold Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""Johnson & Johnson: Negative Alpha Likely Ahead"", ""summary"": ""Johnson & Johnson's talc lawsuit issues continue. Looming loss of exclusivity on JNJ's top drug can drag revenues. Read why JNJ stock is a Hold.""}, {""date"": ""2023-04-03"", ""headline"": ""A March ~6% Gain In My 25 Stock $417k Portfolio Beats The Market For The Third Time In 2023"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Click here for a detailed analysis.""}, {""date"": ""2023-04-04"", ""headline"": ""Dow Jones Futures: AI Stock Keeps Sliding; Johnson & Johnson Rises"", ""summary"": ""Futures: The indexes held up OK Tuesday amid recession fears, but breadth was weak. AI stock C3.ai kept falling overnight. J&J stock rose..""}, {""date"": ""2023-04-04"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J`s proposal to settle talc lawsuits for $8.9 billion sends stock up the most in more than a year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J proposes USD8.9 billion settlement of talc cancer claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""GLOBAL BRIEFING: Growth in Japan's services sector accelerates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J unit files for second bankruptcy to pursue $8.9 billion talc settlement"", ""summary"": ""Johnson & Johnson has agreed to pay $8.9 billion to settle tens of thousands of lawsuits alleging that talc in its iconic Baby Powder and other products caused cancer, the company said. The amount dwarfs J&J\u2019s original offer of $2 billion.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J\u2019s sweetened talc settlement still unsettling"", ""summary"": ""Johnson & Johnson is trying a little harder to settle claims that its talc harmed users. The $494 billion healthcare company said Tuesday night that it will offer plaintiffs a $9 billion pot after it put liabilities associated with talc into a subsidiary that filed for bankruptcy...""}, {""date"": ""2023-04-04"", ""headline"": ""3M's bid to shield itself from earplug lawsuits faces skeptical judges"", ""summary"": ""Federal appeals court judges on Tuesday appeared skeptical of 3M's bid to use the bankruptcy of its subsidiary Aearo Technologies to shield itself from nearly 260,000 lawsuits over allegedly defective military-issue earplugs.""}, {""date"": ""2023-04-04"", ""headline"": ""UPDATE 1-3M's bid to shield itself from earplug lawsuits faces skeptical judges"", ""summary"": ""Federal appeals court judges on Tuesday appeared skeptical of 3M's bid to use the bankruptcy of its subsidiary Aearo Technologies to shield itself from nearly 260,000 lawsuits over allegedly defective military-issue earplugs.  Paul Clement, a lawyer for Aearo, urged a three-judge panel of the 7th U.S. Circuit Court of Appeals in Chicago to reverse a bankruptcy court order allowing the lawsuits to move forward against 3M, even though Aearo is bankrupt.  Clement argued bankruptcy law's so-called \""automatic stay,\"" which shields Aearo from lawsuits while it is bankrupt, should apply to 3M as well, because there is \""complete overlap\"" between the facts and legal defenses in earplug lawsuits against the two companies.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson proposes $8.9bn talc settlement"", ""summary"": ""Johnson & Johnson has proposed an $8.9bn settlement to resolve tens of thousands of lawsuits alleging its talcum powder caused cancer, in an attempt to resolve long-running litigation that has weighed on the healthcare products company.  The proposed deal follows a decade-long legal battle between plaintiffs\u2019 lawyers and J&J.  If approved, it would become the largest product liability settlement in bankruptcy history, according to lawyers involved in the case.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J proposes paying $8.9B to settle talcum powder lawsuits"", ""summary"": ""Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability.  Under a proposal announced Tuesday, a J&J subsidiary will re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history.  The $8.9 billion that J&J would transfer to the subsidiary, LTL Management, would be payable over the next 25 years.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $158.49, moving +1.05% from the previous trading session.""}, {""date"": ""2023-04-04"", ""headline"": ""Dow Jones Falls On Recession Fears; AI Stock Crashes, Many Groups Sell Off"", ""summary"": ""The major indexes retreated Tuesday on recession fears. Megacaps held up, but market breadth was anemic, with many big losers. AI stock C3.ai dived on short-seller claims.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J to Pay $8.9 Billion to Settle Talc-Cancer Lawsuits"", ""summary"": ""(Bloomberg) -- Johnson & Johnson said it agreed to pay $8.9 billion to resolve all cancer lawsuits tied to its talc-based powders and will make a fresh attempt to contain the liability within a bankruptcy filing by one of its units. Most Read from BloombergWarner Bros. Nears Deal for Harry Potter Online TV SeriesChina\u2019s Yuan Replaces Dollar as Most Traded Currency in RussiaJamie Dimon Warns US Banking Crisis Will Be Felt for YearsGoogle Wants You to Never Overpay for a Flight AgainStocks Halt Wi""}, {""date"": ""2023-04-04"", ""headline"": ""UPDATE 1-J&J unit files for second bankruptcy to pursue $8.9 billion talc settlement"", ""summary"": ""A Johnson & Johnson subsidiary filed for bankruptcy a second time on Tuesday, seeking to complete a $8.9 billion settlement of lawsuits alleging that its baby powder and other talc products cause cancer.  J&J subsidiary LTL Management's first bankruptcy was dismissed earlier on Tuesday, after an appellate court ruled that the neither J&J not LTL were in the type of \""financial distress\"" that made them eligible for bankruptcy.  The new bankruptcy filing includes a proposal to pay $8.9 billion over 25 years to resolve all current and future talc claims, according to J&J. The settlement is supported by over 60,000 current claimants, J&J said in a statement.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson to Settle Talc Claims for $8.9 Billion. The Stock Is Jumping."", ""summary"": ""In a press release, the company said that its subsidiary, LTL Management, would refile for bankruptcy protection.""}, {""date"": ""2023-04-04"", ""headline"": ""J&J unit goes bankrupt a second time to pursue $8.9 bln talc settlement"", ""summary"": ""A Johnson & Johnson subsidiary filed for bankruptcy a second time on Tuesday, seeking to complete a $8.9 billion settlement of lawsuits alleging that its baby powder and other talc products cause cancer. (Reporting by Dietrich Knauth; editing by Jonathan Oatis)""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson Subsidiary LTL Management LLC (\""LTL\"") Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims"", ""summary"": ""NEW BRUNSWICK, N.J., April 04, 2023--Johnson & Johnson (NYSE:JNJ) (the Company) today announced that its subsidiary LTL Management LLC (LTL) has re-filed for voluntary Chapter 11 bankruptcy protection to obtain approval of a reorganization plan that will equitably and efficiently resolve all claims arising from cosmetic talc litigation against the Company and its affiliates in North America. To that end, the Company has agreed to contribute up to a present value of $8.9 billion, payable over 25""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson offers record $8.9B talcum powder settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""REFILE-3M's bid to shield itself from earplug lawsuits faces skeptical judges"", ""summary"": ""Federal appeals court judges on Tuesday appeared skeptical of 3M's bid to use the bankruptcy of its subsidiary Aearo Technologies to shield itself from nearly 260,000 lawsuits over allegedly defective military-issue earplugs.  Paul Clement, a lawyer for Aearo, urged a three-judge panel of the 7th U.S. Circuit Court of Appeals in Chicago to reverse a bankruptcy court order allowing the lawsuits to move forward against 3M, even though Aearo is bankrupt.  Clement argued bankruptcy law's so-called \""automatic stay,\"" which shields Aearo from lawsuits while it is bankrupt, should apply to 3M as well, because there is \""complete overlap\"" between the facts and legal defenses in earplug lawsuits against the two companies.""}, {""date"": ""2023-04-04"", ""headline"": ""Exclusive-Johnson & Johnson considers refiling talc-liability bankruptcy after appeals-court defeat"", ""summary"": ""Johnson & Johnson is exploring the idea of placing a subsidiary shouldering tens of thousands of talc lawsuits into bankruptcy proceedings for a second time, despite a January federal appeals court decision invalidating the so-called Texas two-step legal maneuver, according...""}, {""date"": ""2023-04-04"", ""headline"": ""Stock futures rise slightly after Dow, S&P 500 snap four-day win streaks: Live updates"", ""summary"": ""Broader economic concerns weighed on the major benchmarks during the regular trading session Tuesday. ""}, {""date"": ""2023-04-04"", ""headline"": ""Nachawati Law Group: Victims, Johnson & Johnson Reach Multibillion-Dollar Resolution of Talc-Cancer Lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson subsidiary files for bankruptcy again to deal with talc claims"", ""summary"": ""By Yasin Ebrahim""}, {""date"": ""2023-04-04"", ""headline"": ""J&J Considers\u00a0New Bankruptcy Case to Stop Cancer Suits, Lawyers Say"", ""summary"": ""(Bloomberg) -- Johnson & Johnson has threatened to file a new bankruptcy case to try to settle more than 40,000 cancer lawsuits, lawyers for people suing the company said in a court filing. Most Read from BloombergWarner Bros. Nears Deal for Harry Potter Online TV SeriesChina\u2019s Yuan Replaces Dollar as Most Traded Currency in RussiaBernard Arnault\u2019s Fortune Soars Past $200 Billion for First TimeRead the New York Felony Indictment Against TrumpJamie Dimon Warns US Banking Crisis Will Be Felt for Y""}, {""date"": ""2023-04-04"", ""headline"": ""IN BRIEF: J&J subsidiary re-files for bankruptcy amid talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson advanced 1.05% to $158.49 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson stock up nearly 3% after talc-litigation unit re-files for bankruptcy"", ""summary"": ""Johnson & Johnson stock rose nearly 3% in the extended session Tuesday after the company said that its subsidiary LTL Management LLC has re-filed for...""}, {""date"": ""2023-04-04"", ""headline"": ""J&J will pay $8.9 billion to settle claims cosmetic talc products caused cancer"", ""summary"": ""Johnson & Johnson said it would pay an $8.9 billion settlement over claims that its talc-based baby powder caused cancer.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson Subsidiary LTL Management LLC (\u201cLTL\u201d) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""3 Top Healthcare Stocks to Buy for April"", ""summary"": ""Eli Lilly's (NYSE: LLY) shares are down 4% this year (after falling as much as 15% at one point last month), while Johnson & Johnson (NYSE: JNJ) stock has fallen over 12%, and Merck (NYSE: MRK) is down 2% in 2023.  While earnings per share (EPS) were up 13% from the previous year, to $6.90, the company's revenue was up only 1% to $28.5 billion.  The company now has 10 therapies with strong growth potential, led by diabetes drug Mounjaro.""}, {""date"": ""2023-04-04"", ""headline"": ""Beasley Allen/Arnold & Itkin Law Firms: On Eve of J&J Bankruptcy Dismissal, Cancer Victims Prepare to Enter Civil Court System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Biogen names Adam Keeney to head corporate development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson: Still One Of The More Expensive Pharmaceutical Companies"", ""summary"": ""Johnson & Johnson remains as one of the more expensive pharmaceutical companies. Click here to see our take on JNJ stock.""}, {""date"": ""2023-04-04"", ""headline"": ""12 Best Dow Stocks To Buy Right Now"", ""summary"": ""In this article, we will take a look at 12 best Dow stocks to buy right now. If you want to see some more of the best Dow stocks to buy, go directly to the 5 Best Dow Stocks To Buy Right Now. The Dow Jones Industrial Average (DJIA) is a widely recognized stock market [\u2026]""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson: A Huge Opportunity In A Blue-Chip Dividend King"", ""summary"": ""Johnson & Johnson has long been known for its safety, consistency, and dividend growth. See how talc powder lawsuits have added opportunity for JNJ investors.""}, {""date"": ""2023-04-04"", ""headline"": ""3 Dow Stocks That Are Screaming Buys in April"", ""summary"": ""In 2021, corrections were pretty much nowhere to be found, with access to cheap capital sending growth stocks \""to the moon.\""  Whereas the Nasdaq Composite plummeted 33% in 2022, the Dow Jones bounced back to end lower by just 9%.  The reason the Dow has outperformed its peers is because it's packed with 30 generally profitable, mature, multinational businesses.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson's Dividends Not Compensating For Lagging Price Movements"", ""summary"": ""Johnson & Johnson has greatly lagged the broad S&P index, while dividends have remained decent. Check out my recommendation for JNJ stock.""}, {""date"": ""2023-04-04"", ""headline"": ""3 Dividend Aristocrats That Generate Income For Life"", ""summary"": ""When I retire, I plan to live off an income portfolio of at least $1 million. Find out 3 of my favorite dividend aristocrats that are part of my portfolio.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson talc settlement to alleviate overhang, says Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson`s Dividends Not Compensating For Lagging Price Movements"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Johnson & Johnson sets aside $8.9 billion to settle talc claims; stock up 3%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Analysts` Top Healthcare Picks: Johnson & Johnson (JNJ), AbbVie (ABBV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson wins reimbursement for Rybrevant cancer therapy in Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""WHO chief expects COVID emergency to end this year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Markets Mixed Following Private Sector Jobs Report"", ""summary"": ""U.S. equities were mixed following a report from ADP showing the private sector added fewer jobs than expected in February, increasing concerns about a slowdown in economic growth.""}, {""date"": ""2023-04-05"", ""headline"": ""The 3 Most Undervalued Warren Buffett Stocks to Buy in April 2023"", ""summary"": ""It\u2019s a great time to be looking at undervalued Warren Buffett stocks. With inflation, geopolitical crises, and a potential recession all causing economic uncertainty, investors are seeking safe investments with a strong margin of safety. And few investors have proven more capable of finding these sorts of investments than Warren Buffett. His holding company, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), has generated one of the most impressive track records in financial history. And Buffett is p""}, {""date"": ""2023-04-05"", ""headline"": ""The 3 Most Undervalued Blue-Chip Stocks to Buy in April 2023"", ""summary"": ""In good markets and bad, investors are always scouring for a good deal in the stock market. In bull markets, it\u2019s easier to pick top-performing growth stocks. In bear markets, we have to dig a bit deeper and seek out high-quality companies. That\u2019s got investors looking for the most undervalued blue-chip stocks. Blue-chip stocks are often on investors\u2019 radar because they tend to perform well over long stretches of time. The hope is that these stocks keep pace or exceed the performance of the SP""}, {""date"": ""2023-04-05"", ""headline"": ""These Stocks Moved the Most Today: C3.ai, Western Alliance, Albemarle, Tesla, and More"", ""summary"": ""C3.ai fell sharply for a second day after a short seller alleges accounting issues at the artificial intelligence software company, and Western Alliance tumbled after issuing a business update without providing an exact deposit balance.""}, {""date"": ""2023-04-05"", ""headline"": ""Why Johnson & Johnson Stock Was Climbing Today"", ""summary"": ""The healthcare giant reached a $8.9 billion settlement over allegations that its baby powder caused cancer.""}, {""date"": ""2023-04-05"", ""headline"": ""Look to 3 'great American companies' in this market, Jim Cramer says"", ""summary"": ""There are three companies that Cramer thinks have compelling stories and strength: Johnson & Johnson, Eli Lilly, and Procter & Gamble.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J\u2019s $8.9 Billion Agreement Doesn\u2019t Mean its Talc Worries Are Over"", ""summary"": ""Legal experts are uncertain about the fate of Johnson & Johnson's latest effort to settle with plaintiffs who claim its talc products caused cancer.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson: talc settlement shows virtues of Chapter 11 process"", ""summary"": ""To paraphrase Winston Churchill, Chapter 11 bankruptcy is the worst way of resolving product liability \u2014 except for all the others.  Late on Tuesday, an affiliate of Johnson & Johnson filed for bankruptcy protection.  A federal appeals court said the bankruptcy process could not be used by an enterprise that was not facing \u201cfinancial distress\u201d.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson's Rally Does Not Move the Needle"", ""summary"": ""It will take more than the company's potential talc litigation settlement to reverse the stock's downward path the past 12 months.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J Shares Rise on Deal for $9 Billion Settlement"", ""summary"": ""J&J shares climbed after announcing a $9 billion agreement with thousands of plaintiffs over accusations its baby powder and other talc products caused cancer.""}, {""date"": ""2023-04-05"", ""headline"": ""Health Care Up as J&J Rallies -- Health Care Roundup"", ""summary"": ""Health-care companies rose after Johnson &amp; Johnson divulged a historic settlement to the long-simmering talcum-powder litigation. J&J plans to pay at...""}, {""date"": ""2023-04-05"", ""headline"": ""2 Cheap Dividend Aristocrats Using The GGM Model"", ""summary"": ""Two of my favorite current dividend plays yielding near 3%. Both are dividend aristocrats/kings and on sale. Click here to read my most recent analysis.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson rose 4.49% to $165.61 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-04-05"", ""headline"": ""J&J\u2019s First Attempt to Escape Cancer Claims With Bankruptcy Failed. Now It\u2019s Trying Again"", ""summary"": ""(Bloomberg) -- Johnson & Johnson\u2019s first attempt at using bankruptcy to escape claims that its popular baby powder caused cancer was an expensive gamble that drew public scorn and ended in failure. Most Read from BloombergUBS Chairman\u2019s Top-Secret Prep Paid Off in Credit Suisse MomentWarner Bros. Nears Deal for Harry Potter Online TV SeriesTop Tax Mistakes to Avoid If You Make More Than $100,000Wall Street Shuns Risk as Recession Talk Ramps Up: Markets WrapThe Final Mission for a California Mili""}, {""date"": ""2023-04-05"", ""headline"": ""J&J rises as $9 billion talc lawsuit settlement eases overhang on unit spinoff"", ""summary"": ""Johnson & Johnson's shares rose nearly 4% in early trading to hit a near two-month high of $164.48 on Wednesday as the company's $8.9 billion offer to settle talc-related lawsuits gained support of thousands of claimants, easing an overhang on its plans to list consumer...""}, {""date"": ""2023-04-05"", ""headline"": ""NEW YORK MARKET CLOSE: Growth fears send Nasdaq lower for third day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""How major US stock indexes fared Wednesday 4/5/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""FedEx, Conagra rise; Schnitzer Steel, Simply Good Foods fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Dow Jones Rises, Nasdaq Falls As Investors Pour Into Gold; Health Care Stock Breaks Out"", ""summary"": ""Johnson & Johnson raised its proposed combined settlement for thousands of talc cancer cases. Google's touts its AI chip model capabilities.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson Offers to Settle Talc Claims for $8.9 Billion. The Stock Is Jumping."", ""summary"": ""Johnson & Johnson  stock was rising Wednesday after the company proposed a nearly $9 billion settlement over claims that its talcum powder causes cancer.  In a press release, Johnson & Johnson said that its subsidiary, LTL Management, would refile for bankruptcy protection and be funded with $8.9 billion over 25 years to cover talc liabilities.  \u201cImportantly, neither LTL\u2019s original filing nor this refiling is an admission of wrongdoing, nor an indication that the Company has changed its longstanding position that its talcum powder products are safe,\u201d the press release said.""}, {""date"": ""2023-04-05"", ""headline"": ""This portfolio manager\u2019s frugality and eye for income protected her fund from the worst of 2022\u2019s tumult"", ""summary"": ""Ramona Persaud manages the Fidelity Equity-Income Fund (FEQIX). The fund posted a total return of -5.07% in 2022, avoiding the worst of last year's turmoil.""}, {""date"": ""2023-04-05"", ""headline"": ""Dow Jones Rises But Big Tech Sells Off; Gold Holds At $2,000; Johnson & Johnson Settles Baby Powder Claims"", ""summary"": ""Johnson & Johnson raised its proposed combined settlement for thousands of talc cancer cases. Google's touts its AI chip model capabilities.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson Pops After Sweetening Its Talc Settlement By Nearly $7 Billion"", ""summary"": ""J&J reached an $8.9 billion settlement in ongoing litigation over its talc-based baby powders, leading JNJ stock to rise Wednesday.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J (JNJ) Offers $8.9B Settlement for Talc Cancer Lawsuits"", ""summary"": ""To completely resolve its cosmetic talc litigation, J&J (JNJ) offers a settlement amount of $8.9 billion payable over a period of 25 years.""}, {""date"": ""2023-04-05"", ""headline"": ""Midday movers: Johnson & Johnson, Conagra, FedEx and more"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson agrees to pay $8.9 billion to settle talc claims"", ""summary"": ""Yahoo Finance\u2019s Anjalee Khemlani joins the Live show to break down Johnson & Johnson\u2019s $8.9 billion talc settlement.""}, {""date"": ""2023-04-05"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""New private payroll jobs came in below expectation in March and shares of Johnson & Johnson are rising in pre-market trading after news of a settlement on legal claims over its talc products. Here\u2019s what investors need to know today.""}, {""date"": ""2023-04-05"", ""headline"": ""US STOCKS-Wall St eyes subdued open as private payrolls data deepens recession worries"", ""summary"": ""Wall Street's main indexes were set for a subdued open on Wednesday as weaker-than-expected private payrolls data for March deepened worries that the rapid interest rate hikes by the Federal Reserve may tip the U.S. economy into a recession.  Among stocks, Nvidia Corp fell 1.7% in premarket trade after Alphabet Inc's Google said the supercomputers it uses to train its artificial intelligence models were faster and more power-efficient than comparable systems from the chipmaker.""}, {""date"": ""2023-04-05"", ""headline"": ""Stocks making the biggest moves midday: Nvidia, Palantir, Western Alliance, Johnson & Johnson and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-04-05"", ""headline"": ""Better Dividend Stock: AbbVie vs. Johnson & Johnson"", ""summary"": ""The pharmaceutical industry is a great place to look for dividend stocks, and AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) are among the best.  Both drugmakers generally grow their dividends at a good clip, and both are part of the highly exclusive group of Dividend Kings, having raised their payouts for more than 50 years straight.  Let's look into both companies and decide.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J's on the Rise, but This Fintech Stock Is Falling Hard"", ""summary"": ""There's been plenty of volatility in the stock market lately, so many investors seem happy when they get an opportunity to take a break.  Things appeared to be relatively quiet Wednesday morning, as stock index futures were close to unchanged across the board.  Many market participants are waiting for more economic data, and the imminent beginning of earnings season next week will add a new perspective for those looking for direction in the stock market.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J talc resolution would remove overhang, says Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson, Merck share gains contribute to Dow's nearly 75-point climb"", ""summary"": ""Shares of Johnson & Johnson and Merck are posting positive growth Wednesday afternoon, lifting the Dow Jones Industrial Average into positive territory. The...""}, {""date"": ""2023-04-05"", ""headline"": ""2 Dividend Kings That Are Likely to Raise Their Payouts This Month"", ""summary"": ""Dividend Kings have excellent track records -- 50 years straight, in fact -- for increasing their payouts.  While dividend increases are never a guarantee, they are virtually a lock with these types of stocks.  Two companies in this elite group that investors should watch out for this month are Johnson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG).""}, {""date"": ""2023-04-05"", ""headline"": ""J&J rises as $8.9 bln talc lawsuit settlement eases overhang on consumer unit spinoff"", ""summary"": ""Johnson & Johnson's shares rose 3% before the bell on Wednesday as the company's $8.9 billion offer to settle talc-related lawsuits gained support of thousands of claimants, easing an overhang on its plans to list consumer health unit Kenvue.""}, {""date"": ""2023-04-05"", ""headline"": ""US STOCKS-Futures slip with focus on economic data amid recession worries"", ""summary"": ""U.S. stock index futures slipped on Wednesday as investors awaited a fresh batch of economic data, including a report on the labor market, amid worries that rapid interest rate hikes by the Federal Reserve could trigger a steep economic downturn.  Wall Street's main indexes ended lower in the previous session, with the benchmark S&P 500 snapping a four-day winning streak after a fall in U.S. job openings and factory orders added to evidence that the Fed's aggressive monetary tightening was starting to take a toll on the economy.  Focus will be on the ADP National Employment report before the opening bell on Wednesday.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson, Merck share gains contribute to Dow`s nearly 75-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Hold from Bernstein"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson shares rise after company proposes baby powder cancer settlement"", ""summary"": ""Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.\u00a0""}, {""date"": ""2023-04-05"", ""headline"": ""The Economy May Be Weakening. Here\u2019s What That Means for Interest Rate Hikes."", ""summary"": ""Johnson & Johnson offers $8.9 billion talc settlement, Trump pleads not guilty at New York arraignment, Nvidia and Micron fall on China chip complaints, and other news to start your day.""}, {""date"": ""2023-04-05"", ""headline"": ""Stocks Edge Lower, Johnson & Johnson Talc Settlement, Walmart Investor Day, FedEx Cost Cuts, C3.AI Slumps -Five Things To Know"", ""summary"": ""Stock futures edge lower as stagflation concerns clip sentiment; Johnson & Johnson shares gain on new talc settlement plans; Walmart slips lower as retailer confirms 2023 profit outlook ahead of investor day; FedEx to detail cost-cutting plans at drive program update and C3.Ai shares extend slump as short-seller alleges 'serious' accounting issues.""}, {""date"": ""2023-04-05"", ""headline"": ""Dow up nearly 100 points on gains for Johnson & Johnson, Amgen stocks"", ""summary"": ""The Dow Jones Industrial Average is climbing Wednesday morning with shares of Johnson & Johnson and Amgen leading the way for the index. Shares of Johnson &...""}, {""date"": ""2023-04-05"", ""headline"": ""J&J`s potential talc litigation settlement draws mostly positive Street reaction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""These Stocks Are Moving the Most Today: J&J, C3.ai, Walmart, Exelixis, Conagra, and More"", ""summary"": ""Johnson & Johnson proposes to pay at least $8.9 billion to settle claims that its talcum powder causes cancer, while C3.ai extends losses after a short-seller alleges accounting issues at the software company.""}, {""date"": ""2023-04-05"", ""headline"": ""InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J quadrupled its initial offer to settle cancer lawsuits over its talc-based baby powder"", ""summary"": ""Johnson & Johnson (J&J) is willing to pay $8.9 billion to settle tens of thousands lawsuits alleging its talc-based baby powder cause cancer\u2014an allegation the company continues to deny.""}, {""date"": ""2023-04-05"", ""headline"": ""Early notable gainers among liquid option names on April 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Unusually active option classes on open April 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Johnson & Johnson, FedEx and ConAgra Foods rise premarket; UBS falls"", ""summary"": ""By Peter Nurse""}, {""date"": ""2023-04-05"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""4 stocks to watch on Wednesday: FedEx, Exxon and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Wall Street Breakfast Podcast: Digital World Drops Amid Trump's Arraignment"", ""summary"": ""Trump SPAC Digital World drops amid former president's arraignment. Walmart aims to have about 65% of its stores serviced by automation by 2026 end. J&J unit refiles bankruptcy.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J\u2019s proposal to settle talc lawsuits for $8.9 billion sends stock up the most in more than a year"", ""summary"": ""Johnson & Johnson's stock rose more than 3% Wednesday to put it on track for its biggest percentage gain in more than a year.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J firmer on hopes for talc deal, but Western Alliance Bancorp slides as regional bank fears revive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""ADP, Eurozone PMIs, J&J settlement pitch - what's moving markets"", ""summary"": ""By Geoffrey Smith""}, {""date"": ""2023-04-05"", ""headline"": ""Wall Street Breakfast Podcast: Digital World Drops Amid Trump`s Arraignment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J`s talc litigation proposal is positive for stock and removes key overhang, say JPM analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Asian shares mostly fall amid worries about slowing economy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Wall Street slips following latest signs of slowing economy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""J&J talc re-filing settlement cost slightly better than Wells` expectation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""GILD - Chart Of The Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Why did Johnson & Johnson stock go up today? Renewed hope for talc settlements"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""My passive income stream grew by 22.63% in February and by 46.87% in March. Read more as I review my February and March results in this piece.""}, {""date"": ""2023-04-06"", ""headline"": ""JNJ, AbbVie plan to pull US accelerated approvals for some blood cancer treatments"", ""summary"": ""AbbVie Inc and partner Johnson & Johnson intend to voluntarily withdraw the accelerated approvals of their Imbruvica drug in the U.S. for patients with certain types of blood cancer, the companies said on Thursday.""}, {""date"": ""2023-04-06"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson sank 0.28% to $165.15 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-06"", ""headline"": ""Jim Cramer Has Reasons to Back These Two Stocks Despite the Negative Headlines"", ""summary"": ""CNBC's Jim Cramer has his finger on the business news pulse, and early Thursday he gave his prognosis for two big companies that have generated big headlines this week.  Cramer took to social media this morning to weigh in on the reported $8.9 billion settlement Johnson & Johnson  made to settle any potential litigation tied to its talcum powder product that allegedly causes cancer.  \""Many of the articles that question the proposed settlement between JNJ and the plaintiffs don't realize that the plaintiff's lawyers risk getting nothing if this Supreme Court gets its hands on the case,\"" Cramer tweeted.""}, {""date"": ""2023-04-06"", ""headline"": ""The 3 Best Bargain Stocks to Buy for April 2023"", ""summary"": ""We\u2019re at a weird place in the stock market. We\u2019re still well off the all-time highs in most stocks, but at the same time, the market has enjoyed a tremendous rally over the last three to six months. That\u2019s got investors wondering what the best bargain stocks are at this point. Put simply, investors want to put money to work when there\u2019s \u201cblood in the street.\u201d Or at least, that\u2019s what they ought to do, given the long-term bullish nature of the stock market. At the same time, no one wants to get s""}, {""date"": ""2023-04-06"", ""headline"": ""2 Elite Dividend Stocks That Won't Wilt in a Recessionary Environment"", ""summary"": ""Johnson & Johnson and Ford have resilient businesses, stellar dividend programs, and wide economic moats.""}, {""date"": ""2023-04-06"", ""headline"": ""My Dividend Growth Portfolio - Q1 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""JNJ May 26th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Unusually active option classes on open April 6th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Johnson & Johnson (JNJ) Soars 4.5%: Is Further Upside Left in the Stock?"", ""summary"": ""Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.""}, {""date"": ""2023-04-07"", ""headline"": ""Jim Cramer Bluntly Schools Stock-Buyers On 3 'Amazing American' Companies"", ""summary"": ""Jim Cramer, host of CNBC's Mad Money, recently discussed ways investors should handle navigating the current difficult market environment.  The U.S. companies Cramer enthusiastically discussed are Johnson & Johnson , Eli Lilly  and Procter & Gamble .  For example, several lawsuits involving Johnson & Johnson's talc powder had been damaging the company's stock price for years.""}, {""date"": ""2023-04-07"", ""headline"": ""2 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off"", ""summary"": ""A shaky stock market can discourage investors.  The healthcare industry is rapidly expanding, which should allow both of these companies to thrive for many years to come, resulting in regular passive income for investors.  Johnson & Johnson (NYSE: JNJ) is a well-known brand in the pharmaceutical and consumer goods market.""}, {""date"": ""2023-04-07"", ""headline"": ""VHT: Why Vanguard's Healthcare ETF Outperformed Last Week"", ""summary"": ""The Vanguard Health Care VHT ETF is an excellent defensively-oriented fund to hold during challenging economic times. Read about the fund's recent outperformance.""}, {""date"": ""2023-04-07"", ""headline"": ""VHT: Why Vanguard`s Healthcare ETF Outperformed Last Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-07"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q4 2022 Update"", ""summary"": ""Bridgewater Associates\u00e2\u0080\u0099 13F portfolio value decreased from ~$19.75B to ~$18.32B this quarter. Click here for a complete analysis.""}, {""date"": ""2023-04-07"", ""headline"": ""Tracking Ray Dalio`s Bridgewater Associates 13F Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-07"", ""headline"": ""5 Predictable Stocks Warren Buffett and Baillie Gifford Agree On"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-08"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - April 2023"", ""summary"": ""This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe and dividend-paying. Read more here.""}]","{""assetTurnoverTTM"": 0.4623, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.2828, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.0967, ""fcfPerShareTTM"": 6.2383, ""grossMargin"": 0.6608, ""inventoryTurnoverTTM"": 2.272, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0027, ""operatingMargin"": -0.0298, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0298, ""psTTM"": 4.7905, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 5.3266, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1151, ""salesPerShare"": 9.4958, ""sgaToSale"": 0.3392, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
13,2023-04-09,161.43893432617188,2023-04-16,162.11343383789062,0.004178047349816971,U1,"[{""date"": ""2023-04-09"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-09"", ""headline"": ""My Dividend Growth Portfolio March Update: Still Accumulating Cash"", ""summary"": ""Income growth is projected at 7.9% for the year, up from last month. This was primarily due to including an estimated return on cash. Click here for a detailed analysis.""}, {""date"": ""2023-04-10"", ""headline"": ""Johnson & Johnson Under Fire for Latest Bankruptcy Bid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-04-10"", ""headline"": ""Johnson & Johnson talc claimants seek dismissal of latest bankruptcy bid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""J&J talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say"", ""summary"": ""Johnson & Johnson\u2019s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny plaintiffs just compensation, lawyers representing cancer victims argued in a Monday court filing.""}, {""date"": ""2023-04-10"", ""headline"": ""11 High-Dividend Stocks Picked By Billionaire Ray Dalio"", ""summary"": ""In this article, we discuss 11 high-dividend stocks picked by billionaire Ray Dalio. You can skip our detailed analysis of Ray Dalio\u2019s hedge fund, and go directly to read 5 High-Dividend Stocks Picked By Billionaire Ray Dalio. Ray Dalio is an American billionaire investor who founded Bridgewater Associates in 1975 in New York. He has [\u2026]""}, {""date"": ""2023-04-10"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $164.32, marking a -0.5% move from the previous day.""}, {""date"": ""2023-04-10"", ""headline"": ""An Investor's View of Johnson & Johnson's Talc Settlement"", ""summary"": ""What the lawsuit could mean for J&J's spinoffs.  Why the U.S. Department of Justice is taking a look at Activision Blizzard.  Motley Fool producer Ricky Mulvey and Motley Fool analyst Emily Flippen take a closer look at Chewy's growth initiatives and what they could mean for shareholders.""}, {""date"": ""2023-04-10"", ""headline"": ""3 Best Stocks to Buy in April for the Looming Recession"", ""summary"": ""Many investors believe a recession is imminent. Indeed, there are many reasons for such a view, which makes searching for the best stocks to buy in this environment difficult. Inflation is high, interest rates are on the rise, geopolitical concerns remain and the yield curve is steeply inverted. The last factor, yield curve inversion, is probably the most indicative of an upcoming recession. Over the last several decades every time the yield curve has been this inverted, there\u2019s been a recession""}, {""date"": ""2023-04-10"", ""headline"": ""J&J talc unit second bankruptcy must be dismissed, cancer victims' lawyers say"", ""summary"": ""Johnson & Johnson's renewed effort to resolve talc lawsuits through an $8.9 billion bankruptcy settlement must be dismissed as a \""fraudulent scheme\"" that defies a court order rejecting the company's previous attempt to settle the litigation, according to court filing from...""}, {""date"": ""2023-04-10"", ""headline"": ""UPDATE 4-J&J talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say"", ""summary"": ""Johnson & Johnson\u2019s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny plaintiffs just compensation, lawyers representing cancer victims argued in a Monday court filing.  The attorneys contend J&J defied a January appeals court rejection of its first attempt to settle the litigation, noting that a J&J subsidiary refiled for Chapter 11 about two hours after a court dismissed its first bankruptcy.""}, {""date"": ""2023-04-10"", ""headline"": ""J&J talc unit's second bankruptcy must be dismissed, cancer victims' lawyers say"", ""summary"": ""Johnson & Johnson's renewed effort to resolve talc lawsuits through an $8.9 billion bankruptcy settlement must be dismissed as a \""fraudulent scheme\"" that defies a court order rejecting the company's previous attempt to settle the litigation with a controversial legal maneuver...""}, {""date"": ""2023-04-10"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.50% to $164.32 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-10"", ""headline"": ""3 Things About Johnson & Johnson Smart Investors Know"", ""summary"": ""If you've ever been inclined to pop a Tylenol or use a Band-Aid, you've used Johnson & Johnson's (NYSE: JNJ) products.  Smart investors should understand that there are three things in particular that are critical to know about this stock before buying shares.  Johnson & Johnson faces significant possibility of damages from billion-dollar-plus class-action lawsuits brought by those claiming to be harmed by its talcum powder, which was shown to be contaminated for several years with cancer-causing asbestos despite the company's denials.""}, {""date"": ""2023-04-10"", ""headline"": ""AbbVie (ABBV), J&J to Withdraw 2 Blood Cancer Nods for Imbruvica"", ""summary"": ""AbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two blood cancer treatments is based on confirmatory studies data that do not support full approval.""}, {""date"": ""2023-04-10"", ""headline"": ""Can You Still Buy the Dow Jones' Best-Performing April Stocks?"", ""summary"": ""Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.""}, {""date"": ""2023-04-10"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-04-10"", ""headline"": ""Pfizer CEO signs open letter calling for reversal of Texas abortion pill ruling"", ""summary"": ""Pfizer's CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge's controversial ruling on mifepristone.""}, {""date"": ""2023-04-10"", ""headline"": ""U.S. launches $5B program to speed up development of next-gen COVID vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""2 Warren Buffett Favorites to Buy on the Dip"", ""summary"": ""When Warren Buffett chooses stocks, he looks for companies with great long-term stories.  Let's check out two Buffett favorites to buy on the dip.  Amazon (NASDAQ: AMZN) has suffered from headwinds linked to the economy as well as a couple of internal challenges.""}, {""date"": ""2023-04-10"", ""headline"": ""GSK Vs. Bristol-Myers Squibb: Who's More Underrated By Mr. Market"", ""summary"": ""GSK's dividend yield is 3.58%, slightly higher than Bristol-Myers Squibb's 3.22%. BMY's EBITDA margin was 43.7% for 2022, 11.4% more than GSK. Read more here.""}, {""date"": ""2023-04-10"", ""headline"": ""GSK Vs. Bristol-Myers Squibb: Who`s More Underrated By Mr. Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Q1 2023 Dividend Report"", ""summary"": ""I hit a new quarterly record for dividend income in my portfolio. Click here for a complete analysis.""}, {""date"": ""2023-04-10"", ""headline"": ""Johnson & Johnson price target lowered to $179 from $180 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""DivHut Portfolio Update: March 2023"", ""summary"": ""The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book.""}, {""date"": ""2023-04-11"", ""headline"": ""J&J talc unit faces skepticism on bankruptcy settlement support"", ""summary"": ""A Johnson & Johnson company on Tuesday defended its second attempt to resolve talc lawsuits in bankruptcy, telling a U.S. judge it can quickly build consensus around its $8.9 billion settlement offer despite doubts about its assertion that 60,000 plaintiffs would support...""}, {""date"": ""2023-04-11"", ""headline"": ""J&J Unit Says Cancer Victims Who Won\u2019t Settle Seek to Block $8.9 Billion Deal"", ""summary"": ""(Bloomberg) -- A Johnson & Johnson unit said cancer victims who refuse to settle with the company are attempting to intimidate other claimants from signing onto an $8.9 billion deal to end lawsuits over allegedly tainted baby powder.Most Read from BloombergKatie Cotton, Guardian of the Apple Brand for 18 Years, DiesElizabeth Holmes Will Have to Wait Out Her Appeal in PrisonTwitter Company \u2018No Longer Exists,\u2019 Is Now Part of Musk\u2019s XTumbling Money Supply Alarms Economists Who Foresaw InflationRich""}, {""date"": ""2023-04-11"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.03% to $164.27 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-11"", ""headline"": ""12 Best Covid Treatment Stocks to Buy Today"", ""summary"": ""In this piece, we will take a look at the 12 best covid treatment stocks to buy today. For more stocks, head on over to 5 Best Covid Treatment Stocks to Buy Today. If there\u2019s one thing that can be said for sure, it\u2019s that the coronavirus pandemic has changed the world. The deadly disease, [\u2026]""}, {""date"": ""2023-04-11"", ""headline"": ""Analysts Estimate Johnson & Johnson (JNJ) to Report a Decline in Earnings: What to Look Out for"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-04-11"", ""headline"": ""Johnson & Johnson talc victims seek dismissal of latest bankruptcy bid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Johnson & Johnson Should Comfortably Handle Talc Risks"", ""summary"": ""Johnson & Johnson has one of the strongest balance sheets in the industry, and it's using that to drive shareholder returns. Click here for our review of JNJ stock.""}, {""date"": ""2023-04-11"", ""headline"": ""DLN Beats The S&P 500 In Value And Quality, Not In Performance"", ""summary"": ""WisdomTree U.S. LargeCap Dividend Fund is a dividend-oriented ETF invested in U.S. large cap companies. Click here to read more about DLN fund.""}, {""date"": ""2023-04-11"", ""headline"": ""Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has been dealing with tens of thousands of lawsuits related to its talc products, which plaintiffs allege gave them cancer.  There is nothing unusual about a company the size of Johnson & Johnson dealing with some legal issues.  Fortunately, Johnson & Johnson seems to be moving closer to putting this major risk in the rearview mirror.""}, {""date"": ""2023-04-11"", ""headline"": ""US DOJ asks appeals court to block Texas judge abortion pill ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Biden signs bill to end COVID national emergency"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""3 Blue-Chip Stocks to Buy at an All-Time Low in April"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""12 Best Warren Buffett Stocks To Buy According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 12 best Warren Buffett stocks to buy according to hedge funds. For more stocks, head on over to 5 Best Warren Buffett Stocks To Buy According to Hedge Funds. For newcomers, and sometimes seasoned professionals too, investing often feels like a daunting task. Choosing the [\u2026]""}, {""date"": ""2023-04-12"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.21% to $163.92 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-12"", ""headline"": ""My Dividend Stock Portfolio: New All-Time Dividend Record - 99 Holdings With 25 Buys"", ""summary"": ""My dividend income in March amounted to a record $950. This represents growth of 61% Y/Y and 40% sequentially. Click here for a detailed analysis.""}, {""date"": ""2023-04-12"", ""headline"": ""Which Healthcare Company Will Be the First to Get to a $1 Trillion Market Cap?"", ""summary"": ""There are several healthcare companies with market caps in the hundreds of billions.  There are four companies in that group though that have the potential to get there: Johnson & Johnson\u00a0(NYSE: JNJ),\u00a0UnitedHealth Group\u00a0(NYSE: UNH), Novo Nordisk (NYSE: NVO), and Eli Lilly\u00a0(NYSE: LLY).""}, {""date"": ""2023-04-12"", ""headline"": ""Cue Biopharma appoints Verheyen to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Essa Pharma announces agreement with Janssen to evaluate EPI-7386 combos"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Wells Fargo sees `at least in-line` Q1 for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""LVS Advisory Q1 2023 Letter"", ""summary"": """"}, {""date"": ""2023-04-13"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson advanced 1.34% to $166.11 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-04-13"", ""headline"": ""Will Q1 Earnings Fuel a Rally in Dow ETF?"", ""summary"": ""As the index is closely tied to the cyclical sectors, the banking turmoil hit hard the Dow last month. Recession fears have added to the woes.""}, {""date"": ""2023-04-13"", ""headline"": ""Needham med tech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""June 2nd Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Appeals court permits limited access to abortion pill, blocks part of Texas ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Dividend Income Summary: Lanny`s March 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""ClearBridge Appreciation ESG Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-14"", ""headline"": ""Johnson & Johnson Expected to Post a Q1 Earnings Decline"", ""summary"": ""With the talc legal issue settled and strong pharmaceutical sales, Johnson & Johnson is expected to see brighter days ahead after a first-quarter dip.""}, {""date"": ""2023-04-14"", ""headline"": ""J&J (JNJ) to Initiate Q1 Earnings Season for Pharma Sector"", ""summary"": ""Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.""}, {""date"": ""2023-04-14"", ""headline"": ""Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is making another effort to resolve the lawsuits related to its talc baby powder products.  In 2021, Johnson & Johnson created a new subsidiary to take on its talc business, as well as the liability for the asbestos-related lawsuits.  In January of this year, however, an appeals court judge tossed out that effort, so now Johnson & Johnson is making a second attempt to settle the cases.""}, {""date"": ""2023-04-14"", ""headline"": ""Catalyst Watch: Earnings season picks up steam, housing data due"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""ClearBridge Dividend Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""IXJ: Healthcare Dashboard For April"", ""summary"": ""Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Learn why IXJ ETF is a global alternative to XLV.""}, {""date"": ""2023-04-14"", ""headline"": ""Drug manufacturer Catalent`s stock tumbles 25% after profit warning and CFO departure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Novo Nordisk (NVO) and Teva Pharmaceutical (TEVA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Ghana 1st in world to approve new malaria vaccine by Oxford"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-15"", ""headline"": ""Why Johnson & Johnson Is Such an Impressive Dividend Stock"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is a stalwart in the healthcare industry, and it's also a rock-solid dividend investment to own.  The company has been increasing its dividend payments for 60 consecutive years and has a track record few other companies can boast about.  One of the things income investors should pay close attention to when looking at dividend growth stocks is the rate they increase their dividend payments by.""}, {""date"": ""2023-04-15"", ""headline"": ""Johnson & Johnson Stock: Bear vs. Bull"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) isn't exactly a controversial stock because of its reputation for stability, which it earned by being one of the largest and longest-lived healthcare businesses in the world.  Before we dive into the bull thesis, it's important to note that the Johnson & Johnson of the future will be different from the one of today.""}, {""date"": ""2023-04-15"", ""headline"": ""3 Dividend Stocks to Buy and Hold for the Next Decade"", ""summary"": ""The best ones even pay you to hold them for years via generous dividends.  Three Motley Fool contributors identified their picks for dividend stocks to buy and hold for the next decade.  Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""2023-04-15"", ""headline"": ""Stocks To Watch: Eyes On The Health Of Financials, Housing Sector"", ""summary"": """"}, {""date"": ""2023-04-15"", ""headline"": ""3 Dividend Stocks to Buy for a Recession-Proof Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-15"", ""headline"": ""British American Tobacco: 25 Hated Dividend Growth Stocks Compared"", ""summary"": ""British American Tobacco is currently hated by the market for a variety of reasons. Read more about BTI here.""}, {""date"": ""2023-04-15"", ""headline"": ""Dividend Income Summary: Lanny's March 2023 Summary"", ""summary"": ""In March, we (my wife and I) received a dividend income total of $5,707.34. Target, Lockheed Martin and T.""}, {""date"": ""2023-04-16"", ""headline"": ""Wall Street holds steady as earnings season kicks into gear"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""2 of the Lowest-Risk Dividend Stocks in the World"", ""summary"": ""The companies backing these dividends generate massive cash flows and have fortress-like balance sheets.""}, {""date"": ""2023-04-16"", ""headline"": ""Apple Among 14 Companies To Announce Dividend Growth In Late April"", ""summary"": ""Procter & Gamble extended its dividend growth streak to 67 years. Check out my dividend increase predictions for the second half of April.""}]","{""assetTurnoverTTM"": 0.4623, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.2828, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.0967, ""fcfPerShareTTM"": 6.2383, ""grossMargin"": 0.6608, ""inventoryTurnoverTTM"": 2.272, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0027, ""operatingMargin"": -0.0298, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0298, ""psTTM"": 4.7905, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 5.3266, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1151, ""salesPerShare"": 9.4958, ""sgaToSale"": 0.3392, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
14,2023-04-16,162.11343383789062,2023-04-23,159.0342254638672,-0.018994159220034557,D2,"[{""date"": ""2023-04-16"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Could Johnson & Johnson (NYSE:JNJ) Once Again Beat Earnings Forecast?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Wall Street holds steady as earnings season kicks into gear"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""2 of the Lowest-Risk Dividend Stocks in the World"", ""summary"": ""The companies backing these dividends generate massive cash flows and have fortress-like balance sheets.""}, {""date"": ""2023-04-16"", ""headline"": ""Apple Among 14 Companies To Announce Dividend Growth In Late April"", ""summary"": ""Procter & Gamble extended its dividend growth streak to 67 years. Check out my dividend increase predictions for the second half of April.""}, {""date"": ""2023-04-17"", ""headline"": ""Needham med tech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Bert's March 2023 Dividend Income Summary"", ""summary"": """"}, {""date"": ""2023-04-17"", ""headline"": ""Treasury yields little changed as focus remains on economic outlook, earnings"", ""summary"": ""U.S. Treasury yields were little changed on Tuesday, as investors continued to assess the outlook for the U.S. economy and digested the latest round of corporate earnings.""}, {""date"": ""2023-04-17"", ""headline"": ""European stocks set for positive open as investors continue to monitor global economic health"", ""summary"": ""European markets are heading for a higher open Tuesday as investors continue to gauge the health of the global economy.""}, {""date"": ""2023-04-17"", ""headline"": ""J&J\u2019s Earnings Are Tuesday. Watch for News on Spinoff, Talc Litigation."", ""summary"": ""The company is the last of the big pharmaceutical conglomerates, Rivals such as Pfizer have stripped away all but their core biopharma businesses.""}, {""date"": ""2023-04-17"", ""headline"": ""Stock futures are flat Monday night as traders digest latest earnings results"", ""summary"": ""Traders will watch the rollout of further results for signs into how companies are holding up amid a period of persistent inflation and rising interest rates. ""}, {""date"": ""2023-04-17"", ""headline"": ""IPO for J&J\u2019s Consumer Health Division is Coming Soon, CFO Says"", ""summary"": ""The company, the last of the big pharmaceutical conglomerates, raised its full-year adjusted earnings forecast to a range of $10.60-$10.70 a share.""}, {""date"": ""2023-04-17"", ""headline"": ""Netflix reports, Johnson & Johnson, bank earnings: 3 things to watch"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-04-17"", ""headline"": ""Johnson & Johnson: 4 Key Areas Of Focus Ahead Of Q1 Earnings"", ""summary"": """"}, {""date"": ""2023-04-17"", ""headline"": ""How To Allocate $10,000 Among My Top 20 Dividend Stocks Of April 2023"", ""summary"": """"}, {""date"": ""2023-04-17"", ""headline"": ""Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?"", ""summary"": ""In J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara is likely to have driven sales growth in the first quarter""}, {""date"": ""2023-04-17"", ""headline"": ""Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?"", ""summary"": ""Healthcare giant Johnson & Johnson's (NYSE: JNJ) talcum powder litigation has hung over the company like a cloud for years.  J&J recently announced it would settle with tens of thousands of plaintiffs in an agreement worth $8.9 billion.  The settlement isn't final, and some investors may avoid the stock altogether because of the harm the company is alleged to have caused.""}, {""date"": ""2023-04-17"", ""headline"": ""LONDON MARKET CLOSE: FTSE 250 shines but large-caps tepid on Fed bets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Merck`s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Reports From Major Banks Give Investors Optimism About The Stock Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""2 Best Biotech Stocks to Buy for the Long Haul"", ""summary"": ""Tracing its history back to 1886, Johnson & Johnson (NYSE: JNJ) is among the oldest healthcare companies in the U.S. It shouldn't come as a shock to also learn that J&J's $427 billion market capitalization also makes it the biggest drugmaker in the world.  Both were megablockbusters (with $5 billion or more in annual sales) in 2022.  J&J's portfolio also contained a blockbuster (at least $1 billion in annual sales) COVID-19 vaccine and 12 blockbuster drugs, including the antipsychotic medicine Invega and the blood thinner Xarelto.""}, {""date"": ""2023-04-17"", ""headline"": ""The Fed Expects a Recession: 2 Warren Buffett Stocks to Buy Now and 1 to Avoid Like the Plague"", ""summary"": ""Two Berkshire Hathaway holdings are well positioned for a possible economic downturn, while another Buffett favorite is best avoided.""}, {""date"": ""2023-04-17"", ""headline"": ""Johnson & Johnson Q1 Earnings Preview: More Pain Ahead?"", ""summary"": """"}, {""date"": ""2023-04-17"", ""headline"": ""Notable earnings before Tuesday`s open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-04-17"", ""headline"": ""Johnson & Johnson management to meet virtually with Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""U.S. stock futures near highs of the year as earnings season eyed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""The Bank Of Japan Intends To Keep Its Monetary Policy Soft"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Legend Biotech CARTITUDE-4 data `highly impressive,` says Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Geron, CTI rally after leaked data for Legend Biotech`s blood cancer drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J talc unit asks judge to halt cancer lawsuits as it pursues $8.9 billion settlement"", ""summary"": ""A Johnson & Johnson subsidiary is again asking a U.S. judge to pause tens of thousands of lawsuits alleging the company's baby powder and other talc products cause cancer, as it seeks to resolve the litigation in bankruptcy after a federal appeals court found its first attempt...""}, {""date"": ""2023-04-18"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $1,202.00K"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""S&P 500 ekes out gain as tech supports, J&J, Goldman disappoint"", ""summary"": ""The S&P 500 eked out a slim gain on Tuesday after strength in some big technology stocks countered disappointing quarterly reports from Johnson & Johnson and Goldman Sachs as first-quarter earnings season kicked into gear.""}, {""date"": ""2023-04-18"", ""headline"": ""Healthcare Shares Fall; J&J Boosts Earnings Outlook -- Healthcare Roundup"", ""summary"": ""Healthcare companies sank as investors rotated into stocks with more to gain from a strong economy. Johnson &amp; Johnson raised its full-year sales and...""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Remains The Blue-Chip Dividend King To Own"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""US STOCKS-Dow leads Wall St losses as Goldman, J&J results disappoint"", ""summary"": ""The Dow led declines among U.S. stock indexes on Tuesday after quarterly updates from Goldman Sachs and Johnson & Johnson stoked investor worries about the outlook for corporate earnings amid concerns of a recession.""}, {""date"": ""2023-04-18"", ""headline"": ""NEW YORK MARKET CLOSE: US stocks muted after sluggish Goldman results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson's Dividend: 61 And Counting"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""J&J issues cautious 2023 forecast, shares fall"", ""summary"": ""Johnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare conglomerate issued a conservative full-year profit forecast, and its shares fell more than 2%.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J, Goldman stocks cut Dow\u2019s price by 68 points after earnings"", ""summary"": ""Shares of Johnson & Johnson and Goldman Sachs Group Inc. were the biggest drags on the Dow Jones Industrial Average even as both companies reported...""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson 2023 Q1 - Results - Earnings Call Presentation"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson (JNJ) Q1 2023 Earnings Call Transcript"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""These Stocks Are Moving the Most Today: Bank of America, Goldman Sachs, J&J, Lockheed, Netflix, and More"", ""summary"": ""Bank of America, Goldman Sachs, and Johnson & Johnson post first-quarter earnings that beat estimates.""}, {""date"": ""2023-04-18"", ""headline"": ""US STOCKS-Futures gain as investors cheer resilient earnings"", ""summary"": ""U.S. stock index futures climbed on Tuesday as Bank of America and Johnson & Johnson reported upbeat earnings, while signs of uneven economic recovery in China and prospects of more Federal Reserve interest rate hikes capped gains.  Shares of Bank of America Corp advanced 2% in premarket trading after its first-quarter profit rose on higher earnings from customers' interest payments as the Federal Reserve raised borrowing costs.""}, {""date"": ""2023-04-18"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook"", ""summary"": ""First-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J\u2019s Stock Is Rising. It Beat on Earnings, Raised Guidance."", ""summary"": ""The company, the last of the big pharmaceutical conglomerates, raised its full-year adjusted earnings expectations to a range of $10.60-$10.70 a share, from $10.45-$10.65 previously.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J sales in US rise 10%, health care giant raises dividend"", ""summary"": ""Johnson & Johnson beat first-quarter expectations, as growth in the health care giant's home market helped counter another revenue hit overseas because of the strong dollar.  The health care giant booked a $68 million loss on a one-time charge in the quarter related to its baby powder, and revenue grew more than 5% to $24.75 billion, which was better than anticipated.  Johnson & Johnson sells prescription drugs and medical devices.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Stock Higher On Q1 Earnings Beat, Dividend Boost"", ""summary"": ""\""Our first quarter results demonstrate strong performance across all three segments of our business,\"" said CEO Joaquin Duato.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit"", ""summary"": ""Shares of the Dow component rose over 2% in premarket trading as sales across all the company's businesses, including medical devices and consumer health, beat estimates.  Sales of its cancer treatments such as prostate cancer therapy Erleada and multiple myeloma drug Darzalex are closely watched by investors as the company targets about $60 billion in drug sales by 2025 at a time when older drugs face fierce competition.""}, {""date"": ""2023-04-18"", ""headline"": ""J&J raises annual profit forecast on cancer drug strength"", ""summary"": ""Johnson & Johnson on Tuesday raised its 2023 profit forecast, banking on its newer cancer treatments and multiple myeloma drug Darzalex to soften the blow from declining sales for some of its older drugs.  The healthcare conglomerate now expects to earn between $10.60 and $10.70 per share on an adjusted basis for 2023, compared with its prior forecast of between $10.45 and $10.65.  Analysts were expecting a profit of $10.51 per share, according to Refinitiv data.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Reports Q1 2023 Results"", ""summary"": ""NEW BRUNSWICK, N.J., April 18, 2023--Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2023. \""Our first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,\"" said Joaquin Duato, Chairman of the Board and Chief Executive Officer. \""With this momentum, I look forward to the remainder of the year, one filled with exciting catalysts that will create both near- and lon""}, {""date"": ""2023-04-18"", ""headline"": ""J&J talc unit again seeks to halt 38,000 cancer lawsuits"", ""summary"": ""A Johnson & Johnson subsidiary is again asking a U.S. judge to pause tens of thousands of lawsuits alleging that the company's baby powder and other talc products cause cancer, as it takes another shot at resolving the litigation in bankruptcy after a federal appeals court found its first attempt improper.  At a Tuesday hearing in Trenton, New Jersey, LTL Management will argue that the so-called \""automatic stay\"" under bankruptcy law that stops lawsuits against it from moving forward while it is in Chapter 11 proceedings, should also protect J&J, which has a market value of over $430 billion and has not filed for bankruptcy itself.  Two groups of cancer plaintiffs and the U.S. Department of Justice's bankruptcy watchdog, have opposed the company's bid for a stay, arguing that it is a fraudulent attempt to evade the earlier court ruling and that the second bankruptcy has \""slim to nonexistent prospects\"" of success.""}, {""date"": ""2023-04-18"", ""headline"": ""The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now"", ""summary"": ""Staff economists told the FOMC that it's likely that the U.S. will enter into a \""mild recession starting later this year\"" because of the banking crisis.  With the FOMC thinking that a recession is more likely, what should investors do?  At first glance, you might not think\u00a0Dollar General (NYSE: DG) would be such a great stock to buy right now.""}, {""date"": ""2023-04-18"", ""headline"": ""Stocks Edge Higher, Netflix Earnings, Goldman On Deck, Johnson & Johnson, Nvidia Upgrade - Five Things To Know"", ""summary"": ""Stock futures build gains, Treasury yields rise, with earnings in focus; Netflix nudges higher as investors eye paid sharing effect on profits; Goldman Sachs gains as bank earnings re-take center stage on Wall Street; Johnson & Johnson earnings on deck with Kenvue IPO, talc bankruptcy in focus and Nvidia shares jump after HSBC upgrade on ai chip prospects.""}, {""date"": ""2023-04-18"", ""headline"": ""3 Robinhood Stocks to Buy and Hold Forever"", ""summary"": ""Despite its reputation as a platform for the trading of meme stocks, Robinhood Markets does in fact help retail investors trade all sorts of stocks and other commodities.  This trio is made up of well-known large-cap companies that offer dividends.  Microsoft, once just a software company, is now a diversified technology company seeing an increased business through its cloud platforms.""}, {""date"": ""2023-04-18"", ""headline"": ""Judge to decide if he will halt J&J talc lawsuits on Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Unusually active option classes on open April 18th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Great scientific innovation continues to produce great financial results for our company: J&J CFO"", ""summary"": ""Joseph Wolk, Johnson & Johnson CFO, joins 'Squawk Box' to discuss the company's quarterly earnings results, how much the business controls headwinds, and more.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson says procedures trending above pre-Covid levels"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Analysts` Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson does not see material sales of Covid-19 vaccine after Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and more"", ""summary"": ""Shares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell. ""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson says continues to invest in R&D at `competitive levels`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""FTSE 100 and European stocks rise as investors digest UK unemployment data"", ""summary"": ""The UK unemployment rate ticked up to 3.8%.""}, {""date"": ""2023-04-18"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""5 stocks to watch on Tuesday: Johnson & Johnson, Bank of America, Goldman Sachs and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""LONDON MARKET MIDDAY: Miners lift FTSE 100 even as pound rebounds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""TOP NEWS: J&J swings to first quarter loss due to litigation costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Earnings: JNJ Breaks Above Resistance Following Q1 Beat, Targets $180"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson beats on earnings and revenue, raises full-year guidance"", ""summary"": ""J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year.\u00a0""}, {""date"": ""2023-04-18"", ""headline"": ""J&J stock pops as Q1 revenue boosted by Darzalex, COVID vaccine; raises FY23 outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""JNJ Up as Q1 Results Beat Estimates, Raises Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson lifts dividend by 5.3% to $1.19/share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""3 Dividend Stocks to Sell Before They Get Sued by Customers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson raises quarterly dividend 5.3% to $1.19 from $1.13 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson beats Q1 consensus estimates and raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Genmab announces Q1 net sales of DARZALEX $2.26B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Major Earnings Misses And Beats: Your Guide To This Week`s Big Earnings In Play"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""These Stocks Are Moving the Most Today: Goldman Sachs, J&J, Bank of America, Nvidia, Southwest, and More"", ""summary"": ""Goldman Sachs, Bank of America, and Johnson & Johnson post first-quarter earnings that beat estimates.""}, {""date"": ""2023-04-18"", ""headline"": ""LONDON MARKET OPEN: UK job market falters; miners climb on China data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Atlantic Equities Maintains Johnson & Johnson (JNJ) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Jim Cramer Recommends That Investors Hold Tight to One Health Care Stock"", ""summary"": ""CNBC Host Jim Cramer says one stock is down in value for no valid reason.  In fact, Cramer says the stock is a buy.  The stock-picking personality made the comments during a discussion with the financial news network's Jeff Marks on Cramer's Morning Take April 18.""}, {""date"": ""2023-04-19"", ""headline"": ""Johnson & Johnson: U.S. Health Trends A Key Catalyst For Growth"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Johnson & Johnson (JNJ) Declares $1.19 Dividend"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""What Is The Options Market Expecting For Tesla Earnings?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech: Leaked EHA Abstract Shows Outstanding CARTITUDE-4 Results"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Atlantic Equities Sticks to Its Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech announces private placement for ~7.7M shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech Soars after Leaked Cancer Therapy Data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech adds 18% after leaked data on JNJ-partnered CAR-T therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech adds 18% after leaked report on JNJ-partnered CAR-T therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Legend Biotech price target raised to $85 from $75 at BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Johnson & Johnson price target raised to $183 from $179 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Johnson & Johnson price target lowered to $181 from $185 at Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Legend Biotech Blasts Up on Cancer Data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Treasury yields continue to fall on signs of economic contraction"", ""summary"": ""U.S. Treasury yields dropped further on Friday morning after a round of data indicated that the economy may be contracting.""}, {""date"": ""2023-04-20"", ""headline"": ""Why Shares of Protagonist Therapeutics Rose This Week"", ""summary"": ""Shares of Protagonist Therapeutics (NASDAQ: PTGX)\u00a0rose by 23.3% for the week, as of Thursday afternoon, according to data provided by\u00a0S&P Global Market Intelligence.  Protagonist's stock jumped a bit because of increased interest in biotech stocks this week, particularly clinical-stage biotechs with promising therapies.  Johnson & Johnson (NYSE: JNJ), through its subsidiary Janssen Biotech, already has a relationship with Protagonist and could see it as a potential buyout target.""}, {""date"": ""2023-04-20"", ""headline"": ""J&J Wins New, Temporary Shield Against Trials in Talc Bankruptcy"", ""summary"": ""A bankruptcy judge has again shielded Johnson & Johnson from jury trials in roughly 40,000 pending talc-related lawsuits, advancing the company\u2019s second attempt to resolve mass cancer claims through the chapter 11 system.""}, {""date"": ""2023-04-20"", ""headline"": ""US judge halts most talc lawsuits against J&J, stops trials"", ""summary"": ""A U.S. judge on Thursday halted most of the tens of thousands of lawsuits alleging Johnson & Johnson\u2019s baby powder and other talc products caused cancer and stopped any trials as part of a company subsidiary\u2019s second attempt to settle cases in bankruptcy proceedings.""}, {""date"": ""2023-04-20"", ""headline"": ""Healthcare Shares Fall Amid Selloff -- Healthcare Roundup"", ""summary"": ""Healthcare companies dropped amid a broad market selloff. A bankruptcy judge has again shielded Johnson &amp; Johnson from jury trials in roughly 40,000...""}, {""date"": ""2023-04-20"", ""headline"": ""U.S. bankruptcy judge halts 40,000 Johnson & Johnson talc and cancer lawsuits"", ""summary"": ""Judge Michael Kaplan's decision is part of J&J's second attempt to settle tens of thousands of talc-cancer cases in bankruptcy proceedings. ""}, {""date"": ""2023-04-20"", ""headline"": ""J&J Wins Pause of Baby Powder Trials, Must Face New Suits"", ""summary"": ""(Bloomberg) -- Johnson & Johnson must face new lawsuits accusing the company of selling tainted baby powder that caused cancer, a judge ruled, opening the company up to court actions that had been halted for 19 months.Most Read from BloombergElon Musk\u2019s Wealth Plunges $13 Billion as Drama Unfolds Across EmpireAirline Blunder Sells $10,000 Asia-US Business Class Tickets for $300SpaceX Says It Blew Up Starship Rocket After Engine MishapUS, Ukraine Allies Consider Near-Total Ban on Exports to Russi""}, {""date"": ""2023-04-20"", ""headline"": ""UPDATE 4-US judge halts most talc lawsuits against J&J, stops trials"", ""summary"": ""A U.S. judge on Thursday halted most of the tens of thousands of lawsuits alleging Johnson & Johnson\u2019s baby powder and other talc products caused cancer and stopped any trials as part of a company subsidiary\u2019s second attempt to settle cases in bankruptcy proceedings.  U.S. Bankruptcy Judge Michael Kaplan put most of the litigation temporarily on hold during a hearing in Trenton, New Jersey.  The decision, for the most part, granted a request from J&J to freeze cases while it attempts to reach a permanent settlement with current plaintiffs that would also set aside money for future lawsuits.""}, {""date"": ""2023-04-20"", ""headline"": ""Why Shares of Geron Are Up 30% This Week"", ""summary"": ""Shares of Geron\u00a0(NASDAQ: GERN), a clinical-stage biotech company, were up more than 30% this week before CEO John A. Scarlett's scheduled appearance at the Needham Virtual Healthcare Conference on Thursday morning.  The stock soared nearly 20% on Wednesday, as a leaked abstract regarding a trial for Carvykti -- a CAR-T cell blood therapy by Johnson & Johnson and Legend Bio\u00a0-- may have lifted hopes for other blood therapies in the industry, such as Geron's imetelstat.  Geron focuses on blood-related cancers, and imetelstat is its lead pipeline candidate.""}, {""date"": ""2023-04-20"", ""headline"": ""NEW YORK MARKET CLOSE: Weak earnings knock US stocks; Tesla slides 10%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Johnson & Johnson (JNJ) Could Be a Great Choice"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-04-20"", ""headline"": ""Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?"", ""summary"": ""Novartis (NVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.""}, {""date"": ""2023-04-20"", ""headline"": ""Healthcare Sector Update: MedTech Trending Up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""3 of the Best Dividend Kings to Buy for the Rest of 2023"", ""summary"": ""A Dividend King is any stock that has increased its dividend for 50+ consecutive years. These are among the most consistent dividend growers on the market today. One of the leaders happens to be the healthcare giant Johnson & Johnson (NYSE: JNJ), which recently increased its dividend for the 61st consecutive year.""}, {""date"": ""2023-04-20"", ""headline"": ""J&J wins temporary halt of baby powder lawsuits, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Judge extends stay for Johnson & Johnson talc claims another 60 days"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Bankruptcy judge halts J&J talc trials through mid-June, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""14 Best Passive Income Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best passive income stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Best Passive Income Stocks To Buy Now. Last year\u2019s market decline marked one of the worst eras investors had ever seen. [\u2026]""}, {""date"": ""2023-04-20"", ""headline"": ""DIVB: Shareholder Yield Is A Good Idea, But Cambria Did It Better"", ""summary"": """"}, {""date"": ""2023-04-21"", ""headline"": ""Ulcerative colitis market set to hit $9.6B by 2031"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""ClearBridge Sustainability Leaders Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-21"", ""headline"": ""3 Very Low-Risk Ways to Invest $1,000 Right Now"", ""summary"": ""Investing money in the stock market is inherently risky.  Investors are willing to risk losing money for the potential reward of making more if the investment pays off.  Three safer stocks are\u00a0Enterprise Products Partners\u00a0(NYSE: EPD),\u00a0Johnson & Johnson\u00a0(NYSE: JNJ), and\u00a0Camden Property Trust\u00a0(NYSE: CPT).""}, {""date"": ""2023-04-21"", ""headline"": ""11 Best Diversified Stocks to Buy Now"", ""summary"": ""In this article, we discuss the 11 best-diversified stocks to buy now. If you want to skip a detailed analysis including the pros and cons of diversified companies, go directly to the 5 Best Diversified Stocks to Buy Now. During the current economic turmoil and volatility, investing in companies with diversified products and service portfolios [\u2026]""}, {""date"": ""2023-04-21"", ""headline"": ""Thinking Of Buying Healthpeak Properties? Here Are The Properties And Tenants You'd Be Adding To Your Portfolio"", ""summary"": ""Real estate investment trusts (REITs) are one of the most popular income-oriented types of stocks investors can purchase. Receiving monthly or quarterly dividend payments on a regular basis is comforting to those who rely on such payments for ongoing household or other bills. But it\u2019s always important to consider the properties, tenants and contractual agreements that comprise the largest percentage of a REIT\u2019s business to ensure that those payments will continue. Take a look at one healthcare R""}, {""date"": ""2023-04-21"", ""headline"": ""Johnson & Johnson Stock: Should You Buy Before This Big Transition?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has increased earnings over time -- delivering both share price performance and dividend growth to investors.  Should you buy J&J shares before that happens?  J&J has long been known for its three businesses: consumer health, pharmaceuticals, and medtech.""}, {""date"": ""2023-04-21"", ""headline"": ""IN BRIEF: J&J's prostate cancer treatment in Europe marketing backing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""11 Best Undervalued Dividend Stocks to Buy Now"", ""summary"": ""In this article, we discuss 11 best undervalued dividend stocks to buy now. You can skip our detailed analysis of value and dividend stocks and their performance in the past, and go directly to read 5 Best Undervalued Dividend Stocks to Buy Now. Undervalued stocks trade at a price lower than their intrinsic or true [\u2026]""}, {""date"": ""2023-04-21"", ""headline"": ""Carlyle Seeks New Investors For McDonald's China Arm, US Judge Halts Several Johnson & Johnson's Talc-Related Lawsuits, A Look At How Much Alphabet Analysts, Managers And Engineers Get Paid: Today's Top Stories"", ""summary"": ""Bloomberg Carlyle Seeks New Investors For McDonald's $10B China Arm Private equity company Carlyle Group Inc (NASDAQ: CG) reportedly intends to find new investors for its investment in McDonald's Corp's (NYSE: MCD) Chinese operations. The buyout firm, which controls McDonald's China, together with Trustar Capital, has been discussing shifting its ownership to a new investment vehicle. The report added that the prospective deal would provide current limited partners the choice to sell or roll ove""}, {""date"": ""2023-04-21"", ""headline"": ""US Judge Halts Several Lawsuits Related To Johnson & Johnson's Talc Products Caused Cancer"", ""summary"": ""A federal bankruptcy judge Michael Kaplan temporarily held around 38,000 lawsuits alleging Johnson & Johnson's (NYSE: JNJ) baby powder and other talc products caused cancer as a part of J&J's second attempt to settle thousands of talc cases in bankruptcy proceedings. In 2021, Johnson Johnson spun off its subsidiary, LTL Management, to carry its talc-related liabilities and file for Chapter 11 bankruptcy protections. J&J will not have to go to trial over any other talc claims during the pause, bu""}, {""date"": ""2023-04-21"", ""headline"": ""J&J granted marketing authorization for Akeega in Europe"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""OmniAb a new buy at Benchmark on technology to develop monoclonal antibodies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""3 Best Dividend Kings For The Rest Of 2023"", ""summary"": """"}, {""date"": ""2023-04-21"", ""headline"": ""MeiraGTx announces upcoming presentations at ARVO 2023 meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Johnson & Johnson (JNJ) and Lucid Diagnostics (LUCD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""6 big earnings reports: Tesla drops on Q1 flop, Netflix misses outlook | Pro Recap"", ""summary"": ""Here is your Pro Recap of the biggest earnings reports you may have missed this week: a big miss for Tesla; strong numbers at J&J and IBM; and disappointments at Netflix, Goldman and Morgan Stanley.  Tesla (NASDAQ:TSLA) shares dropped more than 9% yesterday on the company\u2019s reported worse-than-expected Q1 results as margins were battered by price cuts.  Tesla's EPS was $0.85, below the consensus estimate of $0.86, while revenues came in at $23.3 billion, compared to the consensus of $23.78B.""}, {""date"": ""2023-04-21"", ""headline"": ""How To Allocate $25,000 Among My Top 30 Picks For April 2023"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""ClearBridge Appreciation Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of April 23"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""ClearBridge Large Cap Value Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""If You're a Dividend Investor, You'll Love This News From Johnson & Johnson"", ""summary"": ""Well it's actually a reality if you hold stocks that pay dividends.  One of those stocks is healthcare giant Johnson & Johnson (NYSE: JNJ).  In fact, J&J is part of a group of companies known as Dividend Kings that have raised their dividends for at least the past 50 years.""}, {""date"": ""2023-04-22"", ""headline"": ""3 Top Dividend Kings to Buy for the Long Haul"", ""summary"": ""Investing in Dividend Kings is just one part of a solid long-term strategy.  The attraction is that their long history of annual dividend increases (50 consecutive years or more) reflects well on the companies' business growth and stability.  Johnson & Johnson (NYSE: JNJ), AbbVie (NYSE: ABBV), and Embecta (NASDAQ: EMBC.V) are Dividend Kings that represent good long-term investments.""}, {""date"": ""2023-04-22"", ""headline"": ""J&J to Lift Dividend for 61st Year. These 6 Others Are Raising Payouts Too."", ""summary"": ""Southern Co. and Costco Wholesale are also on the list of big U.S. companies that have unveiled higher dividends this week.""}, {""date"": ""2023-04-23"", ""headline"": ""J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market"", ""summary"": ""The company is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a test for an IPO market that has been in the doldrums for the past year.""}, {""date"": ""2023-04-23"", ""headline"": ""7 big dividends & buybacks: Costco, J&J hike their payouts | Pro Recap"", ""summary"": ""Here is your Pro Recap of the biggest fresh dividend hikes, special dividends, and stock buybacks you may have missed this week.  Costco Wholesale (NASDAQ:COST) shares rose nearly 2% on Thursday after the company hiked its dividend by 13.3% to $1.02 per share, or $4.08 annualized, for an annual yield of 0.8%.  The dividend will be payable on May 19, 2023, to stockholders of record on May 5, 2023, with an ex-dividend date of May 4, 2023.""}, {""date"": ""2023-04-23"", ""headline"": ""Johnson & Johnson to launch IPO roadshow for consumer health unit \ufffd\ufffd\ufffd WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-23"", ""headline"": ""J&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4623, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.2828, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.0967, ""fcfPerShareTTM"": 6.2383, ""grossMargin"": 0.6608, ""inventoryTurnoverTTM"": 2.272, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0027, ""operatingMargin"": -0.0298, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0298, ""psTTM"": 4.7905, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 5.3266, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1151, ""salesPerShare"": 9.4958, ""sgaToSale"": 0.3392, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
15,2023-04-23,159.0342254638672,2023-04-30,160.0215301513672,0.006208127116161588,U1,"[{""date"": ""2023-04-22"", ""headline"": ""ClearBridge Appreciation Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of April 23"", ""summary"": """"}, {""date"": ""2023-04-23"", ""headline"": ""J&J`s Kenvue consumer health spinoff sets IPO terms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-23"", ""headline"": ""J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market"", ""summary"": ""The company is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a test for an IPO market that has been in the doldrums for the past year.""}, {""date"": ""2023-04-23"", ""headline"": ""7 big dividends & buybacks: Costco, J&J hike their payouts | Pro Recap"", ""summary"": ""Here is your Pro Recap of the biggest fresh dividend hikes, special dividends, and stock buybacks you may have missed this week.  Costco Wholesale (NASDAQ:COST) shares rose nearly 2% on Thursday after the company hiked its dividend by 13.3% to $1.02 per share, or $4.08 annualized, for an annual yield of 0.8%.  The dividend will be payable on May 19, 2023, to stockholders of record on May 5, 2023, with an ex-dividend date of May 4, 2023.""}, {""date"": ""2023-04-23"", ""headline"": ""Johnson & Johnson to launch IPO roadshow for consumer health unit \ufffd\ufffd\ufffd WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-23"", ""headline"": ""J&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson management to meet virtually with Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""March 2023 Passive Income - 36% Year-Over-Year Increase"", ""summary"": ""The market seems to have moved on from the banking crisis and keeps chugging on. I don't think there were any raises or cuts in March, but April has brought a couple so far.""}, {""date"": ""2023-04-24"", ""headline"": ""Top Biotech Stocks For Q2 2023: First Gem Is BioNTech"", ""summary"": """"}, {""date"": ""2023-04-24"", ""headline"": ""3 Dividend Aristocrats to Buy for Consistent Income"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""J&J aims for up to $43 billion valuation for consumer health unit Kenvue"", ""summary"": ""Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its consumer health unit, Kenvue, at a time when investor appetite for new listings has been muted.""}, {""date"": ""2023-04-24"", ""headline"": ""J&J Seeks to Raise up to $3.5 Billion in Kenvue Consumer Health Spinoff"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is seeking to raise as much as $3.5 billion in the spinoff its consumer health business, which would be the biggest US initial public offering since 2021.Most Read from BloombergTucker Carlson Leaves Fox News in Shakeup After SettlementClarence Thomas\u2019s Billionaire Friend Did Have Business Before the Supreme CourtCNN Anchor Don Lemon Says He Has Been Fired From the NetworkFour Reasons Why Investors Expect US Dollar to Keep SlidingTucker Carlson\u2019s Fox News Exit Er""}, {""date"": ""2023-04-24"", ""headline"": ""UPDATE 3-J&J aims for up to $43 bln valuation for consumer health unit Kenvue"", ""summary"": ""Johnson & Johnson said on Monday it was seeking a valuation of up to $42.95 billion in the initial public offering of its consumer health unit, Kenvue, at a time when investor appetite for new listings has been muted.  J&J is offering 151.2 million shares of the common stock of Kenvue priced between $20 and $23 per share, aiming to raise up to $3.5 billion, based on the top end of the proposed range of the listing.  \""It's definitely an important deal in restarting the U.S. IPO market,\"" said Matthew Kennedy, senior IPO market strategist at Renaissance Capital.""}, {""date"": ""2023-04-24"", ""headline"": ""J&J's consumer health unit Kenvue aims to raise up to $3.48 bln in US IPO"", ""summary"": ""Johnson & Johnson's consumer health unit, Kenvue, is looking to raise up to $3.48 billion in its U.S. initial public offering, according to a regulatory filing on Monday. (Reporting by Akash Sriram in Bengaluru)""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow"", ""summary"": ""NEW BRUNSWICK, N.J., April 24, 2023--Johnson & Johnson (NYSE: JNJ) today announced that Kenvue Inc. (\""Kenvue\""), a wholly owned subsidiary of Johnson & Johnson comprising its Consumer Health Business, has launched a roadshow for the initial public offering (\""IPO\"") of 151,204,000 shares of its common stock. Kenvue expects to grant the underwriters a 30-day option to purchase up to an additional 22,680,600 shares of its common stock to cover over-allotments, if any. The IPO price is currently expec""}, {""date"": ""2023-04-24"", ""headline"": ""Investors Discuss News From Bank of America and Johnson & Johnson"", ""summary"": ""And we answer listener questions about retirement accounts, buying stock in your employer, and more.""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson spinoff Kenvue receives IPO value of $40 billion"", ""summary"": ""The Yahoo Finance Live team discusses the rise of Johnson & Johnson stock after a steady decline the past year, amid controversy regarding some products.""}, {""date"": ""2023-04-24"", ""headline"": ""Wall Street Headlines, International Investing, and Stocks to Watch"", ""summary"": ""The \""Motley Fool Money\"" crew kicks things off with a look at what's going on with Netflix.""}, {""date"": ""2023-04-24"", ""headline"": ""Cancer victims urge US judge to dismiss J&J talc unit second bankruptcy"", ""summary"": ""Cancer victims on Monday urged a U.S. judge to dismiss a Johnson & Johnson subsidiary's second bankruptcy filing, saying the company is abusing the bankruptcy system in its renewed attempt to resolve tens of thousands of lawsuits alleging that J&J's baby powder and other...""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO"", ""summary"": ""Investing.com -- Johnson & Johnson (NYSE:JNJ) priced shares of its consumer spinoff Kenvue at $20 to $23 apiece in an initial public offering, the company said in a filing Monday.""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson aims to raise $3 billion in Kenvue IPO"", ""summary"": ""Johnson &amp; Johnson JNJ expects to raise roughly $3 billion in an initial public offering of its consumer-health unit. In a filing with the Securities and...""}, {""date"": ""2023-04-24"", ""headline"": ""UPDATE 2-Cancer victims urge US judge to dismiss J&J talc unit second bankruptcy"", ""summary"": ""Cancer victims on Monday urged a U.S. judge to dismiss a Johnson & Johnson subsidiary's second bankruptcy filing, saying the company is abusing the bankruptcy system in its renewed attempt to resolve tens of thousands of lawsuits alleging that J&J's baby powder and other talc products caused cancer.  The J&J subsidiary, LTL Management, this month filed for bankruptcy a second time, seeking to settle all current and future talc claims for a proposed $8.9 billion.  Plaintiffs have filed more than 38,000 lawsuits that have been consolidated in federal court in New Jersey alleging that J&J talc products sometimes contained asbestos and caused ovarian cancer or mesothelioma.""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO"", ""summary"": ""J&J said it launched a roadshow for Kenvue's IPO of more than 151 million shares of common stock.""}, {""date"": ""2023-04-24"", ""headline"": ""Cancer victims urge US judge to dismiss J&J talc unit's second bankruptcy -court document"", ""summary"": ""Cancer victims on Monday urged a U.S. judge to dismiss a Johnson & Johnson subsidiary's second bankruptcy filing, saying that the company is abusing the bankruptcy system in its renewed attempt to resolve tens of thousands of lawsuits alleging that J&J's baby powder and...""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.61% higher to $163.68 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is reportedly readying an investor roadshow to pitch shares of its consumer-healthcare spinoff business, dubbed Kenvue, as early as Monday. Kenvue plans to start meeting with prospective investors with a goal to raise over $3.5 billion in the offering at a valuation of about $40 billion for Kenvue, its soon-to-be spun-off consumer business, which sells products like Tylenol, Band-Aids, and skin-care brands like Aveeno and Neutrogena. Assuming the company and its adv""}, {""date"": ""2023-04-24"", ""headline"": ""Selecting Dividend Aristocrats Using SCHD Methodology - Winning In April"", ""summary"": """"}, {""date"": ""2023-04-24"", ""headline"": ""Are Investors Undervaluing Johnson & Johnson (NYSE:JNJ) By 25%?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$216 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-04-24"", ""headline"": ""4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates"", ""summary"": ""We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.""}, {""date"": ""2023-04-24"", ""headline"": ""The 3 Greatest Dividend Stocks to Buy Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says"", ""summary"": ""J&J's consumer health unit Kenvue aims to raise $3.5 billion or more in the initial public offering, sources told The Wall Street Journal. ""}, {""date"": ""2023-04-24"", ""headline"": ""JPMorgan pharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Arcellx price target raised to $58 from $45 at Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Bed Bath & Beyond files for bankruptcy protection"", ""summary"": ""CNBC\u2019s 'Squawk Box' crew presents news from Bed, Bath & Beyond, J&J, and more.""}, {""date"": ""2023-04-24"", ""headline"": ""Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""4 stocks to watch on Monday: Coca-Cola, Bed Bath & Beyond and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Wall Street Breakfast Podcast: Philips Rises, Revenue Beat"", ""summary"": """"}, {""date"": ""2023-04-24"", ""headline"": ""Johnson & Johnson Eyes 40B Valuation for its Consumer Health Unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference"", ""summary"": ""NEW BRUNSWICK, N.J., April 25, 2023--Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 39th Annual Strategic Decisions Conference on Wednesday, May 31st, at the New York Hilton Midtown in New York. Joaquin Duato, Chairman of the Board and Chief Executive Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).""}, {""date"": ""2023-04-25"", ""headline"": ""J&J\u2019s $40 Billion Spinoff Could Rule Consumer Health. But It Has One Rival."", ""summary"": ""On Monday afternoon,  Johnson & Johnson  which owns each of these brands, put a number on it: About $40 billion.  Johnson & Johnson is pricing the IPO at between $20 and $23 per share, and expects to raise about $3.2 billion.  At a valuation of $40 billion, Kenvue represents about 9% of Johnson & Johnson\u2019s current market value f $426 billion.""}, {""date"": ""2023-04-25"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.92% higher to $165.18 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-04-25"", ""headline"": ""11 Best Mid-Cap Healthcare Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best mid-cap healthcare stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Mid-Cap Healthcare Stocks To Buy Now. The healthcare industry outlook is currently uncertain due to a combination of factors such as economic troubles, a shortage of healthcare workers, [\u2026]""}, {""date"": ""2023-04-25"", ""headline"": ""3M: Catalysts For A Potential Bankruptcy"", ""summary"": ""3M's likely near-term settlement for earplugs can drop the company to junk ratings and imperil the dividend. Find out why I'm bearish on MMM stock.""}, {""date"": ""2023-04-25"", ""headline"": ""Final Trades: UnitedHealth, Johnson & Johnson & more"", ""summary"": ""The \""Halftime Report\"" traders give their top picks to watch for the second half.""}, {""date"": ""2023-04-25"", ""headline"": ""Genmab: Maintaining Hold Rating Due To Arbitration Dismissal And Pipeline Prospects"", ""summary"": ""Genmab's recent dismissal of its second arbitration case against Janssen regarding Darzalex Faspro royalties suggests that these royalties will likely cease after 2030. Read more here.""}, {""date"": ""2023-04-25"", ""headline"": ""J&J's Kenvue consumer health business prepares for stock IPO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Legend Biotech price target raised to $90 from $79 at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""The $50,000 Dividend Portfolio: Your Path To Financial Freedom"", ""summary"": ""In this article, I discuss a model dividend growth portfolio based on the request of a follower. Read more to see my thoughts.""}, {""date"": ""2023-04-25"", ""headline"": ""Alkermes receives second interim award in Janssen arbitration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Sell These 2 Popular Dividends \ufffd\ufffd\ufffdon the Rip\ufffd\ufffd\ufffd Buy These 2 Instead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.55% to $162.62 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-26"", ""headline"": ""Eli Lilly Earnings Are Soon. All Eyes Are on Its Diabetes Drug, Mounjaro."", ""summary"": ""Expectations for first-quarter sales of its diabetes treatment, Mounjaro, are $433 million.""}, {""date"": ""2023-04-26"", ""headline"": ""Pfizer, BioNTech hit new 52-week lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Merck, AstraZeneca dip as FDA reviews cancer drug ahead of AdCom meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Merck, UnitedHealth share losses lead Dow's 88-point fall"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday morning with shares of Merck and UnitedHealth delivering the stiffest headwinds for the price-weighted...""}, {""date"": ""2023-04-26"", ""headline"": ""The Fed Thinks a Recession Is Likely: 5 Warren Buffett Stocks to Buy Now"", ""summary"": ""These stocks owned by Buffett's Berkshire Hathaway can be safe havens during economic downturns.""}, {""date"": ""2023-04-26"", ""headline"": ""Ocugen: Lots To Sort Through But OCU400 Offers A Glimmer Of Upside Potential"", ""summary"": ""Ocugen still has some promising candidates in the pipeline, most noticeably OCU400. See why we are on the sidelines for OCGN stock.""}, {""date"": ""2023-04-26"", ""headline"": ""EU publishes proposed reforms for pharma industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Johnson & Johnson: Reliable Dividend Of 2.9% With Steady Growth"", ""summary"": ""Spin-off of consumer segment, repositioning primary JNJ business unit to be more pharmaceutical and medical device oriented. See why JNJ stock is a buy.""}, {""date"": ""2023-04-26"", ""headline"": ""Get Defensive with These 3 Cash Flow Producing Machines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Alkermes arbitration award better than expected, says Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""7 Stocks That Are Strong Buys on the Heels of Impressive Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Catalyst watch: FOMC, Apple earnings, Kenvue IPO and jobs report are on tap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""25 Countries with The Highest Standard of Living in 2023"", ""summary"": ""In this article, we will look at the 25 countries with the highest standards of living in 2023. You can skip our detailed analysis and head straight to the list of 10 Countries With the Highest Standard of Living in 2023. To judge the quality of life for any country, the standard of living is [\u2026]""}, {""date"": ""2023-04-27"", ""headline"": ""3 Long-Term Stocks to Buy and Hold Forever"", ""summary"": ""The stock market is at an odd juncture right now. 2022 was a tough, bear market and 2023 had plenty of doom-and-gloom at the start \u2014 yet US markets continue to trade pretty well. With many stocks still down big from the highs though, it\u2019s got investors looking for stocks to buy and hold forever. Put simply, they want stocks to buy for the long term that they can count on year-in and year-out. Whether there\u2019s high-inflation, deep recessions, a debt-ceiling crisis or otherwise. When you\u2019re investi""}, {""date"": ""2023-04-27"", ""headline"": ""The Fed Forecasts a Recession: 2 Top Warren Buffett Stocks to Buy Now"", ""summary"": ""Rising inflation and general economic woes have weighed on the market for a while -- and now, the Federal Reserve is predicting a \""mild\"" recession on the horizon.  While a recession is never great news, it's also no reason to panic.  You can start by following in the footsteps of someone who has invested through many recessions -- and has come out as a winner over time.""}, {""date"": ""2023-04-27"", ""headline"": ""Dividend Champions vs Aristocrats: 12 Under-the-Radar Stocks to Consider"", ""summary"": ""In this article, we discuss 12 under-the-radar dividend champions to consider. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Champions vs Aristocrats: 5 Under-the-Radar Stocks to Consider. Dividend Aristocrats are companies in the S&P 500 Index that have increased their dividend payouts [\u2026]""}, {""date"": ""2023-04-27"", ""headline"": ""AbbVie (ABBV) Q1 Earnings Beat, Skyrizi Sales Underperform"", ""summary"": ""AbbVie's (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates.""}, {""date"": ""2023-04-27"", ""headline"": ""Eli Lilly Results Disappoint. Hopes for Obesity Drug Are Lifting the Stock."", ""summary"": ""Excluding the declining sales of Covid-19 antibodies, revenue rose 10% in the quarter, driven by sales of the diabetes and obesity drug.""}, {""date"": ""2023-04-27"", ""headline"": ""Accuray (ARAY) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""Accuray (ARAY) reports a solid fiscal third-quarter top line on the back of robust segmental performances.""}, {""date"": ""2023-04-27"", ""headline"": ""13 Value Stocks to Buy With High Dividend Yields"", ""summary"": ""In this article, we discuss 13 value stocks to buy with high dividend yields. You can skip our detailed analysis of value and dividend stocks and their performance in the past, and go directly to read 5 Value Stocks to Buy With High Dividend Yields. Value stocks trade at a price lower than their intrinsic [\u2026]""}, {""date"": ""2023-04-27"", ""headline"": ""Talcum powder cancer claims target J&J\u2019s new consumer carve-out"", ""summary"": ""Johnson & Johnson\u2019s newly formed consumer business has been targeted by claims that its talcum powder can cause cancer, days before it attempts to complete the largest US initial public offering in almost 18 months.  The consumer carve-out will sell over-the-counter medicines and healthcare brands such as Tylenol and Band-Aid, as well as J&J baby powder products, while some of those that contain talc will be phased out.  J&J had attempted to shield Kenvue from most of the tens of thousands of talc claims already filed against the group.""}, {""date"": ""2023-04-27"", ""headline"": ""Nevro (NVRO) Q1 Earnings and Revenues Surpass Estimates"", ""summary"": ""Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q1, partly owing to robust domestic performance.""}, {""date"": ""2023-04-27"", ""headline"": ""The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans"", ""summary"": ""Johnson & Johnson aiming to raise $3.5 billion in the IPO spinoff of its consumer healthcare division.  In addition, Motley Fool analyst Nick Sciple continues his conversation with a representative of the anonymous group writing on Substack as \""Doomberg\"" about Tesla's plans for the future and investing for energy pinch points.""}, {""date"": ""2023-04-27"", ""headline"": ""Surmodics (SRDX) Q2 Earnings Top Estimates, FY23 View Revised"", ""summary"": ""Surmodics (SRDX) reports a solid fiscal second-quarter top line on the back of robust Medical Device revenues.""}, {""date"": ""2023-04-27"", ""headline"": ""J&J to retain all talc-related liabilities from litigation in US, Canada"", ""summary"": ""Johnson & Johnson said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United States and Canada and will \""indemnify\"" newly formed consumer health unit Kenvue for all costs.""}, {""date"": ""2023-04-27"", ""headline"": ""Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms Guidance"", ""summary"": ""Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.""}, {""date"": ""2023-04-27"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Merck Q1 Earnings: Delivering Strong Results"", ""summary"": ""Merck reported Q1 results and beat estimates on both lines. Read why I believe that MRK is a good long-term holding, but not a great buy any longer.""}, {""date"": ""2023-04-27"", ""headline"": ""June 9th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""2 High-Yielding Dividend Stocks That Just Boosted Their Payouts"", ""summary"": ""Two stocks that fit both criteria and that increased their dividend payments this month are Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Southern Company\u00a0(NYSE: SO).  Let's find out a bit more about these two high-yielding dividend stocks.  On April 18, healthcare company Johnson & Johnson announced it was going to increase its dividend payment by 5.3%.""}, {""date"": ""2023-04-27"", ""headline"": ""The Fed Expects a Recession: 2 Dow Stocks to Buy Hand Over Fist and 1 to Avoid Like the Plague"", ""summary"": ""Two time-tested Dow stocks are perfectly positioned if the U.S. dips into a recession, while another Dow component has an abysmal track record during economic downturns.""}, {""date"": ""2023-04-27"", ""headline"": ""Fanatics moves one step closer to IPO, hiring Meta's head of investor relations"", ""summary"": ""Fanatics hires Meta IR head Deborah Crawford, who had also run investor relations at Netflix, as the sports platform company takes another step closer to IPO.""}, {""date"": ""2023-04-27"", ""headline"": ""Merck revenue falls after dramatic drop in sales of Covid antiviral treatment "", ""summary"": ""Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations. ""}, {""date"": ""2023-04-27"", ""headline"": ""J&J's consumer unit named in talcum powder cancer claims - FT"", ""summary"": ""Johnson & Johnson's <JNJ.N> newly formed consumer health unit Kenvue has been named in claims that the company's talcum powder can cause cancer, the Financial Times reported on Thursday.""}, {""date"": ""2023-04-27"", ""headline"": ""UPDATE 2-J&J to retain all talc-related liabilities from litigation in US, Canada"", ""summary"": ""Johnson & Johnson said on Thursday it has agreed to retain all talc-related liabilities arising from litigation in the United States and Canada and will \""indemnify\"" newly formed consumer health unit Kenvue for all costs.  The statement comes after the Financial Times reported earlier in the day that Kenvue had been named in claims that its talcum powder can cause cancer.  Kenvue had been named in at least seven talc lawsuits filed since the start of April, according to the newspaper, which cited regulatory filings and people familiar with the matter.""}, {""date"": ""2023-04-27"", ""headline"": ""Eaton Vance Worldwide Health Science Fund`s Top 1st-Quarter Trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""BRIEF-Talcum Powder Cancer Claims Target J&J\u2019S New Consumer Carve-Out Kenvue - FT"", ""summary"": ""* TALCUM POWDER CANCER CLAIMS TARGET J&J'S NEW CONSUMER CARVE-OUT KENVUE - FT""}, {""date"": ""2023-04-27"", ""headline"": ""JNJ's consumer unit targeted by talcum powder cancer claims - FT"", ""summary"": ""Johnson & Johnson's newly formed consumer business Kenvue has been named in at least seven lawsuits claiming the company's talcum powder can cause cancer, the Financial Times reported on Thursday, citing regulatory filings and people familiar with the matter. (Reporting...""}, {""date"": ""2023-04-28"", ""headline"": ""Why J&J\u2019s Kenvue Spinoff Is Just What the IPO Doctor Ordered"", ""summary"": ""The consumer health company features a range of leading brands, a relatively cheap valuation, a solid balance sheet, consistent earnings, and a healthy dividend yield. It\u2019s no tech unicorn, a good thing in 2023.""}, {""date"": ""2023-04-28"", ""headline"": ""What To Expect After The Failed AbbVie Drug Sales"", ""summary"": ""AbbVie's revenue amounted to $12,225 million in the first three months of 2023, 9.7% less than the previous year. Find out my recent analysis of ABBV stock.""}, {""date"": ""2023-04-28"", ""headline"": ""DURA: An ETF Seeking Dividends With Quality"", ""summary"": ""VanEck Durable High Dividend ETF is a large cap dividend fund with valuation and quality criteria well-balanced across sectors. Click here for our full DURA review.""}, {""date"": ""2023-04-28"", ""headline"": ""Merit Medical (MMSI) Tops Q1 Earnings Estimates, Ups FY23 View"", ""summary"": ""Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the first quarter.""}, {""date"": ""2023-04-28"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.43% higher to $163.70 Friday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-04-28"", ""headline"": ""Integer Holdings (ITGR) Q1 Earnings, Revenues Beat Estimates"", ""summary"": ""Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.""}, {""date"": ""2023-04-28"", ""headline"": ""2 Dow 30 Stocks To Watch Before May 2023"", ""summary"": ""Do you have these Dow 30 stocks on your radar right now?""}, {""date"": ""2023-04-28"", ""headline"": ""Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock"", ""summary"": ""Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.""}, {""date"": ""2023-04-28"", ""headline"": ""ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.""}, {""date"": ""2023-04-28"", ""headline"": ""My Top 10 High Dividend Yield Stocks To Invest In May 2023"", ""summary"": ""I will introduce you to 10 companies that provide investors with a relatively high Dividend Yield and which I consider attractive to invest in. Click here to read more.""}, {""date"": ""2023-04-28"", ""headline"": ""Is It Too Late to Buy Johnson & Johnson's Stock?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) (J&J) is a renowned name in the healthcare and consumer goods industries.  The company has been around for over a century and has a strong global presence.  The company has received the prestigious title of Dividend King, which is awarded to companies that have increased their dividend annually for at least 50 years.""}, {""date"": ""2023-04-28"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""J&J to `indemnify` Kenvue from any talc-related costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""First Republic Bank Faces a Critical Weekend. What to Expect."", ""summary"": ""Amazon hit by outlook for cloud business, House investigating SVB collapse, and other news to start your day.""}, {""date"": ""2023-04-28"", ""headline"": ""Johnson & Johnson`s Kenvue targeted by talcum powder cancer claims, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-29"", ""headline"": ""7 High-Yield Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-29"", ""headline"": ""How To Allocate $15,000 Among My Top 10 High Dividend Yield Companies For May 2023"", ""summary"": ""In this article, I will demonstrate how you can build an investment portfolio that is oriented towards generating dividend income with my top 10 high dividend yield companies for May.""}, {""date"": ""2023-04-29"", ""headline"": ""A Johnson & Johnson (NYSE:JNJ) insider lowered their holding by 10% earlier this year"", ""summary"": ""Viewing insider transactions for Johnson & Johnson's ( NYSE:JNJ ) over the last year, we see that insiders were net...""}, {""date"": ""2023-04-29"", ""headline"": ""Stocks To Watch: Eyes On Apple, Cloudflare, Canadian National Railway And Berkshire Hathaway"", ""summary"": ""Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week.""}, {""date"": ""2023-04-30"", ""headline"": ""20 Cities with the Highest Depression Rates in the U.S."", ""summary"": ""In this piece, we will take a look at the twenty cities with the highest depression rates in the U.S. For more cities, head on over to 5 Cities with the Highest Depression Rates in the U.S. The devastating effects of depression cause suffering to countless families each year and also lead to staggering economic [\u2026]""}, {""date"": ""2023-04-30"", ""headline"": ""2 Simple Ways to Make $40,000 in Passive Income"", ""summary"": ""Here are two simple ways to make $40,000 in passive income.  One easy way to generate passive income is to invest in dividend stocks.  The higher the dividend yield of a stock is, the greater your passive income will be.""}, {""date"": ""2023-04-30"", ""headline"": ""US IPO Weekly Recap: J&J Spin-Off Kenvue Launches Billion-Dollar Deal In A 1 IPO Week"", ""summary"": ""The week\u00e2\u0080\u0099s news was led by J&J\u00e2\u0080\u0099s consumer health unit Kenvue, which set terms for its $3.3 billion listing on Monday. Six IPOs submitted initial filings this past week.""}, {""date"": ""2023-04-30"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""J&J`s Kenvue spinoff a rare IPO winner in moribund market, Barron`s says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
16,2023-04-30,160.0215301513672,2023-05-07,159.02444458007812,-0.006230946362941969,D1,"[{""date"": ""2023-04-29"", ""headline"": ""7 High-Yield Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""Johnson & Johnson reports first results from TAR-200 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""The 7 Best Dividend Stocks to Buy for May 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""20 Cities with the Highest Depression Rates in the U.S."", ""summary"": ""In this piece, we will take a look at the twenty cities with the highest depression rates in the U.S. For more cities, head on over to 5 Cities with the Highest Depression Rates in the U.S. The devastating effects of depression cause suffering to countless families each year and also lead to staggering economic [\u2026]""}, {""date"": ""2023-04-30"", ""headline"": ""2 Simple Ways to Make $40,000 in Passive Income"", ""summary"": ""Here are two simple ways to make $40,000 in passive income.  One easy way to generate passive income is to invest in dividend stocks.  The higher the dividend yield of a stock is, the greater your passive income will be.""}, {""date"": ""2023-04-30"", ""headline"": ""US IPO Weekly Recap: J&J Spin-Off Kenvue Launches Billion-Dollar Deal In A 1 IPO Week"", ""summary"": ""The week\u00e2\u0080\u0099s news was led by J&J\u00e2\u0080\u0099s consumer health unit Kenvue, which set terms for its $3.3 billion listing on Monday. Six IPOs submitted initial filings this past week.""}, {""date"": ""2023-04-30"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""J&J`s Kenvue spinoff a rare IPO winner in moribund market, Barron`s says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Why the human genome could be healthcare\u2019s holy grail"", ""summary"": ""23andMe Co-founder & CEO Anne Wojcicki says we\u2019ve only seen the tip of the iceberg for human genomics and DNA research. \u201cLook at all the explosion of all these new technologies with gene therapy, with CRISPR (CRSP), with RNA technologies and understanding the human genome,\u201d Wojcicki told Yahoo Finance at the Milken Global Conference in Beverly Hills, California. Wojcicki says she\u2019s \u2018disappointed\u2019 in the lack of progress around genomics, despite having just crossed a significant milestone, 20 years since the first complete sequencing of the human genome. \u201cI think part of the reason is that genetics tells you a lot about what you're at risk for and it doesn't necessarily financially pay to get you that preventative information and to intervene in that way versus just treating people once they have a disease.\u201d The 23andME (ME) CEO also says they are looking into building new partnerships with pharmaceutical companies once the company\u2019s partnership with GlaxoSmithKline (GSK) ends in July.  Interview Highlights: 1:29 How genetics can tell us more about human diversity 2:20 Why 23andMe CEO is \u2018disappointed\u2019 about genome adoption 5:00 Wojcicki on 23andMe partnership with pharma giant GSK 7:15 Genetics needs to be part of medical school training 8:26 What\u2019s next for 23andMe""}, {""date"": ""2023-05-01"", ""headline"": ""Healthcare And Facebook Help Propel My 25 Stock ~$424K Portfolio To New Highs In April"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends and risk stocks for. See how it performed in April 2023.""}, {""date"": ""2023-05-01"", ""headline"": ""Jim Cramer recaps and grades the stock market's earnings season so far"", ""summary"": ""'Mad Money' host Jim Cramer discusses the companies that have reported so far this earnings season, breaking down who did great, okay, and who has more work to do.""}, {""date"": ""2023-05-01"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.06% to $163.60 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-01"", ""headline"": ""J&J's Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021"", ""summary"": ""Kenvue is parent to a host of household name brands, including Tylenol, Listerine, Band-Aid, Neutrogena and Nicorette""}, {""date"": ""2023-05-01"", ""headline"": ""J&J`s Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Union Pacific Among 12 Companies To Announce Dividend Increases In First Half Of May"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Johnson & Johnson Holding Value In Wake Of Lawsuits"", ""summary"": ""Baby powder controversy has impacted Johnson & Johnson\u00e2\u0080\u0099s share price. It is scrambling to deal with lawsuits. But is JNJ still a buy? Click for our answer.""}, {""date"": ""2023-05-01"", ""headline"": ""Johnson & Johnson reports 73% complete remission for bladder cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""J&J`s Janssen reports 72.7% complete response rate in bladder cancer study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""If I Could Buy Only 1 Warren Buffett Stock in May, This Would Be It"", ""summary"": ""When it comes to investing ideas, I can't think of a better fount of wisdom than Warren Buffett.  Buffett's biggest position in Berkshire's portfolio by far is also my personal biggest individual stock holding -- Apple (NASDAQ: AAPL).  Like Buffett, I think that Apple has great long-term prospects.""}, {""date"": ""2023-05-01"", ""headline"": ""U.S. to end COVID vaccine mandates for foreign travelers, others next week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Johnson & Johnson`s Kenvue to price at $22 per share, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Kenvue, Acelyrin Go Public This Week. Why the Biotech IPO Window Isn\u2019t Open Yet."", ""summary"": ""Two initial public offerings in the industry in a single week wouldn't have been big news in 2021, but this year it is enough to stop traffic.""}, {""date"": ""2023-05-02"", ""headline"": ""Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine"", ""summary"": ""Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies. The company said these investigational CD20-directed autologous CAR-Ts demonstrated favorable overall and complete response rates in Phase 1 studies in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL) in C""}, {""date"": ""2023-05-02"", ""headline"": ""Zimmer Biomet (ZBH) Q1 Earnings Beat Estimates, View Raised"", ""summary"": ""Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.""}, {""date"": ""2023-05-02"", ""headline"": ""UnitedHealth and Other Stocks to Buy for an End to the Fed\u2019s Rate Hikes"", ""summary"": ""This year\u2019s rally may have been spurred by investors front-running the end of the Fed\u2019s tightening who will be motivated to sell stocks once the pause is...""}, {""date"": ""2023-05-02"", ""headline"": ""Hologic's (HOLX) Q2 Earnings Beat Estimates, 2023 View Up"", ""summary"": ""The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.""}, {""date"": ""2023-05-02"", ""headline"": ""IDEXX (IDXX) Q1 Earnings Beat Estimates, Margins Increase"", ""summary"": ""Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.""}, {""date"": ""2023-05-02"", ""headline"": ""Kenvue, Acelyrin Go Public on Thursday. Why the Biotech IPO Window Isn\u2019t Open Yet."", ""summary"": ""Two initial public offerings in the industry in a single week wouldn't have been big news in 2021, but this year it is enough to stop traffic.""}, {""date"": ""2023-05-02"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is a well-known consumer and healthcare company that has been in operation for more than a century.  Meanwhile,\u00a0Intuitive Surgical\u00a0(NASDAQ: ISRG) has made a name for itself as the market leader in robotic surgery.  Johnson & Johnson is wildly popular for its consumer brands, such as Band-Aids, Listerine, Neutrogena, and Tylenol.""}, {""date"": ""2023-05-02"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts` Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Patients Lose Access to Free Medicines Amid Spat Between Drugmakers, Health Plans"", ""summary"": ""The programs have been costing drugmakers billions of dollars a year and have been increasing as health plans seeking to control their own spending have tried to take advantage of the assistance.""}, {""date"": ""2023-05-02"", ""headline"": ""Johnson & Johnson projects earnings impact from CAR-T deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Pfizer earnings and revenue top expectations despite Covid vaccine sales decline"", ""summary"": ""Pfizer topped analysts' expectations with its first-quarter earnings report, despite a sales decline driven by the lower demand for the company's Covid vaccine.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J spinout Kenvue shares climb 22% following $3.8B upsized IPO (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""LONDON BRIEFING: Shell sets USD4 billion buyback; Next backs outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Which Healthcare Stock Is a Compelling Pick for the Long Haul?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""WHO meeting is set to decide whether to end COVID emergency"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Stock market today: Wall Street sinks as bank fears flare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering"", ""summary"": ""NEW BRUNSWICK, N.J. & SKILLMAN, N.J., May 03, 2023--Johnson & Johnson (NYSE: JNJ) and Kenvue Inc. (\""Kenvue\""), a wholly owned subsidiary of Johnson & Johnson, today announced the pricing of Kenvue\u2019s upsized initial public offering (\""IPO\"") of 172,812,560 shares of Kenvue\u2019s common stock at a price to the public of $22.00 per share. In addition, Kenvue has granted the underwriters a 30-day option to purchase up to an additional 25,921,884 shares of its common stock to cover over-allotments, if any.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J's Kenvue prices upsized IPO at upper end of range to raise $3.7 billion -sources"", ""summary"": ""Johnson & Johnson on Wednesday priced the initial public offering (IPO) of its consumer-health business Kenvue Inc at the upper end of its target range to raise $3.66 billion, according to two people familiar with the matter.""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson consumer arm valued at $41bn in biggest US IPO since 2021"", ""summary"": ""Kenvue, the consumer arm of healthcare giant Johnson & Johnson, was valued at $41bn in an upsized initial public offering that marked the biggest US listing in almost 18 months.  The stock will begin trading on the New York Stock Exchange on Thursday.  The deal is the largest since the IPO of electric vehicle maker Rivian in November 2021, and alone will more than double the sum raised in traditional US listings this year.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J Prices Consumer Unit IPO at $22 a Share"", ""summary"": ""The listing of the Tylenol maker would be by far the biggest initial public offering so far this year.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J\u2019s Kenvue Prices IPO at $22 Per Share"", ""summary"": ""(Bloomberg) -- Johnson & Johnson\u2019s consumer health business Kenvue Inc. has priced its initial public offering at $22 per share, according to people familiar with the matter. Most Read from BloombergZelenskiy Denies Ukraine Sent Drones to Hit Putin, KremlinNigeria Targeted a UK Mansion; Its Next Leader\u2019s Son Now Owns ItUS Looks Past India\u2019s Rights Record as China Worries DeepenBanker Pay Surges For Those Willing to Work in Saudi ArabiaCarl Icahn\u2019s Wealth Plunges $10 Billion on Hindenburg Short-S""}, {""date"": ""2023-05-03"", ""headline"": ""UPDATE 2-J&J's Kenvue prices upsized IPO at upper end of range to raise $3.7 bln -sources"", ""summary"": ""Johnson & Johnson on Wednesday priced the initial public offering (IPO) of its consumer-health business Kenvue Inc at the upper end of its target range to raise $3.66 billion, according to two people familiar with the matter.  J&J did not immediately respond to a request for comment.  Kenvue's share sale marks the biggest IPO to result from a corporate carve-out in over two decades.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J's Kenvue prices IPO within range to raise $3.7 bln - source"", ""summary"": ""Johnson & Johnson on Wednesday priced the initial public offering (IPO) of its consumer-health business at the upper end of its target range to raise $3.66 billion, people familiar with the matter said,""}, {""date"": ""2023-05-03"", ""headline"": ""J&J, Cancer Victims Ordered to Start Mediation in Bankruptcy"", ""summary"": ""(Bloomberg) -- A federal judge ordered a new round of settlement talks between Johnson & Johnson and lawyers who spurned the company\u2019s offer to pay $8.9 billion to end tens of thousands of cancer claims filed by people who used the company\u2019s popular baby powder.Most Read from BloombergZelenskiy Denies Ukraine Sent Drones to Hit Putin, KremlinNigeria Targeted a UK Mansion; Its Next Leader\u2019s Son Now Owns ItUS Looks Past India\u2019s Rights Record as China Worries DeepenBanker Pay Surges For Those Willi""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021"", ""summary"": ""A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares priced near the top of the range.""}, {""date"": ""2023-05-03"", ""headline"": ""CVS Health (CVS) Q1 Earnings Surpass Estimates, EPS View Cut"", ""summary"": ""CVS Health's (CVS) robust sales growth across all three operating segments drives top-line results.""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.31% to $162.87 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-03"", ""headline"": ""DENTSPLY SIRONA (XRAY) Q1 Earnings & Revenues Beat Estimates"", ""summary"": ""DENTSPLY SIRONA's (XRAY) Q1 earnings and revenues decline year over year, driven by the unfavorable foreign currency movement and soft demand across all geographical segments.""}, {""date"": ""2023-05-03"", ""headline"": ""With 71% institutional ownership, Johnson & Johnson (NYSE:JNJ) is a favorite amongst the big guns"", ""summary"": ""Key Insights Significantly high institutional ownership implies Johnson & Johnson's stock price is sensitive to their...""}, {""date"": ""2023-05-03"", ""headline"": ""2 Stocks to Buy With $200 That Can Survive Any Recession"", ""summary"": ""Investors have been worried about the possibility of a recession since last year, but an economic downturn just got a bit more likely.  The U.S. Federal Reserve recently predicted a mild recession would hit by late 2023.  Other bodies of economists have already made similar forecasts, but it carries more weight when it comes from the Federal Reserve.""}, {""date"": ""2023-05-03"", ""headline"": ""Penumbra (PEN) Q1 Earnings Top Estimates, Sales Remain Robust"", ""summary"": ""Penumbra's (PEN) sales during the first quarter reflect continued demand for its products. The 2023 outlook is encouraging as earnings improve despite macro challenges.""}, {""date"": ""2023-05-03"", ""headline"": ""How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) recently announced it was increasing its dividend for the 61st consecutive year.  If you're investing in a dividend growth stock, one of the big incentives to hold onto it is that you could be collecting much larger dividend payments in the future.  There are many high-yielding dividend stocks that can offer investors a higher payout than Johnson & Johnson's stock does, but its more modest payout can be safer, and it's also likely to grow.""}, {""date"": ""2023-05-03"", ""headline"": ""FDA approves GSK's RSV vaccine for older adults, world's first shot against virus "", ""summary"": ""The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market. ""}, {""date"": ""2023-05-03"", ""headline"": ""Only 2 Companies Are AAA Rated As U.S. Risks Being A Deadbeat"", ""summary"": ""Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.""}, {""date"": ""2023-05-03"", ""headline"": ""Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Down"", ""summary"": ""Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson Increases Dividend: What Shareholders Need To Know"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""KVUE Stock: Should You Buy Into the Kenvue IPO?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J's consumer health business, Kenvue, is going public this week. Here's what to know"", ""summary"": ""J&J's consumer health spinoff, Kenvue, is expected to set an initial public offering price Wednesday night and trade Thursday on the New York Stock Exchange. ""}, {""date"": ""2023-05-03"", ""headline"": ""Johnson & Johnson`s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""J&J talc bankruptcy judge pushes both sides into settlement talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""3 Dividend Stocks to Count on No Matter What the Market Does"", ""summary"": ""Many of the best dividend stocks also happen to be great companies. The type of consistency we crave in our dividends tends to be a cultural consistency and one that can be found throughout the years of various management at the firm. On the surface, we are looking for dividend stocks to buy. But in reality, we are looking for dividend aristocrats that can deliver across the board. That doesn\u2019t mean simply paying out or raising a dividend. It also includes consistency with its business and the l""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue Shares Jump on First Day of Trading"", ""summary"": ""Shares of Kenvue, the consumer health spinoff of Johnson & Johnson, jumped higher on May 4, 2023, their first day on the markets.""}, {""date"": ""2023-05-04"", ""headline"": ""20 Biggest Holding Companies in USA"", ""summary"": ""In this piece, we will take a look at the 20 biggest holding companies in USA. For more companies such as these, head on over to 5 Biggest Holding Companies in USA. A holding company \u2014 usually a corporation or LLC \u2014 is created for the primary business of holding a controlling interest in the [\u2026]""}, {""date"": ""2023-05-04"", ""headline"": ""PacWest and Western Alliance, Apple earnings, Kenvue IPO: Today's top stories"", ""summary"": ""Yahoo Finance Live anchors Akiko Fujita and Seana Smith take a look back on several of Thursday's leading headlines.""}, {""date"": ""2023-05-04"", ""headline"": ""Maker of Tylenol, Band-Aid\u00a0Climbs in Debut After Biggest US IPO Since 2021"", ""summary"": ""(Bloomberg) -- Kenvue Inc., the consumer health business of Johnson & Johnson, climbed from its initial public offering price during Thursday\u2019s debut session \u2014 breaking a lull in large US listings that\u2019s lasted for more than a year. Most Read from BloombergChina Takes the Yuan Global in Bid to Repel a Weaponized DollarPeter Thiel Says Moving to Florida from Silicon Valley Is Too ExpensiveTD, First Horizon End $13 Billion Merger as Regulators StallZelenskiy Denies Ukraine Sent Drones to Hit Putin""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue hopes to bring consumers the products and solutions 'they need' following IPO: CEO"", ""summary"": ""Kenvue CEO Thibaut Mongon joins Yahoo Finance's Anjalee Khemlani on the floor of the New York Stock Exchange to discuss the IPO of the Johnson & Johnson spinoff and the company's outlook in the personal pharmaceutical space.""}, {""date"": ""2023-05-04"", ""headline"": ""Jim Cramer lays out how to play the impending debt ceiling crisis"", ""summary"": ""Bank stocks won't destroy the market so long as the debt ceiling crisis is resolved, Jim Cramer said on Thursday.\u00a0""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue IPO: corporate carve-outs provide rare payday for bankers"", ""summary"": ""Johnson & Johnson arm continues trend of subsidiary sales serving up the biggest deals in a feeble listings market""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue Stock Jumps in IPO of Former J&J Consumer-Health Business"", ""summary"": ""Shares of the company, which owns brands including Tylenol, Band-Aid, and Neutrogena, jumped 17% as public trading began.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's Kenvue valued at $48 billion after shares jump in market debut"", ""summary"": ""Johnson & Johnson's consumer health spinoff Kenvue Inc rose 16% and fetched a valuation of about $48 billion in its market debut on Thursday, marking the biggest U.S. initial public offering since 2021.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's Kenvue valued at $48 bln in biggest US IPO since 2021"", ""summary"": ""Kenvue Inc fetched a valuation of nearly $48 billion in its market debut after shares of Johnson & Johnson's consumer health business rose 16% at the open on Thursday. (Reporting by Manya Saini and Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)""}, {""date"": ""2023-05-04"", ""headline"": ""Amedisys (AMED) Q1 Earnings Beat Estimates, Margins Dip"", ""summary"": ""Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.""}, {""date"": ""2023-05-04"", ""headline"": ""Tandem Diabetes (TNDM) Q1 Earnings Miss, Gross Margin Dips"", ""summary"": ""According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.""}, {""date"": ""2023-05-04"", ""headline"": ""12 Best Performing Dividend ETFs in 2023"", ""summary"": ""In this article, we discuss 12 best performing dividend ETFs in 2023. You can skip our detailed analysis of dividend exchange-traded funds and their importance in today\u2019s market, and go directly to read 5 Best Performing Dividend ETFs in 2023. Dividend-focused exchange-traded funds invest in stocks of companies that pay dividends. These ETFs can track [\u2026]""}, {""date"": ""2023-05-04"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.45% to $162.13 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue's IPO Extravaganza: A Historic $41 Billion Spinoff from Johnson & Johnson"", ""summary"": ""Johnson & Johnson's (NYSE: JNJ) consumer-healthcare business carve-out, Kenvue Inc, priced its upsized initial public offering of 172.8 million shares at $22.00 per share. The IPO values Kenvue at about $41 billion. The offering was priced at the higher end of the $20 to $23 targeted range, with about 10% more shares sold than planned. Kenvue has granted the underwriters an option to purchase up to 25.9 million shares. Kenvue's common stock has been approved for listing on the New York Stock Exc""}, {""date"": ""2023-05-04"", ""headline"": ""NEW YORK MARKET CLOSE: Banking jitters continue to pull US stocks down"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""FATE Incurs Narrower-Than-Expected Q1 Loss on Lower Expenses"", ""summary"": ""FATE reports lower-than-expected loss on higher collaboration revenues and lower operating expenses in first-quarter 2023.""}, {""date"": ""2023-05-04"", ""headline"": ""Phibro (PAHC) Q3 Earnings Miss Estimates, Gross Margin Up"", ""summary"": ""Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.""}, {""date"": ""2023-05-04"", ""headline"": ""Envista (NVST) Q1 Earnings Miss Estimates, Margins Down"", ""summary"": ""Weakness in China and Russia and lower demand for large capital equipment hurts Envista's (NVST) Q1 revenues.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion"", ""summary"": ""Kenvue, which owns brands including Tylenol, Band-Aid, and Neutrogena, will begin trading Thursday. Shares were priced higher than an earlier range.""}, {""date"": ""2023-05-04"", ""headline"": ""How To Allocate $20,000 Among My Top 20 Dividend Income Stocks For May 2023"", ""summary"": ""This article will show you how you could allocate $20,000 among 10 high dividend yield and 10 dividend growth companies as well as one ETF. Read more here.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's Kenvue likely to fetch up to $46.7 bln valuation in market debut"", ""summary"": ""Kenvue makes Wall Street deubt""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's Kenvue likely to fetch up to $46.7 bln valuation in market debut "", ""summary"": ""Johnson & Johnson's consumer health unit Kenvue Inc was set to fetch a valuation of up to $46.7 billion on Thursday, as its shares were indicated to open nearly 14% above their offer price on the NYSE.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's consumer health spinoff Kenvue soars on trading debut"", ""summary"": ""Investing.com -- Johnson and Johnson's consumer health spinoff Kenvue surged Thursday after making its debut on the New York Stock Exchange.""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion"", ""summary"": ""Kenvue's stock was cheered in its Wall Street debut Thursday, as the J&J spinoff saw its stock open 16.0% above where the initial public offering was priced.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut"", ""summary"": ""Kenvue's debut is the biggest U.S. IPO since EV maker Rivian went public in 2021.""}, {""date"": ""2023-05-04"", ""headline"": ""Qiagen (QGEN) Q1 Earnings Top Estimates, Operating Margin Down"", ""summary"": ""Amid an uncertain macroeconomic environment, Qiagen's (QGEN) first-quarter results reflect an impressive organic top line, led by strength in non-COVID-19 product groups.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J spinout Kenvue shares climb 16% following $3.8B upsized IPO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Myriad Genetics (MYGN) Lags Q1 Earnings, Updates '23 View"", ""summary"": ""Myriad Genetics (MYGN) delivers a year-over-year increase in first-quarter revenues, reflecting a positive volume improvement across the portfolio.""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue stock opens 16% above IPO, valuing the company at $47.7 billion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J spinoff Kenvue opens at $25.53, IPO priced at $22 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""The 3 Most Undervalued Blue-Chip Stocks to Buy in May 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue indicated to open at $25-$25.50, IPO priced at $22 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Interesting JNJ Put And Call Options For June 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Kenvue indicated to open at $24-$25, IPO priced at $22 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""IN BRIEF: J&J prices subsidiary Kenvue's NYSE initial public offering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""5 things to know before the stock market opens Thursday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-05-04"", ""headline"": ""Wall Street Breakfast Podcast: PacWest Confirms Sale Talks"", ""summary"": ""PacWest Bancorp confirms sale talks following stock plunge. Banking conditions have improved; pause decision not yet made: Powell press conference. J&J spinout Kenvue raises $3.8B.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna posts surprise quarterly profit despite waning demand for Covid vaccines"", ""summary"": ""Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product. ""}, {""date"": ""2023-05-04"", ""headline"": ""Johnson and Johnson IPO Today \ufffd\ufffd\ufffd Consumer Healthcare Unit Starts Trading at $22"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Johnson & Johnson`s (NYSE:JNJ) Arm Is Ready to Go Public"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Johnson & Johnson`s (NYSE:JNJ) Arm Ready to Go Public"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""3 Dividend Stocks to Count on No Matter What the Market Does\ufffd\ufffd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""J&J`s Kenvue: Unlocking Value in a Stagnant Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Dividend Income Summary: Lanny`s April 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Artificial Intelligence Engine Predicts GENI Stock to Gain 2% by June 2"", ""summary"": ""The world\u2019s foremost artificial intelligence stock trading algorithm, An-E, predicts that Genius Sports (NYSE:GENI) stock will gain 2.7% by June 2. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked\u2026 but An-E sa""}, {""date"": ""2023-05-05"", ""headline"": ""Kenvue: A Look At The Johnson Spinoff"", ""summary"": ""Kenvue has been spun-off from Johnson & Johnson in a large IPO. The spinoff was well-received by the market. Click here for more post-spinoff take on KVUE stock.""}, {""date"": ""2023-05-05"", ""headline"": ""Artificial Intelligence Engine Predicts TME Stock to Gain 3% by June 2"", ""summary"": ""The world\u2019s foremost artificial intelligence stock trading algorithm, An-E, predicts that Tencent Music Entertainment (NYSE:TME) stock will gain 2.8% by June 2. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked""}, {""date"": ""2023-05-05"", ""headline"": ""Protagonist, A Top 1% Biotech, Briefly Breaks Out On Psoriasis Enthusiasm"", ""summary"": ""Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.""}, {""date"": ""2023-05-05"", ""headline"": ""Artificial Intelligence Engine Predicts IQ Stock to Gain 3% by June 2"", ""summary"": ""The world\u2019s foremost artificial intelligence stock trading algorithm, An-E, predicts that iQiyi (NASDAQ:IQ) stock will gain 3% by June 2. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked\u2026 but An-E saw it comin""}, {""date"": ""2023-05-05"", ""headline"": ""Artificial Intelligence Engine Predicts GOOG Stock to Gain 2.6% by June 2"", ""summary"": ""The world\u2019s foremost artificial intelligence stock trading algorithm, An-E, predicts that Alphabet (NASDAQ:GOOG) stock will gain 2.6% by June 2. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked\u2026 but An-E saw i""}, {""date"": ""2023-05-05"", ""headline"": ""Globus Medical (GMED) Q1 Earnings Beat, Operating Margin Dips"", ""summary"": ""The significant year-over-year surge in Globus Medical's (GMED) Enabling Technologies sales is driven by ongoing demand for the company's robotics and imaging system technologies.""}, {""date"": ""2023-05-05"", ""headline"": ""Insulet (PODD) Q1 Earnings Beat Estimates, Sales View Up"", ""summary"": ""Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.""}, {""date"": ""2023-05-05"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.34% higher to $162.68 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-05-05"", ""headline"": ""My Dividend Growth Portfolio April Update - Dividend ETFs Are Looking Appealing"", ""summary"": ""There are a lot of ok bargains available, but not a lot of great deals. This may be a time to consider ETFs to capture the broad value. Click here to read more.""}, {""date"": ""2023-05-05"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-05-05"", ""headline"": ""Johnson & Johnson price target raised to $170 from $168 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Bruker (BRKR) Tops Q1 Earnings Estimates, Raises '23 Outlook"", ""summary"": ""Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.""}, {""date"": ""2023-05-05"", ""headline"": ""Bio-Rad (BIO) Q1 Earnings Beat Estimates, Operating Margin Down"", ""summary"": ""Bio-Rad's (BIO) first-quarter results reflect core strength across the Life Science and Clinical Diagnostics segments amid ongoing supply-chain constraints.""}, {""date"": ""2023-05-05"", ""headline"": ""Kenvue CEO looks to brand, product innovation to drive growth after IPO"", ""summary"": ""Kenvue CEO Thibaut Mongon said the spinoff's portfolio of brands, which includes Band-Aid, Tylenol and Neutrogena, has \""ample opportunity\"" to grow.\u00a0""}, {""date"": ""2023-05-05"", ""headline"": ""Kenvue Stock Surges On Trading Debut"", ""summary"": ""Johnson & Johnson (JNJ) spinoff Kenvue (KVUE) began trading on Thursday. Read why I think Kenvue likely will not become a high-growth company.""}, {""date"": ""2023-05-05"", ""headline"": ""WHO ends global public health emergency status for COVID-19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""VIG: I Own This ETF So I Can Sleep Like A Baby"", ""summary"": ""Here I'm going to cover Vanguard Dividend Appreciation Index Fund ETF Shares, which focuses on stocks that grow their dividends. Click here for more on VIG.""}, {""date"": ""2023-05-05"", ""headline"": ""Wall Street Breakfast Podcast: Apple Rises On Q2 Results"", ""summary"": ""Apple pops as Q2 results aided by iPhone, unveils $90B buyback. Nonfarm payrolls reports expected to show jobs growth easing in April. The Duckhorn Portfolio buys wine production facility.""}, {""date"": ""2023-05-06"", ""headline"": ""This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock"", ""summary"": ""Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.""}, {""date"": ""2023-05-06"", ""headline"": ""3 Great Income Stocks That Retirees Should Love"", ""summary"": ""If you're looking for additional retirement income, these three stocks should be right up your alley.""}, {""date"": ""2023-05-06"", ""headline"": ""5 Conservative And Cheap Dividend Stocks To Invest In - May 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-07"", ""headline"": ""11 Best Canadian Dividend Stocks For Income Investors"", ""summary"": ""In this article, we discuss 11 best Canadian dividend stocks for income investors. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Canadian Dividend Stocks For Income Investors. Inflation is hammering the globe and Canada is no exception. Inflation in Canada picked [\u2026]""}, {""date"": ""2023-05-07"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) shareholders have earned a 7.9% CAGR over the last five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...""}, {""date"": ""2023-05-07"", ""headline"": ""J&J`s Kenvue Jumps 20% In Market Debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-07"", ""headline"": ""Johnson & Johnson: An Update Following The Kenvue IPO"", ""summary"": ""Johnson & Johnson has spun-off its consumer health business called Kenvue. Read more to see why I remain constructive on JNJ stock.""}, {""date"": ""2023-05-07"", ""headline"": ""Nasdaq, NYSE Stock Trading - Elliott Wave Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-07"", ""headline"": ""Opening Day: J&J`s Kenvue jumps 20% in market debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
17,2023-05-07,159.02444458007812,2023-05-14,157.16712951660156,-0.011679431224432268,D2,"[{""date"": ""2023-05-07"", ""headline"": ""11 Best Canadian Dividend Stocks For Income Investors"", ""summary"": ""In this article, we discuss 11 best Canadian dividend stocks for income investors. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Canadian Dividend Stocks For Income Investors. Inflation is hammering the globe and Canada is no exception. Inflation in Canada picked [\u2026]""}, {""date"": ""2023-05-07"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) shareholders have earned a 7.9% CAGR over the last five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...""}, {""date"": ""2023-05-07"", ""headline"": ""J&J`s Kenvue Jumps 20% In Market Debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-07"", ""headline"": ""Johnson & Johnson: An Update Following The Kenvue IPO"", ""summary"": ""Johnson & Johnson has spun-off its consumer health business called Kenvue. Read more to see why I remain constructive on JNJ stock.""}, {""date"": ""2023-05-07"", ""headline"": ""Nasdaq, NYSE Stock Trading - Elliott Wave Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-07"", ""headline"": ""Opening Day: J&J`s Kenvue jumps 20% in market debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-08"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.23% to $162.31 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-08"", ""headline"": ""Kenvue Announces Closing of Initial Public Offering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-08"", ""headline"": ""Teleflex (TFX) Q1 Earnings Top Estimates, 2023 Sales View Up"", ""summary"": ""Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.""}, {""date"": ""2023-05-08"", ""headline"": ""Does Johnson & Johnson's Kenvue Spinoff Make Sense?"", ""summary"": ""In this podcast, Motley Fool producer Ricky Mulvey and senior analyst Asit Sharma discuss:  Johnson & Johnson's spinoff of its consumer health company, Kenvue. If Darden Restaurants is getting a good deal on its acquisition of Ruth's Hospitality Group.""}, {""date"": ""2023-05-08"", ""headline"": ""These 2 Top Stocks Just Declared Dividend Raises"", ""summary"": ""These companies manage to keep growing and generating excess profits, which is admirable given their age and size.""}, {""date"": ""2023-05-08"", ""headline"": ""The 7 Best Mutual Funds to Invest in for May 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-08"", ""headline"": ""The 7 Best Long-Term Dividend Stocks to Buy in May"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Shockwave Medical ticks higher amid takeover speculation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""New suitors showing interest in ShockWave Medical, Street Insider says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.78% to $161.05 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-09"", ""headline"": ""J&J says Tremfya data shows positive results for ulcerative colitis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Pharma ETFs Gain Post Q1 Earnings"", ""summary"": ""Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.""}, {""date"": ""2023-05-09"", ""headline"": ""Henry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips"", ""summary"": ""Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.""}, {""date"": ""2023-05-09"", ""headline"": ""Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay"", ""summary"": ""Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.""}, {""date"": ""2023-05-09"", ""headline"": ""Bruker's (BRKR) New Buyout to Advance Digital Transformation"", ""summary"": ""Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.""}, {""date"": ""2023-05-09"", ""headline"": ""Here's Why You Should Retain Abbott (ABT) Stock For Now"", ""summary"": ""Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.""}, {""date"": ""2023-05-09"", ""headline"": ""3 Obvious Truths About Growth Stocks That Investors Often Forget"", ""summary"": ""The most important obvious truth about growth-phase businesses is that a company's leaders can be wrong.  Plans can be implemented poorly or incompletely, and external events can throw a wrench into the most carefully calculated maneuvers.  Of course, those risks rarely get mentioned by CEOs and others when they're pitching the company's pivot or its ambitions to penetrate a given market.""}, {""date"": ""2023-05-09"", ""headline"": ""J&J`s Tremfya succeeds in late-stage trial for ulcerative colitis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""COVID-19 vaccine maker Novavax to chop workforce, expenses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""AbbVie Or Johnson & Johnson? Let's Ask Peter Lynch"", ""summary"": ""This article applies Peter Lynch's approach to evaluate AbbVie and Johnson & Johnson. Find out which is the better dividend stock.""}, {""date"": ""2023-05-09"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Cigna (CI), Johnson & Johnson (JNJ) and Crinetics Pharmaceuticals (CRNX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""AbbVie Or Johnson & Johnson? Let`s Ask Peter Lynch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Novartis CEO criticizes US, EU efforts to curb drug company power"", ""summary"": ""Novartis CEO pushes back against government attempts to direct pharma RD""}, {""date"": ""2023-05-10"", ""headline"": ""May Dogs Of The Dow: Buy 2, Watch 4"", ""summary"": ""The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Click for our lists.""}, {""date"": ""2023-05-10"", ""headline"": ""The Dividend Growth Portfolio, 8 Years Later"", ""summary"": ""In early 2015, I bought 15 of the largest cap stocks from the dividend achievers index. The strategy was to create a more retirement-ready portfolio. Click to read.""}, {""date"": ""2023-05-10"", ""headline"": ""3 Dividend Stocks Set to Hike Payouts in 2023"", ""summary"": ""Among the many benefits of dividend investing can come from the compounding effect. When investors reinvest their dividends, they passively buy more shares, increasing future dividend payouts. This cycle increases an investor\u2019s total return annually and over time. This is a key reason for investors to look for dividend stocks with rising dividends. This isn\u2019t to say that dividend yield isn\u2019t important. Investors should also pay close attention to the company\u2019s payout ratio. The two of these rati""}, {""date"": ""2023-05-10"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.37% higher to $161.65 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-05-10"", ""headline"": ""Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""SmileDirectClub (SDC) Q1 Earnings Miss, Gross Margin Up"", ""summary"": ""SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.""}, {""date"": ""2023-05-10"", ""headline"": ""Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat"", ""summary"": ""Emergent (EBS) reports wider-than-expected first-quarter loss. The company updates its 2023 guidance for selected categories.""}, {""date"": ""2023-05-10"", ""headline"": ""Exact Sciences (EXAS) Q1 Earnings Top, Sales View Raised"", ""summary"": ""The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.""}, {""date"": ""2023-05-10"", ""headline"": ""States With the Lowest to Highest Capital Gains Tax Rate"", ""summary"": ""In this article, we will take a look at states with the lowest to highest capital gains tax rates. You can skip our detailed analysis of capital gains taxes and the overall tax structure of different states, and go directly to read 10 States With the Lowest to Highest Capital Gains Tax Rate. Capital gains [\u2026]""}, {""date"": ""2023-05-10"", ""headline"": ""Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Arcellx price target raised to $50 from $39 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Dividend Growth 50: Adieu, And Thanks For The Lessons Learned"", ""summary"": ""After 8 1/2 years, I've dropped the curtain on the real-money DG50 project. Read more to see 3 of my biggest lessons while managing the portfolio.""}, {""date"": ""2023-05-10"", ""headline"": ""Halozyme gains as Piper Sandler upgrades despite Q1 miss"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Q1 2023 Stereotaxis Inc Earnings Call"", ""summary"": ""Q1 2023 Stereotaxis Inc Earnings Call""}, {""date"": ""2023-05-11"", ""headline"": ""Catalyst watch: AI talk, ON Semiconductor event, hedge fund reports and Walmart earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""Tracking Yacktman Asset Management Portfolio - Q1 2023 Update"", ""summary"": ""Yacktman's 13F equity portfolio value increased from $10.04B to $10.11B this quarter. Click here to see an update on the portfolio's trades for Q1 2023.""}, {""date"": ""2023-05-11"", ""headline"": ""The Surprising Reason Nanox Stock Jumped Again Today"", ""summary"": ""Shares of start-up medical-imaging technology company\u00a0Nano-X Imaging (NASDAQ: NNOX), or simply Nanox, jumped again on Thursday after it was announced that a major healthcare company increased its investment in the company.  As of 3:40 p.m. ET, Nanox stock was up a whopping 17% for today's session and is now up more than 200% in May alone.  Johnson & Johnson (NYSE: JNJ) is a behemoth in the healthcare space and, as it turns out, it's an investor in Nanox stock.""}, {""date"": ""2023-05-11"", ""headline"": ""9 Hot Stocks to Watch\u2026 And Their AI Price Predictions"", ""summary"": ""The world\u2019s foremost artificial intelligence (AI) stock trading algorithm, An-E, has issued price predictions on these nine hot stocks. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked\u2026 but An-E saw it coming""}, {""date"": ""2023-05-11"", ""headline"": ""With debt crisis looming, look to these names and sectors, Jim Cramer says"", ""summary"": ""\""Be careful and use the parameters I've laid out,\"" CNBC's Jim Cramer said.""}, {""date"": ""2023-05-11"", ""headline"": ""3 Healthcare Stocks to Buy and Hold for the Next 10 Years"", ""summary"": ""It's always a great idea to buy stocks and hold them for the long term. That means at least five years. This offers you the opportunity to benefit from any dividend payments and/or growth in earnings.""}, {""date"": ""2023-05-11"", ""headline"": ""Warren Buffett\u2019s $5.7 Billion Dividend Portfolio: Top 15 Picks"", ""summary"": ""In this article, we will take a look at Warren Buffett\u2019s top 15 dividend picks. To see more such companies, go directly to Warren Buffett\u2019s Top 5 Dividend Stock Picks. Billionaire Warren Buffett has time and again proved that he is truly peerless when it comes to investing. His simple style and relentless repetition of [\u2026]""}, {""date"": ""2023-05-11"", ""headline"": ""Alcon (ALC) Q1 Earnings Surpass Estimates, 23' EPS View Up"", ""summary"": ""Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.""}, {""date"": ""2023-05-11"", ""headline"": ""Here's Why You Should Retain Walgreens Boots (WBA) For Now"", ""summary"": ""Investors are optimistic about Walgreens Boots (WBA) on consistent partnership growth and a strong focus on strategic execution.""}, {""date"": ""2023-05-11"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.41% to $160.99 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-11"", ""headline"": ""Charles River (CRL) Q1 Earnings Top Estimates, View Narrowed"", ""summary"": ""Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.""}, {""date"": ""2023-05-11"", ""headline"": ""NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall"", ""summary"": ""NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.""}, {""date"": ""2023-05-11"", ""headline"": ""2 Warren Buffett Stocks to Buy Hand Over Fist in May"", ""summary"": ""Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is a lodestar for many investors, and for good reason.  Which Warren Buffett stocks are worth buying in May?  Although the Oracle of Omaha has become decidedly more cautious when it comes to U.S. stocks in recent times, Berkshire's portfolio still contains a handful of outstanding buys for patient investors.""}, {""date"": ""2023-05-11"", ""headline"": ""Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan"", ""summary"": ""Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.""}, {""date"": ""2023-05-11"", ""headline"": ""Johnson & Johnson reports 61.91% increase in ownership of Nano-X Imaging"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""Wall Street Breakfast Podcast: Polar Power Soars"", ""summary"": ""Disney dips amid in-line earnings, improved streaming losses despite sub decline. Polar Power now taking pre-orders for a new line of mobile EV chargers, stock jumps 52%.""}, {""date"": ""2023-05-11"", ""headline"": ""J&J talc victim group seeking $30B in fraudulent conveyance complaint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""How To Build A Dividend Portfolio With $25,000 Among May`s Top 30 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""25 Best US Cities for People With Allergies"", ""summary"": ""In this article, we will take a look at the 25 best US cities for people with allergies. If you want to see more cities in this selection, go to the 5 Best US Cities for People With Allergies. According to Allied Market Research, the market for allergy treatments was valued at $24.6 billion in [\u2026]""}, {""date"": ""2023-05-12"", ""headline"": ""Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment"", ""summary"": ""Protagonist Therapeutics (NASDAQ: PTGX) reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ), on Phase 1 and preclinical studies of JNJ-2113 (formerly PN-235). JNJ-2113 is a macrocyclic peptide that binds to the IL-23 receptor with single-digit picomolar affinity and demonstrated potent, selective inhibition of IL-23 signaling in human T cells. Also Read: Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study Although peptid""}, {""date"": ""2023-05-12"", ""headline"": ""How Apple Pleased Investors"", ""summary"": ""In this podcast, Motley Fool Chief Investment Officer Andy Cross and senior analyst Ron Gross discuss:  The Fed's latest rate hike, April's jobs report, and the latest banking drama. Apple's surprising quarterly results and $90 billion share buyback plan.""}, {""date"": ""2023-05-12"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.13% to $160.78 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-12"", ""headline"": ""Eli Lilly on Pace to Top Johnson & Johnson's Market Cap"", ""summary"": ""Eli Lilly is on pace to surpass Johnson & Johnson's market cap for the first time since 1997, according to Dow Jones Market Data Boosted by the [success of its weight-loss drugs](https://www.wsj.com/articles/eli-lilly-is-priced-for-perfection-in-the-obesity-market-4b3e2363) and a new study showing [progress in fighting Alzheimer's](https://www.""}, {""date"": ""2023-05-12"", ""headline"": ""Eli Lilly's Market Cap Could Surpass J&J's for First Time Since 1997"", ""summary"": ""Eli Lilly\u2019s Friday stock gain puts its market capitalization on pace to close above Johnson & Johnson\u2019s for the first time since October 1997, according to Dow Jones Market Data. Ely Lilly (ticker: LLY) stock is up 1.""}, {""date"": ""2023-05-12"", ""headline"": ""STERIS (STE) Q4 Earnings Beat Estimates, Gross Margin Falls"", ""summary"": ""Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.""}, {""date"": ""2023-05-12"", ""headline"": ""Eli Lilly nears J&J market cap"", ""summary"": ""Eli Lilly's stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer's disease.""}, {""date"": ""2023-05-12"", ""headline"": ""LGI: A Worthy Global Fund To Add To Your Portfolio Today"", ""summary"": ""Lazard Global Total Return and Income Fund invests in a portfolio of stocks from around the world. Is the LGI CEF a good buy now? Click for our analysis.""}, {""date"": ""2023-05-12"", ""headline"": ""Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates"", ""summary"": ""Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.""}, {""date"": ""2023-05-12"", ""headline"": ""Eli Lilly on track to close with a higher market cap than J&J for first time since 1997"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""7 Overvalued Stocks to Sell for May 2023"", ""summary"": ""While chasing returns and profits is the name of the game for investors, one way to torpedo your portfolio is to fill it with overvalued stocks. Stocks become overvalued when they trade at a higher price than their actual value, based on measurements such as earnings and growth projections. Many investors use price-to-earnings ratios, price-to-sales ratios, or price-to-book ratios to determine if a stock is overvalued, undervalued, or fairly valued. It\u2019s one of the many reasons it pays to review""}, {""date"": ""2023-05-12"", ""headline"": ""Piper continues to view ShockWave Medical as `highly coveted asset`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""Wall Street Breakfast Podcast: Musk Announces New Chief Twit, Tesla Rises"", ""summary"": ""Elon Musk says he's picked a new Twitter CEO; Tesla shares jump. PacWest stock resumes drop after pledging more collateral to discount window. J&J talc victim group seeking $30B.""}, {""date"": ""2023-05-12"", ""headline"": ""Musk Announces New Chief Twit, Tesla Rises"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-12"", ""headline"": ""Protagonist and Janssen report data from preclinical studies of JNJ-2113"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-13"", ""headline"": ""How The Pharmaceutical Industry Is Using AI"", ""summary"": ""Industry-leading pharmaceutical firms are adopting AI to drive value for the future of their enterprise. Several companies in the PPH ETF are currently integrating AI into their operations.""}, {""date"": ""2023-05-13"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of May 14"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""2023-05-13"", ""headline"": ""How To Build A Dividend Portfolio With $25,000 Among May's Top 30 Stocks"", ""summary"": ""An investment strategy that combines dividend income with dividend growth, brings several benefits for dividend income investors. Click here to read more.""}, {""date"": ""2023-05-13"", ""headline"": ""2 No-Brainer Healthcare Stocks to Buy Right Now"", ""summary"": ""Return on invested capital (ROIC) may be one of the best metrics to find which stocks will outperform the market.  Measuring a company's profitability compared to its debt and equity, a consistently high ROIC indicates a wide moat surrounding a business's operations.  For example, the top 40% of ROICs in the Motley Fool's \""investable universe\"" nearly doubled the returns of their lower-ranked peers since 2003 -- and did even better if their ROICs were rising over time.""}, {""date"": ""2023-05-13"", ""headline"": ""How To Invest $100,000 Today: The Near-Perfect Portfolio Strategy"", ""summary"": ""With the economy going through boom and bust cycles more frequently, extreme market ups and downs are inevitable. Click here for more.""}, {""date"": ""2023-05-14"", ""headline"": ""Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks"", ""summary"": ""Warren Buffett is credited with saying that his preferred length of time for owning a stock is forever. To give credit where credit is due, the Oracle of Omaha does put his money where his mouth is. Buffett\u2019s holding company, Berkshire Hathaway (NYSE:BRK-A) has several must-have dividend stocks for long-term investing. Buffett has said those stocks will remain in the portfolio until he dies, and maybe after that point. This illustrates a key point about successful dividend investing. You have to""}, {""date"": ""2023-05-14"", ""headline"": ""3 Bargain Dividend Stocks to Boost Your Passive Income"", ""summary"": ""In good times and bad, investors want the best dividend stocks for passive income. However, it\u2019s more than just Googling the top dividend names or biggest yields. In fact, there are a lot of considerations that should go into picking out bargain dividend stocks to boost your passive income. Passive income translates to \u201chands-off.\u201d While this term is used a lot, it\u2019s often misinterpreted. Meaning many passive-income seekers tend to think it means \u201cno work.\u201d While many sources of passive income a""}, {""date"": ""2023-05-14"", ""headline"": ""Elliot Wave Technical Analysis: S&P 500 - Sunday, May 14"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
18,2023-05-14,157.16712951660156,2023-05-21,155.33917236328125,-0.011630658134067606,D2,"[{""date"": ""2023-05-13"", ""headline"": ""How The Pharmaceutical Industry Is Using AI"", ""summary"": ""Industry-leading pharmaceutical firms are adopting AI to drive value for the future of their enterprise. Several companies in the PPH ETF are currently integrating AI into their operations.""}, {""date"": ""2023-05-14"", ""headline"": ""Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks"", ""summary"": ""Warren Buffett is credited with saying that his preferred length of time for owning a stock is forever. To give credit where credit is due, the Oracle of Omaha does put his money where his mouth is. Buffett\u2019s holding company, Berkshire Hathaway (NYSE:BRK-A) has several must-have dividend stocks for long-term investing. Buffett has said those stocks will remain in the portfolio until he dies, and maybe after that point. This illustrates a key point about successful dividend investing. You have to""}, {""date"": ""2023-05-14"", ""headline"": ""3 Bargain Dividend Stocks to Boost Your Passive Income"", ""summary"": ""In good times and bad, investors want the best dividend stocks for passive income. However, it\u2019s more than just Googling the top dividend names or biggest yields. In fact, there are a lot of considerations that should go into picking out bargain dividend stocks to boost your passive income. Passive income translates to \u201chands-off.\u201d While this term is used a lot, it\u2019s often misinterpreted. Meaning many passive-income seekers tend to think it means \u201cno work.\u201d While many sources of passive income a""}, {""date"": ""2023-05-14"", ""headline"": ""Elliot Wave Technical Analysis: S&P 500 - Sunday, May 14"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Noteworthy Tuesday Option Activity: JNJ, COIN, CROX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""FTC Surprise Challenge Of Amgen`s Acquisition Of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.77% to $159.55 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-15"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) has had a rough month with its share price down 3.1%. However, a closer look at its sound...""}, {""date"": ""2023-05-15"", ""headline"": ""New Data Published on Biosense Webster QDOT MICRO\u2122 Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""Seelos Therapeutics price target lowered to $4 from $11 at BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""Learnings From Earnings: Macro Crosscurrents Make Growth Elusive"", ""summary"": ""Markets are being shaped by disparate trends from falling energy prices to rising interest rates.""}, {""date"": ""2023-05-16"", ""headline"": ""Don\u2019t Panic. 3 Defensive Stocks to Diversify Into ASAP"", ""summary"": ""Investors seeking to preserve their capital are increasingly turning to defensive stocks amidst the volatility. These stocks have defensive qualities and the potential to grow dividends, supported by strong free cash flow. While they may not be exciting, defensive stocks have a proven track record of profitability and growth, even in challenging economic conditions. They continuously produce high levels of revenue and cash flow profits, have generally fair price-to-earnings percentages, and offe""}, {""date"": ""2023-05-16"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slipped 0.13% to $159.34 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-16"", ""headline"": ""J&J's proposed talc settlement would pay $400 million to US state AGs"", ""summary"": ""Johnson & Johnson has set aside $400 million to resolve U.S. state consumer protection actions as part of its broader $8.9 billion effort to settle claims that its Baby Powder and other talc products cause cancer.""}, {""date"": ""2023-05-16"", ""headline"": ""FTC Surprise Challenge Of Amgen's Acquisition Of Horizon Therapeutics"", ""summary"": ""Amgen is facing a suit from the FTC to block its acquisition of Horizon Therapeutics. Check out my key takeaways for AMGN and HZNP investors.""}, {""date"": ""2023-05-16"", ""headline"": ""Kenvue Has Gone Public: Should You Buy the Stock?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) officially spun off its consumer health business this month, creating the largest U.S. initial public offering since 2021.  Kenvue (NYSE: KVUE) began trading as a stand-alone business and gives healthcare investors a new stock to potentially add to their portfolios.  Although Kenvue is technically a separate company, Johnson & Johnson will still play a big role in its operations; the healthcare company will own a 90% stake in the business.""}, {""date"": ""2023-05-16"", ""headline"": ""Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) and UnitedHealth Group (NYSE: UNH) are considered great healthcare stocks to hold for the long term because of their size, steady cash flow, and above-average dividends.  Neither stock has performed particularly well this year, with Johnson & Johnson's shares down more than 9% in 2023 and UnitedHealth's shares down more than 7%.  UnitedHealth is the nation's largest private health insurer, with more than 400,000 employees.""}, {""date"": ""2023-05-16"", ""headline"": ""Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-05-16"", ""headline"": ""These 6 Stocks Are Relentless Dividend Growers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""Omnicell new CFO removes uncertainty overhang, says SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""AstraZeneca to exit leading U.S. drug industry group PhRMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""Don`t Panic. 3 Defensive Stocks to Diversify Into ASAP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""Top 5 Buys of Paul Tudor Jones` Firm in the 1st Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Top 5 1st Quarter Trades of Harvest Portfolios Group Inc."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Walgreens to pay San Francisco $230M for its role in city's opioid crisis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q1 2023 Update"", ""summary"": ""Bridgewater Associates\u00e2\u0080\u0099 13F portfolio value decreased from ~$18.32B to ~$16.39B this quarter. Click here to read more about its holdings and trades for Q1 2023.""}, {""date"": ""2023-05-17"", ""headline"": ""Selecting Dividend Aristocrats Using SCHD Methodology - May Update"", ""summary"": ""I propose leveraging the stock selection criteria from SCHD's underlying index to build a portfolio with a subset of Dividend Aristocrats. Learn more here.""}, {""date"": ""2023-05-17"", ""headline"": ""Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears"", ""summary"": ""The assumption among most financial prognosticators is that a recession is most likely on the way, and one prominent name agrees it\u2019s all but inevitable. Legendary investor Paul Tudor Jones sees a recession coming and even has an idea of when it will hit. The Tudor Investment Corp founder and billionaire expects a recession will come into play this fall, mainly as a result of the surge in debt and asset prices in recent years. Such activities are usually followed by an economic downturn. \u201cHistor""}, {""date"": ""2023-05-17"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.22% to $158.99 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-05-17"", ""headline"": ""Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims"", ""summary"": ""As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson (NYSE: JNJ) has earmarked $400 million to end claims alleging it violated state unfair business practices and consumer protection laws by misleading consumers about the safety of its talc products. J&J subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that details how the company intends to pay different types of cancer victims in a bankruptcy settlement. LTL's new filin""}, {""date"": ""2023-05-17"", ""headline"": ""2 Dividend Stocks to Double Up On Right Now"", ""summary"": ""The continued bear market in stocks has a silver lining.  Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Prologis\u00a0(NYSE: PLD) are great stocks to double up on right now for those with a low allocation to these leading dividend payers.  Meanwhile, investors who don't own them yet should consider adding them to their portfolio.""}, {""date"": ""2023-05-17"", ""headline"": ""Tracking Ray Dalio`s Bridgewater Associates 13F Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson...""}, {""date"": ""2023-05-17"", ""headline"": ""3 No-Brainer Stocks to Buy With $1,000 Right Now"", ""summary"": ""This makes every sizable downturn in equities a buying opportunity for patient investors.  What's more, most online brokerages have completely done away with commission fees and minimum deposit requirements, which makes it easier than ever for everyday investors to put their money to work on Wall Street.  The first stock that makes for a smart buy with the major stock indexes well off their all-time highs is Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG), the parent company of internet search engine Google, streaming platform YouTube, and autonomous vehicle company Waymo, among other subsidiaries.""}, {""date"": ""2023-05-17"", ""headline"": ""Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows"", ""summary"": ""If you're buying a dividend stock that's trading near its low for the year, it stands to reason that the yield is also higher than it would normally be.  The tough part is ensuring you have found a quality stock.  Three that qualify are Johnson & Johnson (NYSE: JNJ), Paychex (NASDAQ: PAYX), and Keurig Dr Pepper (NASDAQ: KDP).""}, {""date"": ""2023-05-17"", ""headline"": ""AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial"", ""summary"": ""The combination of AstraZeneca's cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer showed positive results in a late-stage trial, the company said on Wednesday.  The drug maker said patients on the combined treatment showed a meaningful improvement in progression-free survival, or how long a patient lives without the disease getting worse after treatment, than patients given only Tagrisso.  The trial was on patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.""}, {""date"": ""2023-05-18"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2023 Update"", ""summary"": ""Jeremy Grantham\u00e2\u0080\u0099s 13F portfolio value increased from $18.77B to $19.66B this quarter. Click here to see an update on GMO Capital's trades for Q1 2023.""}, {""date"": ""2023-05-18"", ""headline"": ""Spin-offs vs. parent companies: Where to invest?"", ""summary"": ""CNBC's Seema Mody reports on the trend of companies spinning off units, and those new firms performing better than their parent companies. David Dubner, Goldman Sachs global head of mergers and acquisitions, also discusses the trend.""}, {""date"": ""2023-05-18"", ""headline"": ""5 High Yield Stocks With Steady Dividend Growth And An Attractive Valuation"", ""summary"": ""I consider companies that combine a relatively high Dividend Yield and Dividend Growth Rate to be particularly attractive for dividend income investors. Read more here.""}, {""date"": ""2023-05-18"", ""headline"": ""Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15"", ""summary"": ""The world\u2019s foremost artificial intelligence stock trading algorithm, An-E, predicts that Novavax (NASDAQ:NVAX) stock will gain 7% by June 15. An-E (pronounced Annie) has made this kind of prediction before. Back in December, Wall Street was bullish on Johnson & Johnson (NYSE:JNJ). Analysts were convinced JNJ could only go up\u2026 but An-E knew better. The algorithm said that JNJ stock was headed down 10% over one month\u2026 and JNJ stock fell that exact amount. Wall Street was shocked\u2026 but An-E saw it""}, {""date"": ""2023-05-18"", ""headline"": ""7 Upcoming Dividend Increases, Including 1 Dividend King"", ""summary"": ""All these stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. Click here to read more.""}, {""date"": ""2023-05-18"", ""headline"": ""Johnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-05-18"", ""headline"": ""7 High-Quality Dow Stocks to Buy on the Dip"", ""summary"": ""If you\u2019re looking to build a portfolio of high-quality blue chip stocks, Dow stocks should be at or near the top of your list. These stocks, aka the components of the Dow Jones Industrial Average (or DJIA), represent 30 of America\u2019s largest, most venerable companies, across multiple sectors. There are a total of 30 Dow components, but instead of buying the whole bunch, you may want to focus on what could be some of the strongest individual opportunities within the index. While few stocks that ma""}, {""date"": ""2023-05-18"", ""headline"": ""10 Best Stocks to Buy According to Billionaire Paul Tudor Jones"", ""summary"": ""In this piece, we will take a look at the ten best stocks to buy according to billionaire Paul Tudor Jones. For more stocks, head on over to 5 Best Stocks to Buy According to Billionaire Paul Tudor Jones. Paul Tudor Jones is one of the richest people in the world. According to Forbes Magazine, [\u2026]""}, {""date"": ""2023-05-18"", ""headline"": ""Arcellx a buy at Truist on unique cancer cell therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""3 Reliable Dividend Stocks That Fit in Any Investor\u2019s Portfolio"", ""summary"": ""Growth investors could learn a thing or two from income-oriented investors when it comes to reliable dividend stocks. Not only do these dividend stocks pay a healthy and consistent yield, many of these names trade quite well too. A number of growth stocks are still 40% to 50%, or more, below their all-time highs. At the same time, there are a handful of dividend stocks that are not just hitting 52-week highs, but that are hitting all-time highs despite the difficult market environment. Admittedl""}, {""date"": ""2023-05-18"", ""headline"": ""Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""ROBERT WOOD JOHNSON FOUNDATION Buys 3, Sells 2 in 1st Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Tracking Jeremy Grantham`s GMO Capital Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""3 Reliable Dividend Stocks That Fit in Any Investor`s Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Abbott collaboration a positive move for Stereotaxis, says B. Riley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Most stocks end up losing you money. What`s an investor to do?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Kenvue Just IPO'd, but Is the Stock a Buy?"", ""summary"": ""With its listing on the New York Stock Exchange on May 4 and the conclusion of its initial public offering (IPO) on May 8, Kenvue (NYSE: KVUE) is finally a separate entity from Johnson & Johnson (NYSE: JNJ).  The IPO raised net proceeds of $4.2 billion, and it marks the birth of a new giant within the consumer health products industry.  In case you aren't familiar, Kenvue owns the rights to dozens of popular consumer health brands like Listerine, Aveeno, Tylenol, Motrin, Baby Powder, and even Band-Aids.""}, {""date"": ""2023-05-20"", ""headline"": ""argenx: Q1 Earnings, High Stakes Biotech Play - Soaring Success Or Icarus' Fall"", ""summary"": ""argenx impresses with $218M Q1 Vyvgart revenue, exceeding consensus. Check out our analysis of ARGX stock and why we maintain a Hold rating.""}, {""date"": ""2023-05-20"", ""headline"": ""Most stocks end up losing you money. What\u2019s an investor to do?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-20"", ""headline"": ""3 Relatively Safe Stocks to Buy if a Recession Is on the Way"", ""summary"": ""Here's why three Motley Fool contributors think that AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ) are relatively safe stocks to buy if a recession is declared this year.  Prosper Junior Bakiny (AbbVie): It may be hard to believe that AbbVie is a safe stock right now.""}, {""date"": ""2023-05-20"", ""headline"": ""argenx: Q1 Earnings, High Stakes Biotech Play - Soaring Success Or Icarus` Fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""12 Cheap Dividend Stocks With High Yields"", ""summary"": ""In this article, we discuss 12 cheap dividend stocks with high yields. You can skip our detailed analysis of value stocks and their past performance, and go directly to read 5 Cheap Dividend Stocks With High Yields. The Importance of Investing in Undervalued/Cheap Stocks Investing in value stocks is one of the most popular methods to [\u2026]""}, {""date"": ""2023-05-21"", ""headline"": ""Most stocks end up losing you money. So what\u2019s a stock-market investor to do?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Got $1,000? 5 Buffett Stocks to Buy and Hold Forever"", ""summary"": ""It's hard to beat Warren Buffett's knack for making money, which is why so many investors keep a sharp eye on the stocks Buffett buys through his holding company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B).  Of the nearly 50 stocks Buffett currently owns, here are five you might want to buy now and hold forever.  Johnson & Johnson (NYSE: JNJ) is one of the longest-held stocks in Buffett's portfolio, and there are solid reasons you also might want to buy and hold this healthcare stock.""}, {""date"": ""2023-05-21"", ""headline"": ""HDV: This Dividend ETF Proves That High Yield Isn\u2019t Always Best"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}]",{}
19,2023-05-21,155.33917236328125,2023-05-28,152.02003479003906,-0.02136703526062278,D3,"[{""date"": ""2023-05-21"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Relative Strength Alert For Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""12 Cheap Dividend Stocks With High Yields"", ""summary"": ""In this article, we discuss 12 cheap dividend stocks with high yields. You can skip our detailed analysis of value stocks and their past performance, and go directly to read 5 Cheap Dividend Stocks With High Yields. The Importance of Investing in Undervalued/Cheap Stocks Investing in value stocks is one of the most popular methods to [\u2026]""}, {""date"": ""2023-05-21"", ""headline"": ""Most stocks end up losing you money. So what\u2019s a stock-market investor to do?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Got $1,000? 5 Buffett Stocks to Buy and Hold Forever"", ""summary"": ""It's hard to beat Warren Buffett's knack for making money, which is why so many investors keep a sharp eye on the stocks Buffett buys through his holding company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B).  Of the nearly 50 stocks Buffett currently owns, here are five you might want to buy now and hold forever.  Johnson & Johnson (NYSE: JNJ) is one of the longest-held stocks in Buffett's portfolio, and there are solid reasons you also might want to buy and hold this healthcare stock.""}, {""date"": ""2023-05-21"", ""headline"": ""HDV: This Dividend ETF Proves That High Yield Isn\u2019t Always Best"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}, {""date"": ""2023-05-22"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Amgen, J&J settle lawsuit over Stelara biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $908.99K"", ""summary"": """"}, {""date"": ""2023-05-22"", ""headline"": ""Medical device companies are in an 'emerging bull market,' Jim Cramer says"", ""summary"": ""CNBC's Jim Cramer touted the burgeoning bull market of medical devices, which is taking off post Covid.  ""}, {""date"": ""2023-05-22"", ""headline"": ""Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Dividend Growth Investing Like Warren Buffett"", ""summary"": ""3 of Buffett's core investing principles are just as applicable to dividend growth investing as they are to any kind of investing. Read more to see my thoughts.""}, {""date"": ""2023-05-23"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster"", ""summary"": ""With the debt ceiling issue rating as perhaps the single-most critical issue for the market right now, investors should consider targeting safe-haven stocks for debt default. Naturally, the U.S. government defaulting on its obligations would probably spark a ripple effect. However, it\u2019s also important to consider safe havens because raising the debt ceiling presents its own set of problems. At the time of writing, President Joe Biden and House Speaker Kevin McCarthy are resuming discussions abou""}, {""date"": ""2023-05-23"", ""headline"": ""Report of new COVID wave in China pushes shares of vaccine makers higher"", ""summary"": ""Dr. Kavita Patel, fmr. White House health policy director, joins 'Fast Money' to discuss the latest reports of a possible uptick of COVID cases in China, the immunity situation in the country, and the impact an outbreak could have on U.S. companies.""}, {""date"": ""2023-05-23"", ""headline"": ""Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.""}, {""date"": ""2023-05-23"", ""headline"": ""New Weight-Loss Pills Are Coming. What to Know."", ""summary"": ""The new injectable weight-loss drugs from Eli Lilly and Novo Nordisk have been the biggest story of the year for the pharmaceutical industry.""}, {""date"": ""2023-05-23"", ""headline"": ""UPDATE 2-Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions,  according to a filing in Delaware federal court.  Amgen said in a statement on Tuesday that the settlement terms are confidential, but it will allow the company to sell its biosimilar of Stelara \""no later than January 1st, 2025.\""""}, {""date"": ""2023-05-23"", ""headline"": ""Amgen settles J&J patent lawsuit over drug similar to blockbuster Stelara"", ""summary"": ""Johnson & Johnson's Janssen Biotech Inc has settled its lawsuit against Amgen Inc over Amgen's proposed similar version of J&J's top-selling drug Stelara, according to a filing Monday in Delaware federal court.""}, {""date"": ""2023-05-23"", ""headline"": ""Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) and Dollar General (NYSE: DG) are traditionally strong, defensive stocks.  Both companies deliver stable earnings, low volatility, and -- last but certainly not least -- dependable dividends.  Johnson & Johnson stock traditionally has done well during downturns compared to the rest of the market.""}, {""date"": ""2023-05-23"", ""headline"": ""Fate Therapeutics: The Future Remains Cloudy"", ""summary"": ""Fate Therapeutics, Inc. has two early-stage clinical programs and another two about ready to enter the clinic. Click here to read on our take on FATE.""}, {""date"": ""2023-05-23"", ""headline"": ""Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""My Dividend Stock Portfolio: New April Dividend Record - 99 Holdings With 21 Buys"", ""summary"": ""Markets are racing higher as earnings season turned out much better than expected. Click here to read more.""}, {""date"": ""2023-05-23"", ""headline"": ""Debt-Ceiling Fight Sends Investors Hunting for New Havens"", ""summary"": ""Just days or weeks before the government faces a possible funding shortfall, investors are shunning U.S. Treasury bills that will mature over the next several months while paying a premium to buy debt issued by  Microsoft  and  Johnson & Johnson  two of the highest-rated U.S. companies.  The moves have resulted in a situation few on Wall Street have seen: corporate bonds that are trading at a yield discount to Treasurys, which are generally viewed as the world\u2019s safest investment.  Microsoft bonds coming due Aug. 8 are changing hands in recent days at yields barely above 4%, according to Solve Data, which tracks debt markets.""}, {""date"": ""2023-05-23"", ""headline"": ""Tweedy, Browne Fund Q1 2023 Commentary"", ""summary"": ""Portfolio activity slowed somewhat during the quarter as equity prices advanced. Click here to read the full fund letter.""}, {""date"": ""2023-05-23"", ""headline"": ""DGRW: A Wise ETF For Sleeping Well At Night"", ""summary"": ""Followers have asked us to take a closer look at WisdomTree U.S. Quality Dividend Growth Fund ETF. Click for why we think DGRW is a wise ETF for sleeping well.""}, {""date"": ""2023-05-23"", ""headline"": ""Goldman Sachs picks top stocks in case of a hard landing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Ranked: Who Made The Most U.S. Unicorn Acquisitions Since 1997?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and Coherus Biosciences (CHRS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.1%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $156.66, moving -0.1% from the previous trading session.""}, {""date"": ""2023-05-24"", ""headline"": ""10 Dementia Medications that are Approved or in Clinical Trials"", ""summary"": ""In this article, we will be taking a look at the 10 dementia medications that are approved or in clinical trials. To skip our detailed analysis, you can go directly to see the 5 dementia medications that are approved or in clinical trials. Advancements in medicine have absolutely changed the way we live right now, [\u2026]""}, {""date"": ""2023-05-24"", ""headline"": ""14 Best Healthcare Dividend Stocks to Buy"", ""summary"": ""In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and [\u2026]""}, {""date"": ""2023-05-24"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Better Buy: Medtronic vs. Johnson & Johnson"", ""summary"": ""Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are perfect examples of this type of winning long-term investment.  Medtronic sells devices worldwide related to diabetes, cardiovascular, neuroscience, and surgery.  Thanks to its vast portfolio, Medtronic has increased earnings over time.""}, {""date"": ""2023-05-24"", ""headline"": ""Cooper Companies price target raised to $430 from $375 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""10 A-Rated Dividend Aristocrats For The Ultimate High-Yield SWAN Portfolio"", ""summary"": ""The debt ceiling crisis is down to the wire. We're possibly already out of time to prevent default but don't know it. Click for our strategy for these times.""}, {""date"": ""2023-05-24"", ""headline"": ""Wall Street Breakfast: National AI Strategy"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""2023-05-24"", ""headline"": ""New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Alvotech, Advanz Pharma ink pact for five potential biosimilars in Europe"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""MGV ETF: Attractive Valuation, Average Performance"", ""summary"": ""Vanguard Mega Cap Value Index Fund ETF Shares holds large-cap stocks using 5 metrics. Heaviest sectors: healthcare; financials. Click to read our MGV review.""}, {""date"": ""2023-05-25"", ""headline"": ""My Top 10 High Dividend Yield Companies For June 2023"", ""summary"": ""This article introduces 10 companies that are attractive picks for investors. Click here to read about my top 10 high dividend yield picks.""}, {""date"": ""2023-05-25"", ""headline"": ""Protagonist Therapeutics Sees Steady If Bumpy Progress"", ""summary"": ""Protagonist Therapeutics, Inc. has more than doubled so far this year due to progress on a couple of fronts. Click here to read more on PTGX stock.""}, {""date"": ""2023-05-25"", ""headline"": ""Just 2 AAA-Rated Companies Remain As U.S. Risks Being A Deadbeat"", ""summary"": ""Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.""}, {""date"": ""2023-05-25"", ""headline"": ""Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 22% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$202 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""2023-05-25"", ""headline"": ""Legend Biotech a market perform at William Blair on commercial execution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Johnson & Johnson granted fast track designation for milvexian"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Legend: Type II variation application submitted to EMA for CARVYKTI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Bristol-Myers granted FDA Fast Track Designation for 3 milvexian indications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Why 2023 is turning into the year of the healthcare spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Tylenol-Maker Kenvue Poised to Get Wall Street Ratings After IPO"", ""summary"": ""(Bloomberg) -- Kenvue Inc., the consumer health business that Johnson & Johnson spun off this month, will be eligible for ratings from a slew of major Wall Street banks next week, offering a chance to see how analysts are assessing initial public offerings amid the latest equities volatility and recession worries. Most Read from BloombergEurope\u2019s Economic Engine Is Breaking DownCathie Wood\u2019s ARKK Dumped Nvidia Stock Before $560 Billion Surge\u2018Last of Us\u2019 Multiplayer Video Game Faces Setbacks at S""}, {""date"": ""2023-05-26"", ""headline"": ""3 Dow Stocks Poised for a Roaring Relief Rally"", ""summary"": ""It may seem crazy to talk about stocks having a relief rally. But even if you\u2019re the biggest skeptic, you should look at the components of the Dow Jones Industrial Average. Here you\u2019ll find some compelling Dow stocks to buy. I understand there are many reasons to be bearish on this market. The debt ceiling negotiations remain uncomfortably stalemated. The Federal Reserve suggests that higher interest rates will be necessary to combat inflation. And it\u2019s widely believed that the U.S. economy is h""}, {""date"": ""2023-05-26"", ""headline"": ""Bristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation"", ""summary"": ""Bristol Myers (BMY) obtains Fast Track Designation from the FDA for milvexian, which is being developed in collaboration with Johnson and Johnson's Janssen.""}, {""date"": ""2023-05-26"", ""headline"": ""Want Passive Income Forever? Buy These 2 Magnificent Stocks Now"", ""summary"": ""Many investors actively seek dividend stocks, and who can blame them?  Choosing the right dividend stocks is arguably the best way to avoid this risk: Not all dividend stocks are created equal.  With that said, let's turn our attention to two companies that are practically passive income machines and will likely continue rewarding shareholders with payout increases for a long time: Johnson & Johnson (NYSE: JNJ) and Apple (NASDAQ: AAPL).""}, {""date"": ""2023-05-26"", ""headline"": ""Solid Earnings Fuel Potential Bull Market in Medical Devices"", ""summary"": ""CNBC's Jim Cramer predicts a booming bull market for medical devices, with positive earnings reports across the space. INMD, JNJ, ISRG and GEHC can emerge as potential winners.""}, {""date"": ""2023-05-26"", ""headline"": ""Health authorities to target next COVID shot to new strain, WSJ says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know."", ""summary"": ""When you think of Johnson & Johnson (NYSE: JNJ), you may think of shampoo and Band-Aids.  In fact, J&J is in the process of spinning off that business into an entity called Kenvue.  What is J&J's top revenue driver?""}, {""date"": ""2023-05-26"", ""headline"": ""Ashburton (Jersey) Ltd Buys 4, Sells 1 in 1st Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""J&J Janssen unit net drug prices decline for sixth straight year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-27"", ""headline"": ""How To Allocate $15,000 Among My Top 10 High Dividend Yield Companies For June 2023"", ""summary"": ""Implementing a dividend income-oriented investment strategy is an excellent way to help you generate extra income. Click here to read more.""}, {""date"": ""2023-05-28"", ""headline"": ""ChatGPT Stock Portfolio: Top 10 Picks"", ""summary"": ""In this article, we will take a look at ChatGPT stock portfolio. To see more such companies, go directly to ChatGPT Stock Portfolio: Top 5 Picks. If there\u2019s one thing that can be learned from literally hundreds of ChatGPT-related posts out there claiming that the AI chatbot has successfully beaten the market, it\u2019s that ChatGPT\u2019s [\u2026]""}, {""date"": ""2023-05-28"", ""headline"": ""Bearish Bets: 3 Stocks You Should Really Consider Shorting This Week"", ""summary"": ""Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names.  While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names.  Johnson & Johnson  recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.""}, {""date"": ""2023-05-28"", ""headline"": ""Buy the Dip On These Warren Buffett Stocks"", ""summary"": ""If you're like Warren Buffett, you favor solid companies that perform over the long term -- and, at the same time, reward investors with passive income.  Buffett has made his fortune -- and the fortune of others as Berkshire Hathaway chairman -- by sticking to that idea.  Well, an opportunity is here for two Buffett favorites.""}, {""date"": ""2023-05-28"", ""headline"": ""7 Undervalued Blue-Chip Stocks to Buy for June 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
20,2023-05-28,152.02003479003906,2023-06-04,154.60047912597656,0.016974370118395532,U2,"[{""date"": ""2023-05-28"", ""headline"": ""ChatGPT Stock Portfolio: Top 10 Picks"", ""summary"": ""In this article, we will take a look at ChatGPT stock portfolio. To see more such companies, go directly to ChatGPT Stock Portfolio: Top 5 Picks. If there\u2019s one thing that can be learned from literally hundreds of ChatGPT-related posts out there claiming that the AI chatbot has successfully beaten the market, it\u2019s that ChatGPT\u2019s [\u2026]""}, {""date"": ""2023-05-28"", ""headline"": ""Bearish Bets: 3 Stocks You Should Really Consider Shorting This Week"", ""summary"": ""Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names.  While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names.  Johnson & Johnson  recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.""}, {""date"": ""2023-05-28"", ""headline"": ""Buy the Dip On These Warren Buffett Stocks"", ""summary"": ""If you're like Warren Buffett, you favor solid companies that perform over the long term -- and, at the same time, reward investors with passive income.  Buffett has made his fortune -- and the fortune of others as Berkshire Hathaway chairman -- by sticking to that idea.  Well, an opportunity is here for two Buffett favorites.""}, {""date"": ""2023-05-28"", ""headline"": ""7 Undervalued Blue-Chip Stocks to Buy for June 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Johnson & Johnson (JNJ) Receives a New Rating from Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Kenvue initiated with a Neutral at Goldman Sachs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Eli Lilly partners with XtalPi on AI drug discovery in up to $250M deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-05-29"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly"", ""summary"": ""The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...""}, {""date"": ""2023-05-29"", ""headline"": ""Pfizer: Not Quite Dead Money Walking"", ""summary"": ""Pfizer's success in the COVID-19 pandemic has unfortunately become a double-edged sword. Read more to see my analysis of PFE stock and why it is a Buy.""}, {""date"": ""2023-05-29"", ""headline"": ""Buy 8 May Buffett Dividend Dogs And Watch 7"", ""summary"": ""Any collection of stocks is more clearly understood when subjected to yield-based analysis. Read why this Buffett/Berkshire batch is perfect for the dogcatcher process.""}, {""date"": ""2023-05-30"", ""headline"": ""Noteworthy Wednesday Option Activity: JNJ, NNOX, MDGL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""April 2023 Passive Income - Way Behind"", ""summary"": ""The portfolio got 2 raises in April: Johnson & Johnson raised theirs by 5.3%; adds 16.08 in forward income; Procter & Gamble (PG) came through with a little raise, 3%, this added 3.72.""}, {""date"": ""2023-05-30"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves 0.01%: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $154.37, marking a +0.01% move from the previous day.""}, {""date"": ""2023-05-30"", ""headline"": ""Citigroup Reiterates Johnson & Johnson (JNJ) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-05-30"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.01% higher to $154.37 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-05-30"", ""headline"": ""Kenvue\u2019s stock hits fresh post-IPO lows as Tylenol parent company receives tepid reviews from analysts"", ""summary"": ""Kenvue's stock hit new lows as Wall Street analysts start coverage of the Johnson & Johnson spinoff with halfhearted ratings.""}, {""date"": ""2023-05-30"", ""headline"": ""J&J seeks FDA approval for pulmonary arterial hypertension treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Ruling clears way for Purdue Pharma to settle opioid claims, protects Sacklers from lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare"", ""summary"": ""InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare are included in this Analyst Blog.""}, {""date"": ""2023-05-30"", ""headline"": ""Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Johnson & Johnson: The Ultimate Bull Trap Is Here"", ""summary"": ""Johnson & Johnson's Q1 2023 revenue reached $24.75 billion but the share price has declined by 13.38% since the beginning of the year. Find out why JNJ stock is a Hold.""}, {""date"": ""2023-05-30"", ""headline"": ""Next set of COVID boosters to target new Omicron variants \u2013 WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Kenvue initiated with an Outperform at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Johnson & Johnson resumed with a Buy at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""JPMorgan starts Kenvue with Overweight on 'resilient growth'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Why This Stock\u2019s Recent Pullback Is a Great Buying Opportunity"", ""summary"": ""Steris provides sterilization chemicals and disinfectants to hospitals. Its stock has fallen even as earnings and revenue are expected to rise.""}, {""date"": ""2023-05-31"", ""headline"": ""Bernstein Sticks to Their Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""J&J faces new trial over talc cancer claims, amid settlement push"", ""summary"": ""Johnson & Johnson on Wednesday faced the first trial in almost two years over claims that asbestos in its baby powder and other talc products causes cancer, as it seeks to settle thousands of similar cases in bankruptcy court.""}, {""date"": ""2023-05-31"", ""headline"": ""UPDATE 1-J&J faces new trial over talc cancer claims, amid settlement push"", ""summary"": ""Johnson & Johnson on Wednesday faced the first trial in almost two years over claims that asbestos in its baby powder and other talc products causes cancer, as it seeks to settle thousands of similar cases in bankruptcy court.  Emory Hernandez, 24, says he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of exposure to J&J's talc products beginning when he was a baby.""}, {""date"": ""2023-05-31"", ""headline"": ""Obesity Shot Frenzy Makes Eli Lilly World\u2019s Most Valuable Drugmaker"", ""summary"": ""(Bloomberg) -- Eli Lilly & Co.\u2019s third straight month of gains has helped it become the largest pharmaceutical company in the world by market value, surpassing Johnson & Johnson.Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into the EarthS&P 500 Almost Wipes Out Its Monthly Advance: Markets WrapDebt-Limit Deal Wins House Passage, Easing US Default ConcernsHedge Funds Are Deploying ChatGPT to Handle All the Grunt WorkElon Musk Again World\u2019s Richest Person as Arnault\u2019s LVMH Si""}, {""date"": ""2023-05-31"", ""headline"": ""Johnson & Johnson stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $155.06 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-05-31"", ""headline"": ""Bristol Myers' (BMY) Lung Cancer Drug NDA Gets Priority Review"", ""summary"": ""Bristol Myers' (BMY) NDA for repotrectinib for treating patients with NSCLC receives Priority Review from the FDA.""}, {""date"": ""2023-05-31"", ""headline"": ""Johnson & Johnson (JNJ) Bernstein's 39th Annual Strategic Decisions Conference 2023 Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Bernstein's 39th Annual Strategic Decisions Conference 2023 Call May 31, 2023 10:00 AM ETCompany ParticipantsJoaquin Duato - CEO &...""}, {""date"": ""2023-05-31"", ""headline"": ""5 Large Drug Stocks to Watch From a Thriving Industry"", ""summary"": ""Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Roche (RHHBY) and Novartis (NVS) are worth retaining in your portfolio.""}, {""date"": ""2023-05-31"", ""headline"": ""Tracking Tweedy Browne Portfolio - Q1 2023 Update"", ""summary"": ""Tweedy Browne's 13F portfolio value decreased by 2% from $1.88B to $1.84B in Q1 2023. Click here to read more about TBGVX\u00e2\u0080\u0099s portfolio.""}, {""date"": ""2023-05-31"", ""headline"": ""Johnson & Johnson says Tremfya sustained improvements in psoriatic arthritis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Future Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses"", ""summary"": ""Fortune has identified 11 CEO stars in the making\u2014many of them already in the C-suite, and all potential large-company CEOs.""}, {""date"": ""2023-05-31"", ""headline"": ""Janssen says Tremfya showed 'sustainable improvements' in psoriatic arthritis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Wednesday\u2019s Top Analyst Upgrades and Downgrades: Abbott Labs, Boston Scientific, ChargePoint, Coinbase, Dollar General, Equitrans, Ford, Hasbro, Johnson & Johnson, Kenvue, Medtronic and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""What's Ahead for the 10 Stocks That Have Driven Over 80% of U.S. Market Returns So Far in 2023"", ""summary"": """"}, {""date"": ""2023-05-31"", ""headline"": ""Best Of: Inside Johnson & Johnson\u2019s bankruptcy two-step"", ""summary"": ""On May 5th 2020, a couple named Val and Holly Johnson officially make a decision that has been stewing for months.  In their lawsuit, they say that Johnson & Johnson sold them talc-based baby powder that had asbestos in it \u2014 a known carcinogen.""}, {""date"": ""2023-06-01"", ""headline"": ""Best Value Stocks To Buy In June 2023, On Sale Now"", ""summary"": ""This article discusses my best value plays for June that I'm buying now. Learn more about the picks and various valuation methodologies.""}, {""date"": ""2023-06-01"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Johnson & Johnson COVID vaccine authorization revoked by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""3 Stocks That High-Yield ETFs Are Betting On"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""J&J secures dismissal of whistleblower case over misuse of confidential info"", ""summary"": ""A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs' misuse of confidential records they obtained through related litigation.""}, {""date"": ""2023-06-01"", ""headline"": ""US FDA revokes emergency use authorization for J&J's COVID vaccine"", ""summary"": ""The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson & Johnson's COVID-19 vaccine.""}, {""date"": ""2023-06-01"", ""headline"": ""UPDATE 1-J&J secures dismissal of whistleblower case over misuse of confidential info"", ""summary"": ""A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs' misuse of confidential records they obtained through related litigation.  The lawsuit, which accused J&J's DePuy Orthopaedics unit of defrauding the federal government by marketing defective hip implants, was dismissed in December 2021.  J&J has denied wrongdoing.""}, {""date"": ""2023-06-01"", ""headline"": ""REFILE-J&J secures dismissal of whistleblower case over misuse of confidential info"", ""summary"": ""A federal appeals court, in a decision unsealed Wednesday, upheld the dismissal of a whistleblower lawsuit against Johnson & Johnson as a sanction for the plaintiffs' misuse of confidential records they obtained through related litigation.  The lawsuit, which accused J&J's DePuy Orthopaedics unit of defrauding the federal government by marketing defective hip implants, was dismissed in December 2021.  J&J has denied wrongdoing.""}, {""date"": ""2023-06-01"", ""headline"": ""LAVA Therapeutics Shares Climb 26% After Janssen Selects Candidate for Cancer Research"", ""summary"": ""By Adam L. Cataldo LAVA Therapeutics shares soared Thursday after it said a lead candidate aimed at an undisclosed tumor-associated antigen was selected for...""}, {""date"": ""2023-06-01"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.34% to $154.54 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-01"", ""headline"": ""Johnson & Johnson Back in Court Over Talc-Related Cancer Claims"", ""summary"": ""Yesterday, Johnson & Johnson (NYSE: JNJ) faced the trial related to the lawsuit accusing its baby powder and other talc products of causing cancer. This is the first trial in almost two years related to the suit, with the company seeking to settle thousands of similar cases in bankruptcy court, Reuters reported. Emory Hernandez, aged 24, claims to have developed deadly cancer, mesothelioma, due to exposure to JNJ's talc products when he was a baby. JNJ has denied that its talc contains asbestos,""}, {""date"": ""2023-06-01"", ""headline"": ""15 Best Healthcare Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 15 best healthcare stocks to buy now. For more stocks, head on over to 5 Best Healthcare Stocks To Buy Now. In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience. Historically, the demand for healthcare products [\u2026]""}, {""date"": ""2023-06-01"", ""headline"": ""Is It Too Early to Invest In Nano-X Imaging?"", ""summary"": ""It could take years before Nano-X proves there's strong demand for its devices, and even longer to reach profitability.""}, {""date"": ""2023-06-01"", ""headline"": ""2 Dow Stocks to Buy More of in June"", ""summary"": ""The Dow Jones Industrial Average consists of 30 of the most established businesses in the world.  Thus, it shouldn't be a surprise to learn that many of the components that belong to this index have decades of dividend growth to their credit.  Here are two Dow Jones stocks with more than a century of dividend growth between them to consider buying this month.""}, {""date"": ""2023-06-01"", ""headline"": ""AI, Tech Fuel Rebound Of Vanguard Growth ETF, Eroding Value's 2022 Outperformance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""3 Warren Buffett Stocks to Buy (and Never Sell)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Lexicon Pharmaceuticals Secures Key FDA Approval, But Heavy Lifting Remains"", ""summary"": ""Lexicon Pharmaceuticals received FDA approval to market its heart failure drug Inpefa. Read why I think LXRX remains as a high-risk proposition for investors.""}, {""date"": ""2023-06-01"", ""headline"": ""JNJ July 14th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""3 Reliable Dividend Growth Stocks to Buy Hand Over Fist in June"", ""summary"": ""Adding these well-respected dividend payers to your portfolio could give you a stream of passive income that grows throughout your retirement years.""}, {""date"": ""2023-06-01"", ""headline"": ""3 Warren Buffett Stocks That Are Screaming Buys in June"", ""summary"": ""Based on a 58-year track record as CEO of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), it's safe to say Warren Buffett knows a thing or two about investing.  As of this past weekend, he'd overseen a greater than 3,900,000% return in his company's Class A shares (BRK.A) since taking the reins at Berkshire.  What follows are three Warren Buffett stocks that stand out as screaming buys in June.""}, {""date"": ""2023-06-01"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis"", ""summary"": ""Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis have been highlighted in this Industry Outlook article.""}, {""date"": ""2023-06-01"", ""headline"": ""Johnson & Johnson a Top 25 Dividend Giant With 3.07% Yield (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Saturday, June 3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""3M: Positive Lawsuit Developments For This Cheap Dividend King"", ""summary"": ""3M's shares jumped over 9% after agreeing to a tentative settlement of at least $10B for water pollution claims. Click here to see why I rate MMM stock a Buy.""}, {""date"": ""2023-06-02"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rallied 1.57% to $156.97 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-02"", ""headline"": ""S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Popularity"", ""summary"": ""In this article, we will discuss the best dividend aristocrat stocks sorted by hedge fund popularity. You can skip our detailed analysis of dividend aristocrats and their past performance, and go directly to read S&P 500 Dividend Aristocrats List: Top 10 Among Hedge Funds. Dividend aristocrats are companies in the S&P 500 that have a [\u2026]""}, {""date"": ""2023-06-02"", ""headline"": ""14 Best Annual Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best annual dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Annual Dividend Stocks To Buy Now. Dividend stocks are garnering investors\u2019 attention in 2023 as the stock market recovers from [\u2026]""}, {""date"": ""2023-06-02"", ""headline"": ""LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection"", ""summary"": ""LAVA's (LVTX) shares soar as partner J&J (JNJ) selects a lead candidate for development in clinical studies for cancer.""}, {""date"": ""2023-06-02"", ""headline"": ""Lava Therapeutics Boils Up Thanks to New Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""3 High-Quality Dividend Stocks Yielding 3% to Buy in June"", ""summary"": ""Many high-quality\u00a0dividend stocks currently yield around 3%, nearly double that of the S&P 500.  American Tower's dividend yield is currently over 3%, a historically high rate for the data-infrastructure real estate investment trust (REIT).  The company has an exceptional track record of paying dividends.""}, {""date"": ""2023-06-02"", ""headline"": ""High Yield Stock Watchlist: June 2023"", ""summary"": ""There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""2023-06-02"", ""headline"": ""JNJ Whistleblower Case Dismissed Over Confidentiality Breach"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Whistleblower lawsuit against Johnson & Johnson dismissed over leaked trade secrets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""3 Retirement Stocks to Buy to Sleep Like a Baby"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""2023-06-03"", ""headline"": ""The Little-Known Secret to Beating the S&P 500"", ""summary"": ""If you can't beat the\u00a0S&P 500 by picking individual stocks, owning an S&P 500 index fund and at least earning market returns is a smart move.  Not just any dividend-paying stocks, mind you, but those that can grow their dividend payments consistently.  Hartford Funds and Ned Davis Research have been tracking the average annual total returns of companies in the S&P 500 by dividend policy.""}, {""date"": ""2023-06-03"", ""headline"": ""With 65% ownership, Johnson & Johnson (NYSE:JNJ) boasts of strong institutional backing"", ""summary"": ""Key Insights Significantly high institutional ownership implies Johnson & Johnson's stock price is sensitive to their...""}, {""date"": ""2023-06-03"", ""headline"": ""Two Dow Stocks to Buy in June and Hold for the Next Decade"", ""summary"": ""These two stocks look like the best options among the Dow Jones Industrial Average's 30 components right now.""}, {""date"": ""2023-06-03"", ""headline"": ""How To Build Wealth: Buy Low And Sell High Consistently"", ""summary"": ""The strategy discussed is about buying or selling small quantities of shares when certain thresholds are met. Click here to read more about that strategy.""}, {""date"": ""2023-06-03"", ""headline"": ""SVB Securities Keeps Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Janssen presents analysis of infections, parameters in Monumen-TAL1 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Janssen announces results from Phase 1b RedirecTT-1 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-04"", ""headline"": ""The 3 Best Bargain Stocks to Buy in June 2023"", ""summary"": ""The stock market has been barging its way higher so far this year. The S&P 500 is up about 10% in 2023, while the Nasdaq sports a year-to-date gain of 25%. That may have many investors assuming that most stocks have already rallied. However, that\u2019s not the case. So what are the best bargain stocks to buy? Surprisingly, just a handful of stocks are driving almost all of the gains in the S&P 500. In fact, market breadth is concerningly low for some investors, as they wonder whether big tech has en""}, {""date"": ""2023-06-04"", ""headline"": ""2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip"", ""summary"": ""Dividend Kings are among the most steady corporations on the market.  While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group.  Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.""}, {""date"": ""2023-06-04"", ""headline"": ""1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is one of the best dividend stocks on the planet.  The healthcare behemoth has increased its dividend each year for over six decades, putting it in the super-elite class of Dividend Kings.  The company currently offers a roughly 3% dividend yield, which is almost double that of an S&P 500\u00a0Index Fund (recently around 1.6%).""}, {""date"": ""2023-06-04"", ""headline"": ""Morgan Stanley sees broader MedTech impact from weight loss drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-04"", ""headline"": ""2 Warren Buffett Stocks to Buy in June and Hold Forever"", ""summary"": ""These time-tested businesses produce reliable cash flows that they're committed to sharing with investors.""}]",{}
21,2023-06-04,154.60047912597656,2023-06-11,157.59458923339844,0.019366758268466455,U2,"[{""date"": ""2023-06-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""2023-06-04"", ""headline"": ""Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-04"", ""headline"": ""The 3 Best Bargain Stocks to Buy in June 2023"", ""summary"": ""The stock market has been barging its way higher so far this year. The S&P 500 is up about 10% in 2023, while the Nasdaq sports a year-to-date gain of 25%. That may have many investors assuming that most stocks have already rallied. However, that\u2019s not the case. So what are the best bargain stocks to buy? Surprisingly, just a handful of stocks are driving almost all of the gains in the S&P 500. In fact, market breadth is concerningly low for some investors, as they wonder whether big tech has en""}, {""date"": ""2023-06-04"", ""headline"": ""2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip"", ""summary"": ""Dividend Kings are among the most steady corporations on the market.  While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group.  Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.""}, {""date"": ""2023-06-04"", ""headline"": ""1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) is one of the best dividend stocks on the planet.  The healthcare behemoth has increased its dividend each year for over six decades, putting it in the super-elite class of Dividend Kings.  The company currently offers a roughly 3% dividend yield, which is almost double that of an S&P 500\u00a0Index Fund (recently around 1.6%).""}, {""date"": ""2023-06-04"", ""headline"": ""Morgan Stanley sees broader MedTech impact from weight loss drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-04"", ""headline"": ""2 Warren Buffett Stocks to Buy in June and Hold Forever"", ""summary"": ""These time-tested businesses produce reliable cash flows that they're committed to sharing with investors.""}, {""date"": ""2023-06-05"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $158.32 in the latest trading session, marking a +0.86% move from the prior day.""}, {""date"": ""2023-06-05"", ""headline"": ""25 S&P 500 Dividend Aristocrats To Avoid"", ""summary"": ""In this article, we discuss 25 dividend aristocrats to avoid according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 10 S&P 500 Dividend Aristocrats To Avoid. Over the years, there has been an observable shift in focus from growth stocks to dividend stocks [\u2026]""}, {""date"": ""2023-06-05"", ""headline"": ""Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast"", ""summary"": ""Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the drug a larger contributor to J&J\u2019s 2024 and 2025 sales than Wall Street is forecasting.""}, {""date"": ""2023-06-05"", ""headline"": ""IN BRIEF: J&J says Carvykti cuts risk of disease progression in study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Janssen presents longer-term data for Tecvayli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""FDA revokes EUA for J&J's Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Janssen announces results from Phase 3 CARTITUDE-4 study of Carvykti"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Janssen announces Cohort 1 of the Phase 3 THOR study reached primary endpoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Janssen announces results from Phase 2 NORSE, Phase 2 RAGNAR studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., June 06, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Thursday, July 20th to review second-quarter results. Joaquin Duato, Chairman of the Board and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.""}, {""date"": ""2023-06-06"", ""headline"": ""Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements"", ""summary"": ""Alkermes plc (NASDAQ: ALKS) increased its FY23 outlook by $425 million to reflect a final award the company received from arbitration proceedings related to two licensing agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson (NYSE: JNJ). The updated guidance reflects the payment of back royalties of ~$194 million related to 2022 U.S. net sales of the long-acting Invega products and Cabenuva and anticipated royalty revenues related to 2023 sales. \""We are gratified to have""}, {""date"": ""2023-06-06"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 0.09% to $158.18 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-06"", ""headline"": ""Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year\u2019s Biggest IPO"", ""summary"": ""(Bloomberg) -- Kenvue Inc. looked like a winner following its May spinoff from Johnson & Johnson in the year\u2019s biggest IPO. But just a few weeks after the stock\u2019s initial surge, Wall Street is urging investors to avoid the shares.Most Read from BloombergUkraine Dam Blast Blamed on Russia Tips War Into New PhaseApple Headset Looks Sleek in Person But Battery Pack Stands OutApple\u2019s $3,499 Vision Pro Headset Will Test Marketing MightCoinbase Sued by SEC for Breaking US Securities RulesA Wall Street""}, {""date"": ""2023-06-06"", ""headline"": ""Stifel ups Alkermes price target to $33 after final award in Janssen arbitration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""20 Most Respected Professions in the World"", ""summary"": ""This article covers the 20 most respected professions in the world. It will also explore the emerging trends in professions worldwide and the key players making a difference at the global level for various professions. If you want to skip our detailed analysis on the topic, you can head straight to the 5 Most Respected [\u2026]""}, {""date"": ""2023-06-06"", ""headline"": ""Narrow market proving a headwind for mutual funds, opportunity for hedge funds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Alkermes reiterates profitability targets for 2024, 2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Alkermes receives final award from arbital tribunal in proceedings with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (SGHT), Johnson & Johnson (JNJ) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Mizuho Maintains Johnson & Johnson (JNJ) Prior Recommendation"", ""summary"": """"}, {""date"": ""2023-06-07"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.21% higher to $158.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-06-07"", ""headline"": ""Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View"", ""summary"": ""Alkermes (ALKS) receives final award in arbitration proceedings with partner Janssen. It also raises its financial outlook for 2023.""}, {""date"": ""2023-06-07"", ""headline"": ""3 Defensive Stocks to Guard Against Too Much Market Optimism"", ""summary"": ""Defensive stocks, such as utilities, healthcare, and consumer staples, are known for their resilience during economic downturns. These sectors have consistently outperformed the market in 2022 as consumers tend to maintain their spending on these essential products regardless of economic conditions. In times of economic hardship, defensive stocks are favored by investors for their resilience. These stocks are less vulnerable to the broader economic downturn and offer a sense of stability. As int""}, {""date"": ""2023-06-07"", ""headline"": ""J&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Top 16 Dividend Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will discuss top 16 dividend stocks to buy according to hedge funds. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read Top 5 Dividend Stocks To Buy According To Hedge Funds. Dividends can be a significant component of hedge funds\u2019 overall investment strategy [\u2026]""}, {""date"": ""2023-06-07"", ""headline"": ""5 Top Dividend Stocks For June 2023"", ""summary"": ""I look for high-quality stocks trading at great long-term entry points. Find out 5 top dividend stocks to buy in the month of June.""}, {""date"": ""2023-06-07"", ""headline"": ""3 No-Brainer Stocks to Buy With $300 Right Now"", ""summary"": ""A reasonably small amount of money can go a long way when it's invested in industry-leading businesses.""}, {""date"": ""2023-06-07"", ""headline"": ""Alkermes price target raised to $40 from $36 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""Blackrock Rolls Out Climate Conscious ETF, Paralleling NYC's Smoky Skies From Canadian Fires"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""Federal judge tosses 3M earplug unit's bankruptcy filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""10 Reliable Dividend Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 10 reliable dividend stocks billionaires are loading up on. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Reliable Dividend Stocks Billionaires Are Loading Up On. Dividends have been one of the potential income sources for wealthy investors. According to a [\u2026]""}, {""date"": ""2023-06-08"", ""headline"": ""15 Healthcare Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 15 best healthcare stocks billionaires are loading up on. You can skip our detailed discussion on the healthcare sector and its performance, and go directly to read 5 Healthcare Stocks Billionaires Are Loading Up On. The healthcare sector in the US is a multifaceted industry that plays a crucial role [\u2026]""}, {""date"": ""2023-06-08"", ""headline"": ""How To Allocate $25,000 Among My Top 20 Dividend Income Stocks For June 2023"", ""summary"": ""This article shows how to build a portfolio by combining one ETF with high dividend yield and dividend growth companies. Find out more about this portfolio here.""}, {""date"": ""2023-06-08"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson rose 1.10% to $160.26 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-08"", ""headline"": ""3 Bargain Stocks to Buy in June Before They Bounce"", ""summary"": ""Now that Memorial Day is in the rearview mirror, investors are thinking about summer. This is historically a quieter time for markets. That may be the case in 2023. But first, the markets have to digest news on inflation and interest rates. And that\u2019s a reason to look for some bargain stocks to buy for the summer season. A month ago, the Federal Reserve was widely expected to pause (or \u201cskip\u201d) interest rate hikes in June. But after a hot headline number on the jobs report, some analysts are incr""}, {""date"": ""2023-06-08"", ""headline"": ""Johnson & Johnson Relinquishes Top Spot To Eli Lilly, Shares Undervalued Amid Technical Risks"", ""summary"": ""Eli Lilly has surpassed Johnson & Johnson in market cap for the first time. Click here to see our take on JNJ stock.""}, {""date"": ""2023-06-08"", ""headline"": ""Investors in Johnson & Johnson (NYSE:JNJ) have seen favorable returns of 48% over the past five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...""}, {""date"": ""2023-06-08"", ""headline"": ""3 Blue-Chip Stocks to Buy for 100% Returns"", ""summary"": ""The stock market has been led higher by just a handful of names so far this year. Unfortunately, that means many stocks have performed poorly vs. the indices. On the plus side though, that means there are many names that still have plenty of upside. Specifically, we can look for the best blue-chip stocks for high returns. Investors can look for high yield blue-chip stocks or they can look for blue-chip stocks with high potential. They can also look in between for a more balanced approach. Either""}, {""date"": ""2023-06-08"", ""headline"": ""The 3 Best Long-Term Dividend Stocks to Buy in June"", ""summary"": ""The stock market is finally giving us hope of better days ahead, with the U.S. debt ceiling debacle behind us. However, investors who are in it for the long-term understand that the market can be volatile, and it is important to pick companies that are stable and reliable. If you are investing for the long-term, do not focus on an individual stock, but rather on the underlying business. A solid balance sheet and reliable business can generate big returns for investors over time. That said, a div""}, {""date"": ""2023-06-08"", ""headline"": ""JNJ July 28th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""DJD: Attractive Valuation, Average Quality And Return"", ""summary"": ""DJD holds 27 stocks of the Dow Jones paying a dividend. Valuation and dividend growth look attractive, but quality and historical return are average. Read more here.""}, {""date"": ""2023-06-09"", ""headline"": ""US judge rejects 3M effort to resolve earplug lawsuits in bankruptcy"", ""summary"": ""A U.S. judge on Friday dismissed the bankruptcy of 3M subsidiary Aearo Technologies, rejecting an effort to resolve nearly 260,000 lawsuits alleging that 3M military earplugs caused hearing loss for veterans and U.S. service members.""}, {""date"": ""2023-06-09"", ""headline"": ""Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It"", ""summary"": ""Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities.""}, {""date"": ""2023-06-09"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.16% to $160.01 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-09"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2023-06-09"", ""headline"": ""PFM: There Are Better Dividend Growth ETFs"", ""summary"": ""Invesco Dividend Achievers ETF holds over 400 U.S. dividend-growth stocks and is well-diversified. Click for my review of PFM ETF and its prospects.""}, {""date"": ""2023-06-09"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""AbbVie, Amgen among firms targeted for Medicare inflation penalties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""Retailers are gamifying shopping with virtual storefronts to boost engagement, loyalty"", ""summary"": ""J. Crew and a string of other retailers are turning to gamified shopping in virtual storefronts to boost engagement and customer loyalty. ""}, {""date"": ""2023-06-10"", ""headline"": ""Dividend Stock Watch List: Lanny's June 2023 Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-10"", ""headline"": ""Blue Chip Bargain Hunting: 2 Top Stocks to Buy Now"", ""summary"": ""If you say there's not much to like about a bear market, you're right. Last year, all three indexes touched bear territory. And many of us felt the impact on our portfolios. But there actually are two things to like about these sorts of markets: First, they always lead to bull markets.""}, {""date"": ""2023-06-10"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - June 2023"", ""summary"": ""We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges. Read more here.""}, {""date"": ""2023-06-11"", ""headline"": ""7 Top Blue-Chip Stocks to Buy in June 2023"", ""summary"": ""The market probably feels like the movie Groundhog\u2019s Day for many investors. The major indexes continue to trade within a range, which is frustrating both bulls and bears. And with the market entering what is usually a quieter period, it may stay this way until Labor Day. However, one key strategy for profiting in a market like this is to look for some top blue-chip stocks to buy. Blue-chip stocks are large-cap companies that offer investors predictable revenue and earnings growth. Many of these""}, {""date"": ""2023-06-11"", ""headline"": ""Kinnate Biopharma: Trading Below Cash Value"", ""summary"": ""Kinnate Biopharma is advancing a couple of early stage compounds but has hit some bumps in the road since coming to public. Read more on KNTE stock.""}]",{}
22,2023-06-11,157.59458923339844,2023-06-18,161.75088500976562,0.026373340586025362,U3,"[{""date"": ""2023-06-11"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""The First Vaccines for RSV Are Coming Soon. What to Know."", ""summary"": ""The U.S. is on the brink of rolling out a number of shots designed to prevent RSV in young children and in older adults.""}, {""date"": ""2023-06-11"", ""headline"": ""COVID shots should be updated for XBB variants, FDA says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-11"", ""headline"": ""7 Top Blue-Chip Stocks to Buy in June 2023"", ""summary"": ""The market probably feels like the movie Groundhog\u2019s Day for many investors. The major indexes continue to trade within a range, which is frustrating both bulls and bears. And with the market entering what is usually a quieter period, it may stay this way until Labor Day. However, one key strategy for profiting in a market like this is to look for some top blue-chip stocks to buy. Blue-chip stocks are large-cap companies that offer investors predictable revenue and earnings growth. Many of these""}, {""date"": ""2023-06-11"", ""headline"": ""Kinnate Biopharma: Trading Below Cash Value"", ""summary"": ""Kinnate Biopharma is advancing a couple of early stage compounds but has hit some bumps in the road since coming to public. Read more on KNTE stock.""}, {""date"": ""2023-06-12"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $159.90, moving -0.07% from the previous trading session.""}, {""date"": ""2023-06-12"", ""headline"": ""Build a Millionaire\u2019s Portfolio With These 3 Dividend-Paying Stocks"", ""summary"": ""Stock market corrections can be unnerving, but history shows these are often the best time to buy. Millionaire investors know this, so they usually choose wealth-building dividend stocks for their portfolios. When uncertainty and volatility are rising, dividend stocks come into their own. Companies that pay investors to own them are typically profitable, have a clearly defined long-term growth story, and have often been through similar turmoil. Several years ago, J.P. Morgan Asset Management fou""}, {""date"": ""2023-06-12"", ""headline"": ""Top Research Reports for Johnson & Johnson, Oracle & HSBC"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Oracle Corporation (ORCL) and HSBC Holdings plc (HSBC).""}, {""date"": ""2023-06-12"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.07% to $159.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-12"", ""headline"": ""Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock"", ""summary"": ""Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.""}, {""date"": ""2023-06-12"", ""headline"": ""Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara\u00ae"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Alvotech & Teva secure AVT04 license date, for proposed Stelara biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-12"", ""headline"": ""Alvotech, Teva reach settlement with Johnson & Johnson for AVT04"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Johnson & Johnson exec Wengel sells 12,465 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""FedEx, Booking, and 6 Other Stocks That Show Being Average Is Just Fine"", ""summary"": ""Barron's tried to apply the Goldilocks principle to stock-picking. We came up with eight ideas.""}, {""date"": ""2023-06-13"", ""headline"": ""Lightning Round: Too much competition in the Fintech space for PayPal, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Hubbell, PayPal, Viasat, Biohaven, Transocean, Johnson & Johnson, Advance Auto Parts and C3.ai.""}, {""date"": ""2023-06-13"", ""headline"": ""Johnson & Johnson (JNJ) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 4:20 PM ETCompany ParticipantsBiljana Naumovic - Worldwide Vice President,...""}, {""date"": ""2023-06-13"", ""headline"": ""Cramer's Lightning Round: PayPal is \""too cut-throat\"""", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""2023-06-13"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.53% higher to $160.74 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-06-13"", ""headline"": ""Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet"", ""summary"": ""Kenvue, a consumer health spin-off of J&J, has a diversified portfolio of brands and offers a dividend yield of just over 3%. Read more here.""}, {""date"": ""2023-06-13"", ""headline"": ""3 High-Yielding Dividend Stocks That Can Help You Save For Retirement"", ""summary"": ""Inflation increases the difficulty of saving for retirement, but it also highlights why it's extremely important to keep saving.  Three income stocks that can help you save for your retirement are Johnson & Johnson\u00a0(NYSE: JNJ),\u00a0Toronto-Dominion Bank\u00a0(NYSE: TD), and\u00a0Verizon Communications\u00a0(NYSE: VZ).  Let's find out a bit more about these three high-yielding dividend stocks that can help you save for retirement.""}, {""date"": ""2023-06-13"", ""headline"": ""Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David Ricks"", ""summary"": ""Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement schemes, and upcoming drug price negotiations.""}, {""date"": ""2023-06-13"", ""headline"": ""SCHV: Well Diversified, But Still Lagging Competitors"", ""summary"": ""Schwab US Large-Cap Value ETF holds more than 500 stocks with value characteristics. Click here to see how SCHV compares to SPY and how it has performed.""}, {""date"": ""2023-06-13"", ""headline"": ""Could Johnson & Johnson Stock Help You Become a Millionaire?"", ""summary"": ""A fantastic dividend stock with promising opportunities ahead, is it also a no-brainer buy for growth-oriented investors?""}, {""date"": ""2023-06-13"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group"", ""summary"": ""Johnson & Johnson, Oracle, HSBC, NVIDIA and The Cigna Group are part of the Zacks top Analyst Blog.""}, {""date"": ""2023-06-13"", ""headline"": ""Top 20 Most Profitable Pharmaceutical Companies In The World"", ""summary"": ""In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world. If you wish to see the top ones, head straight to the Top 5 Most Profitable Pharmaceutical Companies In The World. Undoubtedly, the pharmaceutical industry stands as one of the most financially rewarding and essential sectors worldwide, leading [\u2026]""}, {""date"": ""2023-06-13"", ""headline"": ""15 Most Profitable Drugs In The World"", ""summary"": ""In this article, we will be taking a look at the 15 most profitable drugs in the world. If you wish to see the top ones, feel free to skip our detailed analysis of the pharma industry and head straight to the 5 Most Profitable Drugs In The World. The pharmaceutical industry has long been [\u2026]""}, {""date"": ""2023-06-13"", ""headline"": ""Experts say the stock market is in a bull market. What bull market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: April And May Review"", ""summary"": ""My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a YTD growth of 29.99%. See the full April & May update here.""}, {""date"": ""2023-06-13"", ""headline"": ""The stock market is in a bull market? What bull market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""300% Dividend Growth, 15% Yields From These \u201cAnti-AI\u201d Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.51% higher to $161.56 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-06-14"", ""headline"": ""Why The Fed Has Just One Core Problem After The Rate Skip"", ""summary"": ""Markets swooned and then ended flat after the Fed paused raising interest rates. Read why investors should focus on inflation and employment numbers.""}, {""date"": ""2023-06-14"", ""headline"": ""3 Long-term Healthcare Stocks to Add to Your Portfolio"", ""summary"": ""One of the greatest changes in the American landscape going forward will be demographics. The Baby Boomers make up the largest generation in the country\u2019s history. With the large amount of wealthy older Americans, there will be more demand than ever for cutting edge pharmaceutical drugs, medical devices, and cutting-edge treatments and therapies. This is a great time to buy reliable healthcare stocks for your portfolio. The healthcare industry has faced some bumps in the road in recent years. Th""}, {""date"": ""2023-06-14"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Been Rising: Are Strong Financials Guiding The Market?"", ""summary"": ""Most readers would already know that Johnson & Johnson's (NYSE:JNJ) stock increased by 4.1% over the past three months...""}, {""date"": ""2023-06-14"", ""headline"": ""Stryker: Good Prospects"", ""summary"": ""Stryker's near-term prospects positive due to positive trends in procedure demand and hospital spend on capital products. Find out our recommendation on SYK.""}, {""date"": ""2023-06-14"", ""headline"": ""Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""RGA Investment Advisors Q1 2023 Investment Commentary"", ""summary"": ""RGA Investment Advisors published their Q1 2023 investment commentary recently. Click here to read more about RGAIA's views.""}, {""date"": ""2023-06-14"", ""headline"": ""2 Unstoppable Warren Buffett Stocks That Can Turn Sitting Cash into Growing Wealth"", ""summary"": ""Warren Buffett doesn't measure the success of his favorite companies by short-term stock performance.  Instead, unstoppable Buffett stocks are ones that have delivered earnings and share price performance over time.  Dividend growth often is an additional plus.""}, {""date"": ""2023-06-14"", ""headline"": ""Nearing Retirement? These Stocks Will Pay You For Life"", ""summary"": ""Every retired investor deserves passive income and peace of mind. These stocks will help achieve that.""}, {""date"": ""2023-06-14"", ""headline"": ""My Dividend Stock Portfolio: New All-Time Dividend Record - 99 Holdings With 25 Buys"", ""summary"": ""US stocks ended May with solid gains and extended their strong performance into June, boosted by positive labor market data and the debt ceiling bill's progress.""}, {""date"": ""2023-06-14"", ""headline"": ""Amgen reportedly hires Moderna chief medical officer as new CMO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""Biggest stock movers today: MicroVision, UnitedHealth and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""FDA panel recommends updated COVID-19 vaccines targeting XBB.1.5 subvariant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""10 A-Rated Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at ten A-rated stocks billionaires are loading up on. For more stocks, head on over to 5 A-Rated Stocks Billionaires Are Loading Up On. The stock market is made up of thousands of companies. Combined with the fact that the regular, retail investor has an unprecedented amount [\u2026]""}, {""date"": ""2023-06-15"", ""headline"": ""CAVA buyers are drawn in by FOMO, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the four camps of bull market buyers in the current market.""}, {""date"": ""2023-06-15"", ""headline"": ""Cramer explains how four different camps of buyers see mixed messages in the Fed's rate strategy"", ""summary"": ""CNBC's Jim Cramer detailed four different buyers' schools of thought following the Fed's rate news on Wednesday.""}, {""date"": ""2023-06-15"", ""headline"": ""The only group that bull market buyers aren't buying right now is tech, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the four camps of bull market buyers in the current market.""}, {""date"": ""2023-06-15"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson rose 1.34% to $163.73 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-15"", ""headline"": ""AbbVie Says BeiGene's Flagship Blood Cancer Drug Infringes Imbruvica Patent"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""If I Had $1,000 to Invest Between Amazon, Johnson & Johnson, and Tesla Stocks, Here's How I'd Do It"", ""summary"": ""Right now, I would scoop up two that offer fantastic growth prospects -- and a third that offers the security of rising dividend payments and a business that can weather any economy.  First, let's talk a bit about Amazon.  The company dominates in two high-growth industries: e-commerce and cloud computing.""}, {""date"": ""2023-06-15"", ""headline"": ""NVIDIA, Johnson & Johnson And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""What Are the 3 Top Dividend Aristocrat Stocks That Are Too Cheap to Ignore?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""BeiGene Sinks after AbbVie Alleges Patent Violation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-16"", ""headline"": ""Why Shares of Fate Therapeutics Soared This Week"", ""summary"": ""Shares of Fate Therapeutics (NASDAQ: FATE) were up by 23.7% for the week as of Friday afternoon, after being as high as 30.8% for the week, according to data provided by S&P Global Market Intelligence.  The company focuses on cellular immunotherapies to treat cancers and immune disorders.  Late last week, the stock received an upgrade from Mizuho (NYSE: MFG) analyst Mara Goldstein, who maintained her buy rating with a price target of $12.""}, {""date"": ""2023-06-16"", ""headline"": ""Alkermes and Cogent Biosciences Stock See Action From Activist Investors"", ""summary"": ""Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences.""}, {""date"": ""2023-06-16"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.31% higher to $164.23 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-16"", ""headline"": ""3 Stocks to Buy for Long-Term, Life-Changing Returns"", ""summary"": ""Investors are always on the hunt for long-term wealth stocks. You know, the kind that you can buy and hold for years (or decades) and generate market-beating returns. We\u2019re all after that \u2014 that\u2019s why we read articles like this one. When investing for the future, readers have to look under the hood and find high-quality businesses. At the same time, it can be hard when looking for long-term investment stocks. That\u2019s because so many of the best stocks have already generated the life-changing retu""}, {""date"": ""2023-06-16"", ""headline"": ""Mersana (MRSN) Down on Partial Ovarian Cancer Study Hold"", ""summary"": ""Mersana's (MRSN) shares decline on partial clinical hold by the FDA on UP-NEXT and UPGRADE-A studies evaluating upifitamab rilsodotin to treat platinum-sensitive ovarian cancer.""}, {""date"": ""2023-06-16"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-16"", ""headline"": ""AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals"", ""summary"": ""AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.""}, {""date"": ""2023-06-17"", ""headline"": ""INSIGHT-For groups fighting U.S. opioid crisis, settlement money can be hard to come by"", ""summary"": ""A series of landmark settlements since 2021 with top drug distributors, pharmacies and drugmakers including Johnson & Johnson set compensation at a total of more than $50 billion nationwide.  More than 900,000 people have died of drug overdoses in the United States since 1999, with opioids playing an outsized role, according to data from the U.S. Centers for Disease Control and Prevention.  Reuters reached out to all 50 states and the District of Columbia to ask whether they had a process for non-governmental organizations to apply for funding from the settlements.""}, {""date"": ""2023-06-17"", ""headline"": ""3 Bargain Stocks to Buy on the Dip"", ""summary"": ""Three Motley Fool contributors think they've identified stocks that are great candidates to buy on the dip right now.  Here's why they picked Bristol Myers Squibb (NYSE: BMY), Pfizer (NYSE: PFE), and Teva Pharmaceutical Industries (NYSE: TEVA).  Prosper Junior Bakiny (Bristol Myers Squibb): Every once in a while, even the most prominent biopharmaceutical companies go through a period during which they have to deal with the loss of patent exclusivity for some key products.""}, {""date"": ""2023-06-17"", ""headline"": ""How To Become Financially Independent, Stress-Free"", ""summary"": ""Retirees need to be financially independent. However, even for folks years away from retirement, it can offer great benefits. Click for our dividend strategy.""}, {""date"": ""2023-06-18"", ""headline"": ""Got $1,000? 3 Elite Dividend Stocks to Buy Right Now"", ""summary"": ""While most stocks have bounced from their bear market lows, many remain well below their highs from when the sell-off started 18 months ago.  Many top-quality dividend stocks now offer attractive dividend yields.  Coca-Cola\u00a0(NYSE: KO),\u00a0Prologis\u00a0(NYSE: PLD), and\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) are among the dividend elite.""}]",{}
23,2023-06-18,161.75088500976562,2023-06-25,162.9820098876953,0.0076112404445598525,U1,"[{""date"": ""2023-06-18"", ""headline"": ""Got $1,000? 3 Elite Dividend Stocks to Buy Right Now"", ""summary"": ""While most stocks have bounced from their bear market lows, many remain well below their highs from when the sell-off started 18 months ago.  Many top-quality dividend stocks now offer attractive dividend yields.  Coca-Cola\u00a0(NYSE: KO),\u00a0Prologis\u00a0(NYSE: PLD), and\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) are among the dividend elite.""}, {""date"": ""2023-06-19"", ""headline"": ""Discovering The Top Dogs: A Guide To Woofing Up Your Returns With Dogs Of The Dow Investing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-19"", ""headline"": ""Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half"", ""summary"": ""Tech stocks have staged a massive comeback in 2023, but value investors should consider looking into currently unloved sectors like healthcare. See my top picks.""}, {""date"": ""2023-06-20"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.06%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $164.13 in the latest trading session, marking a -0.06% move from the prior day.""}, {""date"": ""2023-06-20"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson dropped 0.06% to $164.13 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-20"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-06-20"", ""headline"": ""How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""2023-06-20"", ""headline"": ""Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start"", ""summary"": ""The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall. ""}, {""date"": ""2023-06-20"", ""headline"": ""Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court "", ""summary"": ""The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control. ""}, {""date"": ""2023-06-21"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.15% to $163.88 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-21"", ""headline"": ""Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations "", ""summary"": ""PhRMA's lawsuit is the fourth legal challenge to the law after separate suits from Merck, Bristol Myers Squibb and the U.S. Chamber of Commerce. ""}, {""date"": ""2023-06-21"", ""headline"": ""2seventy bio: Nothing Properly Explains The Low Valuation"", ""summary"": ""2seventy bio, Inc. has a good cash position, a decent early stage pipeline, and strong collaborations. But we have our doubts about TSVT stock. Read more here.""}, {""date"": ""2023-06-21"", ""headline"": ""Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""GE HealthCare, Johnson & Johnson unit announce collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""The AI Tool That Beat Out Top Wall Street Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson advanced 1.06% to $165.62 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-22"", ""headline"": ""Ranking These 5 Dividend Kings From Highest to Lowest Quality"", ""summary"": ""These Dividend Kings are among the most consistent dividend growers on the market. In today's video, I rank five Dividend King stocks from highest quality to lowest. One of those must-own companies is Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""2023-06-22"", ""headline"": ""Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?"", ""summary"": ""With a $427 billion market capitalization, Johnson & Johnson (NYSE: JNJ) is currently the 15th largest publicly traded business on the planet.  Let's examine the pharmaceutical industry and J&J's fundamentals to decide.  Before considering Johnson & Johnson's potential, it's important to consider the state of the industry in which J&J primarily operates (pharmaceuticals).""}, {""date"": ""2023-06-22"", ""headline"": ""AI May Transform Healthcare: 2 Top Stocks to Buy Now"", ""summary"": ""It's no surprise that some healthcare companies are going all-in on this exciting technology.  In the last quarter of that year, it filed more patents -- a total of 48 -- linked to AI than any other healthcare company, according to GlobalData.""}, {""date"": ""2023-06-22"", ""headline"": ""HEQ: Deep Discount On This Low Beta Fund"", ""summary"": ""The John Hancock Hedged Equity & Income Fund is designed to hedge one's portfolio. Click here to learn why I view HEQ CEF as one to be traded tactically.""}, {""date"": ""2023-06-22"", ""headline"": ""Cidara gains as FDA grants fast track status for flu candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Cidara Therapeutics receives U.S. FDA fast track designation for CD388"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Psychedelics Company Silo Pharma Working On Time-Release And Dosage Ketamine Implant And Topical, Hoping To Deliver Steady Pain Relief For Four Million Fibromyalgia Sufferers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""J&J talc bankruptcy unit to establish $750M trust fund with insurers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""How artificial intelligence can make hiring bias worse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-23"", ""headline"": ""10 Companies Likely to be Dividend Aristocrats in the Future"", ""summary"": ""In this article, we discuss 10 companies likely to be Dividend Aristocrats in the future. You can skip our detailed analysis of dividend growers and their performance, and go directly to read 5 Companies Likely to be Dividend Aristocrats in the Future. Dividend Aristocrats are a group of stocks in the S&P 500 that have [\u2026]""}, {""date"": ""2023-06-23"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.08% to $165.48 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-23"", ""headline"": ""IWD: A Well-Diversified Value ETF With A Few Weaknesses"", ""summary"": ""iShares Russell 1000 Value ETF invests in large and mid-cap stocks with low price-to-book and low growth. Find out if the IWD ETF is right for your portfolio.""}, {""date"": ""2023-06-23"", ""headline"": ""Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-24"", ""headline"": ""11 Best Medical\u00a0 Stocks Under $10"", ""summary"": ""In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical Stocks Under $10. The medical industry is one of the most capitally intensive and competitive sectors in the [\u2026]""}, {""date"": ""2023-06-24"", ""headline"": ""Top 30 S&P 500 Stocks by Index Weight"", ""summary"": ""In this article, we discuss the top 30 S&P 500 stocks by index weight. If you want to skip our detailed discussion on the stock market and the S&P 500 index, head over to Top 5 S&P 500 Stocks by Index Weight. The S&P 500 Index, as well as the tech-heavy NASDAQ, edged higher after [\u2026]""}, {""date"": ""2023-06-24"", ""headline"": ""How To Build A Dividend Portfolio With $25,000 Among June's Top 30 Stocks"", ""summary"": ""A dividend income-oriented investment portfolio can earn you extra income via dividend payments. Find out my June top 10 picks to build an investment portfolio.""}, {""date"": ""2023-06-24"", ""headline"": ""Expect a Roaring S&P 500 Bull Market? Here Are the 10 Stocks You'll Want to Own"", ""summary"": ""Is a new bull market here for the S&P 500? It depends on whom you ask.\u00a0 Yes, the index has jumped more than 20% above its previous bear market low. That's enough to qualify as a new bull market for many investors.""}, {""date"": ""2023-06-24"", ""headline"": ""3 Reliable Dividend Stocks to Buy Now and Hold Forever"", ""summary"": ""Like a lot of investors, I'm a big fan of dividend-paying stocks for more reasons than one. I'm a busy guy, so receiving regular cash payments for doing nothing more than holding a stock appeals to me.""}, {""date"": ""2023-06-24"", ""headline"": ""Hershey: Durable Business, Stretched Valuation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Historically, dividend growth stocks have been magnificent long-term investments.  Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and Walgreens Boots Alliance\u00a0(NASDAQ: WBA) are three of the best at growing their dividends.  Coca-Cola is an elite dividend stock.""}, {""date"": ""2023-06-25"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
24,2023-06-25,162.9820098876953,2023-07-02,163.0214080810547,0.00024173338754707174,U1,"[{""date"": ""2023-06-25"", ""headline"": ""Bears Negotiating A Truce As Tech Option Activity Heats Up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Got $500? 3 Magnificent Dividend Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Historically, dividend growth stocks have been magnificent long-term investments.  Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and Walgreens Boots Alliance\u00a0(NASDAQ: WBA) are three of the best at growing their dividends.  Coca-Cola is an elite dividend stock.""}, {""date"": ""2023-06-25"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""California man tells jury of getting cancer after using J&J baby powder"", ""summary"": ""A California man suing Johnson & Johnson told jurors on Monday how his life was upended by a cancer diagnosis that he blames on using the company's baby powder since childhood, as the first trial over the product in nearly two years neared its end.  \""I just turned into a scared little kid,\"" Emory Hernandez, fighting back tears, said of his 2022 mesothelioma diagnosis while testifying in Alameda County Superior Court, according to an online broadcast of the trial by Courtroom View Network.  J&J has denied that its baby powder contained asbestos or causes cancer.""}, {""date"": ""2023-06-26"", ""headline"": ""Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $163.63, moving -1.12% from the previous trading session.""}, {""date"": ""2023-06-26"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.12% to $163.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-26"", ""headline"": ""My Highest Quality Dividend Champions"", ""summary"": ""The article presents the highest-quality Dividend Champions, which are companies listed on U.S. exchanges. Click here to read more.""}, {""date"": ""2023-06-26"", ""headline"": ""Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Take the Zacks Approach to Beat the Market: Shopify, Oracle, Uber in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""2023-06-26"", ""headline"": ""2 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Investors follow what stocks Warren Buffett's Berkshire Hathaway picks for a simple reason.  Since Buffett took over the company in the 1960s, it has become the largest financial stock in the U.S. market and has delivered a five-year return of 79% and a 10-year return of 202% versus 60% and 173%, respectively, for the S&P 500 index.  The best way to see which stocks Berkshire Hathaway is buying or selling is by following the company's 13F reports with the Securities and Exchange Commission.""}, {""date"": ""2023-06-26"", ""headline"": ""Dow falls 109 points on losses for Amgen, Johnson & Johnson shares"", ""summary"": ""Behind losses for shares of Amgen and Johnson & Johnson, the Dow Jones Industrial Average is down Monday morning. The Dow was most recently trading 109...""}, {""date"": ""2023-06-26"", ""headline"": ""J&J submits application to EMA for combination PAH drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Johnson & Johnson's Janssen Pharma Touts Positive Results in Nipocalimab Phase 2 Trial"", ""summary"": ""By Ben Glickman Johnson &amp; Johnson said Monday that its drug, nipocalimab, had positive results in a Phase 2 clinical trial. The Spring House, Penn.-based...""}, {""date"": ""2023-06-26"", ""headline"": ""Chart Of The Day: Is Johnson & Johnson Poised For A Breakout?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Google Accused of Breaching Promised Ad Standards, Big Brands and Government Agencies Affected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.21% to $163.29 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-27"", ""headline"": ""Johnson & Johnson's Talc Cancer Claims Saga: $8.9B Settlement Under Scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""J&J's $8.9 billion talc settlement faces US bankruptcy test"", ""summary"": ""Johnson & Johnson's proposed $8.9 billion settlement of thousands of lawsuits alleging that its talc products cause cancer faces a crucial hurdle this week as a U.S. bankruptcy judge in New Jersey considers whether or not a J&J subsidiary may resolve them by filing for bankruptcy a second time.  J&J subsidiary LTL Management's first attempt to do that was dismissed in April after a U.S. appeals court ruled that it was not in sufficient financial distress to be eligible for bankruptcy protection.""}, {""date"": ""2023-06-27"", ""headline"": ""J&J\u2019s Push to End Cancer Suits Meets Trial in Bankruptcy Court"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is facing a key test of its plan to use the US bankruptcy system to end more than 60,000 claims that a talc-based baby powder it sold for years causes cancer.Most Read from BloombergPutin Blasts Wagner \u2018Traitors\u2019 as Prigozhin Defends RevoltPutin Says Russia Avoided \u2018Civil War\u2019 as Mutiny Case ClosedStudent Loan-Relief Backers Warn Biden \u2018Failure Isn\u2019t an Option\u2019Pickleball Injuries May Cost Americans Nearly $400 Million This Year, According to UBSRussia Latest: Mut""}, {""date"": ""2023-06-27"", ""headline"": ""10 Dow Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 Dow stocks billionaires are loading up on. To see more such companies, go directly to 5 Dow Stocks Billionaires Are Loading Up On. In Tony Robbins\u2019 Money \u2013 Master The Game, there\u2019s a chapter titled Invest Like the .001%: The Billionaire\u2019s Playbook. The chapter mentions the [\u2026]""}, {""date"": ""2023-06-28"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""This Top-Performing Small-Cap Manager Is Betting Big on China"", ""summary"": ""The Matthews Emerging Markets Small Companies fund has delivered a 15.1% annualized three-year return, landing it in the top 1% of its peers. Here\u2019s what...""}, {""date"": ""2023-06-28"", ""headline"": ""Cancer plaintiffs drill down on J&J's support for $8.9 billion talc deal"", ""summary"": ""The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in U.S. bankruptcy court on Wednesday about how much support the company has for the deal.  During a multi-day court hearing in Trenton, New Jersey,  attorneys for plaintiffs alleging that J&J's baby powder and other talc products sometimes contained asbestos and caused ovarian cancer and mesothelioma drilled down on J&J's public statements that it has \""secured commitments from over 60,000 current claimants\"" for the settlement, and that the \""majority\"" of talc claimants support it.""}, {""date"": ""2023-06-28"", ""headline"": ""Cancer plaintiffs drill down on J&J's support for $8.9 bln talc deal"", ""summary"": ""The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in U.S. bankruptcy court on Wednesday about how much support the company has for the deal.  During a multi-day court hearing in Trenton, New Jersey, attorneys for plaintiffs alleging that J&J's baby powder and other talc products sometimes contained asbestos and caused ovarian cancer and mesothelioma drilled down on J&J's public statements that it has \""secured commitments from over 60,000 current claimants\"" for the settlement, and that the \""majority\"" of talc claimants support it.""}, {""date"": ""2023-06-28"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.20% to $162.96 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-28"", ""headline"": ""Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry"", ""summary"": ""Avantor faces near-term challenges amid macro headwinds and revenue growth uncertainties due to continuing COVID roll-off. Read my analysis of AVTR stock here.""}, {""date"": ""2023-06-28"", ""headline"": ""1 Sickly Dividend Stock to Avoid Like the Plague Right Now (and 2 Much Healthier Ones to Buy Instead)"", ""summary"": ""Medical Properties Trust\u00a0(NYSE: MPW) currently offers a 12.5% dividend yield.  Instead, income-seeking investors should focus their attention on healthier\u00a0dividend stocks.  Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Community Healthcare Trust\u00a0(NYSE: CHCT) currently stand out as much safer options.""}, {""date"": ""2023-06-28"", ""headline"": ""12 Best Long-Term Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best long-term dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Long-Term Dividend Stocks To Buy Now. Last year was challenging for the overall stock market and particularly for growth stocks. On [\u2026]""}, {""date"": ""2023-06-28"", ""headline"": ""Noteworthy Wednesday Option Activity: JNJ, UAL, DE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Calculating The Intrinsic Value Of Johnson & Johnson (NYSE:JNJ)"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$201 based on 2 Stage Free Cash Flow to Equity With...""}, {""date"": ""2023-06-28"", ""headline"": ""Johnson & Johnson Unusual Options Activity For June 28"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Johnson & Johnson call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""The Best Stocks to Invest $20,000 in Right Now"", ""summary"": ""Market leaders, dividend stocks, young and up-and-coming players, and recovery stories all make good candidates.  Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery.  Most surgeons train on Intuitive's Da Vinci system -- and that's another reason the company probably will maintain its leadership.""}, {""date"": ""2023-06-29"", ""headline"": ""Johnson & Johnson: Buy The Market (Technical Analysis)"", ""summary"": ""Johnson & Johnson (JNJ) is strategically shifting towards high-growth sectors like pharmaceuticals and medical devices. See why JNJ stock is rated buy.""}, {""date"": ""2023-06-29"", ""headline"": ""7 Up-and-Coming Stocks to Buy for the Next Decade"", ""summary"": ""In arguably most cases involving expert financial advice, you will encounter guidance toward established enterprises, not up-and-coming stocks to buy. While the latter category certainly dials up the heat in terms of overall sexiness, some folks just can\u2019t handle adventurous portfolios. And that\u2019s totally fine \u2013 we\u2019re all different. Nevertheless, for those that have the patience and the tolerance for risk, they may find greater satisfaction with long-term stocks. By that, I\u2019m not talking about b""}, {""date"": ""2023-06-29"", ""headline"": ""Moody's: Pharma outlook stable for next 12-18 months, but with caveats"", ""summary"": ""Moody's, in a note, sees a stable outlook for the drug industry. But there are a few headwinds that might mess up the semi-optimistic picture.""}, {""date"": ""2023-06-29"", ""headline"": ""Is Johnson & Johnson Stock a Strong Buy?"", ""summary"": ""Large-cap pharmaceuticals stocks that pay dividends frequently generate market-beating returns over the long term.  For instance, healthcare behemoth Johnson & Johnson (NYSE: JNJ) hasn't outperformed the broader markets in six years.  J&J also launched several potential blockbuster drugs over the last 12 months.""}, {""date"": ""2023-06-29"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.70% higher to $164.10 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-06-29"", ""headline"": ""Johnson & Johnson: Pay Yourself 7% With This Bond-Like Exposure"", ""summary"": ""Johnson & Johnson may well be the ultimate Sleep-Well-At-Night, or SWAN, stock. Click here for my take on JNJ stock and its prospects.""}, {""date"": ""2023-06-29"", ""headline"": ""Where Will Johnson & Johnson Be in 5 Years?"", ""summary"": ""The stock's returns over the past decade haven't been great -- should investors expect that to change?""}, {""date"": ""2023-06-29"", ""headline"": ""5 High-Yielding Dividend Stocks That Are Bargain Buys"", ""summary"": ""If you're in search of bargain stocks to buy, the healthcare industry is a great place to start looking.  Among them are Johnson & Johnson (NYSE: JNJ),\u00a0AbbVie\u00a0(NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY),\u00a0Amgen (NASDAQ: AMGN), and\u00a0Pfizer (NYSE: PFE) -- all of which pay dividends and offer great value.""}, {""date"": ""2023-06-29"", ""headline"": ""Sell THW, Buy XLV Or THQ"", ""summary"": ""Tekla World Healthcare Fund is closed end fund and one that makes it clear that it is focused on producing income. Click here to see our take on THW.""}, {""date"": ""2023-06-29"", ""headline"": ""OmniAb: Plenty Of Potential"", ""summary"": ""OmniAb shares have recovered marginally from their SPAC-birthed debut. Read more to see a full investment analysis of OABI stock.""}, {""date"": ""2023-06-29"", ""headline"": ""The Stock Market Is Getting Scary. What to Buy Instead of Holding Cash."", ""summary"": ""The S&P 500 has gained just over 20% from a major low point hit in early October, making it much pricier.""}, {""date"": ""2023-06-29"", ""headline"": ""The 3 Most Undervalued Dow Stocks to Buy Now: June 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Johnson & Johnson call buyer realizes 12% same-day gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Retire Rich With 'Dividend King' Royalty"", ""summary"": ""The rate-hike cycle will end (sooner rather than later). Then, dividends should drop and shares should go to normal valuation levels. Click for my top picks.""}, {""date"": ""2023-06-29"", ""headline"": ""Haleon: Leading Business In An Attractive Industry"", ""summary"": ""Haleon's margins are comparably strong in the market. Click here to see why HLN stock is a Buy.""}, {""date"": ""2023-06-29"", ""headline"": ""The Supreme Court knocked down affirmative action in colleges \u2014 and companies could feel the effects too"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Morgan Stanley shakes up its global dividend portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Companies Stick to Workplace Diversity Despite End of Affirmative Action"", ""summary"": ""The Supreme Court's decisions not only dealt a blow to the higher-education system, but to America's private sector as well.""}, {""date"": ""2023-06-30"", ""headline"": ""3 Dividend Stocks to Buy Right This Minute"", ""summary"": ""Since the second half of 2022, the economy has been volatile and this has led to many investors looking for safe and stable stocks to invest in. The market was in a rout and no industry has been spared but after all the uncertainty, we are finally looking at better days ahead. There are still concerns about a looming recession and it could have an impact on the market but there are some dividend stocks to buy now that can thrive even if there is a recession. Investors looking to build a stable p""}, {""date"": ""2023-06-30"", ""headline"": ""Medicare releases updated guidance ahead of drug price negotiations"", ""summary"": ""CMS released revised guidance on Friday, adding transparency to the Medicare negotiation process it is engaging in with drug makers as part of the Inflation Reduction Act.""}, {""date"": ""2023-06-30"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.87% higher to $165.52 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-06-30"", ""headline"": ""Sage Therapeutics: Zuranolone August Approval Likely, Opportunity Uncertain"", ""summary"": ""Sage Therapeutics should find out in August whether its drug, zuranolone, will be approved. Click here to see our take on SAGE stock.""}, {""date"": ""2023-06-30"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""If You Invested $5,000 In Johnson & Johnson In 2018, This Is How Much You Would Have Today"", ""summary"": ""As one of the most prominent healthcare companies on Earth, Johnson & Johnson (NYSE: JNJ) is a stock that's much loved by investors on account of its metronome-like consistent returns.  Between its gradually increasing dividend and plenty of reasons to expect that the business will be more valuable tomorrow than it is today, it's easy to assume that it has a knack for beating the market.  If you invested $5,000 in Johnson & Johnson in mid-2018 and reinvested all your dividends, you'd currently be enjoying a total return of 53%, which means you'd have around $7,640.""}, {""date"": ""2023-06-30"", ""headline"": ""Like shoppers, IPO investors are demanding discounts and showing price sensitivity"", ""summary"": ""IPO investors, much like shoppers in the current inflationary environment, are demanding discounts, according to Renaissance Capital.""}, {""date"": ""2023-06-30"", ""headline"": ""FVAL: Smarter Than Most Value ETFs"", ""summary"": ""Fidelity Value Factor ETF holds 126 stocks with value characteristics. FVAL has rules for the banking industry, so financials are not overweight. Click here for more.""}, {""date"": ""2023-06-30"", ""headline"": ""Medicare revises guidance on drug price negotiations amid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Ranking These 5 Dividend Kings From Highest Quality To Lowest"", ""summary"": ""A Dividend King is any stock that has raised their dividend for 50+ consecutive years. See five Dividend Kings ranked from highest to lowest quality.""}, {""date"": ""2023-06-30"", ""headline"": ""5 Genius Safe Stocks to Buy for the Second Half of 2023"", ""summary"": ""As of the closing bell on June 27, 2023, the benchmark S&P 500 and growth-powered Nasdaq Composite were up by 14% and 29.5%, respectively, for the year.  Although history would suggest the phenomenal start to the new year will continue, there's no shortage of economic indicators and metrics pointing to downside for the U.S. economy and/or stock market.  What follows are five genius safe stocks -- \""safe\"" in the sense that they're profitable, time-tested, and have the ability outperform in any economic environment -- you can confidently buy for the second half of 2023.""}, {""date"": ""2023-06-30"", ""headline"": ""The Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Like choosy shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Like shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-02"", ""headline"": ""10 Best Dividend Penny Stocks to Buy Now"", ""summary"": ""In this article, we will discuss 10 best dividend penny stocks to buy now. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best Dividend Penny Stocks to Buy Now. As we move into the second half of the year, the stock market continues to [\u2026]""}, {""date"": ""2023-07-02"", ""headline"": ""Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
25,2023-07-02,163.0214080810547,2023-07-09,156.84605407714844,-0.03788063222246152,D4,"[{""date"": ""2023-07-02"", ""headline"": ""3 Long-Term Stocks to Make Your \u2018Get Rich\u2019 Dreams Come True"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-02"", ""headline"": ""10 Best Dividend Penny Stocks to Buy Now"", ""summary"": ""In this article, we will discuss 10 best dividend penny stocks to buy now. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best Dividend Penny Stocks to Buy Now. As we move into the second half of the year, the stock market continues to [\u2026]""}, {""date"": ""2023-07-02"", ""headline"": ""Supreme Court ended affirmative action at colleges. That could harm companies\u2019 diversity efforts."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""10 Best July Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best July dividend stocks to buy. You can skip our detailed analysis of dividend capture strategy and performance of dividend stocks, and go directly to read 5 Best July Dividend Stocks To Buy. The investment landscape is undergoing substantial shifts this year as investors explore different strategies to make [\u2026]""}, {""date"": ""2023-07-03"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $163.35 in the latest trading session, marking a -1.31% move from the prior day.""}, {""date"": ""2023-07-03"", ""headline"": ""With 65% institutional ownership, Johnson & Johnson (NYSE:JNJ) is a favorite amongst the big guns"", ""summary"": ""Key Insights Institutions' substantial holdings in Johnson & Johnson implies that they have significant influence over...""}, {""date"": ""2023-07-03"", ""headline"": ""Face to Face - 'Fail Your Way to Success', Says Prof Behind Pioneering Drug Discovery Group At UCT"", ""summary"": ""Inside Professor Kelly Chibale's office the bookshelves are packed with awards. On the walls, framed photographs include his class photo at Cambridge University in the United Kingdom, dated...""}, {""date"": ""2023-07-03"", ""headline"": ""Johnson & Johnson psoriasis pill disappoints in phase 2 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""15 Best Places to Retire in the Caribbean"", ""summary"": ""In this article, we will take a look at the 15 best places to retire in the Caribbean. If you wish to skip our detailed analysis on a million-dollar retirement, and retiring in the Caribbean, you may go to 5 Best Places to Retire in the Caribbean. A Million Dollar Retirement Previously, a comfortable retirement in [\u2026]""}, {""date"": ""2023-07-04"", ""headline"": ""Long-Term Stock Portfolio: Best Stocks for 20 Years"", ""summary"": ""In this piece, we will take a look at the best stocks for the next 20 years. For more stocks on this list, head on over to Long-Term Stock Portfolio: 5 Best Stocks for 20 Years. The world of investments is not for those that are prone to panicking easily. Over a few years, stocks [\u2026]""}, {""date"": ""2023-07-04"", ""headline"": ""3 Spectacular Dividend Stocks to Buy in July"", ""summary"": ""Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Johnson & Johnson (NYSE: JNJ).  Keith Speights (AbbVie): If you're in the market for a high dividend yield, AbbVie could be right up your alley.""}, {""date"": ""2023-07-04"", ""headline"": ""Protagonist says JNJ-2113 met efficacy endpoints in psoriasis study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""The 3 Best Defensive Stocks to Buy Now (and Never Sell)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""15 Countries With The Best Healthcare In The World"", ""summary"": ""In this article, we will be taking a look at the 15 countries with the best healthcare in the world. If you wish to see the top ones, head straight to the 5 Countries With The Best Healthcare In The World. When it comes to ensuring the well-being of their citizens, some countries like Switzerland, [\u2026]""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna announces China investment as country opens doors to foreign pharma"", ""summary"": ""China signals a warmer welcome for Western pharma giants just as Treasury Secretary Janey Yellen leaves for Beijing.""}, {""date"": ""2023-07-05"", ""headline"": ""Go with what's working instead of waiting for what is not working, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer takes a closer look at market underperformers and what they say about the economy at large.""}, {""date"": ""2023-07-05"", ""headline"": ""Cramer examines the worst performers from the first half of 2023, explains why the market seems narrow"", ""summary"": ""CNBC's Jim Cramer told investors on Wednesday that if they're waiting for the market to broaden for a rally, they might be waiting forever.""}, {""date"": ""2023-07-05"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 0.33% to $162.81 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-05"", ""headline"": ""Can Eli Lilly's (LLY) Continue its Ride on Obesity Drug Wave?"", ""summary"": ""Lilly (LLY) continues to raise the bar on obesity drugs as latest data show that participants treated with these experimental drugs achieved mean weight reduction of up to 24%.""}, {""date"": ""2023-07-05"", ""headline"": ""Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment"", ""summary"": ""Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (IL-23R) antagonist JNJ-2113 (formerly PN-235) in adult patients with moderate-to-severe plaque psoriasis presented at World Congress of Dermatology in Singapore. JNJ-2113 is being developed by Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ). In March, Protagonist released preliminary results from the trial, saying it had outperformed the place""}, {""date"": ""2023-07-05"", ""headline"": ""What The World's Top Investors Are Buying And Selling, The Sequel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Here\u2019s Why Johnson & Johnson (JNJ) Declined in Q1"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d first quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy underperformed its benchmark, the Russell 1000 Value Index, in the first quarter. On an absolute basis, the strategy gained from 5 of the 11 sectors in which [\u2026]""}, {""date"": ""2023-07-05"", ""headline"": ""Sorrento sees promising phase 2 results for abivertinib for lymphoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""J&J FRONTIER 1 Phase 2 leaves door open for Ventyx's VTX-958, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Johnson & Johnson Unusual Options Activity For July 05"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Wells Fargo expects Ventyx Biosciences' shares to work into 2H23 catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Protagonist data suggests 'very strong profile' for JNJ-2113, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Rose's Income Garden 80 Stock Portfolio: Update H1 2023 Green With 7 June Raises"", ""summary"": ""Rose's Income Garden portfolio saw 39 companies pay dividends in June, with seven raises and one cut. Click here for a detailed analysis.""}, {""date"": ""2023-07-06"", ""headline"": ""Bausch + Lomb Buys Blink Brands to Expand Eye Drop Portfolio"", ""summary"": ""Bausch + Lomb purchased Blink brands from a J&J subsidiary for $106.5 million to expand its over-the-counter offerings.""}, {""date"": ""2023-07-06"", ""headline"": ""Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink"", ""summary"": ""Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC) consumer products for eye care. The deal marks its second in two weeks to bolster the contact lens maker's portfolio of eye care products. The Blink portfolio of eye drops consists of various eye drops and contact lens rewetting drops that provide immediate and long-lasting symptom relief. According to a 20""}, {""date"": ""2023-07-06"", ""headline"": ""Johnson & Johnson stock outperforms market despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slipped 0.74% to $161.60 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-06"", ""headline"": ""Johnson & Johnson: Supplemental BLA Of Carvykti Gives Great Growth Opportunity"", ""summary"": ""Johnson & Johnson's Supplemental Biologics Licensing Application of CARVYKTI was filed; approval would give JNJ a great growth opportunity. Click here for more on JNJ.""}, {""date"": ""2023-07-06"", ""headline"": ""Voya Global Equity Dividend: 9.2% Yield, What's Not To Like?"", ""summary"": ""The Voya Global Equity Dividend CEF generates a big yield. Read if this fund is a good way to play defense in a volatile market.""}, {""date"": ""2023-07-06"", ""headline"": ""2 Best Biotech Stocks to Buy in July"", ""summary"": ""The pharmaceutical industry can be especially lucrative for investors.  Here are two giant drugmakers for income investors to consider buying this month that look equipped to continue thriving in the future.  When many people think of Johnson & Johnson (NYSE: JNJ), the first thing that comes to mind is consumer health brands under the separate, but 90% company-owned entity, Kenvue (NYSE: KVUE).""}, {""date"": ""2023-07-06"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-07-06"", ""headline"": ""Johnson & Johnson: A Safe and Undervalued Dividend Aristocrat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""3 Super-Safe Dividend Stocks to Buy for the Rest of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""August 25th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Notable Thursday Option Activity: JNJ, TXN, BAC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Bausch + Lomb buys J&J's Blink eye and contact lens drops product line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-07"", ""headline"": ""June 2023 Passive Income Update"", ""summary"": ""I was happy to see such a jump in the trailing 12-month return until I compared everything.""}, {""date"": ""2023-07-07"", ""headline"": ""Passive Income: 3 Dividend Kings Worth A Look"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-07"", ""headline"": ""25 US Companies With The Highest Profit Margins"", ""summary"": ""In this article, we will be taking a look at the 25 US companies with the highest profit margins. If you wish to see the top ones, head straight to the 5 US Companies With The Highest Profit Margins. In the dynamic landscape of the United States business sector, several companies like JP Morgan, Apple, [\u2026]""}, {""date"": ""2023-07-07"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.45% to $159.25 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-07"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?"", ""summary"": ""The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...""}, {""date"": ""2023-07-07"", ""headline"": ""Rare autoantibody diseases : an innovative targeted pathway"", ""summary"": ""Dr Katie Abouzahr, Vice President, Autoantibody Portfolio Development Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson, outlines how precision targeting in drug development...""}, {""date"": ""2023-07-07"", ""headline"": ""2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is one of the most recognized healthcare companies around.  J&J also has pharmaceutical and medtech units.  All of this means investors may feel comfortable adding shares of J&J to their portfolios.""}, {""date"": ""2023-07-07"", ""headline"": ""VONV: Attractive Valuation, Average Performance"", ""summary"": ""Vanguard Russell 1000 Value Index Fund ETF favors stocks with low price-to-book, low sales growth, low projected earnings growth. Click for more on VONV ETF.""}, {""date"": ""2023-07-07"", ""headline"": ""3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-08"", ""headline"": ""Is Johnson & Johnson Stock a Buy?"", ""summary"": ""Let's take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement.""}, {""date"": ""2023-07-08"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - July 2023"", ""summary"": ""This is our monthly series where we highlight 5 companies that are large-cap, relatively safe, dividend-paying, with large discounts. Click for our exclusive list.""}, {""date"": ""2023-07-09"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""If size were a guarantee of performance, Johnson & Johnson (NYSE: JNJ) would be one of the best healthcare stocks to buy, being one of the largest by market cap in the sector.  The new J&J still has many qualities that made it successful, but is it worth investing in the drugmaker?  J&J completed the spinoff of its consumer health division earlier this year.""}, {""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-09"", ""headline"": ""SPLV: Slowing Down Entering The Potential Storm For Stocks Ahead"", ""summary"": ""SPLV's sector allocations play a crucial role in its ability to mitigate market fluctuations. Click here to read more.""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
26,2023-07-09,156.84605407714844,2023-07-16,157.45669555664062,0.003893253694427168,U1,"[{""date"": ""2023-07-09"", ""headline"": ""Johnson & Johnson's Janssen signs licensing agreement with Nanobiotix"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-09"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""If size were a guarantee of performance, Johnson & Johnson (NYSE: JNJ) would be one of the best healthcare stocks to buy, being one of the largest by market cap in the sector.  The new J&J still has many qualities that made it successful, but is it worth investing in the drugmaker?  J&J completed the spinoff of its consumer health division earlier this year.""}, {""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-09"", ""headline"": ""SPLV: Slowing Down Entering The Potential Storm For Stocks Ahead"", ""summary"": ""SPLV's sector allocations play a crucial role in its ability to mitigate market fluctuations. Click here to read more.""}, {""date"": ""2023-07-10"", ""headline"": ""JNJ Crosses Above 3% Yield Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Jurors urged to impose heavy punitive damages in J&J talc trial"", ""summary"": ""Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on Monday urged a jury to order the company to pay heavy punitive damages, calling its conduct negligent and \""despicable.\""  \""A reasonably careful corporation would not sell a product that allowed carcinogens to be applied to babies,\"" Joseph Satterley, a lawyer for Emory Hernandez Valadez, said in a closing argument at the end of a six-week trial in Alameda County Superior Court in California.  J&J has consistently denied that its now-discontinued talc baby powder contains asbestos or causes cancer.""}, {""date"": ""2023-07-10"", ""headline"": ""25 States with the Lowest Poverty Rates in America"", ""summary"": ""In this article, we look at 25 states with the lowest poverty rates in America. You can skip our detailed analysis on poverty in the United States, and head over directly to the 10 States with the Lowest Poverty Rates in America. Poverty rate in the United States has continued to steadily decline over the [\u2026]""}, {""date"": ""2023-07-10"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.16% higher to $159.51 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-07-10"", ""headline"": ""Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit"", ""summary"": ""Johnson & Johnson  will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin,...""}, {""date"": ""2023-07-10"", ""headline"": ""Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical"", ""summary"": ""American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J's Janssen Pharmaceutical to work on co-developing a drug to treat head and neck cancer tumors.""}, {""date"": ""2023-07-10"", ""headline"": ""Lone suspect in Chicago's decades-old Tylenol murders found dead at 76"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""James Lewis, the suspect in the 1982 Tylenol poisonings that killed 7 in the Chicago area, has died"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Cramer\u2019s Mad Dash on Johnson & Johnson: Wait to see how they do on the talc lawsuit"", ""summary"": ""CNBC\u2019s Jim Cramer delivers his daily Mad Dash.""}, {""date"": ""2023-07-10"", ""headline"": ""Meta's Threads Hits 100M Users In Five Days, Foxconn Pulls Out From $19.5B Semiconductor India JV, Novo Nordisk's Weight-Loss Medications Under European Investigation Over Suicidal Risks: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Should You Buy the First Half's Worst-Performing Sector?"", ""summary"": ""After a tough 2022, the first half of this year was like a breath of fresh air for investors.  First, let's talk about why healthcare stocks stumbled recently.  Instead, it's part of a general movement toward stocks that may excel in a bull market.""}, {""date"": ""2023-07-10"", ""headline"": ""Major business group slams disclosure rules as House Republicans probe ESG investing"", ""summary"": ""House Republicans scheduled several hearings this month to probe ESG investing, which has become a big target on the right.""}, {""date"": ""2023-07-10"", ""headline"": ""Johnson & Johnson Bolsters Its Oncology Pipeline With Nanobiotix Radiotherapy Pact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Dividend Stocks: Here\u2019s Where to Invest $1,000 Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""100-Year-Old Survivors' Quest For Tulsa Race Massacre Reparations Ends In Dismissal: Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX"", ""summary"": ""By Colin Kellaher U.S.-listed shares of Nanobiotix surged in premarket trading Monday after the clinical-stage biotechnology company said it inked a...""}, {""date"": ""2023-07-10"", ""headline"": ""Nanobiotix\u2019s stock soars after entering licensing, development deal with J&J\u2019s Janssen Pharmaceutica"", ""summary"": ""Shares of Nanobiotix SA shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global...""}, {""date"": ""2023-07-10"", ""headline"": ""Nanobiotix jumps 56% to $7.85 after global licensing pact with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Nanobiotix announce global licensing pact with Johnson & Johnson for NBTXR3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-11"", ""headline"": ""Dow Jones Today: Index Jumps 300 Points"", ""summary"": ""The Dow Jones led all indexes by moving higher by nearly 1%, as investors anticipate tomorrow\u2019s key inflation data.""}, {""date"": ""2023-07-11"", ""headline"": ""UPDATE 1-US FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as \""most serious\"", saying their use could lead to injuries or death.  The U.S. health regulator said it had received reports of pediatric and adult patients suffering burn injuries when the tools, sold under the brand names MEGA 2000 and MEGA SOFT Reusable Patient Return Electrodes, were used on them.  The tools were recalled by Megadyne Medical Products, which was acquired in 2017 by Ethicon Endo-Surgery, a unit of J&J MedTech.""}, {""date"": ""2023-07-11"", ""headline"": ""Johnson & Johnson's Unit Recalls Certain Electrosurgical Tools Due Risk Of Burn Injuries"", ""summary"": ""The FDA classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson (NYSE: JNJ) unit as the most serious, saying their use could lead to injuries or death. Megadyne is recalling MEGA 2000 and MEGA SOFT reusable patient return electrodes after receiving reports of patients receiving burn injuries from use in both pediatric and adult patients. These burns may be as serious as third-degree burns requiring medical intervention and may lead to a longer hospital stay, sca""}, {""date"": ""2023-07-11"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.55% to $158.63 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-11"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-11"", ""headline"": ""US FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug\nAdministration  on Tuesday classified the recall of certain\nelectrosurgery tools manufactured by a Johnson & Johnson unit\nas most serious, saying their use could lead...""}, {""date"": ""2023-07-11"", ""headline"": ""U.S. FDA classifies recall of J&J's electrosurgical tools as most serious"", ""summary"": ""The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as the most serious, saying their use could lead to injuries or death.  The U.S. health regulator said it had received reports of pediatric and adult patients suffering burn injuries when the tools, sold under the brand names MEGA 2000 and MEGA SOFT Reusable Patient Return Electrodes, were used on them.  The tools are soft pads that conduct an electric current through the patient's body during electrosurgical procedures to heat or cut tissue, or stop bleeding.""}, {""date"": ""2023-07-11"", ""headline"": ""Johnson & Johnson Asbestos Claims Continue: California Man Alleges Baby Powder Led to Rare Cancer"", ""summary"": ""A California man, Emory Hernandez Valadez, claims he developed a rare form of cancer due to exposure to asbestos in Johnson & Johnson's (NYSE: JNJ) talc-based baby powder. Lawyers for Valadez are urging a jury to order Johnson & Johnson to pay heavy punitive damages, citing the company's conduct as negligent and \""despicable.\"" Attorney Joseph Satterley, representing Valadez, stated that a careful corporation wouldn't sell a product that allows carcinogens to be applied to babies. Related: Johnson""}, {""date"": ""2023-07-11"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-11"", ""headline"": ""Newly Released J&J Bankruptcy Plan For Compensating Talcum Powder Cancer Claims Includes Canadian Claims"", ""summary"": ""A Johnson & Johnson subsidiary that is pursuing a US bankruptcy to resolve thousands of talcum powder lawsuits has filed its plan for compensating cancer victims with pending claims, and the proposed...""}, {""date"": ""2023-07-11"", ""headline"": ""Investing in Johnson & Johnson (NYSE:JNJ) five years ago would have delivered you a 46% gain"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...""}, {""date"": ""2023-07-11"", ""headline"": ""Meet Wall Street's Greatest Dividend Stock: A Small-Cap Company 99.9% of Investors Have Probably Never Heard Of"", ""summary"": ""This company has been consistently paying a dividend since James Madison was president of the United States... in 1816.""}, {""date"": ""2023-07-12"", ""headline"": ""2-year Treasury yield continues to slide after cool June CPI figure"", ""summary"": ""U.S. Treasury yields were mostly lower on Thursday after June's inflation print came in cooler than expected.""}, {""date"": ""2023-07-12"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $157.97, marking a -0.42% move from the previous day.""}, {""date"": ""2023-07-12"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.35% to $158.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-07-12"", ""headline"": ""20 Most Hated Brands in the World"", ""summary"": ""In this piece, we will take a look at the 20 most hated brands in the world. If you are not interested in reading the details, head straight to the 5 Most Hated Brands in the World. Starting a business in the US is the first step in building a global brand since it is [\u2026]""}, {""date"": ""2023-07-12"", ""headline"": ""Will Q2 Earnings Drive Dow ETFs Higher?"", ""summary"": ""Nearly one-fourth of the blue-chip firms are expected to announce results this week and the next.""}, {""date"": ""2023-07-12"", ""headline"": ""What Stocks To Buy Today? 3 Good Dividend Stocks In Focus"", ""summary"": ""Good dividend stocks to watch in the stock market now.""}, {""date"": ""2023-07-12"", ""headline"": ""How to Turn $10,000 Into $1,000,000 by Retirement"", ""summary"": ""There's no big secret to earning outsize gains -- simply invest in quality businesses for the long haul.""}, {""date"": ""2023-07-12"", ""headline"": ""FDA classifies J&J electrode recall as most serious type"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""3 Dow Stocks That Are Stand-Out Buys for July (and Beyond)"", ""summary"": ""For the past 127 years, the iconic Dow Jones Industrial Average (DJINDICES: ^DJI) has been one of Wall Street's most-followed indexes, and a barometer for the health of the stock market.  Although the Dow Jones is far from perfect -- it's a share price-weighted index, rather than market cap-weighted -- its 30 components are generally profitable on a recurring basis, time-tested in the sense that they've navigated their fair share of recessions, and multinational.  In other words, these are businesses investors don't have to worry about when they go to sleep at night.""}, {""date"": ""2023-07-12"", ""headline"": ""ABA-Creating long-term change through storytelling"", ""summary"": ""Difference-making thought-leader Tamsen Webster is the opening keynote at the ABA Bank Marketing Conference in September.\nAs an author, public speaker and messaging strategist, Tamsen Webster helps...""}, {""date"": ""2023-07-13"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: June 2023 Review"", ""summary"": ""The significant dividend growth is attributed to rapid rise in interest rates over past 12-18 months, with cash position now yielding nearly 5%. Read more here.""}, {""date"": ""2023-07-13"", ""headline"": ""My Dividend Growth Portfolio - Q2 2023 Summary"", ""summary"": ""In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. Read here for a summary of Q2 of 2023.""}, {""date"": ""2023-07-13"", ""headline"": ""Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer"", ""summary"": ""Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products.""}, {""date"": ""2023-07-13"", ""headline"": ""Exclusive: Rose Health founder Kavi Misri launches new venture to help employers keep workers healthy"", ""summary"": ""For Kavi Misri, a routine visit to the doctor earlier this year brought an unexpected diagnosis \u2014 and sparked the idea for what\u2019s now a Johnson & Johnson Innovation portfolio company planning to raise millions to help keep the local workforce healthy.  The D.C. entrepreneur, who founded Rose Health in 2018 and led that company to an exit last fall, learned in March he had prediabetes, requiring him to change his diet and exercise \u2014 and, he said, leaving him without much of a game plan beyond that.  It collects and analyzes health data for screening and prevention; provides access to clinicians and experts \u2014 including primary care physicians, registered nurses and registered dietitians \u2014 and offers chef-prepared meals through a delivery service with an undisclosed partner.""}, {""date"": ""2023-07-13"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.46% higher to $158.81 Thursday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-07-13"", ""headline"": ""Johnson & Johnson sues researchers who linked talc to cancer"", ""summary"": ""Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer, escalating an attack on scientific studies that the company alleges are inaccurate.  J&J's subsidiary LTL Management, which absorbed the company's talc liability in a controversial 2021 spinoff, last week filed a lawsuit in New Jersey federal court asking it to force three researchers to \""retract and/or issue a correction\"" of a study that said asbestos-contaminated consumer talc products sometimes caused patients to develop mesothelioma.  One of the researchers, Richard Kradin, declined to comment.""}, {""date"": ""2023-07-13"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-13"", ""headline"": ""Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-07-13"", ""headline"": ""Psychedelic Stocks: Don't Bet On Just 1 Company"", ""summary"": ""Will tough times continue for psychedelic stocks? Analyst Alex Carchidi shares his views on the sector and specific stocks like Compass Pathways, Atai and Cybin.""}, {""date"": ""2023-07-13"", ""headline"": ""Interesting JNJ Put And Call Options For March 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""Is Johnson & Johnson Stock Overvalued?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is a favorite of long-term investors everywhere, and it's no surprise why.  Thanks to its diversified business, steady dividend payout, and an ultra-lengthy history of profitable operation, the stock is at home in most retirement portfolios.  Let's analyze its valuation and find out if you are getting a deal when buying the stock right now.""}, {""date"": ""2023-07-13"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""Dividend Income Update June 2023"", ""summary"": ""The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. ""}, {""date"": ""2023-07-14"", ""headline"": ""COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down"", ""summary"": ""COMPASS is short on cash but has major investment house backing. Click here to read why I rate CMPS stock a Sell.""}, {""date"": ""2023-07-14"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.67% higher to $159.87 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-07-14"", ""headline"": ""Tech hiring is rough now \u2013 except in one area (and you\u2019ve probably guessed it)"", ""summary"": ""Though layoffs have roiled tech giants, there's one area where tech talent, especially developers, remain in high demand \u2013 Yes, you guessed it, AI.""}, {""date"": ""2023-07-14"", ""headline"": ""The Bond Bandit - Seize The Anti-ESG Premium"", ""summary"": ""The article compares a set of 14 companies with different credit ratings (Aaa to Baa2) and representative bond portfolios. Click here to read my picks and much more.""}, {""date"": ""2023-07-14"", ""headline"": ""3 Healthcare Stocks for Long-Term Dividend Growth"", ""summary"": ""The U.S. health care sector is attractive for long-term investors, in part because of the growth of the U.S.' population of people in their 60s and older.  The industry is expected to grow going forward, at a rate above gross domestic product growth.  Johnson & Johnson  is a diversified health care company and a leader in the area of pharmaceuticals (~49% of sales), medical devices (~34% of sales) and consumer products (~17% of sales).""}, {""date"": ""2023-07-14"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""Bank Domination: Earnings Season Kicks Off With A Hat Trick As Three Major Banks Post Beats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""3 Best Buffett Stocks to Buy for the Long Haul"", ""summary"": ""Warren Buffett owns plenty of great stocks. These could be the best to buy and hold over the long run.""}, {""date"": ""2023-07-14"", ""headline"": ""Dow up 130 points on gains in shares of UnitedHealth, JPMorgan Chase"", ""summary"": ""The Dow Jones Industrial Average is trading up Friday morning with shares of UnitedHealth and JPMorgan Chase delivering the strongest returns for the index....""}, {""date"": ""2023-07-14"", ""headline"": ""Earnings This Week: Tesla, Netflix And Bank Of America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""7 Failing Dividend Stocks to Stay Far, Far Away From"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""SVB Securities Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""Treasury yields moderate after two-day slide on light inflation data"", ""summary"": ""U.S. Treasury yields climbed on Friday, reversing some of the sharp declines seen in the last two sessions on the back of cooler-than-expected inflation prints.""}, {""date"": ""2023-07-15"", ""headline"": ""Why You Should Aim For $3 Million For Retirement (Gen X'ers And Millennials)"", ""summary"": ""Saving early and regularly, investing wisely, and budgeting expenses are keys to a wealthy retirement. Read why it's a good time for younger generations to look at retirement scenarios.""}, {""date"": ""2023-07-15"", ""headline"": ""2 Warren Buffett Stocks to Buy Hand Over Fist"", ""summary"": ""Buffett's strategy involves buying top companies for reasonable prices -- and holding on to them.""}, {""date"": ""2023-07-16"", ""headline"": ""Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets."", ""summary"": ""Analyst Alex Carchidi updates investors on the psychedelics industry. Super-risky biotech companies low on cash - don't bet on just 1 company.""}, {""date"": ""2023-07-16"", ""headline"": ""3 Dividend Growth Stocks to Buy and Hold"", ""summary"": ""Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years.  With this in mind, three Motley Fool contributors identified dividend growth stocks they think are great picks to buy and hold.  Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).""}, {""date"": ""2023-07-16"", ""headline"": ""Tesla, Netflix, Goldman Earnings To Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Tesla, Netflix, Goldman Earnings Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
27,2023-07-16,157.45669555664062,2023-07-23,167.6209259033203,0.06455254449959802,U5+,"[{""date"": ""2023-07-16"", ""headline"": ""S&P, Dow kick off busy earnings week with small gains, Nasdaq rises nearly 1%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Johnson & Johnson Unusual Options Activity For July 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Electric Week Ahead: Tesla Earnings Among Highlights Along With Retail Sales, But Soft China Growth In Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Monday's Market Minute: This Week It's All About Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets."", ""summary"": ""Analyst Alex Carchidi updates investors on the psychedelics industry. Super-risky biotech companies low on cash - don't bet on just 1 company.""}, {""date"": ""2023-07-16"", ""headline"": ""3 Dividend Growth Stocks to Buy and Hold"", ""summary"": ""Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years.  With this in mind, three Motley Fool contributors identified dividend growth stocks they think are great picks to buy and hold.  Here's why they chose AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE).""}, {""date"": ""2023-07-16"", ""headline"": ""Tesla, Netflix, Goldman Earnings To Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-16"", ""headline"": ""Tesla, Netflix, Goldman Earnings Hit The Deck As Q2 Reporting Season Starts In Earnest: Key Companies To Watch In Week Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""LONDON MARKET EARLY CALL: Stocks to tread water despite New York gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Top Yielding Dividend Aristocrats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""3 Quarterly Reports Investors Can't Ignore This Week"", ""summary"": ""We've got a loaded slate, including quarterly results from Netflix, American Express, and Johnson & Johnson. But how do estimates stack up heading into their respective prints?""}, {""date"": ""2023-07-17"", ""headline"": ""12 Best Dividend Stocks Under $10"", ""summary"": ""In this article, we discuss 12 best dividend stocks under $10. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Stocks Under $10. Despite facing various challenges, such as banking sector instability and concerns about the economy, the U.S. stock market has shown remarkable [\u2026]""}, {""date"": ""2023-07-17"", ""headline"": ""Warren Buffett\u2019s 12 Longest Held Stocks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s 12 longest held stocks. If you want to skip our introduction of the billionaire investor, his life, and investment strategy, then head on over to Warren Buffett\u2019s 5 Longest Held Stocks. Warren Buffett is the richest investor in the world. While his firm, Berkshire [\u2026]""}, {""date"": ""2023-07-17"", ""headline"": ""IN BRIEF: J&J's Rybrevant plus chemo shows improvement in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.50% to $159.07 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-17"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks higher at start of big earnings week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""LONDON MARKET CLOSE: Stocks slip as Chinese growth data disappoints"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""3 Healthcare Stocks to Buy as the Market Gets Defensive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Johnson & Johnson Stock Q2 Earnings Preview: News On Kenvue Distribution Expected?"", ""summary"": ""Johnson & Johnson will release its Q2 earnings report on July 20 before the market opens. Read why I didn't add my position in JNJ and holding Kenvue stock.""}, {""date"": ""2023-07-17"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings in billions of dollars annually thanks to its cystic fibrosis (CF) treatments.  Vertex's Trikafta has the ability to treat 90% of CF patients today.  Vertex also is studying another candidate in pivotal trials that could even beat Trikafta.""}, {""date"": ""2023-07-17"", ""headline"": ""Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Biggest stock movers today: Chewy, BridgeBio Pharma, Acumen Pharmaceuticals and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-07-17"", ""headline"": ""Biggest stock movers today: BridgeBio Pharma, Zai Lab, argenx and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Medicare Negotiations and Q2 Earnings in Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""UPDATE 2-J&J must pay $18.8 mln to California cancer patient in baby powder suit"", ""summary"": ""Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J must pay $18.8 million to California cancer patient in baby powder suit"", ""summary"": ""(Reuters) -Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J must pay $18.8 mln to California cancer patient in baby powder suit"", ""summary"": ""Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.  The jury ruled in favor of Emory Hernandez Valadez, who filed suit last year in California state court in Oakland against J&J, seeking monetary damages.  Hernandez, 24, has said he developed mesothelioma, a deadly cancer, in the tissue around his heart as a result of heavy exposure to the company's talc since childhood.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J Is Latest Drug Maker to Sue Over Medicare Price Rules"", ""summary"": ""Johnson & Johnson joined others in the pharmaceutical industry suing the government over new Medicare prescription drug price rules.""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson sues Biden administration over drug-pricing policies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program"", ""summary"": ""Johnson & Johnson has joined companies such as Merck & Co. Inc. Bristol Myers Squibb Co. and other entities in suing the federal government over Medicare\u2019s...""}, {""date"": ""2023-07-18"", ""headline"": ""UPDATE 3-J&J sues in latest bid to halt Medicare drug price negotiations"", ""summary"": ""Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices.  The pharmaceutical industry says the drug price negotiation program under President Joe Biden's signature Inflation Reduction Act law will curtail profits and compel drugmakers to curb development of groundbreaking new treatments.  With Americans paying more for prescription medicines than any other country, the Biden administration hopes to save $25 billion annually by 2031 by having Medicare negotiate prices for some of the costliest medicines used by its beneficiaries, who are 65 and older.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector"", ""summary"": ""Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment, recovery in surgical procedures and new product launches are likely to have pushed sales growth.""}, {""date"": ""2023-07-18"", ""headline"": ""12 Best Dividend Stocks Under $25"", ""summary"": ""In this article, we discuss 12 best dividend stocks under $25. You can skip our detailed analysis of the market outlook and importance of dividend stocks, and go directly to read 5 Best Dividend Stocks Under $25. Over the years, various stock market patterns have been observed. What may be effective in one market environment [\u2026]""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson sues Biden administration over Medicare drug price negotiations"", ""summary"": ""Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month. ""}, {""date"": ""2023-07-18"", ""headline"": ""J&J becomes latest Big Pharma to sue over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson: Q2 Earnings Will Satisfy Market, But May Mask Wider Issues"", ""summary"": ""Johnson & Johnson is reinventing itself as a pharmaceuticals specialist after spinning out consumer health division. Read what to expect for earnings from JNJ.""}, {""date"": ""2023-07-18"", ""headline"": ""Johnson & Johnson files litigation to challenge Inflation Reduction Act"", ""summary"": ""Johnson & Johnson on Tuesday\nfiled a litigation against the U.S. Department Of Health And\nHuman Services and the Centers Medicare And Medicaid Services\nchallenging the Inflation Reduction Act.\n       ...""}, {""date"": ""2023-07-18"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J files suit against HHS, CMS over drug pricing provisions of IRA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Janssen Pharmaceutical - Treatment with RYBREVANT plus Chemotherapy Resulted in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the Phase 3 PAPILLON study evaluating RYBREVANT  in combination with chemotherapy  in...""}, {""date"": ""2023-07-18"", ""headline"": ""My Dividend Stock Portfolio: New June Dividend Record - 99 Holdings With 28 Buys"", ""summary"": ""The broad S&P500 edged up 1.2% in June, while the Dow Jones rose slightly by 0.8% during the month. Click here to see my complete dividend stock portfolio list.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""LianBio partner NANOBIOTIX enters license agreement with JanssenJohnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""LONDON MARKET MIDDAY: Ocado leads way but FTSE 100 flat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J ordered to pay $18.8M over baby powder cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J ordered to pay $18.8M over man's talc-cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J  requried to pay $18.8M over man's talc-cancer claim, jury rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""J&J ordered to pay $18.8M over baby powder claims, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""3 Biotech Stocks for Getting Rich in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Teva Pharmaceutical: Lacking Capabilities For Strategic Investments"", ""summary"": ""Teva Pharmaceutical's growth is not impressive and it is valued at a significant discount to the rest of the sector. See why TEVA stock is a Sell.""}, {""date"": ""2023-07-19"", ""headline"": ""Our Dividend Growth Portfolio Continues To Outpace The S&P 500"", ""summary"": ""The portfolio was designed to provide greater protection during recessions and severe bear markets, and began to pull away from the S&P 500 in 2020. Explore more here.""}, {""date"": ""2023-07-19"", ""headline"": ""12 Highest Yielding Dow Jones Dividend Stocks"", ""summary"": ""In this article, we discuss 12 highest yielding Dow Jones dividend stocks. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Highest Yielding Dow Jones Dividend Stocks. The Dow Jones Industrial Average, commonly referred to as the Dow, is one of the most [\u2026]""}, {""date"": ""2023-07-19"", ""headline"": ""American Airlines, Travelers, Johnson & Johnson, housing data: What To Watch"", ""summary"": ""Yahoo Finance Live's Brian Sozzi looks ahead to Thursday, July 20, outlining the earnings reports and housing data due out tomorrow.""}, {""date"": ""2023-07-19"", ""headline"": ""Dow futures slip as Tesla, Netflix report"", ""summary"": ""Investing.com - Dow futures were trading lower during Wednesday's evening deals, after major benchmark averages extended fresh 15-month highs, with traders digesting quarterly earnings results from major companies throughout the session.""}, {""date"": ""2023-07-19"", ""headline"": ""Nasdaq 100 futures slip Wednesday evening after Netflix posts results: Live updates"", ""summary"": ""Stock futures TK Wednesday night as investors looked to key corporate earnings results.""}, {""date"": ""2023-07-19"", ""headline"": ""Immunovant Stock: With Anti-FcRn Validation Continuing, This Is A Must-Watch"", ""summary"": ""Immunovant expects results from phase 2b study using batoclimab for treatment of patients with CIDP in first half of 2024. Click here to read more on IMVT stock.""}, {""date"": ""2023-07-19"", ""headline"": ""20 Countries with Highest Rates of Infant Mortality"", ""summary"": ""In this detailed article, we will discuss 20 countries with the highest rates of infant mortality and the causes of such alarming numbers of deaths. If you want to skip the details, read 8 Countries with Highest Rates of Infant Mortality. Countries with the highest rates of infant mortality do not employ sufficient measures to make [\u2026]""}, {""date"": ""2023-07-19"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.20% to $158.74 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-07-19"", ""headline"": ""Microsoft-Activision Adjust Deal Deadline Terms, Goldman Sachs' Q2 Profits Fall 60%, Johnson & Johnson Joins Legal Battle Against US Government On Drug Pricing Negotiation: Today's Top Stories"", ""summary"": ""Benzinga What's Going On With Microsoft-Activision Deal? Companies Adjust Deadline Terms Microsoft Corp (NASDAQ: MSFT) and Activision Blizzard Inc (NASDAQ: ATVI) stocks are grabbing attention amid reports of the companies extending the $69 billion takeover deal to October 18. The terms of the agreement include an increase in the termination fee payable to Activision Blizzard from $3.0 billion to $3.5 billion if the transaction is terminated after August 29, 2023, and to $4.5 billion if the trans""}, {""date"": ""2023-07-19"", ""headline"": ""Johnson & Johnson, D.R. Horton, Taiwan Semi: 3 things to watch"", ""summary"": ""Investing.com -- Stocks were rising as investors took in a slew of corporate earnings, including a miss by Goldman Sachs (NYSE:GS) because of write-downs and a slump in investment banking.""}, {""date"": ""2023-07-19"", ""headline"": ""Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) has reportedly taken legal action against the U.S. government, following the lead of other pharmaceutical companies aiming to obstruct a program that empowers the Medicare government health insurance plan to negotiate lower prices for medication. The pharmaceutical sector asserts that President Joe Biden's hallmark Inflation Reduction Act, which enables the drug price negotiation scheme, will limit profits and force companies to reduce the development of innovative""}, {""date"": ""2023-07-19"", ""headline"": ""NGO urges Johnson & Johnson to not enforce tuberculosis drug patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""IYH: Healthcare Dashboard For July"", ""summary"": ""Pharmaceuticals/biotechnology is the most attractive subsector for value and quality scores. Fast facts on iShares U.S. Healthcare ETF, click for more on IYH.""}, {""date"": ""2023-07-19"", ""headline"": ""Notable earnings before Thursday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""3 No-Brainer Stocks to Buy With $400 Right Now"", ""summary"": ""Despite never knowing (with any certainty) when corrections will begin, how long they'll last, or how steep the ultimate decline will be in the major U.S. stock indexes, history has shown that every sizable drop was eventually put in the rearview mirror by a bull market rally.  With the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite still well below their all-time highs, bargains can still be had.  The first phenomenal stock that makes for a surefire buy with $400 right now is healthcare conglomerate Johnson & Johnson (NYSE: JNJ), which is perhaps better known as J&J.""}, {""date"": ""2023-07-19"", ""headline"": ""Johnson & Johnson - Protecting the Healthcare Innovation Ecosystem"", ""summary"": ""Johnson & Johnson and its Janssen pharmaceutical companies have delivered transformative medicines to patients for more than 130 years.\nOur ability to deliver these breakthroughs is possible because...""}, {""date"": ""2023-07-19"", ""headline"": ""Wall Street Breakfast: Scorching Summer"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""2023-07-19"", ""headline"": ""Goldman Sachs, Johnson & Johnson fall premarket; Carvana, Microsoft rise"", ""summary"": ""Investing.com -- U.S. futures traded largely unchanged Wednesday, consolidating after recent strong gains as investors digest a deluge of important corporate earnings.""}, {""date"": ""2023-07-19"", ""headline"": ""Johnson & Johnson's First Talc-Related Trial In Two Years: Court Orders To Pay Around $19M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Wall Street Breakfast Podcast: Microsoft Unveils Pricing For AI Tool"", ""summary"": ""Microsoft hits all-time high after unveiling pricing for AI tool, Copilot. J&J ordered to pay $18.8M over baby powder cancer claim, jury rules. Carvana drops after moving earnings date.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Stock Gains as JNJ Goes on Legal Offensive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Notable Friday Option Activity: JNJ, QCOM, IBM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Mortgage rates, American Airlines, Johnson & Johnson: Top stories"", ""summary"": ""Yahoo Finance Live anchor Alexandra Canal breaks down the latest housing data while also taking a look at the stock performance of American Airlines and pharmaceutical company Johnson & Johnson after reporting earnings.""}, {""date"": ""2023-07-20"", ""headline"": ""S&P 500 Gains and Losses Today: Stocks Mixed After Latest Earnings Reports"", ""summary"": ""The Dow rose, but the S&P 500 slipped 0.7% on Thursday, July 20, 2023, while the Nasdaq tumbled almost 2% after the latest round of corporate earnings reports.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Stock Just Got A Surprising New Price Target"", ""summary"": ""Johnson & Johnson's stock hasn't performed as well as the broader stock market this year because of concerns lawsuits over its talc-based products could cost it billions. However, investors have grown increasingly optimistic lately.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, Tesla, Netflix: Earnings movers"", ""summary"": ""Pharma company Johnson & Johnson's shares jump following its earnings beat. Tesla shares slide following an earnings miss and a disappointing earnings call with CEO Elon Musk. Netflix's stock falls on a revenue miss despite huge gains in subscriber growth figures. Yahoo Finance Live anchors Seana Smith and Alexandra Canal break down the earnings data on several top stocks.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson's Stock Lifted the Dow Today"", ""summary"": ""Shares of Johnson & Johnson rose 6.1% after the healthcare company reported better-than-expected earnings and [boosted its full-year guidance](https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2).""}, {""date"": ""2023-07-20"", ""headline"": ""Stock Market Today: Nasdaq Spirals After Disappointing Netflix, Tesla Earnings"", ""summary"": ""While the Nasdaq slumped today, the Dow extended its longest win streak in years on solid Johnson & Johnson earnings. Stocks closed mixed Thursday as investors combed over the latest round of corporate earnings reports. While the Dow Jones Industrial Average extended its longest win streak in years thanks to strong results from Johnson & Johnson (JNJ), disappointing reports from Netflix (NFLX) and Tesla (TSLA) sent the Nasdaq Composite tumbling. Taking a closer look at the numbers, pharmaceutica""}, {""date"": ""2023-07-20"", ""headline"": ""J&J CFO: Medicare and Health Dept. are 'going after the wrong target' to reduce drug price inflation"", ""summary"": ""J&J became the latest big pharma company to sue the federal government over Medicare price negotiations. CFO Joe Wolk explains why.""}, {""date"": ""2023-07-20"", ""headline"": ""US STOCKS-Tesla, Netflix pull Nasdaq and S&P lower, Dow ends higher"", ""summary"": ""The S&P 500 and Nasdaq fell on Thursday, weighed down by drops in Tesla and Netflix following their quarterly results, but the Dow advanced for a ninth straight day thanks to gains in Johnson & Johnson following a strong annual forecast.  Tesla's shares tumbled after the electric-vehicle maker reported a drop in its second-quarter gross margins to a four-year low and CEO Elon Musk hinted at more price cuts.""}, {""date"": ""2023-07-20"", ""headline"": ""CNBC Daily Open: Tech stocks were battered"", ""summary"": ""The Dow Jones Industrial Average outperformed other major indexes, in a stark reversal of the tech frenzy that's gripped markets since May.""}, {""date"": ""2023-07-20"", ""headline"": ""Asia markets to mostly fall as Japan's inflation rises slightly in June"", ""summary"": ""Investors in will watch Japan's inflation numbers today, in preparation for the Bank of Japan's rate decision next Friday""}, {""date"": ""2023-07-20"", ""headline"": ""Cramer picks his winners as the market starts to look outside of tech"", ""summary"": ""After a down day for tech stocks, CNBC's Jim Cramer picked winners he thinks will thrive in a broadening market.""}, {""date"": ""2023-07-20"", ""headline"": ""US STOCKS-Nasdaq, S&P fall as Tesla, Netflix weigh; Dow poised for ninth straight climb"", ""summary"": ""The S&P 500 and Nasdaq fell on Thursday, weighed down by drops in Tesla and Netflix following their quarterly results, but the Dow was higher for a ninth straight day thanks to gains in Johnson & Johnson following a strong annual forecast.  Tesla's shares tumbled 9.20% and were on track for their biggest daily percentage drop since April 20 after the electric-vehicle maker reported a drop in its second-quarter gross margins to a four-year low and CEO Elon Musk hinted at more price cuts.""}, {""date"": ""2023-07-20"", ""headline"": ""These 2 Stocks Just Sent the Dow Jones Soaring"", ""summary"": ""Two notable Dow stocks moved higher.  Johnson & Johnson (NYSE: JNJ) and IBM (NYSE: IBM) both released their latest financial results, and investors were quite pleased with what they saw from both companies.  Shares of Johnson & Johnson were up 6.5% near midday on Thursday.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson (JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""This is Jessica Moore, vice president of investor relations for Johnson & Johnson.  Joining me on today's call are Joaquin Duato, chairman of the board and chief executive officer; Joe Wolk, executive vice president, chief financial officer; and Erik Haas, worldwide vice president of litigation.  As a reminder, you can find additional materials including today's presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investors.jnj.com.""}, {""date"": ""2023-07-20"", ""headline"": ""Kenvue stock down despite strong first quarter as solo company"", ""summary"": ""Kenvue, the consumer brand spinoff of J&J, reporter its first every quarterly earnings as a solo company.""}, {""date"": ""2023-07-20"", ""headline"": ""Stock futures are little changed after Dow registers longest rally since 2017: Live updates"", ""summary"": ""Wall Street is coming off a mixed session.""}, {""date"": ""2023-07-20"", ""headline"": ""Health Care Climbs as J&J Earnings -- Health Care Roundup"", ""summary"": ""Health-care companies rose after strong earnings gave Johnson &amp; Johnson a jolt. A sharp increase in heart procedures and higher demand for cold and flu...""}, {""date"": ""2023-07-20"", ""headline"": ""Markets Mixed at Midday on Weaker Earnings Reports"", ""summary"": ""U.S. equites were mixed at midday on July 20, 2023 as weak earnings news, especially in the tech sector, held back gains.""}, {""date"": ""2023-07-20"", ""headline"": ""What Stocks To Buy Today? 2 Dow Jones Industrial Average Stocks To Watch"", ""summary"": ""Dow Jones Industrial Average stocks to watch in the stock market right now.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson rallied 6.07% to $168.38 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-07-20"", ""headline"": ""Stock market today: Dow sidesteps tech wreck to keep winning streak alive"", ""summary"": ""Investing.com -- The Dow closed higher Thursday, wrapping its ninth straight day of gains and its longest winner streak since 2017 as a climb in Johnson and Johnson and IBM offset the wreck in tech amid a selloff in Tesla and Netflix.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J (JNJ) Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps"", ""summary"": ""J&J (JNJ) beats estimates for second-quarter earnings and sales. It raises full-year sales and earnings guidance.""}, {""date"": ""2023-07-20"", ""headline"": ""NEW YORK MARKET CLOSE: Tesla, Netflix send tech lower but J&J shines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories"", ""summary"": ""Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues Tesla Inc (NASDAQ: TSLA) has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts. According to safety recall reports uploaded on the National Highway Traffic Safety Administration website, the front-facing camera might be misaligned on certain 2023 Model S, X, and Y v""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Rips Off the Kenvue Band-Aid"", ""summary"": ""Johnson & Johnson  just rained on the parade of its own consumer health arm, and it is unclear what comes next.  In early May, the healthcare giant sold shares in  Kenvue  which makes brands such as Tylenol, Band-Aids and Listerine, in an initial public offering.  On Thursday, Kenvue reported its first quarterly results as a public company, and it beat analyst estimates on both the top and bottom lines.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J Beats Estimates and Boosts Outlook as Medtech Product Demand Grows"", ""summary"": ""Shares of Johnson & Johnson advanced as the pharmaceutical and medical products firm posted better-than-expected results and raised its guidance on higher demand for its medtech products.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson investors can soon swap their shares for Kenvue stock \u2014 here's what you need to know"", ""summary"": ""J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch \""as early as the coming days.\"" ""}, {""date"": ""2023-07-20"", ""headline"": ""Kenvue separation from J&J has 'always been in the plan': CEO"", ""summary"": ""Johnson & Johnson spin-off Kenvue reported a strong earnings beat, maintaining an upbeat 2023 outlook after making its IPO debut in May. Kenvue CEO Thibaut Mongon joins Yahoo Finance's Anjalee Khemlani to discuss Kenvue's future of a fully separate company from Johnson & Johnson, with Mongon saying Kenvue's IPO \""released a lot of energy in the organization.\"" Mongon goes on to discuss Kenvue's forecast heading into volatile markets and its impact on stock performance.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson stock rises on earnings beat, guidance boost"", ""summary"": ""Johnson & Johnson's second quarter results beat analyst estimates on both the top and bottom line, thanks in part to strength in its MedTech business. The healthcare products company (JNJ) also raised its full-year guidance. Johnson & Johnson CFO Joe Wolk tells Yahoo Finance Live that things like people catching up on surgical procedures as well as new products boosted the company's results. On the company's legal challenge to the Inflation Reduction Act, Wolk referred to it as an \""assault on innovation,\"" arguing that it will hurt patients.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J Stock Roars Higher, Retaking Its 200-Day Line As Small Drugs Drive Big Beat"", ""summary"": ""Johnson & Johnson beat quarterly expectations Thursday, helped by its new cancer drug Carvykti, and JNJ stock surged.""}, {""date"": ""2023-07-20"", ""headline"": ""Tylenol Maker Kenvue Sinks on Looming J&J Exchange Offer"", ""summary"": ""(Bloomberg) -- Kenvue Inc., the consumer-focused spinoff of Johnson & Johnson that owns brands such as Band-Aid and Tylenol, fell on Thursday after J&J said it\u2019s preparing to launch an exchange offer for its majority stake. Most Read from BloombergApple Tests \u2018Apple GPT,\u2019 Develops Generative AI Tools to Catch OpenAIA $500 Billion Corporate-Debt Storm Builds Over Global EconomyNadella\u2019s Microsoft Payouts Top $1 Billion on 1,000% Stock BoomTesla Sinks as Musk Warns of More Blows to ProfitabilityMu""}, {""date"": ""2023-07-20"", ""headline"": ""Why Johnson & Johnson Stock Is Rising Today"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is having a strong start to Thursday's trading session.  Ahead of the opening bell, J&J released 2023 second-quarter earnings that exceeded Wall Street's expectations on both top and bottom lines.  The second quarter of 2023 was a successful one for J&J, as the company reported strong growth in its pharmaceutical and medtech segments.""}, {""date"": ""2023-07-20"", ""headline"": ""2 Ultra-Safe Dividend Stocks Retirees May Want to Consider Buying"", ""summary"": ""The best dividend stocks for retirees combine a decent yield with a strong track record of dividend safety and growth.  Here is an overview of two ultra-safe dividend stocks that retirees may want to consider buying.  Target (NYSE: TGT) is one of the largest retailers in the U.S., with 1,954 stores across the country.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, Kenvue, Abbott Labs all beat earnings estimates"", ""summary"": ""Johnson & Johnson, Kenvue, and Abbott Labs posted second quarter results that topped analyst estimates. Yahoo Finance Live breaks down the market reaction to the reports.""}, {""date"": ""2023-07-20"", ""headline"": ""Weekly Jobless Claims Below Expectations"", ""summary"": ""Weekly Jobless Claims Below Expectations.""}, {""date"": ""2023-07-20"", ""headline"": ""These Stocks Are Moving the Most Today: Tesla, Netflix, Discover, D.R. Horton, Catalent, and More"", ""summary"": ""Tesla's gross profit margins decline in the second quarter, revenue comes up short at Netflix, Discover stock slumps after a steep profit drop, and D.R. Horton beats earnings expectations.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, Goldman Sachs share gains contribute to Dow's 150-point jump"", ""summary"": ""Buoyed by positive gains for shares of Johnson & Johnson and Goldman Sachs, the Dow Jones Industrial Average is up Thursday afternoon. Shares of Johnson &...""}, {""date"": ""2023-07-20"", ""headline"": ""Q2 Beats for J&J, American; Jobless Claims, Philly Fed Lower"", ""summary"": ""Both J&J and American Airlines put up solid beats on top and bottom lines, while the labor market remains buoyant.""}, {""date"": ""2023-07-20"", ""headline"": ""Stocks to Watch Thursday: Tesla, Netflix, J&J, TSMC"", ""summary"": ""\u2198\ufe0f [**Tesla (TSLA)**](https://www.wsj.com/market-data/quotes/TSLA): The electric car maker reported a [jump in second-quarter profit](https://www.wsj.com/articles/tesla-tsla-q2-earnings-report-2023-9be2b571), but [Elon Musk](https://www.""}, {""date"": ""2023-07-20"", ""headline"": ""Here's What Key Metrics Tell Us About Johnson & Johnson (JNJ) Q2 Earnings"", ""summary"": ""Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson: After an Earnings Beat, Here's What to Expect From the Stock"", ""summary"": ""Johnson & Johnson  reported an earnings beat Thursday morning as their Pharmaceutical and MedTech divisions outperformed estimates.  The On-Balance-Volume (OBV) line shows weakness since December suggesting that sellers of JNJ have been more aggressive than buyers.  The weekly OBV line is firming.""}, {""date"": ""2023-07-20"", ""headline"": ""Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue"", ""summary"": ""A surge in heart procedures and higher demand for cold and flu medicines helped  Johnson & Johnson  report solid gains in revenue and profit for the second quarter.  J&J\u2019s quarterly earnings are regarded as a bellwether for healthcare because the company has large pharmaceutical, medical-device and consumer-health divisions.  The overall improvement in J&J\u2019s results suggests an easing of some of the challenges that have dogged health-product makers in recent years: supply-chain constraints, hospital staffing shortages and Covid-19 pandemic restrictions.""}, {""date"": ""2023-07-20"", ""headline"": ""Nasdaq Crashes As Netflix And Tesla Sink, Dow Roars And Dollar Rallies: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Earnings > Inertia, At Least For Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Dow heads for longest winning streak in nearly 6 years; S&P 500, Nasdaq slide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, Abbott rise; Discover Financial, Equifax fall, Thursday, 7/20/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""LONDON MARKET CLOSE: FTSE 100 supported by mining stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Most Active Equity Options For Midday - Thursday, July 20"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom."", ""summary"": ""The company reports better-than-expected numbers, but ongoing litigation remains a concern for investors.""}, {""date"": ""2023-07-20"", ""headline"": ""Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates"", ""summary"": ""Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 7.28% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-07-20"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Tesla shares fell after reporting revenue that beat expectations but lower profit margins thanks to price cuts, and Netflix shares tumbled after it missed on revenue projections despite strong subscriber growth. Here\u2019s what investors need to know today.""}, {""date"": ""2023-07-20"", ""headline"": ""Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Video: Thursday's ETF Movers: XLV, ARKK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Dow On Track For 9 Straight After Johnson & Johnson Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Win Streak Threatened: Tesla, Netflix Results Bring Pressure As Housing, Leading Indicators Data Awaited"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""The stock rallies of the Dow\u2019s earnings reporters are adding 120 points to the Dow\u2019s price"", ""summary"": ""The shares of the three Dow Jones Industrial Average components that reported earnings are a big reason the Dow is up Thursday while the broader stock market...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, IBM share gains lead Dow's nearly 250-point climb"", ""summary"": ""Led by strong returns for shares of Johnson & Johnson and IBM, the Dow Jones Industrial Average is up Thursday morning. Shares of Johnson & Johnson and IBM...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson\u2019s stock jumps after earnings top estimates and company raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J could reportedly launch Kenvue exchange offer in \""coming days\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Dow up 270 points, on track for longest winning streak in nearly 6 years; S&P 500, Nasdaq slide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Breaks Above 200-Day Moving Average - Bullish for JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""U.S. stocks mostly lower, though Dow heads for longest winning streak in nearly 6 years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Trending : J&J Raises Guidance as 2Q Results Top Street Views"", ""summary"": ""9:34 a.m. ET -- Johnson & Johnson is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The healthcare giant posted...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, IBM share gains lead Dow's 150-point jump"", ""summary"": ""Led by positive gains for shares of Johnson & Johnson and IBM, the Dow Jones Industrial Average is climbing Thursday morning. Shares of Johnson & Johnson and...""}, {""date"": ""2023-07-20"", ""headline"": ""J&J CFO Joseph Wolk On Q2 Earnings Beat: We\u2019re In A Very Strong Position For Second Half Of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson (JNJ): A Comprehensive GF Score Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""U.S. stocks mostly lower as Netflix, Tesla weigh on Nasdaq; IBM, J&J boost Dow"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Early notable gainers among liquid option names on July 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Unusually active option classes on open July 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J CEO says Abiomed integration 'going really well'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Johnson & Johnson in conjunction with their 2023 Q2 earnings call.""}, {""date"": ""2023-07-20"", ""headline"": ""4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J CFO says capital allocation priorities aren't changing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Legend Biotech shares gain on multiple-myeloma drug sales"", ""summary"": ""Shares of Legend Biotech Corp. gained 3.7% premarket on Thursday after the company said its multiple myeloma therapy Carvykti, a collaboration with Johnson &...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson CEO says 'nothing has changed' with respect to MARIPOSA study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J says will be 'back in the torte system' if judge dismisses bankruptcy claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson to seek appeal of talc case based on 'erroneous' rulings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J says to provide 'timely' new guidance when no longer Kenvue majority holder"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""J&J says launch of Kenvue exchange offer could come as soon as 'coming days'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson : 2023 Second-Quarter Press Release & Supplemental Schedules"", ""summary"": ""FOR IMMEDIATE RELEASE\n      \n      \n        \n          2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson : FINAL - JNJ Earnings Presentation Q2 2023"", ""summary"": ""1\n      \n    \n    \n      \n        2nd Quarter 2023 Earnings Call\n      \n      \n        July 20, 2023\n      \n    \n    \n      \n        \n          Cautionary Note on Forward-looking...""}, {""date"": ""2023-07-20"", ""headline"": ""TOP NEWS: J&J ups full-year guidance after \""robust\"" second quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson : 2Q23 Other Financial Disclosures"", ""summary"": ""Second Quarter 2023\n      \n      \n        Other Financial Disclosures\n      \n      \n        Table of Contents\n      \n      \n        \n          \n            \n              Table 1:...""}, {""date"": ""2023-07-20"", ""headline"": ""LONDON MARKET MIDDAY: Commodities continue to give FTSE 100 boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Tylenol, Benadryl parent Kenvue tops earnings expectations, amid strength in pain care, cold and flu product demand"", ""summary"": ""Tylenol, Benadryl and Listerine brands parent Kenvue Inc. reported Thursday second-quarter profit and revenue that beat expectations, provided an upbeat...""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Reports Q2 2023 Results"", ""summary"": ""2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational growth of 6.2%*. Operational growth excluding COVID-19 Vaccine of...""}, {""date"": ""2023-07-20"", ""headline"": ""J&J raises annual profit forecast on medical devices, cancer drugs strength"", ""summary"": ""Johnson & Johnson raised its\n2023 profit forecast on Thursday, banking on the strength in its\nmedical devices business and demand for its cancer drugs such as\nDarzalex.\n              The company...""}, {""date"": ""2023-07-20"", ""headline"": ""Earnings Scheduled For July 20, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Nasdaq Futures Dragged Down By Tesla, Netflix After Q2 Prints: Analyst Sees Buying Spree Lasting Until Earnings 'Problems Show Up'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""JNJ Up as Q2 Results Beat Estimates, Raises Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson\u2019s stock up 2.4% premarket after earnings top estimates and company raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Genmab reports Q2 worldwide net sales of DARZALEX $2.43B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Johnson & Johnson\u2019s Talc Worries Rear as Company Prepares for Earnings"", ""summary"": ""Johnson & Johnson  is slated to report its financial results for the second quarter on Thursday, amid new investor anxiety over the thousands of lawsuits the company faces over its talc-based products.  Johnson & Johnson (ticker: JNJ) stock briefly fell as much as 1.5% in premarket trading Wednesday, after a jury in a California state court decided late Tuesday that the company must pay $18.8 million to a 24-year-old man who says he developed cancer after using Johnson & Johnson\u2019s products.  Johnson & Johnson has been struggling to move past the talc cases, which it says are baseless.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson : JNJ-Q2 2023 Transcript Final"", ""summary"": ""REFINITIV STREETEVENTS\n        \n        \n          EDITED TRANSCRIPT\n        \n        \n          JNJ.N - Q2 2023 Johnson & Johnson Earnings Call\n        \n        \n         ...""}, {""date"": ""2023-07-21"", ""headline"": ""Dow notches tenth straight day of gains"", ""summary"": ""The Dow Jones Industrial Average eked out a tenth straight day of gains, closing just 2.5 points higher on Friday. Yahoo Finance Live breaks down how earnings from components such as JPMorgan Chase and American Express impacted the index's action this week.""}, {""date"": ""2023-07-21"", ""headline"": ""AbbVie (ABBV) to Report Q2 Earnings: What's in the Cards?"", ""summary"": ""AbbVie's (ABBV) Q2 performance will likely reflect Skyrizi and Rinvoq sales trying to make up for the declining Humira sales following the loss of U.S. exclusivity.""}, {""date"": ""2023-07-21"", ""headline"": ""JNJ Has a Deal for Stockholders. Investors Will Need to Make a Call."", ""summary"": ""Johnson & Johnson will offer its holders to chance to swap their shares for Kenvue stock""}, {""date"": ""2023-07-21"", ""headline"": ""Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas"", ""summary"": ""Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.  ""}, {""date"": ""2023-07-21"", ""headline"": ""5 ETFs to Buy on JNJ's Q2 Earnings Strength"", ""summary"": ""Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.""}, {""date"": ""2023-07-21"", ""headline"": ""Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review"", ""summary"": ""The Dow Jones lead the market rally, while Tesla, Netflix and Taiwan Semiconductor hit growth stocks Thursday.""}, {""date"": ""2023-07-21"", ""headline"": ""Insiders At Johnson & Johnson Sold US$2.2m In Stock, Alluding To Potential Weakness"", ""summary"": ""In the last year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""2023-07-21"", ""headline"": ""AbbVie: Loss Of Exclusivity Is A Natural End Process"", ""summary"": ""AbbVie has had some big shoes to fill due to the loss of exclusivity for Humira after 20 years of monopoly and $200B in revenues. See why ABBV stock is a Hold.""}, {""date"": ""2023-07-21"", ""headline"": ""Stock Market News for Jul 21, 2023"", ""summary"": ""Wall Street closed mixed on Thursday following mixed earnings results of second-quarter 2023.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Here's How Big Your Portfolio Can Get by Investing Just $50 a Week"", ""summary"": ""Investing is a long-term game, and even if you don't have a lot of money to invest right now, there's no better time to start.  Here's a look at just how big your portfolio could grow from investments of $50 every week.  At that rate of growth, an investment would double in value in a little over seven years, and would triple in value in less than 12 years.""}, {""date"": ""2023-07-21"", ""headline"": ""Stocks in Focus on Dow Jones ETF's First 9-Day Run Since 2017"", ""summary"": ""The Dow Jones index jumped more than 150 points on Jul 20, to log its first nine-day rally since 2017""}, {""date"": ""2023-07-21"", ""headline"": ""J&J sues researchers who wrote talc powder linked to cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""The Bristol-Myers Squibb Phenomenon: A Game Changer In The Pharmaceutical Industry"", ""summary"": ""On July 27, 2023, Bristol-Myers Squibb will release its financial report for the second quarter of 2023. Read more to see a detailed analysis on BMY stock.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson\u2019s Inflection Point: What It Means For Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""5 things to know before the stock market opens Friday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson price target raised to $175 from $165 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""GLOBAL BROKER RATINGS: Deutsche Bank cuts SiriusXM to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson price target raised to $175 from $170 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Q2 2023 Johnson & Johnson Earnings Call"", ""summary"": ""Q2 2023 Johnson & Johnson Earnings Call""}, {""date"": ""2023-07-21"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Legend Biotech (LEGN) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-21"", ""headline"": ""Johnson & Johnson Takes Over #12 Spot From Eli Lilly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-22"", ""headline"": ""Credit Suisse Maintains Johnson & Johnson (JNJ) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-07-22"", ""headline"": ""JP Morgan Maintains Johnson & Johnson (JNJ) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-07-22"", ""headline"": ""Morgan Stanley Reiterates Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-23"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript July 20, 2023 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, expectations were $2.62. Operator: Good morning, and welcome to Johnson & Johnson\u2019s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. [\u2026]""}, {""date"": ""2023-07-23"", ""headline"": ""Johnson & Johnson\u2019s Q2 is positive for MedTech - Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""On A Winning Streak! Many Market Signs Appear More Bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4592, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.2345, ""eps"": 1.9969, ""ev"": 462321.78, ""fcfMargin"": 0.1731, ""fcfPerShareTTM"": 5.5993, ""grossMargin"": 0.7309, ""inventoryTurnoverTTM"": 2.2226, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.2912, ""operatingMargin"": 0.3258, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.3258, ""psTTM"": 4.932, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.2324, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1231, ""salesPerShare"": 6.8583, ""sgaToSale"": 0.2691, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
28,2023-07-23,167.6209259033203,2023-07-30,171.84616088867188,0.02520708534797489,U3,"[{""date"": ""2023-07-23"", ""headline"": ""Russia Is Seizing European Company Assets \u2014 What US Businesses Are Still At Risk?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""From Snowball to Avalanche: Understanding Buffett's Approach to Compound Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript July 20, 2023 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, expectations were $2.62. Operator: Good morning, and welcome to Johnson & Johnson\u2019s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. [\u2026]""}, {""date"": ""2023-07-23"", ""headline"": ""Johnson & Johnson\u2019s Q2 is positive for MedTech - Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""On A Winning Streak! Many Market Signs Appear More Bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""12 Best Low Volatility Stocks to Buy Now"", ""summary"": ""In this article, we discuss the 12 best low volatility stocks to buy now. If you want to see more stocks in this selection, check out the 5 Best Low Volatility Stocks to Buy Now. In the first half of 2023, global economic growth picked up pace, reaching 2.8%. Up to this point, the impact of [\u2026]""}, {""date"": ""2023-07-24"", ""headline"": ""S&P 500 Gains and Losses Today: Oil Industry Stocks Surge as Oil Prices Rise"", ""summary"": ""U.S. equities gained after better-than-expected second quarter earnings reports, with the S&P 500 rising 0.4% on Monday, July 24, 2023.""}, {""date"": ""2023-07-24"", ""headline"": ""3 Reasons Why Growth Investors Shouldn't Overlook Johnson & Johnson (JNJ)"", ""summary"": ""Johnson & Johnson (JNJ) possesses solid growth attributes, which could help it handily outperform the market.""}, {""date"": ""2023-07-24"", ""headline"": ""NEW YORK MARKET CLOSE: Dow extends winning streak ahead of rate call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Are You Looking for a High-Growth Dividend Stock?"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-07-24"", ""headline"": ""Eli Lilly: Does 'Miracle' Weight Loss Franchise Justify Rising Price Tag?"", ""summary"": ""Eli Lilly's share price won't stop climbing on the promise of its miracle diabetes and weight loss drug, tirzepatide. Learn more about LLY stock here.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson\u2019s Kenvue Stock Swap Is a Good Deal for Investors"", ""summary"": ""The company plans on exchanging up to 1.5 billion shares of Kenvue stock that it owns, for outstanding shares of J&J common stock.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson Offers Exchange for Shares of Spinoff Kenvue"", ""summary"": ""Johnson & Johnson offers its shareholders the choice to exchange its shares for Kenvue's, the consumer health company it spun off just two months ago.""}, {""date"": ""2023-07-24"", ""headline"": ""3 Ultrareliable Dividend Stocks to Buy and Hold for Decades"", ""summary"": ""These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come.""}, {""date"": ""2023-07-24"", ""headline"": ""Mattel, AMC Entertainment, Chevron rise premarket; Tesla, Domino's fall"", ""summary"": ""Investing.com -- U.S. futures traded higher Monday, starting a crucial week, which includes more corporate earnings and a Federal Reserve meeting, on a positive note.""}, {""date"": ""2023-07-24"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson: Resilient, But Clarification On Liability Issue Is Needed"", ""summary"": ""Johnson & Johnson has seen solid second quarter results, triggering a modest hike in the full-year guidance. Read more about JNJ stock here.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson Wants to Swap Kenvue Shares. Expect Details Today."", ""summary"": ""The company plans J&J plans on exchanging up to 1.5 million shares of Kenvue stock that it owns, for outstanding shares of J common stock.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson Lost Its Court Battle But Won The Q2 Match"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""J&J starts share exchange offer for consumer health spin-off Kenvue"", ""summary"": ""J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.""}, {""date"": ""2023-07-24"", ""headline"": ""UPDATE 2-J&J starts share exchange offer for consumer health spin-off Kenvue"", ""summary"": ""Johnson & Johnson said on Monday it had launched an exchange offer under which its stockholders can opt for shares of Kenvue, its newly listed consumer health unit.  J&J, which currently owns an 89.6% stake in Kenvue, said it intends to split off at least 80.1% of the consumer health company's shares as part of the offering.  The offering will help J&J move a step closer in its plan to spin off the unit and focus on its larger medical devices and pharmaceuticals businesses.""}, {""date"": ""2023-07-24"", ""headline"": ""Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement"", ""summary"": ""SKILLMAN, N.J., July 24, 2023--Kenvue Inc. (NYSE: KVUE) announced intent to file a Form S-4 Registration Statement today with the Securities and Exchange Commission.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., July 24, 2023--Johnson & Johnson (NYSE: JNJ) today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") through an exchange offer. Kenvue, formerly Johnson & Johnson\u2019s Consumer Health business, completed its initial public offering (\""IPO\"") in May 2023. Through the planned exchange offer, Johnson & Johnson shareholders can exchange all, some or none of their shares of Johnson & Johnson common stock for shares of Kenvue commo""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson, Chevron share gains contribute to Dow's 175-point climb"", ""summary"": ""The Dow Jones Industrial Average is trading up Monday morning with shares of Johnson & Johnson and Chevron delivering the strongest returns for the blue-chip...""}, {""date"": ""2023-07-24"", ""headline"": ""Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY and TECVAYLI for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has recommended...""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer"", ""summary"": ""J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.""}, {""date"": ""2023-07-24"", ""headline"": ""Teva Pharmaceuticals and Alvotech expand biosimilars partnership"", ""summary"": ""Teva Pharmaceuticals Industries Ltd. and Alvotech announced Monday that they are expanding their collaboration in the U.S. biosimilars market. Under the...""}, {""date"": ""2023-07-24"", ""headline"": ""Biosense Webster Launches the OPTRELL\u2122 Mapping Catheter with TRUEref\u2122 Technology for Mapping of Complex Cardiac Arrhythmias"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Syndax and Incyte gain on mid-stage win for immune disorder therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson Launches Exchange Offer Regarding Separation of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Syndax and Incyte gain after Phase 3 win for immune disorder therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson : Consolidated Financial Statements - Form 8-K"", ""summary"": ""The following are certain preliminary results of selected unaudited financial and other information of Johnson & Johnson for the fiscal three and six months ended July 2, 2023 and actual...""}, {""date"": ""2023-07-24"", ""headline"": ""GLOBAL BROKER RATINGS: UBS cuts Tesla to 'neutral' from 'buy'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson launches exchange offer on Kenvue holding after IPO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson to spin off at least 80.1% of Kenvue shares in an exchange offer"", ""summary"": ""Johnson & Johnson said Monday it is planning to spin off at least 80.1% of its shares of Kenvue Inc. through an exchange offer. The consumer goods and...""}, {""date"": ""2023-07-24"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Biogen (BIIB) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson launches Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson price target raised to $175 from $171 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Kenvue to file S-4 registration statement in connection with JNJ exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Johnson & Johnson launches exchange offer for separation of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""CEO of J&J spinoff Kenvue says big companies can lose focus: \u2018By definition you are little more remote from where the action is\u2019"", ""summary"": ""Kenvue, spun off from Johnson & Johnson in May, generated $15 billion in sales last year, enough to put it at rank 275 on 2022's Fortune 500 list.""}, {""date"": ""2023-07-24"", ""headline"": ""Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""4 Stocks to Buy Following Beat-and-Raise Quarters"", ""summary"": ""These companies beat expectations and raised their outlooks, undeniably a positive sign for investors. Is it time to buy following the better-than-expected results?""}, {""date"": ""2023-07-25"", ""headline"": ""2 Top Dividend Stocks to Buy and Hold Forever"", ""summary"": ""There are several reasons many investors gravitate toward dividend stocks.  Let's consider two of them: Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT).  Over the years, Johnson & Johnson has certainly been the precise kind of company dividend seekers gravitate toward.""}, {""date"": ""2023-07-25"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""The gigantic healthcare conglomerate recently raised its outlook, suggesting its plan to slim down is working as intended.""}, {""date"": ""2023-07-25"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-07-25"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-25"", ""headline"": ""3 Stocks You Can Keep Forever"", ""summary"": ""Parker Hannifin (NYSE: PH), Johnson & Johnson (NYSE: JNJ) and Lowe's Companies (NYSE: LOW) represent stability for investors.  The first two are Dividend Kings, meaning they have raised their quarterly dividends for 50 or more consecutive years, while Lowe's just increased its dividend for its 49th consecutive year.  Parker Hannifin, founded in 1917, isn't well-known to consumers because it sells its products to industry and government buyers, but the company's reach is huge.""}, {""date"": ""2023-07-25"", ""headline"": ""Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) recently provided investors with details of the long-awaited split of its consumer healthcare business\u00a0Kenvue\u00a0(NYSE: KVUE).  It will split off at least 80.1% of its Kenvue shares through an exchange offer with investors.  Johnson & Johnson announced its intention to separate its consumer health business from its pharmaceutical and medical technology segments in November 2021.""}, {""date"": ""2023-07-25"", ""headline"": ""GSK, J&J tout Cabenuva preference over Gilead's Biktarvy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Analysts Are Increasing Price Targets of These 10 Stocks"", ""summary"": ""In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts. If you want to see more such stocks on the list, go directly to Analysts Are Increasing Price Targets of These 5 Stocks. As the Federal Reserve approaches the end of its rate-hiking cycle, investors are reconsidering shares of [\u2026]""}, {""date"": ""2023-07-25"", ""headline"": ""Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc"", ""summary"": ""NEW BRUNSWICK - Johnson & Johnson  today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc.   through an exchange offer.\nKenvue, formerly Johnson & Johnson's Consumer...""}, {""date"": ""2023-07-25"", ""headline"": ""AbbVie Q2 2023 Earnings Preview: Pharma Faces Toughest Test, Street Demands Answers"", ""summary"": ""AbbVie will announce its Q2 2023 earnings this Thursday, July 27. Check out if ABBV stock is a Buy, Sell, or Hold ahead of its upcoming earnings results.""}, {""date"": ""2023-07-25"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Tonix Pharma (TNXP) and Gilead Sciences (GILD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Wall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""Building The Dividend Growth Portfolio In 2023"", ""summary"": ""My US dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. Check out my dividend growth portfolio in 2023.""}, {""date"": ""2023-07-26"", ""headline"": ""Allogene: I Am Less Sanguine About Allogeneic CAR-T's Prospects Than Before"", ""summary"": ""Allogene Therapeutics is the leading developer of allogeneic CAR-T. There was a time when its logic appealed to me. Click here to see my view of ALLO stock now.""}, {""date"": ""2023-07-26"", ""headline"": ""Top Analyst Reports for Johnson & Johnson, Zoetis & Lam Research"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Zoetis (ZTS) and Lam Research Corporation (LRCX).""}, {""date"": ""2023-07-26"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.19% higher to $172.72 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-07-26"", ""headline"": ""Like Growing Dividend Income? Buy This Dividend King"", ""summary"": ""No healthcare company embodies consistency more than Johnson & Johnson (NYSE: JNJ): The business has grown its dividend for 61 consecutive years, the lengthiest dividend growth streak in the entire healthcare sector.  This robust portfolio of medicines, medical devices, and consumer health products supports J&J's $435 billion market capitalization, which makes it the biggest pharmaceutical company in the world.  J&J's net sales grew by 6.3% over the year-ago period to $25.5 billion in the second quarter ended June 30.""}, {""date"": ""2023-07-26"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""2023-07-26"", ""headline"": ""3 No-Brainer Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Each quarter, Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) is required to release a 13F.  This filing with the Securities and Exchange Commission (SEC) reveals any purchases or sales Buffett made in the Berkshire stock portfolio during the previous quarter.  It's important for investors not to make any trading decisions based on what Berkshire did, but the filing is interesting nonetheless.""}, {""date"": ""2023-07-26"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Is Going Strong: Is the Market Following Fundamentals?"", ""summary"": ""Most readers would already be aware that Johnson & Johnson's (NYSE:JNJ) stock increased significantly by 8.6% over the...""}, {""date"": ""2023-07-26"", ""headline"": ""\u2018Set It and Forget It\u2019 With These 3 Stocks to Buy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""J&J's Medtech Business Is Soaring. Time to Buy the Stock?"", ""summary"": ""You may not automatically think of pharma giant Johnson & Johnson (NYSE: JNJ) as a high-growth company.  Yes, J&J is practically a household name, thanks to consumer products like Aveeno lotions and Band-Aid bandages.  Things are changing at J&J though -- and a new era of growth might have already started.""}, {""date"": ""2023-07-27"", ""headline"": ""Judge dismisses J&J cancer lawsuit strategy for second time, Reuters says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Judge dismisses J&J cancer lawsuit strategy again, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Janssen submits supplemental application to FDA for Edurant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed."", ""summary"": ""The industry has launched a legal war against a new law that would let Medicare negotiate prices. The odds are in Big Pharma's favor.""}, {""date"": ""2023-07-27"", ""headline"": ""Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Catalyst watch: Amazon earnings, jobs report and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.56% higher to $173.69 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-07-27"", ""headline"": ""Company Updates and Marketing Lessons From the Grateful Dead"", ""summary"": ""Trends in travel and consumer spending based on results from United Airlines, American Airlines,\u00a0Discover, and American Express.  Motley Fool Money's Alex Friedman caught up with author David Scott about the lessons he and Hubspot co-founder Brian Halligan think businesses can borrow from the Grateful Dead.""}, {""date"": ""2023-07-27"", ""headline"": ""AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View"", ""summary"": ""AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.""}, {""date"": ""2023-07-27"", ""headline"": ""AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry"", ""summary"": ""You would need to be extremely bullish on the growth prospects of these companies to be willing to buy stock at those kinds of premiums.  If you want to invest in a sector where there may be excellent growth opportunities to take advantage of right now and where stocks are at much more manageable valuations, you should take a look at the healthcare industry.  Many healthcare companies struggled in recent years as the COVID-19 pandemic weighed down their operations and dampened demand.""}, {""date"": ""2023-07-27"", ""headline"": ""Fed's July Rate Hike and Comments Match Expectations: 5 Picks"", ""summary"": ""We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.""}, {""date"": ""2023-07-27"", ""headline"": ""3 Top Blue Chip Stocks to Ride the Dow Rally"", ""summary"": ""As the Dow continues to scale upward, it's prudent to invest in stocks such as JPMorgan (JPM), Walmart (WMT) and Johnson & Johnson (JNJ) that are listed on the said index and are financially sound.""}, {""date"": ""2023-07-27"", ""headline"": ""If You Invested $25,000 in Johnson & Johnson 20 Years Ago, This Is How Much You Would Have Today"", ""summary"": ""It's a big name in healthcare, but has Johnson & Johnson been a great investment over the past two decades?""}, {""date"": ""2023-07-27"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Johnson & Johnson upgraded to Buy from Hold at Spin-Off Research"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""September 8th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Better Medtech Buy: J&J vs. Medtronic"", ""summary"": ""If you're shopping for a healthcare stock that promises growth, the medical technology space could offer some good choices.  In fact, some medtech players are even posting impressive growth.  Two giants in the space are Johnson & Johnson (NYSE: JNJ) and Medtronic (NYSE: MDT).""}, {""date"": ""2023-07-27"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy"", ""summary"": ""Johnson & Johnson, Zoetis, Lam Research, Aon and Dominion Energy are included in this Analyst Blog.""}, {""date"": ""2023-07-27"", ""headline"": ""A Historic Opportunity To Win Big With Dividend Stocks"", ""summary"": ""Dividend stocks are today offering a historic opportunity. Share prices are down and dividend yields are now materially higher. Click here for our dividend strategy.""}, {""date"": ""2023-07-27"", ""headline"": ""7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""3 Biotech Stocks You Better Be Buying on Each and Every Dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Johnson & Johnson exec Fasolo sells 20,000 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""10 Recession-Proof Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 recession-proof stocks billionaires are loading up on. To see more such companies, go directly to 5 Recession-Proof Stocks Billionaires Are Loading Up On. Latest data on inflation has upped the hopes of investors as market naysayers who had been warning of recession for several [\u2026]""}, {""date"": ""2023-07-28"", ""headline"": ""Johnson & Johnson\u2019s Second Talc Bankruptcy Case Thrown Out"", ""summary"": ""A New Jersey bankruptcy judge threw out the second chapter 11 case that Johnson & Johnson filed to resolve its mass talc liabilities, again shutting down the healthcare-product company\u2019s plan to achieve an $8.9 billion settlement.""}, {""date"": ""2023-07-28"", ""headline"": ""UPDATE 3-J&J effort to resolve talc lawsuits in bankruptcy fails a second time"", ""summary"": ""A U.S. judge on Friday shot down Johnson & Johnson's  second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.  U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey, ruled that a J&J company's second bankruptcy, like its first, must be dismissed because the talc lawsuits did not put it in immediate \""financial distress.\""  \""In sum, this Court smells smoke, but does not see the fire,\"" Kaplan wrote, referring to the J&J unit LTL.""}, {""date"": ""2023-07-28"", ""headline"": ""J&J effort to resolve talc lawsuits in bankruptcy fails a second time"", ""summary"": ""NEW YORK (Reuters) -A U.S. judge on Friday shot down Johnson & Johnson's  second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.  U.S. Bankruptcy Judge Michael Kaplan in Trenton, New Jersey, ruled that a J&J company's second bankruptcy, like its first, must be dismissed because the talc lawsuits did not put it in immediate \""financial distress.\""  \""In sum, this Court smells smoke, but does not see the fire,\"" Kaplan wrote, referring to the J&J unit LTL.""}, {""date"": ""2023-07-28"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $174.48 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-07-28"", ""headline"": ""Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time "", ""summary"": ""The decision jeopardizes J&J's proposed $8.9 billion settlement that would stop new lawsuits over its talc baby powder and other products from being filed.""}, {""date"": ""2023-07-28"", ""headline"": ""The 'lingering uncertainties' for Johnson & Johnson in talc legal fight"", ""summary"": ""A judge is expected to rule soon on whether J&J can use a controversial bankruptcy strategy to dispose of roughly 100,000 claims.""}, {""date"": ""2023-07-28"", ""headline"": ""Dorian and Oxford Industries have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""Dorian and Oxford Industries are part of the Zacks Bull and Bear of the Day article.""}, {""date"": ""2023-07-28"", ""headline"": ""Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""3 Things About Johnson & Johnson Every Smart Investor Knows"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) is a value investor's dream stock.  The company has been around for 137 years and has a well-deserved reputation for thriving even during economic downturns.  The company is popular in part because of its reliable quarterly dividend, which it has raised for 61 consecutive years, including a 5.3% bump this year to $1.19 a share, leaving a yield of around 2.78%.""}, {""date"": ""2023-07-28"", ""headline"": ""Got $2,500? 2 Top Stocks You Can Buy and Hold for a Lifetime"", ""summary"": ""These two rock-solid stocks are rejigging their portfolios to boost dividends and overall shareholder returns.""}, {""date"": ""2023-07-28"", ""headline"": ""How Productive Assets Outshine Gold in Buffett's Investment Philosophy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""2seventy bio downgraded at Morgan Stanley after Abecma sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""SLB, Johnson & Johnson And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""13 Safe Stocks To Invest In"", ""summary"": ""In this article, we will be taking a look at 13 safe stocks to invest in. To skip our detailed analysis of current recession concerns in the US and more, you can go directly to see the 5 Safe Stocks To Invest In. The Federal Reserve\u2019s July interest rate hike of 25 basis points that [\u2026]""}, {""date"": ""2023-07-28"", ""headline"": ""J&J seeks pediatric indication for HIV drug Edurant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""The 3 Best Blue-Chip Dividend Stocks to Buy for July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""J&J talc lawsuits bankruptcy plan rejected for a second time"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-29"", ""headline"": ""Johnson & Johnson : Notice of Possible Blackout Period and Regulation BTR Trading Restrictions - Form 8-K"", ""summary"": ""Notice of Possible Blackout Period and Regulation BTR Trading Restrictions\n          \n        \n      \n    \n    \n      This blackout notice  is being provided in...""}, {""date"": ""2023-07-29"", ""headline"": ""11 Best Magic Formula Stocks to Buy Now"", ""summary"": ""In this article, we will take a look at the 11 best magic formula stocks to buy now. To see more such companies, go directly to 5 Best Magic Formula Stocks to Buy Now. Magic Formula investing strategy was first described by legendary value investor Joel Greenblatt in his 2005 book entitled The Little Book [\u2026]""}, {""date"": ""2023-07-29"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Zoetis (ZTS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-29"", ""headline"": ""Bristol-Myers Squibb's Bright Future Unfolds Beyond Q2 2023 Turmoil"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""10 Best August Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best August dividend stocks to buy. You can skip our detailed analysis of dividend stocks and the dividend capture strategy, and go directly to read 5 Best August Dividend Stocks To Buy. In the stock market, various strategies may gain popularity at different times, but investors consistently gravitate toward [\u2026]""}, {""date"": ""2023-07-30"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 24% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$231 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""2023-07-30"", ""headline"": ""These 3 Quarterly Releases Positively Shocked The Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""4 Top Stocks and 3 Top Cryptocurrencies for August"", ""summary"": ""The stock market has rallied so far this year, particularly in the period between the last earnings season and this one.  Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE) stand out as two value-oriented plays, while Nike (NYSE: NKE) is a beaten-down name-brand stock that hasn't rallied like the broader market.  On the growth side of the spectrum, HubSpot (NYSE: HUBS) is a software company with room to run.""}, {""date"": ""2023-07-30"", ""headline"": ""These 3 Dow Stocks Are Set to Soar in 2023 and Beyond"", ""summary"": ""Three iconic Dow stocks are sitting on huge catalysts and preparing themselves for big things to come.""}, {""date"": ""2023-07-30"", ""headline"": ""Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings"", ""summary"": ""These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.""}, {""date"": ""2023-07-30"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
29,2023-07-30,171.84616088867188,2023-08-06,166.48826599121094,-0.031178438143473985,D4,"[{""date"": ""2023-07-30"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Latest Talc Trouble Sinks Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Latest Talc Trouble Sinks Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""7 Stocks to Buy Before They Surpass 2021 Highs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""PRESS DIGEST-New York Times business news - July 31"", ""summary"": ""July 31  - The following are the top stories on\nthe New York Times business pages. Reuters has not verified\nthese stories and does not vouch for their accuracy.\n              \n         ...""}, {""date"": ""2023-07-30"", ""headline"": ""J&J falls after bankruptcy plan rejected for second time"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""10 Best August Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best August dividend stocks to buy. You can skip our detailed analysis of dividend stocks and the dividend capture strategy, and go directly to read 5 Best August Dividend Stocks To Buy. In the stock market, various strategies may gain popularity at different times, but investors consistently gravitate toward [\u2026]""}, {""date"": ""2023-07-30"", ""headline"": ""AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 24% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Johnson & Johnson is US$231 based on 2 Stage Free Cash Flow to Equity Johnson...""}, {""date"": ""2023-07-30"", ""headline"": ""These 3 Quarterly Releases Positively Shocked The Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""4 Top Stocks and 3 Top Cryptocurrencies for August"", ""summary"": ""The stock market has rallied so far this year, particularly in the period between the last earnings season and this one.  Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE) stand out as two value-oriented plays, while Nike (NYSE: NKE) is a beaten-down name-brand stock that hasn't rallied like the broader market.  On the growth side of the spectrum, HubSpot (NYSE: HUBS) is a software company with room to run.""}, {""date"": ""2023-07-30"", ""headline"": ""These 3 Dow Stocks Are Set to Soar in 2023 and Beyond"", ""summary"": ""Three iconic Dow stocks are sitting on huge catalysts and preparing themselves for big things to come.""}, {""date"": ""2023-07-30"", ""headline"": ""Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings"", ""summary"": ""These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets.""}, {""date"": ""2023-07-30"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""S&P 500 Gains and Losses Today: Oil Industry Stocks Advance as Oil Prices Climb"", ""summary"": ""The S&P 500 was little changed to start the week on Monday, July 31, 2023, edging 0.2% higher as oil stocks gained on the back of higher oil prices.""}, {""date"": ""2023-07-31"", ""headline"": ""Dow Jones Today: Index Higher For Second Straight Month"", ""summary"": ""The Dow closed July with a gain of 3%, moving up 100 points, or 0.28% on the session, as investors watch earnings and prepare for Friday\u2019s job report.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St finishes strong month on upbeat company earnings"", ""summary"": ""Second-quarter earnings for S&P 500 companies are estimated to have fallen 6.4% year-over-year, Refinitiv data through Friday showed.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.""}, {""date"": ""2023-07-31"", ""headline"": ""J&J Leads Losses on the Dow After Court Rejects Bankruptcy Plans"", ""summary"": ""Johnson & Johnson shares dropped after a judge ruled against its plan to resolve talcum powder-related lawsuits.""}, {""date"": ""2023-07-31"", ""headline"": ""S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken"", ""summary"": ""Paramount and Disney, along with AI play Adobe, led the S&P 500. Dexcom and several medical products firms struggled.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St ends strong month on upbeat company earnings"", ""summary"": ""The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.  Citigroup raised its 2023-end and mid-2024 S&P 500 targets to 4,600 and 5,000, respectively, to reflect a higher possibility of a soft landing.""}, {""date"": ""2023-07-31"", ""headline"": ""Cramer sours on Johnson & Johnson as lawsuits pile up"", ""summary"": ""CNBC's Jim Cramer on Monday explained his decision to cut Johnson & Johnson from the Investing Club's Charitable Trust.""}, {""date"": ""2023-07-31"", ""headline"": ""Jim Cramer's Trust just sold its position in Johnson & Johnson \u2014 Here's why"", ""summary"": ""'Mad Money' host Jim Cramer breaks down why his Charitable Trust sold off its position in Johnson & Johnson.""}, {""date"": ""2023-07-31"", ""headline"": ""Jim Cramer walks through latest investing decisions for his Charitable Trust"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the latest decisions affecting stocks in his Charitable Trust.""}, {""date"": ""2023-07-31"", ""headline"": ""J&J shares on track for biggest daily drop in 3 years on talc setback"", ""summary"": ""Johnson & Johnson has now failed twice to resolve talc suits by offloading the related liabilities into a new company and placing it into bankruptcy.  Lawsuits had alleged baby powder and other talc products sometimes contained asbestos and caused mesothelioma, ovarian cancer and other cancers.  J&J has said its talc products are safe and do not contain asbestos.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St poised to end strong month with muted session"", ""summary"": ""The key stock indexes are on track to end the month higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fueled bets on a rate-hike pause.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.  Citigroup raised its 2023-end and mid-2024 S&P 500 targets to 4,600 and 5,000, respectively, to reflect a higher possibility of a soft landing.""}, {""date"": ""2023-07-31"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 3.98% to $167.53 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-31"", ""headline"": ""Johnson & Johnson: second talc bankruptcy dismissal hits share price"", ""summary"": ""Johnson & Johnson is a very valuable company, notwithstanding its efforts to convince US federal judges of the contrary.  Late on Friday, a New Jersey bankruptcy court ruled that the big pharma company could not pursue a bankruptcy deal with tens of thousands of consumers who claim its talc powder caused serious illness.  The court said that a financially engineered J&J subsidiary \u2014 created through the so-called Texas two-step process \u2014 was \u201cnot sufficiently financially distressed to avail itself of bankruptcy\u201d.""}, {""date"": ""2023-07-31"", ""headline"": ""Johnson & Johnson Is the Dow\u2019s Leading Decliner. Disney Stock Stands Out."", ""summary"": ""Johnson & Johnson stock was dropping, while Walt Disney was rising in midday trading Monday, with the three major stock indexes little changed. Johnson & Johnson (ticker: JNJ) shares fell 3.7% and were on pace for their largest percentage decrease since June 2020, according to Dow Jones Market Data.""}, {""date"": ""2023-07-31"", ""headline"": ""These Stocks Are Moving the Most Today: SoFi, New Relic, XPeng, Nikola, Palantir, Wayfair, and More"", ""summary"": ""SoFi Technologies posts a narrower-than-expected second-quarter loss and raises guidance, New Relic is being acquired, Nikola receives a large order, Palantir shares continue their rally, and Wayfair stock is upgraded.""}, {""date"": ""2023-07-31"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks climb to end strong month on upbeat note"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Stock market today: Dow wraps up second monthly gain in July as energy jumps"", ""summary"": ""Investing.com -- The Dow closed higher Monday to wrap up a second-straight positive month for July after shrugging off a dip in health care as energy stocks racked up gains.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St inches up, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Second-quarter earnings for S&P 500 companies are now estimated to have fallen 6.4% year-over-year, according to Refinitiv data.  The tech-heavy Nasdaq led Wall Street higher last week as megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research posted strong quarterly earnings.""}, {""date"": ""2023-07-31"", ""headline"": ""Why Johnson & Johnson Stock Is Sinking Today"", ""summary"": ""Shares of Johnson & Johnson (NYSE: JNJ) were sinking 4.2% lower as of 11:04 a.m. ET on Monday.  Judge Michael Kaplan with the U.S. Bankruptcy Court for the District of New Jersey dismissed a bankruptcy case filed by J&J subsidiary LTL Management.  Johnson & Johnson created LTL Management in 2021 as a separate company to bear all of its talc liabilities.""}, {""date"": ""2023-07-31"", ""headline"": ""Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge's Rejection of Johnson & Johnson's Proposed $8.9B Settlement"", ""summary"": ""Trial Lawyers Press on with J&J Litigation, Justice for Cancer Victims\n\n...""}, {""date"": ""2023-07-31"", ""headline"": ""Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge\u2019s Rejection of Johnson & Johnson\u2019s Proposed $8.9B Settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""S&P 500 stutters on final day of trade for July"", ""summary"": ""Investing.com -- The S&P 500 was largely unchanged Monday as falling health care stocks capped upside momentum on the final day of trade in July ahead of another wave of earnings this week.""}, {""date"": ""2023-07-31"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-31"", ""headline"": ""J&J Just Can\u2019t Seem to Solve Its Talc Problem. The Latest Setback."", ""summary"": ""The Monday selloff in Johnson & Johnson stock appears to have been sparked by an unfavorable ruling by a bankruptcy judge in New Jersey.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St rises, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Investors await quarterly reports from Apple, Amazon.com and AMD later this week, while July ISM Manufacturing reading and three sets of employment data, including July's non-farm payrolls, are also in focus.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Wall St set to open higher, eyes monthly gain on U.S. soft landing hopes"", ""summary"": ""Wall Street futures rose on Monday with key benchmarks set to end July higher on upbeat company earnings and hopes of a soft landing for a resilient U.S. economy, while cooling inflation fuels bets on a rate-hike pause.  Second-quarter earnings for S&P 500 companies are now estimated to have fallen 6.4% year-over-year, according to Refinitiv data.  \""We've wrapped up a solid month ... and we're at a point in time where we clearly have seen enough of the earnings reports to know that they're going to come in better than feared,\"" said Art Hogan, chief market strategist at B Riley Wealth.""}, {""date"": ""2023-07-31"", ""headline"": ""US Stocks Take A Breather, Nasdaq Notches Fifth Straight Month Of Gains: Investors Gear Up For Pivotal Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Shares of SoFi Networks surged ahead of its earnings report and trucking company Yellow shut down operations as it prepares for bankruptcy. Here\u2019s what investors need to know today.""}, {""date"": ""2023-07-31"", ""headline"": ""US STOCKS-Futures inch up ahead of more megacap earnings, employment data"", ""summary"": ""U.S. stock index futures edged up on Monday with key benchmarks on track to end July higher, while investors awaited quarterly earnings from more megacap companies and a crucial employment report later this week.  All three main U.S. indexes ended last week higher as signs of cooling inflation and a resilient economy cemented investor bets on a soft landing for the country.  Upbeat quarterly earnings from megacap growth companies such as Alphabet, Meta Platforms as well as chipmakers Intel and Lam Research have also boosted investor sentiment.""}, {""date"": ""2023-07-31"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Janssen Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Pediatric Indication for HIV-1 Therapy EDURANT"", ""summary"": ""TITUSVILLE - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking to...""}, {""date"": ""2023-07-31"", ""headline"": ""Johnson & Johnson Subsidiary to Appeal Bankruptcy Court Ruling that Deprived Talc Claimants of an Equitable and Efficient Resolution"", ""summary"": ""NEW BRUNSWICK - Johnson & Johnson   today announced its subsidiary LTL Management LLC  will appeal the ruling by the United States Bankruptcy Court for the District of New Jersey dismissing the...""}, {""date"": ""2023-07-31"", ""headline"": ""Stocks Mixed, Jobs Data On Deck, Johnson & Johnson Talc Plans, Walmart In India, Yellow Bankruptcy - 5 Things To Know"", ""summary"": ""Stock futures mixed amid 'soft landing' hopes for U.S. economy; Week Ahead: jobs data in focus, earnings reports accelerate; Johnson & Johnson slides as talc bankruptcy plan rejected by judge; Walmart buys out Tiger Global, expands Flipkart stake and Yellow slides as Teamsters say trucking giant preparing for bankruptcy.""}, {""date"": ""2023-07-31"", ""headline"": ""Video: S&P 500 Movers: JNJ, NWL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Video: Dow Movers: JNJ, CVX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""5 stocks to watch on Monday: J&J, ON Semiconductor, Yum China and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Walmart, Chevron, Adobe rise premarket; Johnson & Johnson, Carvana fall"", ""summary"": ""Investing.com -- U.S. futures edged higher Monday, at the start of a week that includes more earnings from tech giants as well as the important monthly jobs report.""}, {""date"": ""2023-07-31"", ""headline"": ""Citi expects further litigation rounds after J&J subsidiary ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Cidara antifungal drug Rezzayo launched in US by partner Melinta"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""These Stocks Are Moving the Most Today: SoFi, Nikola, XPeng, Palantir, and More"", ""summary"": ""SoFi Technologies posts a narrower-than-expected second-quarter loss and raises guidance, Nikola receives a large order, New Relic is being acquired,...""}, {""date"": ""2023-08-01"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Dow Jones Today: Caterpillar Earnings Lift Index"", ""summary"": ""The price-weighted index rode gains from Caterpillar to move higher by 0.2%, or roughly 70 points, despite more than two-thirds of the index\u2019s stocks falling.""}, {""date"": ""2023-08-01"", ""headline"": ""Pfizer reports mixed quarterly results on uncertain COVID outlook"", ""summary"": ""Pfizer reports mixed second quarter earnings as uncertainty around COVID remains a headwind.""}, {""date"": ""2023-08-01"", ""headline"": ""Merck upgrades guidance on stronger 2023 outlook as COVID business declines"", ""summary"": ""Merck reported stronger-than-expected second quarter earnings.""}, {""date"": ""2023-08-01"", ""headline"": ""Top 25 S&P 500 Stocks by Index Weight for August 2023"", ""summary"": ""The Standard & Poor's 500 Index, or simply the S&P 500, is a market-capitalization-weighted index of roughly 500 large-cap U.S. stocks. The index accounts for 80% of the market value of the U.S. equities market.""}, {""date"": ""2023-08-01"", ""headline"": ""Merck (MRK) Beats on Q2 Earnings and Sales, Ups 2023 View"", ""summary"": ""Merck (MRK) beats Q2 estimates for earnings and sales. It raises its 2023 guidance. Stock rises in pre-market.""}, {""date"": ""2023-08-01"", ""headline"": ""Company News for Aug 1, 2023"", ""summary"": ""Companies in The News Are: XOM, JNJ, ON, NFLX""}, {""date"": ""2023-08-01"", ""headline"": ""Why Jim Cramer Sold One of His Favorite Pharma Stocks"", ""summary"": ""Johnson & Johnson  has been facing tens of thousands of lawsuits for several years now, alleging that the company's baby powder and other talc products sometimes contained asbestos and have caused a variety of cancers in the company's customers.  The company recently proposed a nearly $9 billion settlement plan that would involve a bankruptcy filing and prevent new lawsuits from being filed against it.  \""Normally when we sell a stock it's because something's changed at the company,\"" Cramer, whose charitable trust just sold all of it's J&J holdings, said.""}, {""date"": ""2023-08-01"", ""headline"": ""DGRO: Consistent Dividend Growth For Patient Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Companies Weigh Growing Power of Cloud Providers Amid AI Boom"", ""summary"": ""A wave of partnerships between AI model makers and cloud providers is leading tech chiefs to assess the benefits of convenience versus becoming too reliant on any one vendor.""}, {""date"": ""2023-08-01"", ""headline"": ""3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Do Your Investments Pass the 5.45% Test? Here's How To Avoid Leaving Money On The Table"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""The RBA Left The Interest Rate Unchanged Again. Rising Oil Prices Boost Energy Sector Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""U.S. Credit Rating Downgrade Won't Derail This Bull Market"", ""summary"": ""Stocks have intrinsic monetary value due to their ability to generate future free cash flows, unlike gold and Bitcoin. Click here for a detailed analysis.""}, {""date"": ""2023-08-02"", ""headline"": ""Dow Jones Today: Index Dives on Rating Cut"", ""summary"": ""Investors reacted to the Fitch Rating agency\u2019s downgrade of U.S. credit, sending long-term bonds higher and the Dow Jones lower by about 1%, or 350 points.""}, {""date"": ""2023-08-02"", ""headline"": ""J&J talc cancer plaintiffs want 6-month ban on further bankruptcy filings"", ""summary"": ""Lawyers for thousands of people who claim Johnson & Johnson's talc-based powders caused them to develop cancer on Wednesday urged a U.S. judge to temporarily block the company from seeking bankruptcy protection for a third time for its talc subsidiary.  J&J's attempt at resolving thousands of cancer lawsuits in bankruptcy court stumbled for a second time last week, when a judge ruled that the talc subsidiary, LTL Management, was not in the kind of immediate financial distress necessary to trigger bankruptcy protection.""}, {""date"": ""2023-08-02"", ""headline"": ""J&J, Cancer Victims Agree to Quick Appeal of Bankruptcy Ruling"", ""summary"": ""(Bloomberg) -- Johnson & Johnson and a committee of cancer victims have agreed to speed up a court appeal of their fight regarding whether the health-care giant can use bankruptcy to end as many as 100,000 talc-related claims.Most Read from BloombergFitch\u2019s US Credit Downgrade Sparks Criticism Along With UneaseMissing Goldman Sachs Analyst Confirmed Dead by New York PoliceS&P 500 Drops 1% After Rally as Bond Yields Climb: Markets WrapPoland Sends Troops to Belarus Border After Airspace BreachWhy""}, {""date"": ""2023-08-02"", ""headline"": ""United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates"", ""summary"": ""United Therapeutics' (UTHR) second-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the company's top line.""}, {""date"": ""2023-08-02"", ""headline"": ""2 Remaining AAA-Rated Companies Shine As U.S. Gets Downgraded"", ""summary"": ""Lawmakers are playing chicken with the debt ceiling. Luckily there are still two U.S. S&P 500 companies left with AAA credit ratings.""}, {""date"": ""2023-08-02"", ""headline"": ""Why J&J's 'Texas-two step' setback could make it harder for companies to shed lawsuits"", ""summary"": ""A ruling against Johnson & Johnson raises new questions about a controversial bankruptcy tactic companies use to resolve costly claims.""}, {""date"": ""2023-08-02"", ""headline"": ""Horizon Kinetics Q2 2023 Commentary"", ""summary"": ""Horizon Kinetics recently released its Q2 2023 commentary. Click here to read the full fund letter.""}, {""date"": ""2023-08-02"", ""headline"": ""The timing may be perfect for this dividend-stock fund if the market is getting close to a top"", ""summary"": ""The TrueShares Low Volatility Equity Income ETF sailed through the 2022 bear market. It is actively managed to focus on quality, value and attractive yields.""}, {""date"": ""2023-08-02"", ""headline"": ""3 Consumer Staples Stocks to Dump ASAP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""10 Recent IPOs in 2023 to Consider"", ""summary"": ""In this piece, we will take a look at ten recent IPOs in 2023. If you want to skip background activity in the sector this year, then head on over to 5 Recent IPOs in 2023 to Consider. Most companies don\u2019t list their shares on the stock market. While big ticket names such as Apple, [\u2026]""}, {""date"": ""2023-08-02"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Time To Go Defensive With These ETFs"", ""summary"": ""The stock market has been on a tear lately, with the most volatile stocks crushing their defensive counterparts. Click here to read more about low-volatility investing.""}, {""date"": ""2023-08-03"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights."", ""summary"": ""The U.S. stock market has been roaring higher lately, even though it has started off August on a tough note. While the S&P 500 has fallen about 2% so far this month, it\u2019s been on a strong run otherwise. Regardless of the next direction, investors should be looking at blue-chip stocks to buy. Blue-chip stocks should be on investors\u2019 radar whether the stock market is going up or down. The S&P 500 has enjoyed a five-month win streak, gaining more than 21% from the March low to the July high. At tha""}, {""date"": ""2023-08-03"", ""headline"": ""Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs"", ""summary"": ""In light of Fitch Ratings' downgrade of U.S. credit, investors might be interested in identifying companies and countries that still hold the desirable 'AAA' credit rating.""}, {""date"": ""2023-08-03"", ""headline"": ""Q2 Earnings Season Scorecard and Research Reports for JNJ, Pioneer Natural & Others"", ""summary"": ""Today's Research Daily features a real-time Q2 scorecard and updated reports on JNJ (JNJ), General Dynamics (GD), Pioneer Natural Resources (PXD) and others.""}, {""date"": ""2023-08-03"", ""headline"": ""Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss"", ""summary"": ""Sarepta's (SRPT) second-quarter 2023 earnings beat estimates. Though total revenues register strong year-over-year growth during the quarter, the same misses the mark.""}, {""date"": ""2023-08-03"", ""headline"": ""J&J\u2019s $40 Billion Kenvue Stock Swap:\u00a0What You Need to Know"", ""summary"": ""Johnson & Johnson is allowing shareholders to swap for shares of Kenvue, which has brands like Tylenol, at a discount.""}, {""date"": ""2023-08-03"", ""headline"": ""With 71% ownership of the shares, Johnson & Johnson (NYSE:JNJ) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable to...""}, {""date"": ""2023-08-03"", ""headline"": ""Sell Alert: 3 Healthcare Stocks to Dump ASAP"", ""summary"": ""Healthcare stocks are generally thought of as safe or even recession-proof investments. This is because the underlying companies provide essential products and services that are required no matter what the broader economy is doing. While they may not offer the most exciting returns, they are usually considered to be solid long-term performers. That said, there are a few healthcare stocks to dump that we will look at today. From an investment perspective, some potential red flags that could signa""}, {""date"": ""2023-08-03"", ""headline"": ""JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Goldman in, Microsoft out of BofA Alpha Surprise Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""3 of the Safest Dividend Kings"", ""summary"": ""Income investors should focus on stocks that pay solid yields but also those that have sustainable payouts and strong business models. The Dividend Kings are an excellent place to look for stocks with sustainable dividends, as they have raised their dividends each year for more than 50 consecutive years. The following three Dividend Kings have low dividend payout ratios and recession-proof business models, meaning their dividends are well-covered even during a recession. Walmart (WMT) Source: fo""}, {""date"": ""2023-08-04"", ""headline"": ""Bruker (BRKR) Q2 Earnings and Revenues Top, '23 Sales View Up"", ""summary"": ""Bruker (BRKR) delivers better-than-expected earnings and revenues in the second quarter of 2023.""}, {""date"": ""2023-08-04"", ""headline"": ""My Dividend Growth Portfolio: Mid-Summer Update"", ""summary"": ""Discover why the author sold Cardinal Health in favor of Home Depot, ADP, and CME Group. Also, learn about Blackstone's variable dividend and Johnson & Johnson's latest exchange offer.""}, {""date"": ""2023-08-04"", ""headline"": ""Better Buy: Johnson & Johnson vs. Proctor & Gamble"", ""summary"": ""Dividend stocks are the best way to invest if stock market volatility scares you away from investing your hard-earned money.  The two companies I'll be discussing in this article are longtime dividend payers in the consumer and healthcare industries.  Both Proctor & Gamble (NYSE: PG) and Johnson & Johnson (NYSE: JNJ) have earned the title of Dividend King.""}, {""date"": ""2023-08-04"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk"", ""summary"": ""Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk are part of the Zacks top Analyst Blog.""}, {""date"": ""2023-08-04"", ""headline"": ""Itching for a Good Trade? Johnson & Johnson Spinoff Kenvue Should Offer Relief"", ""summary"": ""Boasting brands like Band-Aid and Benadryl, Kenvue has now become the largest pure-play consumer health company, and it will soon offer two distinct -- and excellent -- opportunities.""}, {""date"": ""2023-08-04"", ""headline"": ""J&J gets expanded approval for cardiac ablation products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""J&J says Biosense Webster gains US FDA approval for ablation products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""5 Forever Dividend Stocks"", ""summary"": ""When it comes to investing, it is important to build a strong foundation of high-quality positions.""}, {""date"": ""2023-08-04"", ""headline"": ""Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-05"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - August 2023"", ""summary"": ""Discover five large-cap dividend-paying stocks that are currently offering substantial discounts, allowing investors to enjoy moderate to high yields.""}, {""date"": ""2023-08-06"", ""headline"": ""25 Most Health-Conscious States in the US"", ""summary"": ""In this article, we will be taking a look at the 25 most health-conscious states in the U.S. If you wish to see the top ones, head straight to the 5 Most Health-Conscious States in the U.S. According to the Commonwealth Fund, healthcare spending in the United States is much greater than in other high-income [\u2026]""}]",{}
30,2023-08-06,166.48826599121094,2023-08-13,171.22567749023438,0.02845492726360388,U3,"[{""date"": ""2023-08-06"", ""headline"": ""25 Most Health-Conscious States in the US"", ""summary"": ""In this article, we will be taking a look at the 25 most health-conscious states in the U.S. If you wish to see the top ones, head straight to the 5 Most Health-Conscious States in the U.S. According to the Commonwealth Fund, healthcare spending in the United States is much greater than in other high-income [\u2026]""}, {""date"": ""2023-08-07"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy for August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Johnson & Johnson Plans Exchange Offer for Kenvue"", ""summary"": ""It is a question of financial value""}, {""date"": ""2023-08-07"", ""headline"": ""Dow Jones Today: Index Rebounds with 400-Point Gain"", ""summary"": ""Following last week\u2019s downward turn, the Dow Jones Industrial Average bounced back, rising 407 points, or 1.2%, as investors readied for new inflation data to close out the week.""}, {""date"": ""2023-08-07"", ""headline"": ""Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference"", ""summary"": ""Johnson & Johnson  will participate in the 2023 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7th. Ashley McEvoy, EVP, Worldwide...""}, {""date"": ""2023-08-07"", ""headline"": ""Future Prospects For Johnson & Johnson Following Strong Q2 Performance"", ""summary"": ""Johnson & Johnson, the mastodon of the healthcare sector, released its financial results for the 2nd quarter of 2023. Read why JNJ stock is a hold.""}, {""date"": ""2023-08-07"", ""headline"": ""August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new Breakout Stocks for Week 32 curated by the MDA model for 10% short-term upside and additional model selections. Click here to read more.""}, {""date"": ""2023-08-07"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) A Risky Investment?"", ""summary"": ""The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...""}, {""date"": ""2023-08-07"", ""headline"": ""New Data May Push Insurers to Cover Novo, Lilly Obesity Drugs"", ""summary"": ""Results of a study show Novo Nordisk's Wegovy reduced the risk of heart attack and stroke in obese and overweight patients by a greater-than-expected degree.""}, {""date"": ""2023-08-07"", ""headline"": ""WKLY: Want Weekly Dividends? Check Out This ETF from SoFi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""IN BRIEF: Fresenius agrees on FYB202 US entry date with J&J"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""What Makes A Hold-Forever Stock?"", ""summary"": ""Forever stocks are companies that diversify to reduce risk by not relying solely on one market or product for revenue. Check out the list of my forever stocks.""}, {""date"": ""2023-08-08"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.05% higher to $173.18 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-08-08"", ""headline"": ""Perrigo (PRGO) Beats on Q2 Earnings & Sales, Reiterates '23 View"", ""summary"": ""Perrigo (PRGO) reports encouraging second-quarter 2023 results. Management reaffirms the financial guidance for 2023.""}, {""date"": ""2023-08-08"", ""headline"": ""Cantor biotech/biopharma analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Eli Lilly\u2019s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""Healthcare giant Johnson & Johnson (NYSE: JNJ) has a lot going its way.  Should investors take this opportunity to pick up the company's shares on the dip, or are Johnson & Johnson's legal troubles enough of a reason to avoid the stock?  First, we need some background to understand the latest developments in Johnson & Johnson's long battle against these cases.""}, {""date"": ""2023-08-08"", ""headline"": ""My Dividend Stock Portfolio: New July Dividend Record - 99 Holdings With 26 Buys"", ""summary"": ""Investment activity remained robust, and dividend income hit a record high. Additionally, passive income equivalent to almost 5 weeks of work was earned in 2023.""}, {""date"": ""2023-08-08"", ""headline"": ""Novavax shares jump after Covid vaccine maker posts surprise quarterly profit "", ""summary"": ""Novavax is working to strengthen its financial position after it raised doubts about its ability to stay in business earlier this year. ""}, {""date"": ""2023-08-08"", ""headline"": ""Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%"", ""summary"": ""Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline.\u00a0""}, {""date"": ""2023-08-08"", ""headline"": ""Eli Lilly's stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook"", ""summary"": ""Eli Lilly's stock soared Tuesday toward its biggest gain in more than 20 years, following a strong earnings report and upbeat outlook for its Mounjaro drug.""}, {""date"": ""2023-08-09"", ""headline"": ""Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Tracking Yacktman Asset Management Portfolio - Q2 2023 Update"", ""summary"": ""Yacktman Asset Management's 13F portfolio value grows to $10.55B, with Canadian Natural Resources as largest holding. See here for additions and deletions.""}, {""date"": ""2023-08-09"", ""headline"": ""Kenvue Set to Join S&P 500"", ""summary"": ""Kenvue Inc. (NYSE: KVUE) will be added to the S&P 500 effective prior to the open on a date to be announced conditioned upon the successful completion of a voluntary exchange offer being conducted by S&P 500 & S&P 100 constituent Johnson & Johnson (NYSE: JNJ). Johnson & Johnson announced its intention to split off at least 80.1% of Kenvue shares it owns through a voluntary exchange offer that expires Friday, August 18. Kenvue will replace an S&P 500 company to be named in a separate press releas""}, {""date"": ""2023-08-09"", ""headline"": ""Kenvue Will be Added to S&P 500 After J&J Exchange Offer"", ""summary"": ""The Johnson & Johnson spinoff is the consumer health company that makes Listerine and Tylenol.""}, {""date"": ""2023-08-09"", ""headline"": ""Kenvue, the J&J spinoff, will join the S&P 500 index"", ""summary"": ""Kenvue Inc., maker of Tylenol, Benadryl and other household names in health-care products, is joining the S&P 500 index, index provider S&P Dow Jones Indices...""}, {""date"": ""2023-08-09"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slumped 0.06% to $173.07 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-08-09"", ""headline"": ""Protagonist: Rusfertide Has Potential For Patients With Polycythemia Vera"", ""summary"": ""Protagonist Therapeutics is progressing with the use of rusfertide drug for polycythemia vera treatment in a phase 3 study. Find out why PTGX stock is a Strong Buy.""}, {""date"": ""2023-08-09"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $11,600.00K"", ""summary"": """"}, {""date"": ""2023-08-09"", ""headline"": ""Johnson & Johnson's Talc Problems Aren't Going Away"", ""summary"": ""The biggest risk facing\u00a0Johnson & Johnson\u00a0(NYSE: JNJ) today is its exposure to talc-related lawsuits.  The company developed a plan to address the issue and limit its liability by creating a subsidiary that would then file for bankruptcy protection.  In 2021, Johnson & Johnson created a subsidiary, LTL Management.""}, {""date"": ""2023-08-09"", ""headline"": ""5 Defensive Stocks for Stable Returns Amid Recent Volatility"", ""summary"": ""We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.""}, {""date"": ""2023-08-09"", ""headline"": ""A Bull Market Is Coming: 2 Warren Buffett Stocks to Buy and Hold Forever"", ""summary"": ""Few investors are better known than Warren Buffett, who is widely regarded as the greatest stock picker of all time.  One of Buffett's signature qualities is his long-term approach to investing.  It's not surprising then that his conglomerate, Berkshire Hathaway, has an investment portfolio full of stocks worth holding on to for good.""}, {""date"": ""2023-08-09"", ""headline"": ""Medicare Part D drug price increases far exceed inflation - AARP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""22 Highest Paid Medical Specialties in the World"", ""summary"": ""In this article, we will look at the 22 highest-paid medical specialties in the world. We have also covered analysis on salaries for doctors in the US while discussing healthcare giants and their initiatives for global healthcare. If you want to skip our detailed analysis, head straight to the 5 Highest-Paid Medical Specialties in the [\u2026]""}, {""date"": ""2023-08-09"", ""headline"": ""3 No-Brainer Stocks to Buy With $200 Right Now"", ""summary"": ""A reasonably small amount of money can go a long way when it's invested in game-changing companies.""}, {""date"": ""2023-08-09"", ""headline"": ""The Year\u2019s Top 3 Value ETFs as of August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""What Makes A Hold-Forever-Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Kenvue set to join S&P500"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Kenvue to be added to S&P 500, date to be announced"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""IN BRIEF: Johnson & Johnson's blood cancer therapy approved by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.52% to $172.17 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-08-10"", ""headline"": ""These 10 medications are likely targets for Medicare price negotiations this fall"", ""summary"": ""It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.""}, {""date"": ""2023-08-10"", ""headline"": ""Achieving Alpha By Investing In Current Wealth And Present Value"", ""summary"": """"}, {""date"": ""2023-08-10"", ""headline"": ""UPDATE 2-US FDA approves Johnson & Johnson's blood cancer therapy"", ""summary"": ""Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.  The therapy, talquetamab-tgvs branded as Talvey, belongs to a class of treatments called bispecific antibodies designed to bring a cancer cell and an immune cell together so the body's immune system can kill the cancer.  Talvey was approved as a weekly or biweekly subcutaneous, or under-the-skin, injection to treat patients with relapsed multiple myeloma who have received at least four prior lines of treatment,  the company said.""}, {""date"": ""2023-08-10"", ""headline"": ""FDA grants accelerated approval of Janssen's Talvey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""X CEO Linda Yaccarino explains reason for getting rid of Twitter name"", ""summary"": ""X CEO Linda Yaccarino explained to CNBC on Thursday why the company decided to get rid of its Twitter branding.""}, {""date"": ""2023-08-10"", ""headline"": ""KVUE Stock Alert: Kenvue to Join the S&P 500"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""The Zacks Analyst Blog Highlights PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy"", ""summary"": ""PepsiCo, Johnson & Johnson, Intuitive Surgical, Kimberly-Clark and Atmos Energy are included in this Analyst Blog.""}, {""date"": ""2023-08-10"", ""headline"": ""3 Top Biotech Stocks Defying the Bear Market"", ""summary"": ""If you look at the S&P 500, which is up more than 18% this year, or the Nasdaq Composite, which is up more than 34% in 2023, it appears the markets are booming.  The iShares Biotechnology ETF is down more than 3% so far in 2023, and the SPDR S&P Biotech EFT is down more than 5%.  The two ETFs reflect negative market sentiment toward biotech stocks, in general, this year.""}, {""date"": ""2023-08-10"", ""headline"": ""Notable open interest changes for August 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Disney, Capri, Sonos, Wynn Resorts rise premarket; Tapestry, Penn fall"", ""summary"": ""Investing.com -- U.S. futures rose Thursday, with investors awaiting a key inflation release which could provide clues towards future Federal Reserve interest rate decisions.""}, {""date"": ""2023-08-10"", ""headline"": ""Johnson & Johnson Gets FDA OK of Talvey in Heavily Pretreated Multiple Myeloma"", ""summary"": ""By Colin Kellaher Johnson & Johnson has won U.S. Food and Drug Administration accelerated approval of its Talvey bispecific antibody for certain adults with the incurable blood cancer multiple...""}, {""date"": ""2023-08-10"", ""headline"": ""Johnson & Johnson wins FDA nod for new multiple myeloma therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Johnson & Johnson Gets FDA OK of Talvey in Heavily Pretreated Multiple Myeloma >JNJ"", ""summary"": ""By Colin Kellaher Johnson &amp; Johnson has won U.S. Food and Drug Administration accelerated approval of its Talvey bispecific antibody for certain adults...""}, {""date"": ""2023-08-10"", ""headline"": ""Post-IPO NeurAxis A Robust Contender To Earn Front Line Designation Treating Pediatric FAP And IBS ($NRXS)"", ""summary"": ""Successful IPO to NYSE-Amer market raises over $6 million to fuel expanding treatment reach of IB-Stim technologyNeurAxis scored a significant milestone on Wednesday, making its NYSE-American...""}, {""date"": ""2023-08-10"", ""headline"": ""Want to Make $1,000 in 2 Weeks? Buy 99 Shares of J&J Stock."", ""summary"": ""Many individual investors are trying to do that by purchasing 99 shares of  Johnson & Johnson  to take advantage of the \u201codd-lot\u201d rule in the company\u2019s $40 billion exchange offer for  Kenvue  The potential payoff if things go right is more than $1,000.  The opportunity arises because the Johnson & Johnson (ticker: JNJ) exchange offer for Kenvue (KVUE), which holds the consumer health business formerly owned by J&J, allows holders of less than 100 shares of J&J stock\u2014or an odd lot \u2014to get a full allocation of Kenvue if they submit all their shares.  Other J&J shareholders are likely to be prorated, meaning they won\u2019t get a full allocation of Kenvue.""}, {""date"": ""2023-08-10"", ""headline"": ""The 7 Safest Stocks to Buy in August"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Janssen Pharmaceutical : Akeega Gets FDA Approval to Treat Prostate Cancer Patients"", ""summary"": ""By Stephen Nakrosis Janssen Pharmaceutical said Friday that the Food and Drug Administration approved Akeega as a treatment for a specific type of prostate cancer. Akeega, or niraparib and...""}, {""date"": ""2023-08-11"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $173.85 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-08-11"", ""headline"": ""Pharma ETFs in Focus Post Q2 Earnings"", ""summary"": ""Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.""}, {""date"": ""2023-08-11"", ""headline"": ""The Low Budget Dividend Portfolio: August Update"", ""summary"": ""Discover insights into a personal dividend growth portfolio, including investment strategy, decision-making process, and lessons learned.""}, {""date"": ""2023-08-11"", ""headline"": ""Johnson & Johnson (JNJ) Could Be a Great Choice"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-08-11"", ""headline"": ""Supreme Court temporarily blocks Purdue's $6B opioid settlement"", ""summary"": ""The Supreme Court has motioned to temporarily pause Purdue Pharma's $6 billion opioid settlement over a provision that would give the Sackler family immunity from lawsuits and liabilities. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the story.""}, {""date"": ""2023-08-11"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) shareholders have earned a 8.2% CAGR over the last five years"", ""summary"": ""The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...""}, {""date"": ""2023-08-11"", ""headline"": ""Is Kenvue Stock a Buy After Earnings?"", ""summary"": ""If you've ever been to a convenience store, odds are that you've encountered products sold by Kenvue (NYSE: KVUE).  If that name doesn't sound familiar, it might be because until recently Kenvue's products were part of a larger conglomerate, Johnson & Johnson.  Kenvue just held its first earnings report as a stand-alone public company, and beat Wall Street expectations on both the top and bottom lines.""}, {""date"": ""2023-08-11"", ""headline"": ""WHO names Eris a coronavirus variant of interest. Here\u2019s what you need to know."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Most Active Equity Options For Midday - Friday, Aug. 11"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Janssen Pharmaceutical - U.S. FDA Approves TALVEY, a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma"", ""summary"": ""HORSHAM - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration has granted accelerated approval of TALVEY , a first-in-class...""}, {""date"": ""2023-08-11"", ""headline"": ""Notable open interest changes for August 11th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-12"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-12"", ""headline"": ""3 Unstoppable Dividend Stocks to Buy Right Now"", ""summary"": ""Income investors won't be happy with dividends that aren't sustainable.  Instead, they want to own dividend stocks that they can depend on.  Here's why they think AbbVie (NYSE: ABBV), Johnson & Johnson (NYSE: JNJ), and Novartis (NYSE: NVS) are unstoppable dividend stocks to buy right now.""}, {""date"": ""2023-08-12"", ""headline"": ""How To Invest $100,000 Today: 5 Strategies Including The Near-Perfect Portfolio Strategy"", ""summary"": ""Discover five investment strategies, including the Near-Perfect Portfolio, aimed at capital preservation, sustainable income, and long-term growth. Click for more.""}, {""date"": ""2023-08-12"", ""headline"": ""HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street\u2019s \u201cStrong Buy\u201d Rating?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
31,2023-08-13,171.22567749023438,2023-08-20,169.88621520996094,-0.007822788613873866,D1,"[{""date"": ""2023-08-12"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""IN BRIEF: Johnson & Johnson gets FDA approval for Akeega tablet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""7 Dividend Stocks to Buy as Investor Sentiment Falters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""Pfizer wins FDA nod for multiple myeloma therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Nanobiotix announces expiration of HSR antitrust waiting period for NBTXR3 pact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""J&J Investors Need to Decide Soon if They Want Kenvue Stock"", ""summary"": ""The $40 billion exchange offer for shares of Kenvue expires Friday but brokerage firms want retail investors to make their instructions before then""}, {""date"": ""2023-08-14"", ""headline"": ""August MDA Breakout Stocks Week 33 - 2023: Facing The Largest Negative Signal Since February"", ""summary"": ""The Momentum Gauges and S&P 500 Gauges have turned negative. Read why this indicates a shift in market momentum and the need for caution in stock selection.""}, {""date"": ""2023-08-14"", ""headline"": ""Tylenol Maker Kenvue\u2019s Share Swap Opens Door for\u00a0More Investors"", ""summary"": ""(Bloomberg) -- It\u2019s a decisive week for investors looking to get involved in Johnson & Johnson\u2019s record split-off of most of its $40 billion stake in Kenvue Inc., the maker of Tylenol and Listerine.Most Read from BloombergRussia Calls Emergency Key Rate Meeting as Ruble PlungesOutsider Milei Upends Argentina\u2019s Election With Primary WinBig Tech Takes the Lead in Thin Trading Session: Markets WrapChina Finance Giant\u2019s Missed Payments Alarm Regulators, MarketsZuckerberg Says \u2018Time to Move On\u2019 From""}, {""date"": ""2023-08-14"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Janssen Pharmaceutical - U.S. FDA Approves AKEEGA, the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer"", ""summary"": ""HORSHAM - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food & Drug Administration has approved AKEEGA , the first-and-only dual action tablet combining a...""}, {""date"": ""2023-08-14"", ""headline"": ""Meet the Only 2 Publicly Traded Companies With a Higher Credit Rating Than the U.S. Government"", ""summary"": ""In 1980, more than 60 public companies possessed the highly coveted AAA credit rating from Standard & Poor's. Today, only two remain.""}, {""date"": ""2023-08-14"", ""headline"": ""Johnson & Johnson wins FDA nod for new prostate cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Notable open interest changes for August 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Catalent accused of misleading investors in shareholder suit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""J&J\u2019s Kenvue Deal Could Be Too Popular. What Happens if It Is."", ""summary"": ""If demand is too high, J&J holders who participate will be able to swap only part of their investments for Kenvue""}, {""date"": ""2023-08-15"", ""headline"": ""Johnson & Johnson (JNJ) Presents at UBS MedTech, Tools and Genomics Summit Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) UBS MedTech, Tools and Genomics Summit Conference Call August 15, 2023 2:00 PM ETCompany ParticipantsCeline Martin - Group ChairmanJasmina Brooks \u00e2\u0080\u0093...""}, {""date"": ""2023-08-15"", ""headline"": ""Hims & Hers: Niche Telehealth Player With Huge Potential"", ""summary"": ""Hims & Hers Health beat expectations with strong Q2 results and raised revenue guidance. Find out why I see great potential in HIMS stock despite issues.""}, {""date"": ""2023-08-15"", ""headline"": ""Boston Scientific's (BSX) POLARx System Gets FDA Approval"", ""summary"": ""Boston Scientific's (BSX) POLARx enables doctors to expand and modify the new POLARx catheter to match a patient's unique anatomy during an ablation treatment.""}, {""date"": ""2023-08-15"", ""headline"": ""What investors need to know about Johnson & Johnson, Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""J&J\u2019s Kenvue Spinoff  Is Almost Here. What to Do Now."", ""summary"": ""The $40 billion exchange offer for shares of Kenvue expires Friday, but brokerage firms want retail investors to make their instructions before then.""}, {""date"": ""2023-08-15"", ""headline"": ""Flames, Not Smoke : LTL Management LLC's Second Chapter 11 Filing Dismissed By The Bankruptcy Court For The District Of New Jersey For Lack Of Imminent And Immediate Financial Distress"", ""summary"": ""On July 28, 2023, Judge Michael Kaplan of the Bankruptcy Court for the District of New Jersey issued an opinion granting motions to dismiss LTL Management LLC's second chapter 11 case, finding that...""}, {""date"": ""2023-08-15"", ""headline"": ""15 Worst Performing Blue Chip Stocks in 2023"", ""summary"": ""In this piece, we will take a look at the 15 worst performing blue chip stocks in 2023. If you want to skip a background of what\u2019s been going on in this lucrative sector this year, then head on over to 5 Worst Performing Blue Chip Stocks in 2023. In traditional poker, a blue chip [\u2026]""}, {""date"": ""2023-08-15"", ""headline"": ""Get In on This Skin Disease Drug Before Big Pharma Does"", ""summary"": ""Biotech MoonLake Immunotherapeutics is developing a drug that has shown great promise for inflammatory skin conditions.""}, {""date"": ""2023-08-15"", ""headline"": ""Citi sees Kenvue stock outperforming after exchange offer closes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Citi opens 'positive catalyst watch' on Kenvue into split-off close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Buffett\u2019s Builder Bet Beats the Curve. Why It Was Such a Bold Play."", ""summary"": ""China Cuts key rates as economy sours, Intel expands deal aimed at speeding chip manufacturing, and other news to start your day.""}, {""date"": ""2023-08-15"", ""headline"": ""Thinking about trading options or stock in Advanced Micro Devices, Nuvei, Applied Optoelectronics, Johnson & Johnson, or Rigetti Computing?"", ""summary"": ""NEW YORK, Aug. 15, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, NVEI, AAOI, JNJ, and RGTI. ...""}, {""date"": ""2023-08-15"", ""headline"": ""Johnson & Johnson Stock: Outlook Amid Lawsuits"", ""summary"": ""There is renewed uncertainty in Johnson & Johnson's talc lawsuits settlement and its potential impact on JNJ stock. Check out the ramifications of recent events.""}, {""date"": ""2023-08-15"", ""headline"": ""Notable open interest changes for August 15th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""NeurAxis Earns $14 Price Target from GSCR Analyst Based on Potential to Revolutionize Pediatric FAP and IBS Treatments ($NRXS)"", ""summary"": ""NeurAxis stock is doing something many newly listed companies' shares aren't: trading higher. In fact, despite the bullish start by many in the past few months, short-selling investors have been...""}, {""date"": ""2023-08-16"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""This Company\u2019s 10-Year Yield Beats Out The Average Bond"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Johnson & Johnson finalizes an exchange ratio of 8.0324 in Kenvue split-off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders to exchange their shares of Johnson & Johnson for shares of common stock of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") currently held by Johnson & Johnson.""}, {""date"": ""2023-08-16"", ""headline"": ""Nearing Retirement? These Stocks Are as Safe as They Come"", ""summary"": ""Most people nearing retirement can't afford the risk of owning stocks that could decline significantly in the face of an economic downturn and never recover.  Johnson & Johnson\u00a0(NYSE: JNJ) and\u00a0Coca-Cola\u00a0(NYSE: KO) are two of the safest stocks in the world.  Johnson & Johnson is one of the safest companies out there.""}, {""date"": ""2023-08-16"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-08-16"", ""headline"": ""Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider"", ""summary"": ""I explain my reasons for not participating in Johnson & Johnson's (JNJ) Kenvue (KVUE) stake split-off despite attractive incentives. Click here to read more.""}, {""date"": ""2023-08-16"", ""headline"": ""Cantor biotech/biopharma analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Interesting JNJ Put And Call Options For November 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""A New Stock Is About to Join the S&P 500. Does History Show That Buying It Now Could Pay Off?"", ""summary"": ""Want to know one of the great things about investing in an S&P 500 index fund?  A new stock is about to join the S&P 500.  Johnson & Johnson (NYSE: JNJ) announced in November 2021 that it planned to spin off its consumer health unit.""}, {""date"": ""2023-08-16"", ""headline"": ""Live Off The Fat Of The Land With These Two Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Notable open interest changes for August 16th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Johnson & Johnson says final exchange ratio 8.0324 in split-off of Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Here's Why it is a Good Time to Buy J&J's (JNJ) Stock Now"", ""summary"": ""J&J's (JNJ) Pharma sales are being driven by key drugs like Darzalex and new products. J&J's Pharma and MedTech units are likely to continue to drive sales growth in 2023.""}, {""date"": ""2023-08-17"", ""headline"": ""AbbVie (ABBV) Gets EU Approval for Migraine Prevention Drug"", ""summary"": ""Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist approved in the EU to prevent episodic and chronic migraines.""}, {""date"": ""2023-08-17"", ""headline"": ""4 moments from Jim Cramer's August Monthly Meeting of the CNBC Investing Club"", ""summary"": ""Here's a sneak peek.""}, {""date"": ""2023-08-17"", ""headline"": ""Jim Cramer gives his view on what investors should do if they own J&J stock"", ""summary"": ""Jim Cramer talks about the Johnson & Johnson exchange offer for shares of its split off consumer unit Kenvue. In the CNBC Investing Club's Monthly Meeting, Jim gave his view of what do to about J&J.""}, {""date"": ""2023-08-17"", ""headline"": ""America\u2019s courts weigh in on how firms resolve liability claims"", ""summary"": ""The Supreme Court is reviewing Purdue Pharma\u2019s bankruptcy plan""}, {""date"": ""2023-08-17"", ""headline"": ""J&J Holders to Get 8 Kenvue Shares for Each J&J Share in Exchange Offer"", ""summary"": ""Johnson & Johnson  will issue just over eight shares of  Kenvue  stock for each of its own shares in what is likely to be an oversubscribed exchange offer totaling nearly $40 billion.  The pricing period for the exchange offer ran from Monday through Wednesday.  Johnson & Johnson (ticker: JNJ) said late Wednesday that the exchange ratio has been set at roughly 8.03 shares of Kenvue (KVUE) for each of its own shares.""}, {""date"": ""2023-08-17"", ""headline"": ""Most Active Equity Options For Midday - Thursday, Aug. 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Thoughts For Thursday: Slipsliding Sideways"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Opinion: The Fed Is Losing the Battle Against Inflation, and There's No Easy Fix"", ""summary"": ""Wall Street may be forced to \""take its medicine\"" to resolve stubbornly high core inflation.""}, {""date"": ""2023-08-17"", ""headline"": ""Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Notable open interest changes for August 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You"", ""summary"": ""Kenvue Inc., the largest OTC drug company, may become a dividend king, but is it better than Johnson & Johnson? Click here for our comparison of KVUE and JNJ stock.""}, {""date"": ""2023-08-17"", ""headline"": ""Wall Street Breakfast Podcast: More Rate Hikes Ahead?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Thoughts For Thursday: Slipsliding, Sideways"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""BUZZ Investing: A Shift In Market Leadership"", ""summary"": ""7 tech stocks accounted for almost 75% of the S&P 500's year-to-date gains, marking the technical start of a new bull market, even as investors raised concerns about narrow market breadth.""}, {""date"": ""2023-08-18"", ""headline"": ""AARP urges courts to keep drug pricing talks on track"", ""summary"": ""AARP is one of the few groups so far to have filed an amicus brief on supporting of the U.S. Department of Health and Human Services. The suit from the U.S. Chamber of Commerce and several pharmaceutical companies, including Merck (MRK) and Johnson & Johnson (JNJ), is asking the courts to delay the implementation of a new law that would let Medicare negotiate the prices of certain drugs. Yahoo Finance Health Care Reporter Anjalee Khemlani reports the details.""}, {""date"": ""2023-08-18"", ""headline"": ""Kenvue is a Timely Stock"", ""summary"": ""Kenvue is seperating from J&J giving shareholders a short term opportunity""}, {""date"": ""2023-08-18"", ""headline"": ""Medical device at heart of $16.6B J&J acquisition recalled"", ""summary"": ""Just a few months after Johnson & Johnson Inc. acquired Danvers medical device maker Abiomed Inc. for a whopping $16.6 billion, the device at the heart of the acquisition \u2014 a minimally invasive heart pump \u2014 is being partially recalled.""}, {""date"": ""2023-08-18"", ""headline"": ""J&J\u2019s Swap Offer for Kenvue Is About to Expire. Proration Figure Will Be Key."", ""summary"": ""Wall Street is betting that the proration will be about 30%, meaning that participating J&J holders will get 30% of their stock converted into Kenvue.""}, {""date"": ""2023-08-18"", ""headline"": ""Tylenol Litigation Could Be a Headache for Kenvue"", ""summary"": ""The Johnson & Johnson spinoff faces suits alleging the painkiller can cause neurological disorders. Kenvue says Tylenol is safe.""}, {""date"": ""2023-08-18"", ""headline"": ""Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market"", ""summary"": ""Viatris surpassed expectations in Q2 2023 with increased revenue and R&D spending. Click here to find out why VTRS stock is rated as a buy.""}, {""date"": ""2023-08-18"", ""headline"": ""IN BRIEF: EU approves reduced dosing frequency for J&J's Tecvayli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Europe Approves Reduced Dosing For Johnson & Johnson's Cell Therapy For Multiple Myeloma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Dow down nearly 100 points on losses for shares of Johnson & Johnson, Microsoft"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Notable open interest changes for August 18th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Tiny Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-19"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-19"", ""headline"": ""10 Dividend Growth Stocks For August 2023"", ""summary"": ""The article presents the ten highest-quality Dividend Radar stocks for further research and possible investment. Click here to read more.""}, {""date"": ""2023-08-20"", ""headline"": ""10 Stocks ChatGPT Said Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will be taking a look at the 10 stocks ChatGPT said will make me rich in 10 years. To skip our detailed analysis of generative AI and its application in the field of investing, you can go directly to see the 5 Stocks ChatGPT Said Will Make Me Rich in 10 Years. [\u2026]""}, {""date"": ""2023-08-20"", ""headline"": ""Warren Buffett\u2019s 11 Growth Stock Picks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s growth stock picks. If you want to skip our introduction to the investor and growth investing, then head on to Warren Buffett\u2019s 5 Growth Stock Picks. Warren Buffett is one of the most successful investors of our time. His investment strategy depends on identifying [\u2026]""}, {""date"": ""2023-08-20"", ""headline"": ""Dow falls more than 200 points to start the week as rates march higher: Live updates"", ""summary"": ""Traders weighed a rise in yields to multiyear highs on Monday, fueling losses for the Dow.""}, {""date"": ""2023-08-20"", ""headline"": ""Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson...""}, {""date"": ""2023-08-20"", ""headline"": ""3 Stocks I Will \""Never\"" Sell"", ""summary"": ""For me, there are at least three stocks in my portfolio I don't anticipate getting rid of anytime soon: Johnson & Johnson (NYSE: JNJ), Meta Platforms (NASDAQ: META), and Amazon (NASDAQ: AMZN).  Johnson & Johnson needs no introduction -- it has been a leading healthcare company for a long time.  Second, we can point to Johnson & Johnson's solid fundamentals.""}, {""date"": ""2023-08-20"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 20"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the August 20 weekly update.""}]",{}
32,2023-08-20,169.88621520996094,2023-08-27,164.92922973632812,-0.02917826774530541,D3,"[{""date"": ""2023-08-19"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Nasdaq Snaps Losing Streak; Dow Dragged Red"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Johnson & Johnson stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""These Are the ONLY 7 Warren Buffett Stocks to Consider in August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Lawsuits unlikely to hinder Medicare drug price negotiations \u2013 UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Kenvue rises on exchange offer oversubscription; JNJ falls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Johnson & Johnson Investors Pounce On Oversubscribed Kenvue Deal, How You Can Still Earn $500 A Month"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""10 Stocks ChatGPT Said Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will be taking a look at the 10 stocks ChatGPT said will make me rich in 10 years. To skip our detailed analysis of generative AI and its application in the field of investing, you can go directly to see the 5 Stocks ChatGPT Said Will Make Me Rich in 10 Years. [\u2026]""}, {""date"": ""2023-08-20"", ""headline"": ""Warren Buffett\u2019s 11 Growth Stock Picks"", ""summary"": ""In this piece, we will take a look at Warren Buffett\u2019s growth stock picks. If you want to skip our introduction to the investor and growth investing, then head on to Warren Buffett\u2019s 5 Growth Stock Picks. Warren Buffett is one of the most successful investors of our time. His investment strategy depends on identifying [\u2026]""}, {""date"": ""2023-08-20"", ""headline"": ""Dow falls more than 200 points to start the week as rates march higher: Live updates"", ""summary"": ""Traders weighed a rise in yields to multiyear highs on Monday, fueling losses for the Dow.""}, {""date"": ""2023-08-20"", ""headline"": ""Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Johnson...""}, {""date"": ""2023-08-20"", ""headline"": ""3 Stocks I Will \""Never\"" Sell"", ""summary"": ""For me, there are at least three stocks in my portfolio I don't anticipate getting rid of anytime soon: Johnson & Johnson (NYSE: JNJ), Meta Platforms (NASDAQ: META), and Amazon (NASDAQ: AMZN).  Johnson & Johnson needs no introduction -- it has been a leading healthcare company for a long time.  Second, we can point to Johnson & Johnson's solid fundamentals.""}, {""date"": ""2023-08-20"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 20"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the August 20 weekly update.""}, {""date"": ""2023-08-21"", ""headline"": ""Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Where Johnson & Johnson Stands With Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Regeneron, J&J receive millions to develop new COVID therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Regeneron awarded $326M from U.S. for next-generation COVID antibody"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""20 Cities With The Most Hispanics"", ""summary"": ""In this article, we look at 20 cities with the most Hispanics in the United States. You can skip our detailed analysis on the economic contributions of the Hispanic or Latino community and head over directly to the 5 Cities with the Most Hispanics. Hispanics are Americans who trace their roots to Spain, Mexico, Latin [\u2026]""}, {""date"": ""2023-08-21"", ""headline"": ""Kenvue Will Join the S&P 500 Friday. It Could Boost the Stock."", ""summary"": ""The action could lift shares of Kenvue, but Johnson & Johnson stock could come under pressure due to index selling.""}, {""date"": ""2023-08-21"", ""headline"": ""Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600"", ""summary"": ""Kenvue Inc. (NYSE: KVUE) will replace Advance Auto Parts Inc. (NYSE: AAP) in the S&P 500, and Advance Auto Parts will replace Emergent BioSolutions Inc. (NYSE: EBS) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, August 25. As previously announced on August 9, the addition of Kenvue is the result of S&P 500 and S&P 100 constituent Johnson & Johnson (NYSE: JNJ) offering to exchange the shares of Kenvue held for shares of Johnson & Johnson in a split-off exchange offer""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna, Pfizer stocks rise amid new Covid variants"", ""summary"": ""Covid vaccine maker stocks including Moderna (MRNA), Pfizer (PFE), and BioNTech (BNTX), rose as concerns grow about new Covid variants.""}, {""date"": ""2023-08-21"", ""headline"": ""Legend Biotech: Working On Supply Issues"", ""summary"": ""Carvykti's successful manufacturing ramp-up and clinical de-risking in earlier lines of multiple myeloma put Legend Biotech in a strong position. Learn more on LEGN stock here.""}, {""date"": ""2023-08-21"", ""headline"": ""J&J spinoff Kenvue to replace Advance Auto Parts on the S&P 500"", ""summary"": ""Kenvue Inc. the maker of Tylenol and Benadryl, will replace auto-parts retailer Advance Auto Parts Inc. on the S&P 500 Index S&P Dow Jones Indices said on...""}, {""date"": ""2023-08-21"", ""headline"": ""Merck's (MRK) Welireg Meets Renal Cell Carcinoma Study Goals"", ""summary"": ""Based on interim data from a late-stage study, Merck's (MRK) Welireg achieves statistically significant improvements in one of the study's dual endpoints of progression-free survival.""}, {""date"": ""2023-08-21"", ""headline"": ""Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS"", ""summary"": ""UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.""}, {""date"": ""2023-08-21"", ""headline"": ""Is Johnson & Johnson's Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""A deep dive into the intrinsic value, financial strength, profitability, and growth of Johnson & Johnson (JNJ)""}, {""date"": ""2023-08-21"", ""headline"": ""Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?"", ""summary"": ""Want to start the week ahead of the pack? Check out Momentum Mondays!""}, {""date"": ""2023-08-21"", ""headline"": ""11 Most Profitable Biotech Stocks Today"", ""summary"": ""In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on over to 5 Most Profitable Biotech Stocks Today. Biotechnology [\u2026]""}, {""date"": ""2023-08-21"", ""headline"": ""Tupperware, Kenvue, Earthstone Energy: Market Movers"", ""summary"": ""Tupperware Brands (TUP), a new addition to the meme stock roster, sees its shares surge after Federated Hermes (FHI) raises its stick in the company. Kenvue (KVUE) stock trends higher over demand on parent company Johnson & Johnson's (JNJ) stock swap it offered shareholders. Permian Resources (PR) is set to buy Earthstone Energy (ESTE) in a $4.5 billion deal scheduled to close by the end of 2023. Yahoo Finance Live host Julie Hyman highlights several of the top trending stocks following this morning's opening bell.""}, {""date"": ""2023-08-21"", ""headline"": ""J&J\u2019s Kenvue Exchange Offer Was Too Popular. What Happens to Shares Now."", ""summary"": ""Johnson & Johnson investors who elected to participate in the swap will see just 23.8% of their shares converted into Kenvue stock""}, {""date"": ""2023-08-21"", ""headline"": ""5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace"", ""summary"": ""Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), Novo Nordisk (NVO), Novartis (NVS) and AstraZeneca (AZN) are worth retaining in your portfolio.""}, {""date"": ""2023-08-21"", ""headline"": ""KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Wall Street Lunch: Big Kenvue Demand"", ""summary"": ""J&J share swap offer for Kenvue is oversubscribed. Nvidia leads chip stocks up again as its earnings approach. See what J.P. Morgan\u00e2\u0080\u0099s AI sentiment model says. Listen now.""}, {""date"": ""2023-08-21"", ""headline"": ""Johnson & Johnson, Nike share losses lead Dow's 100-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Most Active Equity Options For Midday - Monday, Aug. 21"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""J&J says it will retain 9.5% stake in Kenvue carve-out after exchange offer"", ""summary"": ""Investing.com -- Shares in Johnson&Johnson (NYSE:JNJ) slipped on Monday after the American healthcare giant said it will retain about a 9.5% stake in its consumer health carve-out Kenvue (NYSE:KVUE) following a share exchange offer.""}, {""date"": ""2023-08-21"", ""headline"": ""Video: Dow Movers: JNJ, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Dow Reverses Gains, Looks To Extend Slump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Fed\u2019s Powell Will Walk an Economic Tightrope. Why Markets May Not Like It."", ""summary"": ""Retailers\u2019 earnings will show how eagerly consumers are spending, J&J spinoff Kenvue faces lawsuits over Tylenol ingredient, and other news to start your day.""}, {""date"": ""2023-08-21"", ""headline"": ""J&J to hold 9.5% stake in Kenvue after share exchange offer"", ""summary"": ""Shares of the consumer health company rose 1.4% in premarket trading.  \u200dJ&J launched the exchange offer last month under which its stockholders could opt for shares of the former consumer health unit related to the spinoff.""}, {""date"": ""2023-08-21"", ""headline"": ""Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer"", ""summary"": ""NEW BRUNSWICK, N.J., August 21, 2023--Johnson & Johnson (NYSE: JNJ) today announced that, based on preliminary results, its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") common stock owned by Johnson & Johnson was oversubscribed. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023. Under the terms of the exchange offer, 8.0324 shares""}, {""date"": ""2023-08-21"", ""headline"": ""Johnson & Johnson, Intel share losses contribute to Dow's nearly 200-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""European Commission Approves Reduced Dosing Frequency for Janssen's Bispecific Antibody TECVAYLI"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted the approval of a Type II variation application for TECVAYLI , providing...""}, {""date"": ""2023-08-21"", ""headline"": ""J&J says Kenvue tender offer was oversubscribed, expects 23.8% of tendered shares will be exchanged"", ""summary"": ""Johnson & Johnson said Monday that 802.7 million shares of its common stock were validly tendered and not validly withdrawn in a Kenvue Inc. tender offer...""}, {""date"": ""2023-08-21"", ""headline"": ""J&J to accept 191.0 million shares as part of Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Dow's 86-point fall led by losses for shares of Johnson & Johnson, Intel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""4 stocks to watch on Monday: Kenvue, VMware and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Notable open interest changes for August 21st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Titan Medical Signs Licensing Agreement with Auris Health"", ""summary"": ""By Robb M. Stewart Canadian medical technology company Titan Medical entered a licensing agreement with Johnson &amp; Johnson's Auris Health business...""}, {""date"": ""2023-08-21"", ""headline"": ""Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""\u2018The sharks are still there.\u2019 Stock market\u2019s decline is just beginning, this top fund manager says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Titan Medical enters license agreement with Auris Health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q2 2023 Update"", ""summary"": ""Bridgewater Associates' 13F portfolio value decreased by approximately 1% in Q2 2023. Click here to read the full Q2 2023 update.""}, {""date"": ""2023-08-21"", ""headline"": ""Johnson & Johnson, Kenvue share exchange offer oversubscribed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Johnson & Johnson reports preliminary results of Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Kenvue to join S&P 500, replacing Advance Auto Parts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""J&J\u2019s Janssen said to be closing much of Dutch vaccine division"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""12 Best Cheap Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best cheap dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Cheap Dividend Stocks To Buy Now. Investing in cheap stocks is like finding a great deal at a store \u2013 it\u2019s about picking [\u2026]""}, {""date"": ""2023-08-22"", ""headline"": ""J&J\u2019s Exchange Offer for Kenvue Is Tricky From a Tax Standpoint. What to Do."", ""summary"": ""J&J holders who participated in the exchange offer can choose which J shares they want to use for their cost basis in Kenvue.""}, {""date"": ""2023-08-22"", ""headline"": ""Health care stocks: What the market technicals show"", ""summary"": ""Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.\u00a0 Woods says he focuses on those four health care stocks, \""because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.\""\u00a0 The Health Care Select Sector (XLV) \""continues to make higher lows, as it goes along,\"" Woods notes. \""If you're a little skittish on the overall market, health care is a safety sector,\"" Woods says.""}, {""date"": ""2023-08-22"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 0.79% to $166.02 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-22"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-22"", ""headline"": ""J&J (JNJ) to Keep 9.5% Stake in Kenvue Post Share Exchange"", ""summary"": ""J&J's (JNJ) offer to exchange its shares for the shares of Kenvue, its recently-separated consumer healthcare business, gets oversubscribed. The exchange ratio is 8.0324 for every share of J&J.""}, {""date"": ""2023-08-22"", ""headline"": ""5 Blue-Chip Stocks for a Stable Portfolio Amid Volatility"", ""summary"": ""We have narrowed our search to five blue-chip such stocks with strong growth potential for the rest of 2023. These are: WMT, JPM, JNJ, CAT, MCD.""}, {""date"": ""2023-08-22"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca"", ""summary"": ""Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca are part of the Zacks Industry Outlook article""}, {""date"": ""2023-08-22"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Microsoft submitted a new proposal to U.K. regulators for its stalled acquisition of Activision Blizzard, and Zoom shares rose after the video conferencing provider beat earnings projections on strength in its enterprise business. Here\u2019s what investors need to know today.""}, {""date"": ""2023-08-22"", ""headline"": ""Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference"", ""summary"": ""Johnson & Johnson will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th. Joaquin Duato, Chairman of...""}, {""date"": ""2023-08-22"", ""headline"": ""Johnson & Johnson announces European approval of Talvey in myeloma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""NeurAxis Is Changing The Pediatric IBS And FAP Treatment Landscape To Drug-Free ($NRXS)"", ""summary"": ""NeurAxis is doing something other companies can't or won't do: provide a drug-free way to treat debilitating pediatric conditions, including Irritable Bowel Syndrome and Functional Abdominal Pain ....""}, {""date"": ""2023-08-22"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value increased by 10% this quarter, reaching $21.60B. Check out GMO Capital's holdings and trades for Q2 2023.""}, {""date"": ""2023-08-23"", ""headline"": ""Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition"", ""summary"": ""Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.""}, {""date"": ""2023-08-23"", ""headline"": ""Bridgewater's Approach: Stocks for an Upcoming Recession"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson sank 0.90% to $164.53 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-08-23"", ""headline"": ""UPDATE 2-J&J's Janssen to close part of its vaccine division -Telegraaf"", ""summary"": ""Johnson & Johnson's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported.  In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results.  \""We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs,\"" Johnson & Johnson said, adding that its facility in Leiden, Netherlands was an \""important site\"".""}, {""date"": ""2023-08-23"", ""headline"": ""J&J's Janssen to close part of its vaccine division -Telegraaf"", ""summary"": ""AMSTERDAM (Reuters) -Johnson & Johnson's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported.  In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results.  \""We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs,\"" Johnson & Johnson said, adding that its facility in Leiden, Netherlands was an \""important site\"".""}, {""date"": ""2023-08-23"", ""headline"": ""J&J's Janssen to close part of its vaccine division"", ""summary"": ""Johnson & Johnson's Dutch business Janssen, which helped to develop the single-dose COVID-19 vaccine, will close almost its entire vaccine division, the company said on Wednesday, confirming Dutch media reports.  Johnson & Johnson confirmed in an emailed response that it is exiting some of its vaccine research and development, which it said it had disclosed in its 2023 second-quarter results.  Dutch daily De Telegraaf reported that 2,500 people worked at Janssen, a quarter of which were in the section specialising in infectious diseases and vaccines.""}, {""date"": ""2023-08-23"", ""headline"": ""J&J Makes It Official: Kenvue Stock Swap Was a Huge Hit With Shareholders"", ""summary"": ""Johnson & Johnson investors were able to exchange less than a quarter of their shares for the consumer split off. The company will update financial guidance next week""}, {""date"": ""2023-08-23"", ""headline"": ""European Commission Approves TALVEY, Janssen's Novel Bispecific Therapy for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted conditional marketing authorisation of TALVEY as monotherapy for the...""}, {""date"": ""2023-08-23"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc."", ""summary"": ""NEW BRUNSWICK, N.J., August 23, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (\""Kenvue\"") common stock owned by Johnson & Johnson. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023.""}, {""date"": ""2023-08-23"", ""headline"": ""J&J-backed startup raises $150M in VC for neuroscience drugs"", ""summary"": ""Less than six months after it made its public debut, a new startup working on precision medicines for brain disorders has bagged another $150 million.""}, {""date"": ""2023-08-23"", ""headline"": ""Megacap stocks setting up for potential breakout - Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""J&J Accepts 191M Shares in Exchange for 1.53B Kenvue Shares, Finalizing Separation"", ""summary"": ""By Adriano Marchese Johnson &amp; Johnson will exchange 191 million of its stock in exchange for 1.53 billion shares of Kenvue, the operator of brands such...""}, {""date"": ""2023-08-23"", ""headline"": ""Kenvue becomes \u2018fully independent\u2019 after final separation from J&J"", ""summary"": ""Kenvue Inc. kicks off life as a fully independent public company Wednesday after completing its separation from Johnson & Johnson the company said in a...""}, {""date"": ""2023-08-23"", ""headline"": ""Johnson & Johnson completes Kenvue separation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Kenvue becomes fully independent company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Johnson & Johnson reports final results from Kenvue exchange offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Kenvue to replace Advance Auto Parts in S&P 500 at open on 8/25"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""AARP to join US government in two more lawsuits over Medicare drug pricing negotiations"", ""summary"": ""AARP is gearing up for legal battles brought by pharma companies against Medicare drug pricing negotiations that impact its members.""}, {""date"": ""2023-08-24"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.34% higher to $165.09 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-08-24"", ""headline"": ""CVS Health launches new brand Cordavis to target $100 billion biosimilar market"", ""summary"": ""CVS is launching a new business segment that will negotiate with drugmakers to produce private label products for it to sell, the healthcare giant said Wednesday.""}, {""date"": ""2023-08-24"", ""headline"": ""5 Defensive Stocks to Buy Amid Lingering Market Volatility"", ""summary"": ""Volatility has gripped Wall Street again. So, investing in defensive stocks like McKesson Corporation (MCK), Entergy Corporation (ETR), PepsiCo, Inc. (PEP), Johnson & Johnson (JNJ) and Atmos Energy Corporation (ATO) is a safe bet.""}, {""date"": ""2023-08-24"", ""headline"": ""Johnson & Johnson: Kenvue Separation Won't Impact Dividends"", ""summary"": ""Johnson & Johnson recently completed the Kenvue spinoff. Read why I see a stable profitability and growth path ahead for JNJ.""}, {""date"": ""2023-08-24"", ""headline"": ""Kenvue is called cheap by Goldman Sachs on a valuation basis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Galapagos cut to Neutral at Citi on lack of catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Goldman Sachs, Johnson & Johnson share gains contribute to Dow's nearly 125-point jump"", ""summary"": ""The Dow Jones Industrial Average is trading up Thursday morning with shares of Goldman Sachs and Johnson & Johnson delivering strong returns for the index....""}, {""date"": ""2023-08-24"", ""headline"": ""Johnson & Johnson goes ex-dividend tomorrow"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc"", ""summary"": ""Johnson & Johnson today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. ...""}, {""date"": ""2023-08-24"", ""headline"": ""Drugs picked for Medicare price negotiations to be announced on Tuesday \u2013 Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Thanks For The Bounce, Nvidia!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Crohn's disease drugmakers set to benefit from expected rise in cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Johnson & Johnson : Acquisition/Asset Disposal - Form 8-K"", ""summary"": ""jnj-20230823 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ...""}, {""date"": ""2023-08-25"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.43% to $166.25 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-25"", ""headline"": ""Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why"", ""summary"": ""Novo Nordisk's (NVO) commercial and pipeline progress with its popular obesity drug, Wegovy, continues to drive the share price momentum.""}, {""date"": ""2023-08-25"", ""headline"": ""Emergent BioSolutions (EBS) Down 12% in a Week: Here's Why"", ""summary"": ""Shares of Emergent (EBS) are on a downward trajectory since the ticker was dropped from the S&P SmallCap 600 index.""}, {""date"": ""2023-08-25"", ""headline"": ""J&J\u2019s Kenvue Exchange Offer Was a Big Win for the Little Guy"", ""summary"": ""Small investors earned a nice payday of more than $1,000 if they tendered 99 shares of stock in the swap, which expired last week.""}, {""date"": ""2023-08-25"", ""headline"": ""AstraZeneca files lawsuit against U.S. over drug pricing"", ""summary"": ""AstraZeneca (AZN) joins Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers (BMY) in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President Biden's Inflation Reduction Act (IRA). Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to break down the lawsuit and what to expect moving forward.""}, {""date"": ""2023-08-25"", ""headline"": ""Johnson & Johnson, Salesforce share gains lead Dow's nearly 250-point jump"", ""summary"": ""Shares of Johnson & Johnson and Salesforce are seeing strong returns Friday afternoon, sending the Dow Jones Industrial Average into positive territory. The...""}, {""date"": ""2023-08-25"", ""headline"": ""Pharma Giants Unite Against Drug Price Negotiation: AstraZeneca Latest To Challenge The Government"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Pro Take: Corporate Venture Capital Provides Path for Long-Term Tech Strategy"", ""summary"": ""Companies that make venture-capital investments can get an inside view of where markets and technology are headed.""}, {""date"": ""2023-08-25"", ""headline"": ""AstraZeneca latest drugmaker to challenge Medicare drug price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Johnson & Johnson's Janssen submits supplemental biologics application"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Alkermes: A Complicated Story Right Now"", ""summary"": ""Alkermes is a drugmaker focused on neuroscience & oncology with a market cap of $4.9B. Read why I'm withholding any investment recommendation around ALKS stock.""}, {""date"": ""2023-08-25"", ""headline"": ""The Buffett List: 6 Dividend Buys In August"", ""summary"": ""Analyst-augured top-ten net gains from Buffett\u00e2\u0080\u0099s August dividend dogs ranged 19.12%-56.48% from CVX, COF, DHI, LPX, KHC, BAC, PARA, ALLY, C, and top pick GM per YCharts data. Read more here.""}, {""date"": ""2023-08-25"", ""headline"": ""J&J submits sBLA for Rybrevant for first-line non-small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""Janssen submits sBLA for expanded Rybrevant approval to FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage."", ""summary"": ""Hawaiian Electric suspends dividend as troubles build, fast-fashion rivals Shein and Forever 21 team up, and other news to start your day.""}, {""date"": ""2023-08-26"", ""headline"": ""7 Very Oversold Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-26"", ""headline"": ""Ken Fisher\u2019s Top 15 Healthcare Stock Picks"", ""summary"": ""In this article, we discuss the top 15 healthcare stock picks of Ken Fisher. If you want to skip our detailed discussion about the healthcare industry, head directly to Ken Fisher\u2019s Top 5 Healthcare Stock Picks. The healthcare sector was forever changed by the COVID-19 pandemic. While it highlighted the weaknesses in the global medical [\u2026]""}, {""date"": ""2023-08-27"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}, {""date"": ""2023-08-27"", ""headline"": ""3 Stocks to Buy That Can Beat a Bear Market"", ""summary"": ""Look for companies that can generate revenue -- and turn it into a profit -- regardless of the economic environment.""}, {""date"": ""2023-08-27"", ""headline"": ""Is It Too Late to Buy Eli Lilly Stock?"", ""summary"": ""Stock for the drugmaker Eli Lilly (NYSE: LLY) is up more than 49% in 2023, making it one of the hottest mega-cap stocks of the year.  Let's delve into Eli Lilly's fundamentals and valuation to see if an answer can be found.  As you'd expect for a stock that has rallied, Eli Lilly's underlying fundamentals are very strong: Through the first half of 2023, the company has had seven products on pace to each generate at least $1 billion in revenue in 2023.""}, {""date"": ""2023-08-27"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
33,2023-08-27,164.92922973632812,2023-09-03,159.20506286621094,-0.03470680654525826,D4,"[{""date"": ""2023-08-26"", ""headline"": ""7 Very Oversold Warren Buffett Stocks to Buy Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-27"", ""headline"": ""13 Best Defensive Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 13 best defensive stocks to buy now. To see more such companies, go directly to 5 Best Defensive Stocks To Buy Now. The US stock markets are jumpy amid analyst firms downgrading banks and some analysts suggesting the economy is still not out the recession [\u2026]""}, {""date"": ""2023-08-27"", ""headline"": ""3 Stocks to Buy That Can Beat a Bear Market"", ""summary"": ""Look for companies that can generate revenue -- and turn it into a profit -- regardless of the economic environment.""}, {""date"": ""2023-08-27"", ""headline"": ""Is It Too Late to Buy Eli Lilly Stock?"", ""summary"": ""Stock for the drugmaker Eli Lilly (NYSE: LLY) is up more than 49% in 2023, making it one of the hottest mega-cap stocks of the year.  Let's delve into Eli Lilly's fundamentals and valuation to see if an answer can be found.  As you'd expect for a stock that has rallied, Eli Lilly's underlying fundamentals are very strong: Through the first half of 2023, the company has had seven products on pace to each generate at least $1 billion in revenue in 2023.""}, {""date"": ""2023-08-27"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Republicans say Medicare drug negotiations will mean fewer new meds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Drug Companies Mixed as Medicare Plans to Negotiate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""See which drugs President Biden is targeting first for Medicare price-lowering talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $69,225.00K"", ""summary"": """"}, {""date"": ""2023-08-28"", ""headline"": ""ADVENT Offers Up An Early Present For Boston Scientific Investors"", ""summary"": ""Boston Scientific surprised the Street with better-than-expected ADVENT study results. Click here to read more.""}, {""date"": ""2023-08-28"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.18% to $164.29 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-28"", ""headline"": ""J&J (JNJ) Seeks Full FDA Nod for Rybrevant in Lung Cancer"", ""summary"": ""J&J's (JNJ) FDA filing is based on a late-stage study showing that treatment with Rybrevant plus chemotherapy improved progression-free survival in certain NSCLC patients.""}, {""date"": ""2023-08-28"", ""headline"": ""Johnson & Johnson (JNJ): A Modestly Undervalued Gem in the Healthcare Sector?"", ""summary"": ""A Comprehensive Analysis of its Market Value""}, {""date"": ""2023-08-28"", ""headline"": ""16 Best Dividend Paying Stocks To Buy Now"", ""summary"": ""In this article, we discuss 16 best dividend paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. The investment landscape is continuously evolving this year. It started with the rise of tech stocks. Seven [\u2026]""}, {""date"": ""2023-08-28"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Viridian Chart Of The Week: How Capital Intensive Is Cannabis?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking Approval of RYBREVANT in Combination with Chemotherapy for the First-line Treatment of Patients with Locally Advanced or Metast"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration seeking...""}, {""date"": ""2023-08-28"", ""headline"": ""Video: Dow Movers: JNJ, MMM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""The 7 Most Promising Blue-Chip Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""3 Widely Owned Dow Stocks Prominent Billionaires Are Selling"", ""summary"": ""Some of Wall Street's most-successful billionaire money managers are paring down or parting ways with a trio of top-tier companies.""}, {""date"": ""2023-08-28"", ""headline"": ""A Step Closer To Cheaper Drugs For Americans: Price Negotiation And Its Implications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""7 Reliable Retirement Stocks to Secure a Golden Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For"", ""summary"": ""Drugmakers like Eli Lilly and Pfizer could see profits fall if their blockbuster medicines are on the list.""}, {""date"": ""2023-08-28"", ""headline"": ""Medicenna Therapeutics appoints Jeff Caravella as CFO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new sample Breakout Stocks for Week 35 curated by the MDA model for a 10% short-term upside along with a Dow pick. Click here for a detailed analysis.""}, {""date"": ""2023-08-28"", ""headline"": ""Hedge and mutual funds rotate from tech; see the stocks they love and shun"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Johnson & Johnson seeks full approval of Balversa for bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""The Most-Sold Guru Stocks of the 2nd Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Expensive Drugs Targeted for First U.S. Price Negotiations"", ""summary"": ""Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.""}, {""date"": ""2023-08-29"", ""headline"": ""What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?"", ""summary"": ""Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.""}, {""date"": ""2023-08-29"", ""headline"": ""Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List"", ""summary"": ""The Inflation Reduction Act gives Medicare the ability to directly negotiate the prices of certain drugs for the first time.""}, {""date"": ""2023-08-29"", ""headline"": ""J&J (JNJ) Seeks Full FDA Nod for Balversa in Urothelial Cancer"", ""summary"": ""J&J (JNJ) submits a supplemental new drug application to the FDA for full approval of Balversa to treat urothelial carcinoma.""}, {""date"": ""2023-08-29"", ""headline"": ""Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now"", ""summary"": ""Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.""}, {""date"": ""2023-08-29"", ""headline"": ""Biden admin unveils ten drugs picked for Medicare price negotiations"", ""summary"": ""The Biden administration has released the list of the first ten drugs that will be subject to Medicare price negotiations. The Center for Medicare Director Dr. Meena Seshamani tells Yahoo Finance Live that they are looking at \""the benefits that a drug brings to populations. Does it address an unmet need? Does it address different populations that have needs?\"" When it comes to why some drugs were chosen Dr. Seshamani says the organization followed the criteria written in the Inflation Reduction Act, adding that the list will not change. These are the ten drugs Medicare will be negotiating the prices of:Eliquis- Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance- Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia- Merck (MRK) Farxiga- AstraZeneca (AZN) Entresto- Novartis (NVS) Enbrel- Amgen (AMGN) Imbruvica- Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara- Johnson & Johnson (JNJ) Fiasp, NovoLog- Novo Nordisk (NVO)""}, {""date"": ""2023-08-29"", ""headline"": ""Medicare Drugs Targeted Under Inflation Reduction Act"", ""summary"": ""Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.""}, {""date"": ""2023-08-29"", ""headline"": ""Best Buy results, Medicare negotiations list, Hurricane Idalia: Top stories"", ""summary"": ""Best Buy (BBY) lowers its full-year sales outlook despite topping earnings estimates. The Biden administration has shared its list of ten prescription drugs that will be subject to pricing negotiations between manufacturers and Medicare. Tropical Storm Idalia has officially been upgraded to a hurricane. It's expected to make landfall on Florida's west coast on Wednesday.Yahoo Finance Live's Brad Smith highlights three of this morning's biggest stories.""}, {""date"": ""2023-08-29"", ""headline"": ""The 10 Drugs Medicare Can Negotiate Were Just Announced. These Pharma Stocks Are Impacted."", ""summary"": ""The Inflation Reduction Act gives Medicare the ability to directly negotiate the prices of certain drugs for the first time.""}, {""date"": ""2023-08-29"", ""headline"": ""Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-08-29"", ""headline"": ""JPMorgan says time to buy MedTech based on past"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""US President Biden fires new salvo in war on prescription drug costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations"", ""summary"": ""The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.""}, {""date"": ""2023-08-29"", ""headline"": ""UPDATE 5-US names first 10 drugs for Medicare price negotiation"", ""summary"": ""The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.  President Joe Biden\u2019s signature Inflation Reduction Act (IRA), signed into law last year, allows the Medicare health program for Americans aged 65 and over to negotiate prices for some of its most costly drugs.  \""There is no reason why Americans should be forced to pay more than any developed nation for life-saving prescriptions just to pad Big Pharma\u2019s pockets,\"" Biden said in a statement.""}, {""date"": ""2023-08-29"", ""headline"": ""White House names first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Biden administration announces first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""SPLG: The Market\u2019s Lowest-Cost S&P 500 ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...""}, {""date"": ""2023-08-29"", ""headline"": ""Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Biden unveils first 10 drugs subject to Medicare price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Medicare lists first ten drugs selected for pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Drug-Free Way To Treat Pediatric IBS And FAP Earns NeurAxis A $14 Price Target ($NRXS)"", ""summary"": ""NeurAxis is a low-float, under-the-radar biotech worthy of investors' attention. It has, after all, earned analysts, including the lead at Goldman Smallcap Research, who published a decidedly...""}, {""date"": ""2023-08-29"", ""headline"": ""How To Earn $500 A Month From Johnson & Johnson Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $82,260.00K"", ""summary"": """"}, {""date"": ""2023-08-30"", ""headline"": ""Set and Forget: 3 Dividend Stocks Perfect for Your IRA"", ""summary"": ""Dividend stocks provide essential passive income for many investors. For those heading into retirement, this is especially true. Companies that pay dividends are generally more stable, with consistent and predictable cash flow growth allowing such companies to return capital to shareholders. For the long-term investor, such companies are often better bets from a risk perspective. Those entering or nearing retirement may want to know that their capital is safe. Thus, for those with capital preser""}, {""date"": ""2023-08-30"", ""headline"": ""Medicare's drug pricing list didn't impact company stocks \u2014 here's why"", ""summary"": ""Company stocks were unaffected by the Biden Administration's historic announcement Tuesday of Medicare's first list of drugs for negotiating prices.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson Forecasts Double-Digit Earnings Growth After Kenvue Spin-Off"", ""summary"": ""Johnson & Johnson on Wednesday released its first earnings forecast as a standalone pharmaceutical and medical devices company, estimating double-digit growth in earnings this year.""}, {""date"": ""2023-08-30"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks rise again as hopes for rate pause build"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Merck's (MRK) Keytruda Receives EU Nod in Gastric Cancer"", ""summary"": ""Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-line treatment for HER2-positive advanced gastric cancer in adults whose tumors express PD-L1.""}, {""date"": ""2023-08-30"", ""headline"": ""Medicare price negotiation list: What it means for pharma companies"", ""summary"": ""On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.\u00a0\u00a0 The ten drugs and pharma companies impacted are:\u00a0 Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)""}, {""date"": ""2023-08-30"", ""headline"": ""J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries"", ""summary"": ""The United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194 for a six-month course of the treatment represented a 55% and 33% price reduction, respectively.  Bedaquiline is one of the three new drugs developed against tuberculosis (TB) in more than half a century, and it is a key part of recommended treatment regimens for drug-resistant TB infections.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson Revises Guidance After Kenvue Spinout. There\u2019s Good News on the Dividend."", ""summary"": ""Johnson & Johnson maintained its quarterly dividend of $1.19 a share after spinning out consumer-health company Kenvue.""}, {""date"": ""2023-08-30"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q2 2023 Update"", ""summary"": ""Tweedy, Browne's 13F portfolio value increased by 4% to $1.91B, with 46 holdings. Click here to read more.""}, {""date"": ""2023-08-30"", ""headline"": ""HP, Peloton, Rite Aid fall premarket; Nvidia gains"", ""summary"": ""Investing.com -- U.S. futures traded with small losses Wednesday, handing back some of the recent gains ahead of the release of more important labor market economic data.""}, {""date"": ""2023-08-30"", ""headline"": ""1 Top Dividend Stock to Buy Hand Over Fist Right Now"", ""summary"": ""If you're looking for a reliable dividend stock that can deliver consistent income and growth, you should consider Kenvue (NYSE: KVUE), the consumer healthcare spin-off from Johnson & Johnson (NYSE: JNJ).  Kenvue is one of the leading players in the consumer healthcare industry, with a portfolio of well-known brands such as Aveeno, Tylenol, Listerine, Neutrogena, and Band-Aid.  Kenvue has a long history of innovation, quality, and customer loyalty, as well as a solid financial performance and dividend policy.""}, {""date"": ""2023-08-30"", ""headline"": ""Pharma Giant Johnson & Johnson, Lupin Offer Significant Price Cuts On Tuberculosis Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""TOP NEWS: J&J forecasts strong growth in earnings after Kenvue split"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Genmab Is Down To Attractive Levels"", ""summary"": ""Genmab's stock is down 15% since late 2022 highs. Dependence on Darzalex will decrease considerably in the following years. Find out why GMAB stock is a Buy.""}, {""date"": ""2023-08-30"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""UPDATE 2-J&J expects double-digit 2023 profit growth after Kenvue spinoff"", ""summary"": ""Johnson & Johnson on Wednesday forecast double-digit  profit growth for 2023 after spinning off consumer health company Kenvue, unveiling the first outlook for its standalone drugs and medical device businesses.  J&J finalized the biggest shake-up in its 137-year history earlier this month through an exchange of its shares with Kenvue's, leaving the pharmaceutical giant with a reduced 9.5% stake in its former unit.  Kenvue debuted on the New York Stock Exchange in May and has a market capitalization of nearly $79 billion, with J&J generating $13.2 billion in cash proceeds as a result of its debt offering and initial public offering.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson Reveals Updated 2023 Projections After Finalizing Biggest Shake Up In 135 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation"", ""summary"": ""NEW BRUNSWICK, N.J., August 30, 2023--Johnson & Johnson (NYSE: JNJ) (\""the Company\"") today announced updates to its financials and 2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech. The Company has published a recorded webinar for investors to provide additional context behind the updated financials and 2023 guidance found in this release, which may be accessed by visiting the Investors section of the Company's website at""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson : Guidance Call Transcript - Updated"", ""summary"": ""Johnson & Johnson Updated Financials and 2023 Guidance Published August 30, 2023 Slide 1: Johnson & Johnson Updated Financials & 2023...""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson : Guidance Press Release with attachments"", ""summary"": ""FOR IMMEDIATE RELEASE Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation ...""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson : Final - JNJ Guidance Webcast"", ""summary"": ""Johnson & Johnson Updated Financials & 2023 Guidance August 30, 2023 Cautionary Note on Forward-looking Statements ...""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson : Janssen Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of BALVERSA\u00ae (erdafitinib) for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations"", ""summary"": ""News Release Media Contacts: Suzanne Frost Phone: +1 416-317-0304 Ania DiAntonio ...""}, {""date"": ""2023-08-30"", ""headline"": ""4 stocks to watch on Wednesday: Salesforce, Texas Instruments and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Johnson & Johnson (JNJ), PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), BioMarin Pharmaceutical (BMRN) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Hold from Bank of America Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Kenvue Fits Right In With Other Dividend Aristocrats"", ""summary"": ""Kenvue (ticker: KVUE) is the new addition, which is a strange thing to say about a 135-plus-year-old consumer health company that sells iconic brands such as Tylenol, Band-Aid, Listerine, and Neutrogena.  The stock was just spun out by Johnson & Johnson (JNJ) to shareholders in an exchange offer.  The stock is now in the aristocrats index and exchange-traded funds that track the index, such as the  ETF (NOBL) and the  ETF (KNG).""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""J&J revises 2023 sales, profit outlook lower after Kenvue separation, will maintain dividend"", ""summary"": ""Johnson & Johnson updated on Wednesday its 2023 financial guidance in the wake of the Kenvue Inc. separation that was completed last week. The drug maker now...""}, {""date"": ""2023-08-30"", ""headline"": ""Crypto Scores Big Win Over the SEC. Why the Battle\u2019s Far From Over."", ""summary"": ""HP\u2019s results show effects of weaker demand and soft pricing, the 10 drugs on Medicare\u2019s price negotiating list, and other news to start your day.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson updates financials and outlook after Kenvue separation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson maintains its quarterly dividend of $1.19 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson sees FY23 adjusted operational sales growth 6.2%-7.2%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Johnson & Johnson revises FY23 adjusted EPS view to $10.00-$10.10"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""10 Best September Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best September dividend stocks to buy. You can skip our detailed analysis of dividend stocks and dividend capture strategy, and go directly to read 5 Best September Dividend Stocks To Buy. Dividend investing is a popular way to increase your earnings and generate income through investments. While it might [\u2026]""}, {""date"": ""2023-08-31"", ""headline"": ""Pete Davidson Reveals He's Tried Ketamine To Cope With Depression"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""Wells Fargo Maintains Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-31"", ""headline"": ""3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth"", ""summary"": ""Most investors agree that finding a brilliant blue-chip stock can do wonders for a portfolio. Knowing that stock in a large, well-capitalized, reputable company gives investors some sense of calm. Blue-chip companies have been in business for significant years, have reliable earnings, plenty of free cash flow, and tend to pay dividends to stockholders. Prime examples of blue-chip stocks include Walmart (NYSE:WMT), McDonald\u2019s (NYSE:MCD) and Johnson & Johnson (NYSE:JNJ). These can anchor a portfol""}, {""date"": ""2023-08-31"", ""headline"": ""25 Countries With The Worst Healthcare System"", ""summary"": ""In this article, we will determine which countries have the worst healthcare systems in the world and delve into the implications of challenges in this sector. If you wish to see the list directly, head to 8 Countries With The Worst Healthcare System. Despite the surge of healthcare innovations in this era, it\u2019s disheartening to [\u2026]""}, {""date"": ""2023-08-31"", ""headline"": ""Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list"", ""summary"": ""Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.""}, {""date"": ""2023-08-31"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-31"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-31"", ""headline"": ""J&J (JNJ) Updates 2023 Guidance After Final Kenvue Separation"", ""summary"": ""With the complete separation of the Consumer Health segment, J&J (JNJ) is now a two-sector company focused on the Pharmaceutical and MedTech fields.""}, {""date"": ""2023-08-31"", ""headline"": ""Novo Nordisk: Super Focused Pharma Company For The Long Run"", ""summary"": ""Novo Nordisk is one of the most qualitative big pharma companies globally. Read why I am bullish on NVO stock with the long-term investment horizon here.""}, {""date"": ""2023-08-31"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""Johnson & Johnson Just Cut an Entire Division. Is It Still a Buy?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) plans to cut or dramatically scale down its vaccine and infectious disease division.  The move comes roughly around the same time the company finalizes the spinoff of its consumer health division, called Kenvue.  Given these changes, some investors have reason to question the behemoth's growth prospects, as J&J can no longer expect to boost its revenue with new commercialized vaccines or through new personal care products.""}, {""date"": ""2023-08-31"", ""headline"": ""2 Dividend Kings That Face Massive Legal Risks"", ""summary"": ""Investing in dividend growth stocks has proven to be a great long-term strategy for investors.  Dividend Kings have that designation because they managed to raise their payouts annually for at least 50 consecutive years.  A couple of Dividend Kings that investors may want to think twice about investing in right now are 3M (NYSE: MMM) and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""2023-08-31"", ""headline"": ""Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?"", ""summary"": ""The healthcare giant's immunology drug Stelara brought in more than $9 billion in revenue last year.""}, {""date"": ""2023-08-31"", ""headline"": ""Video: Dow Movers: JNJ, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""Timeless Wisdom of 4 Legendary Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""Johnson & Johnson price target lowered to $186 from $195 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""J&J Dividend Decision Shows Power of Free Cash Flow"", ""summary"": ""J&J plans to maintain its quarterly dividend even after separating its Kenvue business. It didn't have to do that to keep its status as a Dividend Aristocrat.""}, {""date"": ""2023-09-01"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $160.48, marking a -0.74% move from the previous day.""}, {""date"": ""2023-09-01"", ""headline"": ""Novartis sues US government over Medicare drug price regulation"", ""summary"": ""Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto.  The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people.  Other drugs selected were Bristol Myers Squibb and Pfizer\u2019s blood thinner Eliquis, Merck's diabetes drug Januvia, and Eliquis rival Xarelto from Johnson & Johnson .""}, {""date"": ""2023-09-01"", ""headline"": ""CDC: Dividend ETF With Unconventional Market Timing"", ""summary"": ""VictoryShares US EQ Income Enhanced Volatility Wtd is a defensive ETF with unconventional market timing and lower risk in drawdowns. Learn more about CDC here.""}, {""date"": ""2023-09-01"", ""headline"": ""7 Cash Cow Stocks for Recession-Resilient Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs\u00a0"", ""summary"": ""States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.""}, {""date"": ""2023-09-01"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""EU regulators warn pregnant women not to use topiramate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""GLOBAL BROKER RATINGS: UBS cuts Volkswagen and Renault to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-02"", ""headline"": ""Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?"", ""summary"": ""The healthcare behemoth has increased its dividend payment for 61 straight years.  A big driver of\u00a0Johnson & Johnson's\u00a0ability to steadily increase its payout is the durability of its diversified business model.  Johnson & Johnson has been working on the separation of its consumer health business for years.""}, {""date"": ""2023-09-02"", ""headline"": ""8 Pharma Stocks Affected by New  Drug Price Negotiation Rules"", ""summary"": ""Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?""}, {""date"": ""2023-09-02"", ""headline"": ""20 Best Companies to Work For in 2023"", ""summary"": ""In this article, we will look at the 20 best companies to work for in 2023. If you want to skip our in-depth analysis, head straight to the 5 Best Companies to Work for in 2023. As we step into 2023, the adage \u201cpeople are a company\u2019s greatest asset\u201d has never rung truer. The competitive [\u2026]""}, {""date"": ""2023-09-02"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - September 2023"", ""summary"": ""In addition to the primary list that yields just under 3%, we present two other groups of 5 DGI stocks each, with moderate to high yields. Read more here.""}, {""date"": ""2023-09-03"", ""headline"": ""4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032"", ""summary"": ""Let's consider several companies that fit this description: Johnson & Johnson (NYSE: JNJ), Visa (NYSE: V), Mastercard (NYSE: MA), and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B).  And here's one thing they have in common: They all have a vote of confidence from Warren Buffett, arguably the greatest investor of all time, who has famously said that his favorite holding period is forever.""}, {""date"": ""2023-09-03"", ""headline"": ""Is It Too Late to Buy Veeva Systems Stock?"", ""summary"": ""Veeva Systems' (NYSE: VEEV) stock price jumped 8% on Aug. 31 after the cloud software specialist posted its latest earnings report. For the second quarter of fiscal 2024, which ended on July 31, its revenue grew 10% year over year to $590 million and exceeded analysts' estimates by $8 million.""}, {""date"": ""2023-09-03"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-03"", ""headline"": ""Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}]",{}
34,2023-09-03,159.20506286621094,2023-09-10,159.28443908691406,0.0004985784953952521,U1,"[{""date"": ""2023-09-03"", ""headline"": ""4 Warren Buffett Stocks That Could Join the Trillion-Dollar Club by 2032"", ""summary"": ""Let's consider several companies that fit this description: Johnson & Johnson (NYSE: JNJ), Visa (NYSE: V), Mastercard (NYSE: MA), and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B).  And here's one thing they have in common: They all have a vote of confidence from Warren Buffett, arguably the greatest investor of all time, who has famously said that his favorite holding period is forever.""}, {""date"": ""2023-09-03"", ""headline"": ""Is It Too Late to Buy Veeva Systems Stock?"", ""summary"": ""Veeva Systems' (NYSE: VEEV) stock price jumped 8% on Aug. 31 after the cloud software specialist posted its latest earnings report. For the second quarter of fiscal 2024, which ended on July 31, its revenue grew 10% year over year to $590 million and exceeded analysts' estimates by $8 million.""}, {""date"": ""2023-09-03"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-03"", ""headline"": ""Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""2023-09-04"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-04"", ""headline"": ""Despite a slower Q2, Needham sees medtech market growing 7% in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-04"", ""headline"": ""AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-04"", ""headline"": ""J&J\u2019s $40 Billion Split-Off Sets Stage for Pharma, Medical Tech Expansion \ufeff"", ""summary"": ""The healthcare giant\u2019s separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.""}, {""date"": ""2023-09-04"", ""headline"": ""3 Dow Stocks to Sell in September Before They Crash and Burn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Johnson & Johnson initiated with a Hold at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""The 25 Best Stocks By Shareholder Wealth Creation (1926-2022)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Stock market today: Wall Street loses ground as weak stretch continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-09-05"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-09-05"", ""headline"": ""Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories"", ""summary"": ""Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? Meta Platforms Inc (NASDAQ: META) announced a significant development regarding Facebook News in the U.K., France, and Germany. The dedicated news tab on Facebook, known as Facebook News, will cease to exist in early December. The move is part of Meta's ongoing effort to prioritize features that users express interest in, like short-form videos, to maintain its competitive edge versus TikTok. Hollywood Strike Impact""}, {""date"": ""2023-09-05"", ""headline"": ""Short sellers return to profit in August as US stocks rally pauses - Ortex"", ""summary"": ""Short sellers returned to profit in August following two months of losses as U.S. stocks' rally hit a pause after a steady climb this year, data and analytics company Ortex said.  The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.  Healthcare conglomerate Johnson & Johnson was the most profitable short trade last month, with short sellers reaping about $1.3 billion, Ortex data showed.""}, {""date"": ""2023-09-05"", ""headline"": ""Sizing Up Stereotaxis"", ""summary"": ""Stereotaxis is a medical device company with potential milestones ahead. Read more to see the financial analysis and future projections of STXS stock.""}, {""date"": ""2023-09-05"", ""headline"": ""Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Novartis sues U.S. government over price regulation, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Eterna appoints Dorothy Clarke to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Raymond James Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""September Dogs Of The Dow: Walgreens Now Tops All By Yield"", ""summary"": ""There were two Dow Index stocks showing dividends exceeding single share price this month. Click here for a detailed analysis.""}, {""date"": ""2023-09-05"", ""headline"": ""Addex Therapeutics announces ADX71149 study readout expected in 2Q24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Astellas withdraws federal lawsuit over Medicare drug pricing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""J&J's Janssen ends Phase 3 MACiTEPH study evaluating macitentan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""UPDATE 1-J&J to pull the plug on hypertension drug study"", ""summary"": ""Johnson & Johnson said on Wednesday it has decided to stop a late-stage study testing its experimental drug to treat a type of hypertension.  The study was testing the drug candidate, macitentan, in patients with chronic thromboembolic pulmonary hypertension, which is caused by abnormally high pressure in small blood vessels in the lungs.  The decision followed an independent data monitoring committee recommendation after a pre-planned interim analysis, the company said.""}, {""date"": ""2023-09-06"", ""headline"": ""HSBC Initiates Coverage of Johnson & Johnson (JNJ) with Hold Recommendation"", ""summary"": """"}, {""date"": ""2023-09-06"", ""headline"": ""IBM notifies J&J unit Janssen CarePath's customers of unauthorized data access"", ""summary"": ""The personal information was part of a database used on the Janssen CarePath platform, according to IBM.  IBM, which manages the database, said it was unable to determine the extent of the unauthorized access.  Social Security numbers and financial account information were not contained in the database or affected, IBM said, without providing details about the number of affected customers and users.""}, {""date"": ""2023-09-06"", ""headline"": ""J&J to pull the plug on hypertension drug study"", ""summary"": ""Johnson & Johnson said onWednesday it has decided to stop a late-stage study testing itsexperimental drug to treat a type of hypertension. The study was testing the drug candidate,...""}, {""date"": ""2023-09-06"", ""headline"": ""J&J stops hypertension drug study"", ""summary"": ""Johnson & Johnson said onWednesday it has decided to stop a late-stage study testing itsexperimental drug to treat a type of hypertension.(Reporting by Mariam Sunny in Bengaluru; Editing by...""}, {""date"": ""2023-09-06"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.66% to $158.01 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-06"", ""headline"": ""12 Best Healthcare ETFs To Buy"", ""summary"": ""In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for the healthcare sector in 2023. The previous year was rather challenging for equity and fixed income [\u2026]""}, {""date"": ""2023-09-06"", ""headline"": ""IBM announces data incident for Janssen CarePath database"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""UPDATE 2-J&J says drug combo contains lung cancer from spreading for longer duration"", ""summary"": ""Johnson & Johnson said on Wednesday its combination drug helped increase the duration of no progress in a type of non small-cell lung cancer in patients.  The therapy met the main goals of the study that tested a combination of antibody treatment Rybrevant and experimental drug lazertinib against chemotherapy in patients with a more common mutation in EGFR protein that causes rapid cell growth.  J&J's therapy was tested in patients in whom the disease progressed even after they were treated with AstraZeneca's Tagrisso.""}, {""date"": ""2023-09-06"", ""headline"": ""15 Stocks to Buy with Steady Dividends"", ""summary"": ""In this article, we discuss 15 stocks to buy with steady dividends. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Stocks to Buy with Steady Dividends. Investment trends have evolved significantly over time in response to shifts in the market and the [\u2026]""}, {""date"": ""2023-09-06"", ""headline"": ""Apple, Merck share losses lead Dow's 175-point drop"", ""summary"": ""Behind negative returns for shares of Apple and Merck, the Dow Jones Industrial Average is falling Wednesday morning. The Dow was most recently trading 176...""}, {""date"": ""2023-09-06"", ""headline"": ""Johnson & Johnson succeeds in lung cancer trial for Rybrevant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Is J&J a Buy After the Kenvue Separation?"", ""summary"": ""The transition prompted J&J to lower its sales and earnings per share guidance for the year to account for the lost consumer health earnings.  There's been a lot of talk about buying J&J as it heads into a new era of growth -- but the revised earnings forecast may make you think twice.""}, {""date"": ""2023-09-06"", ""headline"": ""Dow drops 88 points on losses for shares of Merck, Johnson & Johnson"", ""summary"": ""Shares of Merck and Johnson & Johnson are trading lower Wednesday morning, sending the Dow Jones Industrial Average into negative territory. Shares of Merck...""}, {""date"": ""2023-09-06"", ""headline"": ""Janssen to Showcase New Insights and Commitment to Accelerating Hope and Healing for Serious Mental Illness at Psych Congress 2023"", ""summary"": ""Titusville - The Janssen Pharmaceutical Companies of Johnson & Johnson will showcase data from its neuropsychiatry portfolio at Psych Congress 2023.The Company will present 15 posters, including...""}, {""date"": ""2023-09-06"", ""headline"": ""Cidara Shares Rally Premarket as J&J Moves Forward on Influenza Pact"", ""summary"": ""By Colin Kellaher Shares of Cidara Therapeutics rose sharply in premarket trading Wednesday after the biotechnology company said a Johnson &amp; Johnson unit...""}, {""date"": ""2023-09-06"", ""headline"": ""J&J lung cancer drug combo meets late-stage study goals"", ""summary"": ""Johnson & Johnson said onWednesday its drug rybrevant, along with experimental druglazertinib, met both the main goals of a late-stage study whentreating a type of lung cancer. ...""}, {""date"": ""2023-09-06"", ""headline"": ""7 Retirement Stocks That Every Long-Term Investor Should Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""GLOBAL BROKER RATINGS: Shore Capital raises B&M; HSBC likes Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Cidara receives election to proceed notice for CD388 from Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Janssen Pharmaceutical says primary endpoint met in Phase 3 MARIPOSA-2 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $160.03, moving +1.28% from the previous trading session.""}, {""date"": ""2023-09-07"", ""headline"": ""Kenvue Stock Falls 6%. It May Be Fears on Tylenol Lawsuits."", ""summary"": ""The stock dropped below its IPO price for the first time Thursday. The litigation is at an early stage but seems to be worrying Wall Street.""}, {""date"": ""2023-09-07"", ""headline"": ""Warren Buffett Dividend Stocks by Sectors and Industries"", ""summary"": ""In this article, we discuss Warren Buffett\u2019s dividend stocks by sectors and industries. You can skip our detailed analysis of Warren Buffett\u2019s portfolio and dividend stocks, and go directly to read 5 Warren Buffett Dividend Stocks by Sectors and Industries. Warren Buffett, one of the most successful investors in history, has shown a preference for [\u2026]""}, {""date"": ""2023-09-07"", ""headline"": ""Healthcare Stocks Push the Dow Higher"", ""summary"": ""Healthcare stocks were gaining Thursday, helping to raise the Dow, while the Nasdaq and S&P 500 dropped. Shares of Amgen (ticker: AMGN) gained 1.7% as the biotechnology stock was the second-best performer in the Dow Jones Industrial Average.""}, {""date"": ""2023-09-07"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson rose 1.28% to $160.03 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-09-07"", ""headline"": ""Johnson & Johnson (JNJ): A Modestly Undervalued Gem?"", ""summary"": ""A Comprehensive Analysis of Its Market Value""}, {""date"": ""2023-09-07"", ""headline"": ""Dell downgraded to Sell, McDonald's upgraded: Wall Street's top analyst calls"", ""summary"": ""Dell downgraded to Sell, McDonald's upgraded: Wall Street's top analyst calls""}, {""date"": ""2023-09-07"", ""headline"": ""Johnson & Johnson (JNJ) 2023 Wells Fargo Securities Healthcare Conference - (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) 2023 Wells Fargo Securities Healthcare Conference September 7, 2023 10:15 AM ETCompany ParticipantsMichael Bodner - Global Head of Heart RecoveryAndrew...""}, {""date"": ""2023-09-07"", ""headline"": ""Vanguard High Dividend Yield ETF: A 3.1% Yielding Dividend ETF For Your Retirement Portfolio"", ""summary"": ""Vanguard High Dividend Yield ETF is a diversified investment portfolio focused on high-quality dividend stocks. Find out if VYM is a buy.""}, {""date"": ""2023-09-07"", ""headline"": ""1 Brand-New Dividend Stock Income Investors Won't Want to Miss"", ""summary"": ""In its brief time on the public markets, Kenvue (NYSE: KVUE) has already shown it has all the makings of a high-quality dividend stock.  Just a short time after its official separation from healthcare giant Johnson & Johnson\u00a0(NYSE: JNJ), Kenvue is already paying a dividend that yields 3.5% at recent prices.  Kenvue is the world's largest consumer healthcare products company by revenue (over $15 billion in 2022).""}, {""date"": ""2023-09-07"", ""headline"": ""J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit"", ""summary"": ""The decision to end the CTEPH study on J&J's (JNJ) Opsumit (macitentan) was made at the recommendation of the study's independent DMC, following a pre-planned interim analysis.""}, {""date"": ""2023-09-07"", ""headline"": ""Dow rallies 111 points on gains in shares of Intel, UnitedHealth"", ""summary"": ""Shares of Intel and UnitedHealth are trading higher Thursday afternoon, sending the Dow Jones Industrial Average into positive territory. The Dow was most...""}, {""date"": ""2023-09-07"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Janssen - Phase 3 MARIPOSA-2 Study Meets Dual Primary Endpoint Resulting in Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival for RYBREVANT plus Chemotherapy"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the three-arm Phase 3 MARIPOSA-2 study evaluating RYBREVANT , a bispecific antibody...""}, {""date"": ""2023-09-07"", ""headline"": ""Janssen Announces Update to Phase 3 MACiTEPH Study Evaluating Macitentan 75mg in Patients with Chronic Thromboembolic Pulmonary Hypertension"", ""summary"": ""RARITAN - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its decision to stop the Phase 3 MACiTEPH study evaluating macitentan 75 mg in patients with Chronic Thromboembolic...""}, {""date"": ""2023-09-07"", ""headline"": ""Canaccord starts Kenvue at Buy on 'great risk/reward opportunity'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""8 Dividend Aristocrat Stocks to Buy Now With a Recession (and Inflation) Looming Large in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""FedEx: Strong Business But Risky At Current Valuations"", ""summary"": ""FedEx ranks as America's second most trusted B2B brand, bolstering its customer loyalty and market position. Find out why I'm neutral on FDX stock for now.""}, {""date"": ""2023-09-07"", ""headline"": ""Canaccord starts Kenvue at buy; cites global reach, consumer demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Pfizer Vs. Gilead Sciences: COVID-19 Battle Of Pharma Titans"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""AOC Has It Right on CEO David Zaslav\u2019s Pay"", ""summary"": ""Readers weigh in on Warner Bros. Discovery CEO David Zaslav, Barron\u2019s fall market outlook, BLS statistics, and the FCC, Kenvue, and the Fed""}, {""date"": ""2023-09-08"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-09-08"", ""headline"": ""Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors"", ""summary"": ""Kenvue  is formerly the Consumer Healthcare division of Johnson & Johnson  .  Kenvue is the proprietor of well-known brands such as Aveeno, Band-Aid, Benadryl, Johnson's Baby, Listerine, Mylanta, Neutrogena, Tylenol, and Visine.  In this daily bar chart of KVUE, below, I can see that prices have declined since the start of their spinoff from JNJ.""}, {""date"": ""2023-09-08"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.33% higher to $160.56 Friday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-09-08"", ""headline"": ""J&J's Janssen submits EMA marketing application for erdafitinib"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Kroger agrees to pay $1.2B to settle opioid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""September Rally? 3 Healthcare Stocks to Buy Before Liftoff."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""The 5 Best Healthcare Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Shareholder Derivative Suits In New Jersey"", ""summary"": ""Shareholder derivative suits have become an increasingly important tool for holding corporate executives accountable for their actions. In New Jersey, these suits allow shareholders to sue company...""}, {""date"": ""2023-09-08"", ""headline"": ""3 Shaky Stocks to Sell in September Before It\u2019s Too Late"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""The 7 Best Dow Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Johnson & Johnson price target lowered to $158 from $175 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Analyst Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-09"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-09"", ""headline"": ""Big Pharma\u2019s Battle With the Biden Administration Could Have Legs"", ""summary"": ""Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.""}, {""date"": ""2023-09-09"", ""headline"": ""3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing"", ""summary"": ""If you add both of these types of stocks to your portfolio, you're likely to benefit over the long haul.  Three great examples are healthcare companies Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) and beverage powerhouse Coca-Cola (NYSE: KO).""}, {""date"": ""2023-09-10"", ""headline"": ""25 Most Biodiverse Countries in the World"", ""summary"": ""In this piece, we will take a look at the 25 most biodiverse countries in the world. To skip our analysis of global biodiversity, its ecological and economic impacts, as well as some companies that operate within this space, go ahead and see the 5 Most Biodiverse Countries in the World. Biodiversity, or biological diversity, [\u2026]""}, {""date"": ""2023-09-10"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip"", ""summary"": ""The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.""}, {""date"": ""2023-09-10"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autisim warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
35,2023-09-10,159.28443908691406,2023-09-17,160.1673583984375,0.005543035569480104,U1,"[{""date"": ""2023-09-09"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Johnson & Johnson stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""September Self-Indexing Strategies For A Possible Blue October"", ""summary"": ""Magic Formula is still one of my favorite broad-based indexing strategies. Find out the top 30 dividend paying Magic Formula stocks scored for September 2023.""}, {""date"": ""2023-09-10"", ""headline"": ""AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""DTD: Almost Identical To DLN, And No Specific Edge"", ""summary"": ""WisdomTree Total U.S. Dividend ETF is almost identical to DLN in strategy and behavior. Learn why DTD ETF has lagged S&P 500 and SCHD.""}, {""date"": ""2023-09-10"", ""headline"": ""25 Most Biodiverse Countries in the World"", ""summary"": ""In this piece, we will take a look at the 25 most biodiverse countries in the world. To skip our analysis of global biodiversity, its ecological and economic impacts, as well as some companies that operate within this space, go ahead and see the 5 Most Biodiverse Countries in the World. Biodiversity, or biological diversity, [\u2026]""}, {""date"": ""2023-09-10"", ""headline"": ""The 7 Best Warren Buffett Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip"", ""summary"": ""The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.""}, {""date"": ""2023-09-10"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Kenvue shares may gain after FDA comments in Tylenol-Autisim warning label  lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Key ingredient in Sudafed, Dayquil and many other decongestant drugs doesn\u2019t relieve congestion: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Key drug in Sudafed, Dayquil and many other decongestants doesn\u2019t relieve congestion: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Doctor asks court to toss J&J lawsuit against her over cancer research"", ""summary"": ""A medical researcher has asked a court to throw out a lawsuit that Johnson & Johnson filed against her over her 2019 study on the links between cosmetic talc products and cancer, saying that her research is sound and protected by free speech rights.  Dr. Jacqueline Moline, who has served as a plaintiffs' expert in more than 200 cases alleging that J&J talc products caused patients to develop cancer, said in a Friday court filing in federal court in Trenton, New Jersey, that the lawsuit was an effort to \""intimidate\"" scientific experts.  Scientific conclusions based on accurate descriptions of the data and methodology used to develop them are protected by the First Amendment of the U.S. Constitution's protections for free speech and academic freedom, according to Moline's court filing.""}, {""date"": ""2023-09-11"", ""headline"": ""10 Best Dividend ETFs"", ""summary"": ""In this article, we discuss 10 best dividend ETFs. You can skip our detailed analysis of dividend stocks and exchange-traded funds, and their performance, and go directly to read 5 Best Dividend ETFs. Investing in exchange-traded funds (ETFs) is a good investment strategy for many investors as they offer several advantages, including diversification, liquidity, and [\u2026]""}, {""date"": ""2023-09-11"", ""headline"": ""J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe"", ""summary"": ""J&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered metastatic UC. Balversa is approved by the FDA under the accelerated pathway.""}, {""date"": ""2023-09-11"", ""headline"": ""Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-09-11"", ""headline"": ""AI Integration In Biotech & Pharma: Companies Positioned To Benefit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Bayer: Undervalued With Clear Catalysts"", ""summary"": ""Bayer's stock\u00c2\u00a0has had a volatile performance, reaching highs and lows since December 2022, when I first wrote about this company. Read more on BAYRY stock here.""}, {""date"": ""2023-09-11"", ""headline"": ""Sandoz to commercialize biosimilar to J&J blockbuster drug Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Could This Issue Sink Johnson & Johnson's Stock Price?"", ""summary"": ""Pharmaceutical giant Johnson & Johnson (NYSE: JNJ) is no stranger to legal issues.  This dark cloud has hovered above Johnson & Johnson's head for a while now, but it is facing another legal obstacle of a different nature.  Among the many things that landmark legislation achieved was to grant Medicare the ability to negotiate directly with drugmakers on the prices it pays for some of the drugs the U.S. government spends the most on each year.""}, {""date"": ""2023-09-11"", ""headline"": ""Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Erdafitinib for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer"", ""summary"": ""Belgium - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Marketing Authorisation Application to the European Medicines Agency seeking approval of...""}, {""date"": ""2023-09-11"", ""headline"": ""JNJ January 2026 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding."", ""summary"": ""Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup.""}, {""date"": ""2023-09-11"", ""headline"": ""Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""3 Bulletproof Stocks to Buy Before the Next Recession Strikes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""12 Best Pharma ETFs"", ""summary"": ""In this article, we discuss the 12 best pharma ETFs. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. As of 2023, Deloitte has valued the pharmaceutical, biotechnology, and medical technology industries at $2.83 trillion. A report on the Global Pharmaceuticals Outlook by [\u2026]""}, {""date"": ""2023-09-12"", ""headline"": ""Novartis' (NVS) Sandoz Gets Rights for Stelara Biosimilar"", ""summary"": ""Novartis (NVS) announces an agreement with Samsung Bioepis for exclusive rights to commercialize the biosimilar of Stelara in Europe and North America. The company discontinues the development of GT005 in geographic atrophy.""}, {""date"": ""2023-09-12"", ""headline"": ""AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo"", ""summary"": ""Data from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut the risk of disease progression or death by 38% in certain lung cancer patients.""}, {""date"": ""2023-09-12"", ""headline"": ""Popular nasal decongestant doesn't actually relieve congestion, FDA advisers say"", ""summary"": ""WASHINGTON \u2014 The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the...""}, {""date"": ""2023-09-12"", ""headline"": ""Popular nasal decongestant doesn't actually relieve congestion, FDA experts say"", ""summary"": ""WASHINGTON \u2014 The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the...""}, {""date"": ""2023-09-12"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Bristol Myers, J&J invest in Boston biotech's $72M VC round"", ""summary"": ""A biotech startup incubated by GV has added two more Big Pharma firms to its already-formidable cap table.""}, {""date"": ""2023-09-12"", ""headline"": ""FDA panel says OTC nasal decongestant doesn't work as intended"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Janssen Pharmaceutical - Treatment with RYBREVANT and Lazertinib Plus Chemotherapy Showed Durable Progression-Free Survival in Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer"", ""summary"": ""SINGAPORE - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced follow-up results from the Phase 1b/2 CHRYSALIS-2 study cohort evaluating the safety and tolerability of the...""}, {""date"": ""2023-09-12"", ""headline"": ""AbbVie's Skyrizi outperforms JNJ\u2019s Stelara in Crohn's disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""This Proven 200% Dividend Growth Strategy Is a Peter Lynch Favorite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""FTC warns pharma industry on improperly listed patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""P&G, J&J face class action suits over cold medicine drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $163.99, marking a +0.25% move from the previous day.""}, {""date"": ""2023-09-13"", ""headline"": ""Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains"", ""summary"": ""In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth potential. Once again, it\u2019s been thrust into the limelight due to global health challenges. With inflation rearing its head and consumers prioritizing essentials, healthcare indisputably emerges as a non-negotiable expenditure. This context has led to a surge in investors scouting the market for prime h""}, {""date"": ""2023-09-13"", ""headline"": ""Globus Medical: Almost Having My Back"", ""summary"": ""Analysis of Globus Medical, Inc.'s recent acquisition of NuVasive, its record in the spine industry, operating momentum, and valuation. Click for more on GMED.""}, {""date"": ""2023-09-13"", ""headline"": ""Johnson & Johnson (JNJ) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Johnson & Johnson (NYSE:NYSE:JNJ) Morgan Stanley 21st Annual Global Healthcare Conference September 13, 2023 10:10 AM ETCompany ParticipantsJoaquin Duato - Chairman and Chief Executive...""}, {""date"": ""2023-09-13"", ""headline"": ""Here's My Top Growth Stock to Buy in 2023"", ""summary"": ""The growth train is leaving the station and you don't want to miss it. Find out why this stock remains a strong buy even after doubling in 2023.""}, {""date"": ""2023-09-13"", ""headline"": ""Better Buy: J&J vs. Kenvue"", ""summary"": ""When you used to think of Band-Aid bandages and Tylenol, you probably thought of healthcare giant Johnson & Johnson (NYSE: JNJ).  This summer, J&J completed its spinoff of its consumer health business, forming a new company called Kenvue (NYSE: KVUE).  This left J&J with two other units -- pharmaceuticals and medtech -- and set Kenvue off on the road to growing the consumer health business independently.""}, {""date"": ""2023-09-13"", ""headline"": ""The most popular decongestants don\u2019t actually work: FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""J&J investigated by South African authorities over 'excessive' drug pricing - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Johnson & Johnson ditching script logo after 130 years"", ""summary"": ""Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.""}, {""date"": ""2023-09-14"", ""headline"": ""3 Blue-Chip Stocks to Watch in the \u2018Green Zone\u2019"", ""summary"": ""Blue-chip stocks represent ownership in established, financially sound businesses, but are the blue-chips you\u2019re taking a look at today in the \u201cGreen Zone stocks\u201d category? TradeSmith offers investors valuable tools for determining which stocks to watch. A good example is its Health Indicator feature. This comprehensive indicator provides an overall rating of a stock\u2019s current health. Using this metric, you can quickly find potential opportunities to explore. Broken down into three \u201czones\u201d (gree""}, {""date"": ""2023-09-14"", ""headline"": ""UPDATE 2-J&J, P&G, Walgreens sued after FDA panel ruling on cold medicine decongestant"", ""summary"": ""Johnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel declared ineffective.  Proposed class actions were filed on Wednesday and Thursday, after the panel reviewed several studies and concluded this week that the ingredient phenylephrine marketed as a decongestant was essentially no better than a placebo.  According to an agency presentation, about 242 million products with phenylephrine were sold in the United States last year, generating $1.76 billion of sales and accounting for about four-fifths of the market for oral decongestants.""}, {""date"": ""2023-09-14"", ""headline"": ""J&J, P&G sued after FDA panel ruling on cold medicine decongestant"", ""summary"": ""A new lawsuit accuses Johnson & Johnson and Procter & Gamble of deceiving consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel this week declared ineffective.  According to a proposed class action on Wednesday filed in Pensacola, Florida, federal court, the companies knew or should have known by 2018 that their marketing claims about products containing phenylephrine were false and misleading.  That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine's effectiveness could no longer be relied upon, the complaint said.""}, {""date"": ""2023-09-14"", ""headline"": ""At Johnson & Johnson, a New Look but Old Hurdles"", ""summary"": ""The company led by Joaquin Duato launches a branding as it focuses on higher-risk prescription drugs and medical devices after shedding its consumer business.""}, {""date"": ""2023-09-14"", ""headline"": ""Johnson & Johnson is getting rid of its script logo after more than 130 years"", ""summary"": ""Johnson & Johnson is signing off on a new logo.  The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.  The original script \u2014 based on co-founder James Wood Johnson's signature \u2014 will still be seen for now on consumer products like baby shampoo from Kenvue, a new company recently spun off from J&J.""}, {""date"": ""2023-09-14"", ""headline"": ""Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity"", ""summary"": ""NEW BRUNSWICK, N.J., September 14, 2023--For more than 135 years, Johnson & Johnson (the \""Company\"") (NYSE: JNJ) has provided health care products and solutions to people worldwide. Now, with its exclusive focus on healthcare innovation and tackling the toughest health challenges, the Company is updating its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.""}, {""date"": ""2023-09-14"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Janssen to be renamed Johnson & Johnson Innovative Medicine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""3 Warren Buffett Stocks That Are Near Their 52-Week Lows"", ""summary"": ""Growth stocks are getting some love again in 2023, and that normally means value investments get pushed to the back burner.  Warren Buffett's Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) holds many quality value stocks, and several of them are on sale right now.  Three Buffett/Berkshire stocks that are trading near their 52-week lows are Coca-Cola\u00a0(NYSE: KO),\u00a0Johnson & Johnson (NYSE: JNJ), and\u00a0Paramount Global\u00a0(NASDAQ: PARA).""}, {""date"": ""2023-09-14"", ""headline"": ""My Dividend Stock Portfolio: New August Dividend Record - 99 Holdings With 27 Buys"", ""summary"": ""The S&P 500 and Dow Jones Industrial Average both saw slim positive returns in August. Check out the latest dividend stock portfolio update.""}, {""date"": ""2023-09-15"", ""headline"": ""With ecstasy a potential PTSD therapy, psychedelic treatments could take off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""Top Analyst Reports for Meta Platforms, Walmart & Johnson & Johnson"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Walmart Inc. (WMT) and Johnson & Johnson (JNJ).""}, {""date"": ""2023-09-15"", ""headline"": ""This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business"", ""summary"": ""Ashley McEvoy pivoted from over-the-counter products to medical devices.""}, {""date"": ""2023-09-15"", ""headline"": ""AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths"", ""summary"": ""AstraZeneca's (AZN) strong revenue growth outperforms AbbVie's (ABBV) declining sales. Click here to read more on the battle of the pharmaceutical behemoths.""}, {""date"": ""2023-09-15"", ""headline"": ""Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices"", ""summary"": ""U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging \u201cexcessive\u201d prices for a key tuberculosis drug, the country's antitrust regulator said Friday.  J&J's Belgium-based subsidiary Janssen Pharmaceuticals is also under investigation, South Africa's Competition Commission said.  The commission, which regulates business practices, said it opened the investigation this week based on information that the companies \u201cmay have engaged in exclusionary practices and excessive pricing\u201d of the tuberculosis drug bedaquiline, which is sold under the brand name Sirturo.""}, {""date"": ""2023-09-15"", ""headline"": ""3 Great Dividend Stocks You Can Buy for Less Than $50"", ""summary"": ""These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.""}, {""date"": ""2023-09-15"", ""headline"": ""The 3 Most Undervalued Dow Stocks to Buy in September 2023"", ""summary"": ""The Dow Jones Industrial Average has climbed 5.3% so far this year. The index is trailing the S&P 500, which has climbed 17.8%. Additionally, at least two Dow stocks, Johnson and Johnson (NYSE:JNJ) and Walgreens (NYSE:WBA), are being weighed down by potentially ruinous litigation. Meanwhile, Home Depot (NYSE:HD) is a victim of the frozen residential real estate market and Disney\u2019s (NYSE:DIS) business model is falling apart. So I would definitely not recommend buying an ETF that tracks Dow stocks""}, {""date"": ""2023-09-15"", ""headline"": ""25 Most Admired Companies in 2023"", ""summary"": ""In this article, we will be analyzing the most admired companies in the world, their characteristics, and some recent initiatives taken by them to maintain their market position. If you wish to skip our detailed analysis, you can move directly to the 5 Most Admired Companies in 2023. What Makes A Company Admired? Companies around [\u2026]""}, {""date"": ""2023-09-15"", ""headline"": ""Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""Novartis shareholders approve 100% spinout of Sandoz unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""The Dogs of the Dividend Aristocrats"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-16"", ""headline"": ""IXJ: Healthcare Dashboard For September"", ""summary"": ""Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. Read more here.""}, {""date"": ""2023-09-17"", ""headline"": ""3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income"", ""summary"": ""After years of lower yields, income-focused investors have many more attractive options these days.  While the overall dividend yield of the market remains well below its historical average (currently around 1.5% for the\u00a0S&P 500), many companies offer much more attractive yields.  American Tower\u00a0(NYSE: AMT),\u00a0Brookfield Renewable\u00a0(NYSE: BEPC)(NYSE: BEP), and\u00a0Kenvue\u00a0(NYSE: KVUE) currently offer\u00a0dividend yields more than double the market's average.""}, {""date"": ""2023-09-17"", ""headline"": ""Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued"", ""summary"": ""Johnson & Johnson stock has shown resilience in the face of bad news. Check out what makes JNJ an appealing investment choice.""}, {""date"": ""2023-09-17"", ""headline"": ""Acelyrin, MoonLake rivalry heats up as both chase blockbuster PsA market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
36,2023-09-17,160.1673583984375,2023-09-24,159.22491455078125,-0.005884119317943637,D1,"[{""date"": ""2023-09-17"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""AARP weighs in on Merck case challenging Medicare drug negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income"", ""summary"": ""After years of lower yields, income-focused investors have many more attractive options these days.  While the overall dividend yield of the market remains well below its historical average (currently around 1.5% for the\u00a0S&P 500), many companies offer much more attractive yields.  American Tower\u00a0(NYSE: AMT),\u00a0Brookfield Renewable\u00a0(NYSE: BEPC)(NYSE: BEP), and\u00a0Kenvue\u00a0(NYSE: KVUE) currently offer\u00a0dividend yields more than double the market's average.""}, {""date"": ""2023-09-17"", ""headline"": ""Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued"", ""summary"": ""Johnson & Johnson stock has shown resilience in the face of bad news. Check out what makes JNJ an appealing investment choice.""}, {""date"": ""2023-09-17"", ""headline"": ""Acelyrin, MoonLake rivalry heats up as both chase blockbuster PsA market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-09-18"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., September 18, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 17th to review third-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson\u2019s executive team.""}, {""date"": ""2023-09-18"", ""headline"": ""Johnson & Johnson: A Very Cautious 'Buy'"", ""summary"": ""Johnson & Johnson is a stable dividend payer, and the stock could be slightly undervalued right now. Click here to read my analysis of JNJ stock.""}, {""date"": ""2023-09-18"", ""headline"": ""Kenvue: Interesting Times"", ""summary"": ""Kenvue's shares have fallen since its IPO due to high valuations and concerns about its growth composition. Click here for more on KVUE stock.""}, {""date"": ""2023-09-18"", ""headline"": ""Johnson & Johnson: Kenvue Spin-Off Unlikely To Drive Market-Beating Returns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""The Zacks Analyst Blog Highlights Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley"", ""summary"": ""Meta Platforms, Walmart, Johnson & Johnson, Pfizer and Morgan Stanley are part of the Zacks top Analyst Blog.""}, {""date"": ""2023-09-18"", ""headline"": ""Johnson & Johnson's Reinvention - Is A New Logo Enough?"", ""summary"": ""Johnson & Johnson's transformation, marked by the split-off of its consumer health division, is a significant shift in strategy. Click here to see if the new logo is enough.""}, {""date"": ""2023-09-18"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Rani Therapeutics initiates Phase 1 study of RT-111"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.17%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $162.20, moving -0.17% from the previous trading session.""}, {""date"": ""2023-09-19"", ""headline"": ""7 Safe and Steady Dividend Stocks to Buy for Volatile Time"", ""summary"": ""Navigating the unpredictable waters of today\u2019s market, safe dividend stocks emerge as a beacon of reliability. Despite an optimistic kickoff this year, the broader market sentiment has chilled. For investors eager to remain engaged but wary of current volatilities, turning to trusted companies offering consistent dividends might be the savvy move. Recent data adds weight to this strategy. Recently, CNBC highlighted that August\u2019s core inflation, excluding food and energy, edged up by 0.3%, exceed""}, {""date"": ""2023-09-19"", ""headline"": ""Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare"", ""summary"": ""Regeneron Pharmaceuticals Q2 2023 revenue exceeded expectations despite competition and falling Eylea sales. Click here to read an analysis on REGN stock now.""}, {""date"": ""2023-09-19"", ""headline"": ""CSQ: This Blended Fund Has Appealing Features, But Its Price Is Too High"", ""summary"": ""Calamos Strategic Total Return Fund's market performance has been decent, but there are other funds that have outperformed it. Read more on CSQ CEF here.""}, {""date"": ""2023-09-19"", ""headline"": ""10 Best Investments During A Recession"", ""summary"": ""insIn this article, we discuss 10 best investments during a recession. If you want to skip our discussion on the stock market and recessionary concerns, head directly to 5 Best Investments During A Recession. The United States economy managed to steer clear of a recession due to a robust job market. However, this is typically [\u2026]""}, {""date"": ""2023-09-19"", ""headline"": ""FDRR: Attractive Value And Quality, Yet Lagging In Rising Rates"", ""summary"": ""FDRR ETF holds dividend stocks showing a positive correlation to 10-year U.S. Treasury yields. Find out why I'm neutral on the fund.""}, {""date"": ""2023-09-19"", ""headline"": ""Kenvue Is Not The Better Johnson & Johnson, Also Not For Dividend Investors"", ""summary"": ""Kenvue faces significant challenges in the consumer healthcare sector. Read why KVUE stock might not be the ideal choice for those seeking a ""}, {""date"": ""2023-09-20"", ""headline"": ""Rockville life sciences firm Emmes names former J&J exec Peter Ronco as its new CEO"", ""summary"": ""Rockville clinical research organization The Emmes Co. has tapped a former Johnson & Johnson and Bristol Myers-Squibb Co. executive to be its next CEO.  The company, which conducts research for public- and private-sector clients, announced Wednesday that Peter Ronco will replace replace Dr. Christine Dingivan as CEO, effective immediately.  Dingivan, Emmes\u2019 CEO since September 2020, will serve as a senior adviser to Executive Chairman Sastry Chilukiri and Emmes\u2019 board of directors, the company said in an announcement.""}, {""date"": ""2023-09-20"", ""headline"": ""Consumers seek consolidation of class actions against P&G, Johnson & Johnson over decongestant"", ""summary"": ""Plaintiffs suing Procter & Gamble and other drug companies over a supposedly ineffective nasal decongestant are asking a federal panel to consolidate the cases in New Jersey District Court.""}, {""date"": ""2023-09-20"", ""headline"": ""Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash"", ""summary"": ""No one likes to think about a market crash, but the best way to stay afloat through such a time is to think ahead, plan, and be prepared.  You could hedge against a market crash by choosing stocks that probably won't plummet during the worst of times and are sure to thrive over time.  Market leaders and companies with either strong brand strength or products people can't avoid buying are good candidates.""}, {""date"": ""2023-09-20"", ""headline"": ""3 No-Brainer Stocks to Buy With $500 Right Now"", ""summary"": ""Since the beginning of the decade, Wall Street's major stock indexes have navigated their way through two bear markets.  Although they've rebounded in a big way from their 2022 bear market lows, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite remain firmly below their all-time highs.  What this represents is an opportunity for patient investors to pounce on plain-as-day bargains.""}, {""date"": ""2023-09-20"", ""headline"": ""Amazon, Disney, Boeing boosted in Wells Fargo Signature Picks portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.77% to $161.66 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-21"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Blockbuster Cancer Treatment Stymied by Supply Chain\u2014for Now"", ""summary"": ""A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing.""}, {""date"": ""2023-09-21"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: September 2023 Fair Value Update"", ""summary"": ""I've been building my cash position in preparation for a market crash and taking advantage of high interest rates. Read more here.""}, {""date"": ""2023-09-22"", ""headline"": ""20 Most Innovative Companies in America"", ""summary"": ""In this article, we will take a look at the most innovative companies in America. If you want to explore similar companies, you can go to 5 Most Innovative Companies in America. Innovation and American Companies Innovation comes with new and creative ideas that bring a healthy change in society. Innovation in business and technology [\u2026]""}, {""date"": ""2023-09-22"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 0.72% to $160.50 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-22"", ""headline"": ""The Buffett List: 5 Dividend Buys For September"", ""summary"": ""An update on Warren Buffett's holdings and dividend stocks, revealing top picks and potential gains for September. Explore more details here.""}, {""date"": ""2023-09-22"", ""headline"": ""Protagonist Therapeutics: There Are Reasons Behind Johnson & Johnson's Optimism"", ""summary"": ""We look at the pros and cons of J&J's oral IL-23 drug, JNJ-2113, compared to Protagonist Therapeutics, Inc.'s oral treatment. Click for more on PTGX.""}, {""date"": ""2023-09-22"", ""headline"": ""Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-09-23"", ""headline"": ""Johnson & Johnson: The Bull Case Can No Longer Be Ignored"", ""summary"": ""JNJ's best-in-class ""}, {""date"": ""2023-09-24"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}, {""date"": ""2023-09-24"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}]",{}
37,2023-09-24,159.22491455078125,2023-10-01,154.5126495361328,-0.02959502303984951,D3,"[{""date"": ""2023-09-24"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}, {""date"": ""2023-09-24"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}, {""date"": ""2023-09-25"", ""headline"": ""Immunovant drives OmniAb higher after data update; argenx slips"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""Retirement Passive Income Snowball: VYM May Be All You Need"", ""summary"": ""Vanguard High Dividend Yield Index Fund's trailing 12-month dividend yield is 3.2%. Compared to major equity indexes, the yield is actually quite high. Learn more on VYM ETF here.""}, {""date"": ""2023-09-25"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slumped 0.15% to $160.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-25"", ""headline"": ""Cooper Offers A Great Business But A Somewhat Tricky Valuation"", ""summary"": ""The Cooper Companies, Inc. has above average growth and margin leverage potential. Click here to find out why COO stock is rated as a buy.""}, {""date"": ""2023-09-25"", ""headline"": ""Alvotech partner starts biosimilar threat to JNJ\u2019s Stelara in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""3M, Merck share losses lead Dow's nearly 100-point drop"", ""summary"": ""Shares of 3M and Merck are trading lower Monday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M and Merck are...""}, {""date"": ""2023-09-26"", ""headline"": ""Notable Wednesday Option Activity: JNJ, RIVN, KRTX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here\u2019s how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.77%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $159.02, moving -0.77% from the previous trading session.""}, {""date"": ""2023-09-26"", ""headline"": ""15 Best Dividend Aristocrat Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best dividend aristocrat stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Aristocrat Stocks To Buy Now. Dividend Aristocrats are a select group of publicly traded companies in the S&P 500 that have raised [\u2026]""}, {""date"": ""2023-09-26"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.77% to $159.02 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-26"", ""headline"": ""Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar"", ""summary"": ""Novartis' (NVS) Sandoz broadens its biosimilar portfolio with Tyruko's approval, a biosimilar of the multiple sclerosis drug Tysabri in the EU.""}, {""date"": ""2023-09-26"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Johnson & Johnson, one of the largest healthcare companies in the world, has been around for decades, has historically crushed the market, and continues to generate steady revenue and profits.  First, the company is a proven innovator in healthcare.  There is always a need for better, safer, more effective therapies or medical devices.""}, {""date"": ""2023-09-26"", ""headline"": ""This Is the Holy Grail of Investing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""What to Note in the AI Megatrend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.20% to $157.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-27"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here's how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Almost 1,500 high-grade corporate bonds issued by some household names are currently trading between 50 and 80 cents on the dollar.""}, {""date"": ""2023-09-27"", ""headline"": ""Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday afternoon with shares of Walgreens Boots and Johnson & Johnson facing the biggest declines for the...""}, {""date"": ""2023-09-27"", ""headline"": ""The Kellogg Split"", ""summary"": ""Why Kellogg is splitting up its business.  Motley Fool host Ricky Mulvey and sports journalist John Nash analyze newly listed TKO Holdings, the company that runs both WWE and UFC, and address the challenges it may face.  To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.""}, {""date"": ""2023-09-27"", ""headline"": ""Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall"", ""summary"": ""Shares of Johnson & Johnson and Verizon are seeing declines Wednesday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of...""}, {""date"": ""2023-09-27"", ""headline"": ""Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday morning with shares of Walgreens Boots and Johnson & Johnson delivering the stiffest headwinds for the...""}, {""date"": ""2023-09-27"", ""headline"": ""Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Relative Strength Alert For Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""3 Things About Johnson & Johnson That Smart Investors Know"", ""summary"": ""J&J recently spun off its consumer health business into a separate entity called Kenvue, and the healthcare giant is even changing its famous logo -- red printed letters will replace the cursive.  Meanwhile, J&J's share price doesn't reflect the idea of these exciting new times.  J&J's consumer health business brought in about $14 billion in revenue last year, so you may be wondering why spinning this unit off is a good idea.""}, {""date"": ""2023-09-27"", ""headline"": ""Arm, Instacart, Birkenstock ... the IPOs of 2023 and beyond"", ""summary"": ""The most well known IPOs so far this year that have made headlines and moved the markets.""}, {""date"": ""2023-09-28"", ""headline"": ""IN BRIEF: J&J reports positive results for Rybrevant in combination"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.15% to $156.88 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-28"", ""headline"": ""3 Dividend Kings With Recession-Proof Payouts"", ""summary"": ""These names, which have raised their payouts for over 50 straight years, have dividends that are well-covered even during a recession.""}, {""date"": ""2023-09-28"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""UPDATE 1-J&J's lung cancer therapy combo succeeds in late-stage study"", ""summary"": ""Johnson & Johnson said on Thursday its cancer therapy combination met the main goal in a late-stage study testing it as a treatment for patients with a type of lung cancer.  The drugmaker said an interim analysis of data from the study showed a trend \""favoring\"" the combination of its antibody treatment Rybrevant and experimental drug lazertinib, when compared to AstraZeneca's cancer drug osimertinib or Tagrisso.  J&J said it plans to submit data for an upcoming scientific conference, including additional details on certain secondary goals from the study.""}, {""date"": ""2023-09-28"", ""headline"": ""J&J hit with 11,000 new talc complaints after settlement tossed, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Interesting JNJ Put And Call Options For November 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""There\u2019s a sale on corporate bonds. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""SCHX ETF: A Large-Cap ETF for Large Gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Needham medtech/diagnostics analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Johnson & Johnson posts Phase 3 win for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.72% to $155.75 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-29"", ""headline"": ""Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times"", ""summary"": ""In the new century, economic uncertainty often looms. Finding investment opportunities that can weather the storm is a quest every investor undertakes. The article lists the \u201cRecession-Proof Royals\u201d, three titans of their respective industries who have not only stood the test of time but have thrived during economic downturns. These can be considered recession proof stocks. The first one\u2019s diverse product categories maintain stable demand, regardless of the economic climate. The second one\u2019s mul""}, {""date"": ""2023-09-29"", ""headline"": ""UPDATE 1-Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""2023-09-29"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""2023-09-29"", ""headline"": ""These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders"", ""summary"": ""Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.""}, {""date"": ""2023-09-29"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""GENEVA (Reuters) -Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""2023-09-29"", ""headline"": ""Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging him to take \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (TB), Unitaid said this was an \""incomplete solution\"", saying countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""2023-09-29"", ""headline"": ""Don\u2019t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Dividend Aristocrats Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend aristocrats ranked by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Aristocrats Ranked By Yield: Top 10. At the start of the year, there was a lot of excitement surrounding tech stocks. However, [\u2026]""}, {""date"": ""2023-09-29"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""IN BRIEF: Fresenius Kabi gains European marketing review for FYB202"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-30"", ""headline"": ""15 Warren Buffett Stocks That Are On Sale Now"", ""summary"": ""In this article, we will discuss the 15 Warren Buffett stocks that are on sale now. If you want to explore similar stocks, you can also take a look at 5 Warren Buffett Stocks That Are On Sale Now. Warren Buffett stands out as the most successful investor after nearly six decades of making waves [\u2026]""}, {""date"": ""2023-09-30"", ""headline"": ""3 Magnificent Dividend Stocks to Buy in October"", ""summary"": ""There's no better time than October to invest in high-quality dividend stocks.  Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October.  Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""2023-09-30"", ""headline"": ""LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}]",{}
38,2023-10-01,154.5126495361328,2023-10-08,156.38763427734375,0.012134830040387623,U2,"[{""date"": ""2023-10-01"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}, {""date"": ""2023-10-02"", ""headline"": ""Sanofi announces deal for potential E. coli vaccine with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Sanofi, Janssen Team Up to Develop, Commercialize Vaccine for E. Coli"", ""summary"": ""By Adria Calatayud Sanofi and Johnson &amp; Johnson's Janssen Pharmaceuticals have entered into an agreement to jointly develop and commercialize a vaccine...""}, {""date"": ""2023-10-02"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-02"", ""headline"": ""My Dividend Growth Portfolio September Update - Fall Bargains Are Here"", ""summary"": ""Discover dividend growth bargains in the market, as cash yields at 5%. Despite a slight dip in 2023, unaccounted income from a cash pile prevails. Read here for more.""}, {""date"": ""2023-10-02"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.""}, {""date"": ""2023-10-02"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.39% to $155.15 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-02"", ""headline"": ""J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study"", ""summary"": ""J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.""}, {""date"": ""2023-10-02"", ""headline"": ""Corporate bonds are on sale. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Johnson & Johnson Urged To Expand Access Tuberculosis Medication"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Food Stocks: Worth a Bite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The October 2023 Heat Map"", ""summary"": ""Discover the 3-step process of selecting wide-moat stocks, with a focus on attractively valued candidates. See a heat map of investment candidates here.""}, {""date"": ""2023-10-03"", ""headline"": ""Novartis to Complete Spinoff of Generic Drug Division"", ""summary"": ""Swiss pharmaceutical maker Novartis plans to spin off its Sandoz generic drugs division starting Wednesday, to focus on its core drug R&D business.""}, {""date"": ""2023-10-03"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.12% higher to $155.34 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-10-03"", ""headline"": ""October Dogs Of The Dow: 3 Buyable, 7 Watchable"", ""summary"": ""Discover how the Dow Jones adds and selects stocks, the highest-yielding stocks in October, and the leading performers in the Dow Industrial Index. Click for more.""}, {""date"": ""2023-10-03"", ""headline"": ""'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories"", ""summary"": ""Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft Corp's (NASDAQ: MSFT) CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence (AI). Nadella's remarks came during his testimony in a landmark antitrust trial in the U.S., where he highlighted the challenges posed by exclusive deals that tech giants, notably Alphabet Inc (NASDAQ: GO""}, {""date"": ""2023-10-03"", ""headline"": ""Behind the new malaria vaccine endorsed by the World Health Organization"", ""summary"": ""The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.""}, {""date"": ""2023-10-03"", ""headline"": ""Sanofi (SNY) Inks Deal With J&J to Develop E. coli Vaccine"", ""summary"": ""Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.""}, {""date"": ""2023-10-03"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-03"", ""headline"": ""UPDATE 1-Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson in a trial over four plaintiffs' claims that they developed cancer from being exposed to the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case.  A lawyer for the plaintiffs did not immediately respond to a request for comment.""}, {""date"": ""2023-10-03"", ""headline"": ""Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""(Reuters) -A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial.  J&J Worldwide Vice President of Litigation Erik Haas said in a statement that the decision \""resoundingly rejects ... the 'junk science' advanced by purported 'experts' paid by the mass tort asbestos bar.\""""}, {""date"": ""2023-10-03"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""10 U.S. drugmakers agree to participate in price negotiations with Medicare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""NJ appeals court throws out $223.8M talc verdict against J&J: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""12 Best Places to Retire in Dominican Republic"", ""summary"": ""This article looks at the 12 best places to retire in Dominican Republic. If you wish to skip our detailed analysis of Dominican Republic\u2019s economic growth and foreign investments, you may go to the 5 Best Places to Retire in Dominican Republic. Dominican Republic\u2019s Economic Growth and Foreign Investments According to the World Bank, the [\u2026]""}, {""date"": ""2023-10-03"", ""headline"": ""Court throws out $223.8M verdict against J&J in talc case, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Berenberg: Get defensive with healthcare, utilities and telecoms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says\u00a0"", ""summary"": ""Novo Nordisk is latest drugmaker to challenge negotiation program in court.""}, {""date"": ""2023-10-03"", ""headline"": ""Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Johnson & Johnson in pact with Sanofi for E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Sanofi announces pact with J&J to develop and commercialize E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""IN BRIEF: J&J notes study showing long-term efficacy of Spravato"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Notable Thursday Option Activity: JNJ, BE, GE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""7 Top Healthcare Stocks That Pay Dividends"", ""summary"": ""Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts. Genuinely, I hope that\u2019s the case. But you can wish on one hand and, well, you know the rest. Primarily, the core benefit of top healthcare stocks that pay dividends centers on the \u201cpermanent\u201d relevance of the underlying sector. To be clear, all sectors suffer the vulner""}, {""date"": ""2023-10-04"", ""headline"": ""Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories"", ""summary"": ""Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its collaboration with PwC to combine its latest AI capabilities. The collaboration will combine Palantir's latest AI capabilities with PwC's industry experience to help clients realize value with data and AI-enabled operations. Palantir has chosen the U.K. as its European headquarters for AI research and development. Anthropic Navigating The AI Landscape With""}, {""date"": ""2023-10-04"", ""headline"": ""14 Best Bear Market Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 14 best bear market stocks to buy now. If you want to see more stocks in this selection, go directly to the 5 Best Bear Market Stocks To Buy Now. The US economy successfully avoided a recession owing to its resilient job market. However, it\u2019s worth noting that the job [\u2026]""}, {""date"": ""2023-10-04"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-10-04"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Johnson & Johnson initiated with an Outperform at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""BofA\u2019s Alpha Surprise Model: Lots of Energy additions, Con. Dis. deletions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Johnson & Johnson Dividend Stock Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""S&P 500 Gains and Losses Today: Clorox Shares Dip After Warning of Cyberattack's Impact"", ""summary"": ""The S&P 500 was little changed on Thursday, Oct. 5, 2023 ahead of Friday's jobs report, and Clorox shares tumbled after warning a cyberattack would have a significant negative impact on its quarterly earnings.""}, {""date"": ""2023-10-05"", ""headline"": ""Johnson & Johnson Wins an Analyst's Heart, but Its Charts Aren't So Hot"", ""summary"": ""The pharmaceutical giant's technical signals lean toward the bearish side even as it gains a buy recommendation.""}, {""date"": ""2023-10-05"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""3 Ways AI Can Help Healthcare Companies Grow"", ""summary"": ""If you want to invest in artificial intelligence (AI), tech stocks aren't your only options.  There are plenty of ways that AI can and will help transform the healthcare industry.  One of the big benefits of AI assistants is that they can summarize notes in meetings.""}, {""date"": ""2023-10-05"", ""headline"": ""Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""RBC Analyst Bullish on Johnson & Johnson (NYSE: JNJ) Post-Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""November 24th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""2 Magnificent Dividend Kings to Buy Now"", ""summary"": ""The three major stock market indexes have progressively declined over the past month, and the Dow Jones Industrial Average even slipped into negative territory for the year.  A look at the list of Dividend Kings is the perfect place to start because these players have track records of at least 50 years of dividend growth.  Let's take a look at two magnificent Dividend Kings that make great buys right now -- and could reward you with growing passive income over time.""}, {""date"": ""2023-10-05"", ""headline"": ""3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October"", ""summary"": ""These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.""}, {""date"": ""2023-10-05"", ""headline"": ""Howard Hughes Holdings spinning off Seaport Entertainment to shareholders"", ""summary"": ""Houston conglomerate names former MGM executive Anton D. Nikodemus as chief executive of Seaport Entertainment as an independent company.""}, {""date"": ""2023-10-05"", ""headline"": ""Johnson & Johnson draws bullish initiation at RBC on consumer spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""11 Best Stocks to Buy in Falling Markets According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 11 best stocks to buy in falling markets according to hedge funds. For more recession-resilient stocks, head over to 5 Best Stocks to Buy in Falling Markets. Recessions are inevitable and the market has been forecasting a recession in the near future for quite some [\u2026]""}, {""date"": ""2023-10-06"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""2023-10-06"", ""headline"": ""Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""2023-10-06"", ""headline"": ""Wall Street Lunch: Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""IN BRIEF: J&J applies for indication extension to EMA for Rybrevant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""IPOs are out of fashion. Here's what companies are doing instead."", ""summary"": ""Companies under pressure to unlock value unfurled a mini-flurry of spinoff activity in recent days, but some spinoff stocks have gotten a cool reception.""}, {""date"": ""2023-10-06"", ""headline"": ""Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""The Fed's December meeting is now uncertain, with a coin toss between a quarter-point hike and no move. Click here to read more.""}, {""date"": ""2023-10-07"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-07"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - October 2023"", ""summary"": ""In addition to the primary list that yields just over 3%, we present two other groups of five DGI stocks each. Explore more details here.""}, {""date"": ""2023-10-08"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
39,2023-10-08,156.38763427734375,2023-10-15,155.60391235351562,-0.005011405968570637,D1,"[{""date"": ""2023-10-07"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""J&J Medtech gets FDA clearance for DePuy TriALTIS Spine System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""3 Artificial Intelligence Stocks That Could Outperform the \u2018Godfather of AI\u2019"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.57% higher to $158.54 Monday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-10-09"", ""headline"": ""J&J (JNJ) Seeks EU Nod for Rybrevant for First-Line NSCLC"", ""summary"": ""J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.""}, {""date"": ""2023-10-09"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On"", ""summary"": ""Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.""}, {""date"": ""2023-10-09"", ""headline"": ""Janssen announces 30 company sponsored presentations at EADV Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Protagonist Therapeutics announces advancement of JNJ-2113 across indications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""2023-10-10"", ""headline"": ""September 2023 Passive Income Update"", ""summary"": ""Fortis\u00c2\u00a0decided to get king status and boost their dividend by 4.4%. This raise adds $23.60 to our forward income. Check out our income update for September.""}, {""date"": ""2023-10-10"", ""headline"": ""J&J reports 510(k) clearance from FDA for TriLEAP System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-10"", ""headline"": ""DSTL: A Cash Flow-Focused ETF"", ""summary"": ""Distillate US Fundamental Stability & Value ETF picks stocks based on criteria including cash flow yield, cash flow stability & debt. Read more on DSTL ETF here.""}, {""date"": ""2023-10-10"", ""headline"": ""Family Dollar recalls dozens of P&G, J&J, Colgate products in 23 states due to incorrect temperature storage"", ""summary"": ""Family Dollar voluntarily recalled dozens of OTC drugs and medical devices sold at its stores because they had been stored at improper temperatures.""}, {""date"": ""2023-10-10"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.11% to $158.36 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-10"", ""headline"": ""Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-10-10"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Hold from DBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-10"", ""headline"": ""High Yield Stock Watchlist - October 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""2023-10-10"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Peering Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Beat the Market With These 7 Warren Buffett Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Eli Lilly (NYSE:LLY) Slips despite Positive Phase 3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.38% to $156.18 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-11"", ""headline"": ""Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato"", ""summary"": ""This week\u2019s episode of Fortune\u2018s Leadership Next podcast features conversations from the Fortune CEO Initiative conference.""}, {""date"": ""2023-10-11"", ""headline"": ""Birkenstock has an advantage that others in the 2023 IPO class don't have"", ""summary"": ""The brand's origin story is older than the United States.""}, {""date"": ""2023-10-11"", ""headline"": ""Will The Recent Spin-Off be Beneficial for Johnson & Johnson (JNJ)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. U.S. equities fell from the first-half highs amid fears of slowing consumer spending and higher interest rates. The strategy performed strongly in this environment outperforming the Russell 1000 Value [\u2026]""}, {""date"": ""2023-10-11"", ""headline"": ""2 No-Brainer Dividend King Stocks to Buy Right Now"", ""summary"": ""Buying stocks may not seem all that attractive at the moment.  Investors, though, should bear in mind that high-quality dividend stocks have consistently outperformed most other asset classes over the long term, especially during times of economic uncertainty.  Blue chip dividend stocks, in effect, have often been a source of strength for investors in turbulent markets.""}, {""date"": ""2023-10-11"", ""headline"": ""25 Most Innovative Companies in the World in 2023"", ""summary"": ""In this article, we will take a look at the most innovative companies in the world in 2023. If you want to explore similar companies, you can go to 5 Most Innovative Companies in the World in 2023. Innovation doesn\u2019t arrive straight away. Governments and organizations invest heavily in research and development, scientific publications, and [\u2026]""}, {""date"": ""2023-10-11"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Bert's September Dividend Income Summary"", ""summary"": ""We received $3,570.87 in September dividend income. This was a 16.52% dividend increase compared to September 2022.""}, {""date"": ""2023-10-12"", ""headline"": ""Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-12"", ""headline"": ""15 Worst Performing Dow Stocks YTD"", ""summary"": ""In this article, we discuss 15 worst performing Dow stocks year-to-date. If you want to skip our detailed discussion on stock market performance overall, head directly to 5 Worst Performing Dow Stocks YTD. In a July report by J.P. Morgan, it was stated that global economic growth is expected to slow down in the latter [\u2026]""}, {""date"": ""2023-10-12"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.10% higher to $156.33 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-10-12"", ""headline"": ""Dow ETF in Focus Ahead of Q3 Earnings"", ""summary"": ""With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.""}, {""date"": ""2023-10-12"", ""headline"": ""Retirement Stock Portfolio: 10 Low Risk Investments"", ""summary"": ""In this article, we discuss the 10 best low-risk investment options to add to your retirement portfolio. You can skip our detailed analysis of the retirement phenomenon within the U.S., and go directly to read the Retirement Stock Portfolio: 5 Low Risk Investments. In 2021, the economy faced persistent challenges due to the COVID-19 pandemic\u2019s [\u2026]""}, {""date"": ""2023-10-12"", ""headline"": ""7 High-Growth S&P 500 Stocks to Buy Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Supreme Court to hear arguments on Purdue Pharma bankruptcy case on Dec. 4"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Eli Lilly Treatment For Crohn's Tops Placebo In Latest Study, Makes Plans For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future"", ""summary"": ""Prescription drugs can be expensive. That's especially problematic for retirees living on fixed incomes. Sure, insurance can partially offset those high costs. However, seniors age 65 and older still pay for more than half of prescription drug costs out of their own pockets, according to the Health Policy Institute.""}, {""date"": ""2023-10-12"", ""headline"": ""Eli Lilly succeeds in Phase 3 trial for Crohn's disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Alvotech biosimilar for JNJ\u2019s Stelara rejected in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Johnson & Johnson price target raised to $162 from $158 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-12"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-12"", ""headline"": ""Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-13"", ""headline"": ""How big companies from EY to Johnson & Johnson are learning to master AI prompts"", ""summary"": ""Embracing AI is the easy part\u2014firms have already moved on to harder parts like making AI actually work for their business.""}, {""date"": ""2023-10-13"", ""headline"": ""Top 30 Oncology Companies in the World"", ""summary"": ""In this article, we shall cover the top 30 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 10 Oncology Companies in the World. According to a report by McKinsey and Company, the economic outlook for the US healthcare industry in 2023 [\u2026]""}, {""date"": ""2023-10-13"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.33% higher to $156.85 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-10-13"", ""headline"": ""J&J (JNJ) to Report Q3 Earnings, Its First After Unit Spin-Off"", ""summary"": ""J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.""}, {""date"": ""2023-10-13"", ""headline"": ""Johnson & Johnson Q3 Earnings Preview: Don't Count On Different Proposition Post Kenvue Spin-Out"", ""summary"": ""Johnson & Johnson (JNJ) will announce its Q3 earnings on October 17. Read why I would not be surprised to see an earnings miss followed by a selloff.""}, {""date"": ""2023-10-13"", ""headline"": ""Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-14"", ""headline"": ""3 Dividend Growth Stocks You Can Buy and Hold Forever"", ""summary"": ""What's better than a stock that pays dividends?  A stock with growing dividends and a business that's built for long-term success.  Here's why they believe that AbbVie (NYSE: ABBV), Eli Lilly (NYSE: LLY), and Johnson & Johnson (NYSE: JNJ) are dividend growth stocks that you can buy and hold forever.""}, {""date"": ""2023-10-14"", ""headline"": ""Johnson & Johnson Stock: Is Now the Time to Sell?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
40,2023-10-15,155.60391235351562,2023-10-22,151.7845001220703,-0.02454573393224213,D3,"[{""date"": ""2023-10-15"", ""headline"": ""LONDON MARKET OPEN: Stocks steady as eyes on oil, Israel, US earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Pfizer's Sequel: Return Of The Value Stock"", ""summary"": ""Pfizer focuses on core growth and strategic acquisitions in oncology to offset downgraded revenue projections. Learn why I rate PFE stock a hold.""}, {""date"": ""2023-10-15"", ""headline"": ""Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Stock market today: Wall Street rises, and oil and gold slip as some of last week's moves unwind"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""LONDON MARKET OPEN: Stocks rise as UK wage inflation eases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Stock market today: Wall Street drifts after a strong retail sales report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson earnings: What to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""J&J lung cancer drug combo had superior progression-free survival in study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson\u2019s Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector\u2019s Influence"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""LONDON MARKET EARLY CALL: FTSE to edge lower; wage data due"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Markets Pop on Bargain Hunting, Stronger Economy"", ""summary"": ""The small-cap Russell 2000, still under water over the past month, led the way higher today.""}, {""date"": ""2023-10-16"", ""headline"": ""Bank earnings, Fedspeak, House Speaker: What to watch"", ""summary"": ""Goldman Sachs (GS) and Bank of America (BAC) report their third-quarter earnings on Tuesday, October 17. September retail sales data is also expected out tomorrow while Fed regulators are set to speak. Lastly, House lawmakers will vote on Rep. Jim Jordan's (R-Oh.) candidacy as the next Speaker of the House. Yahoo Finance's Josh Lipton previews what investors should pay attention to tomorrow. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson\u2019s Earnings Are Coming. They\u2019ll Be the First Since the Kenvue Spinoff."", ""summary"": ""An update in August after the split leaves investors with fewer questions for Tuesday's results.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.43% higher to $157.53 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-10-16"", ""headline"": ""Bank of America reports, Johnson & Johnson, retail sales: 3 things to watch"", ""summary"": ""Investing.com -- Stocks surged on Monday as investors turned their attention to a wave of earnings reports from big banks, big tech firms such as Netflix (NASDAQ:NFLX), and Tesla (NASDAQ:TSLA) this week.""}, {""date"": ""2023-10-16"", ""headline"": ""My Dividend Growth Portfolio - Q3 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation"", ""summary"": ""The Federal Reserve has significantly ratcheted up interest rates over the past several quarters to help cool inflation.  As their share prices have fallen, their dividend yields have increased, which compensates investors for their higher risk profiles relative to bonds and CDs.  Kenvue is new to paying dividends.""}, {""date"": ""2023-10-16"", ""headline"": ""Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""LONDON MARKET CLOSE: Europe boosted by bullish open in New York"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Companies with lower implied volume have higher potential for earnings surprise - BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson Resumed The Bearish Cycle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""2023-10-16"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""WSJ\u2019s Take on the Week Podcast: A Key Fed Official on What\u2019s Next for Interest Rates"", ""summary"": ""This week, we\u2019re looking at what the Federal Reserve is focused on as it plots the course of interest rates. Minutes revealed that in their most recent meeting a majority of rate-setting officials said one more rate hike would be appropriate.""}, {""date"": ""2023-10-16"", ""headline"": ""Johnson & Johnson: A Conservative High-Yield Dividend Aristocrat Buy"", ""summary"": ""Johnson & Johnson is a defensive pick with a renewed focus on its pharmaceutical and medtech segments. Find out why JNJ stock is a Buy.""}, {""date"": ""2023-10-16"", ""headline"": ""LONDON MARKET MIDDAY: Stocks mixed on conflict and US earnings nerves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company\u2019s baby powder caused cancer, the health-care giant told investors Tuesday.Most Read from BloombergGaza Hospital Blast Kills Hundreds as Israel, Hamas Trade BlameIsrael Latest: Biden to Visit as Oil Climbs After Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinping\u2019s Gamble on V""}, {""date"": ""2023-10-17"", ""headline"": ""Stocks Face Bumpy Road As Macro Risks Remain"", ""summary"": """"}, {""date"": ""2023-10-17"", ""headline"": ""S&P 500 Gains and Losses Today: Chipmaker Shares Drop Amid Tightening Export Rules"", ""summary"": ""The S&P 500 dipped 0.01% on Tuesday, Oct. 17, 2023, as news that retail sales jumped more than expected in September renewed concerns about more Fed rate hikes.""}, {""date"": ""2023-10-17"", ""headline"": ""These Stocks Moved the Most Today: Nvidia, VMware, VF Corp., Bank of America, Lucid, Wyndham, and More"", ""summary"": ""Nvidia tumbles as the Biden administration is tightening its restriction on exports of artificial intelligence chips to China, earnings from Bank of America beat Wall Street forecasts, and Lucid's third-quarter production falls.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) has spent several quarters working toward sharpening its focus on its innovative medicine and medical technology (MedTech) businesses. It took a huge step forward by completing the spin-off of its former consumer healthcare business,\u00a0Kenvue\u00a0(NYSE: KVUE), to shareholders during the third quarter.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street\u2019s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses. This is the company\u2019s first quarterly report since the biggest shakeup in its 13- year-old history when it completed the separation from its consumer health spinoff Kenvue back in August. JNJ Reported A Better Than Expected Third Quarter During the third quarter, JNJ g""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""This is Jessica Moore, vice president of investor relations for Johnson & Johnson.  As a reminder, you can find additional materials including today's presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com.  Please note that this presentation and forward-looking statements regarding, among other things, the company's future operating and financial performance, market position, and business strategy.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off"", ""summary"": ""J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson dropped 0.91% to $156.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-10-17"", ""headline"": ""NEW YORK MARKET CLOSE: Blue-chips end flat but chip curbs rattle tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Stock Market Today: Dow ekes out gain, but rising Treasury yields stifle upside"", ""summary"": ""Investing.com -- The Dow eked out a gain Tuesday, but upside momentum was stifled by a jump in Treasury yields following stronger retail sales data that underscored ongoing strength in the economy, stoking fresh fears about another Federal Reserve rate hike before year end.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows"", ""summary"": ""Johnson & Johnson beat profit and sales estimates and boosted its outlook as pharmaceutical and medical device sales gain while demand for COVID-19 vaccines wanes.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views"", ""summary"": ""Johnson & Johnson beat third-quarter forecasts Tuesday and raised its outlook for the year. JNJ stock skidded lower after the open.""}, {""date"": ""2023-10-17"", ""headline"": ""S&P 500 falls as Nvidia slip, rising yields overshaddow quarterly earnings"", ""summary"": ""Investing.com -- The S&P 500 fell Tuesday as investor sentiment was soured by Nvidia-led weakness in chip stocks and a jump in Treasury yields following stronger retail sales data that boosted bets on a Fed rate hike by year end.""}, {""date"": ""2023-10-17"", ""headline"": ""Retail Sales Increased More Than Expected"", ""summary"": ""Retail Sales Increased More Than Expected""}, {""date"": ""2023-10-17"", ""headline"": ""Stocks to Watch Tuesday: J&J, Lockheed Martin, Goldman Sachs, Bank of America, VF"", ""summary"": ""\u2198\ufe0f [**Goldman Sachs (GS)**](https://www.wsj.com/market-data/quotes/GS): The bank posted declines in quarterly profit and revenue, but narrowly [beat consensus estimates](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-10-17-2023/card/goldman-sachs-profit-falls-33--6x5YoO6CkK0jiZWvWVtB) for both.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J Stock Dips After Healthcare Giant Posts Earnings"", ""summary"": ""Johnson & Johnson ([JNJ](https://www.wsj.com/market-data/quotes/JNJ?)) raised its adjusted earnings outlook for the year after posting higher third-quarter revenue, despite a drop in sales of its Covid-19 vaccine.""}, {""date"": ""2023-10-17"", ""headline"": ""The 'New' Johnson & Johnson Reports, But Where Are the Rest of the Numbers?"", ""summary"": ""On Tuesday morning, Johnson & Johnson  reported the firm's third quarter financial results.  For the three month period ended October 1st, Johnson & Johnson posted an adjusted EPS from continuing operations of $2.66  $1.69  on revenue of $21.351B.  Both the top line and adjusted bottom line results exceeded Wall Street's expectations.""}, {""date"": ""2023-10-17"", ""headline"": ""Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3"", ""summary"": ""Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard"", ""summary"": ""Already, market participants have had a chance to respond to the latest results from some of the biggest banking institutions in the country, and now the focus will shift to other segments of the economy.  One company that a lot of market participants wanted to look at closely was Johnson & Johnson (NYSE: JNJ), as the healthcare giant offers a pulse on what's becoming an increasingly important sector of the market.  Shares of Johnson & Johnson were down almost 1% Tuesday morning.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson raises guidance, Q3 results top estimates"", ""summary"": ""Johnson & Johnson (JNJ) reported third quarter results that topped analyst estimates on both the top and bottom lines. The health care company also raised its full-year guidance. The report was the company's first earnings release since it spun off its consumer health business, Kenvue (KVUE). Yahoo Finance Live breaks down the numbers.\u00a0 For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (JNJ) Reports Q3 Earnings: What Key Metrics Have to Say"", ""summary"": ""Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (JNJ) Reports Strong Q3 2023 Results with Notable Sales and EPS Growth"", ""summary"": ""Company increases full-year guidance for sales and adjusted EPS""}, {""date"": ""2023-10-17"", ""headline"": ""J&J Sees Boom in Heart Device Sales in Third Quarter"", ""summary"": ""A standout performer in Johnson & Johnson\u2019s third quarter was the group of special catheters and other [electrophysiology products](https://www.wsj.com/articles/j-j-makes-a-16-6-billion-bet-on-heart-pumps-to-lift-medical-device-sales-11667388513) used to diagnose and treat irregular heart rhythms.  \u201cWe continue to take market share with our existing products and we have plans for new products [in that space](https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2) to come out as early as 2024,\u201d J&J Chief Financial Officer Joseph Wolk told The Wall Street Journal.""}, {""date"": ""2023-10-17"", ""headline"": ""Wall Street Lunch: Sept. Retail Sales Spark Treasury Yield Surge"", ""summary"": ""The 10-yr yield surges close to 4.85%, 30-yr close to 5% after Sept. retail sales; Goldman Sachs Q3 revenue beat estimates; Bank of America posts results beat. Read more.""}, {""date"": ""2023-10-17"", ""headline"": ""Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""These Stocks Are Moving the Most Today"", ""summary"": ""Johnson & Johnson, Bank of America, and Goldman Sachs are scheduled to report third-quarter earnings on Tuesday, Ericsson slumps after withdrawing margin guidance, and NetScout reduces its outlook for fiscal 2024.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Raises Its Profit Outlook, but Its Charts Still Don't Impress"", ""summary"": ""The technical indicators of the pharmaceutical and medical device giant suggest that the bump it stands to get from its latest earnings announcement may not be sustainable.""}, {""date"": ""2023-10-17"", ""headline"": ""Dow rises as investors digest strong retail sales and earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-10-17"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Bank of America shares rose after reporting better-than-expected earnings on higher interest income and Johnson & Johnson delivered an earnings beat on medical device and pharmaceutical sales. Here\u2019s what investors need to know today.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson sees GLP-1 impact on weight loss surgeries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Stock Rises. It Lifts Guidance in First Post-Kenvue Earnings."", ""summary"": ""The company raises its expected annual adjusted earnings to a range of $10.07 to $10.13 a share and now expects annual sales of $83.6 billion to $84 billion.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost"", ""summary"": ""Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.""}, {""date"": ""2023-10-17"", ""headline"": ""These Stocks Are Moving the Most Today: J&J, Bank of America, Goldman, Lockheed, Ericsson, NetScout, and More"", ""summary"": ""Johnson & Johnson's third-quarter adjusted earnings beat analysts' estimates. Bank of America and Goldman Sachs also are scheduled to report third-quarter earnings Tuesday.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J begins restructuring at medical device unit after sales miss"", ""summary"": ""(Reuters) -Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedic business after third-quarter medical devices sales fell short of Wall Street expectations, reflecting the company's narrowed focus since spinning off its consumer health unit.  J&J said it plans to exit certain markets and stop selling some products under its orthopedic business as part of the  restructuring program.  Without its consumer health business and medical devices undergoing restructuring, pressure on J&J's large pharmaceutical unit is likely to intensify as the company aims to reach its goal of $57 billion in drug sales by 2025.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J lifts profit outlook on strong demand for top-seller Stelara"", ""summary"": ""(Reuters) -Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara.  Investors are focused on how J&J, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Johnson & Johnson recorded a $21-billion gain in the third quarter from the spin-off of its consumer health unit.""}, {""date"": ""2023-10-17"", ""headline"": ""U.S. stocks stay lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J raises annual profit forecast on strong cancer drug demand"", ""summary"": ""Johnson & Johnson on Tuesday raised its 2023 profit forecast, banking on growing demand for its newer cancer treatments such as Carvykti and Tecvayli and recorded a $21 billion gain from the spin off of its consumer health unit.  Investors are focused on how Johnson & Johnson, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Excluding its consumer health unit, the company now expects 2023 adjusted profit of $10.07 to $10.13 per share, compared with its previous outlook of $10.00 to $10.10 per share.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Reports Q3 2023 Results"", ""summary"": ""NEW BRUNSWICK, N.J., October 17, 2023--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2023. \""Johnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,\"" said Joaquin Duato, Chairman of the Board and Chief Executive Officer. \""With a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson beats earnings estimates and downplays obesity drugs\u2019 impact on its med-tech business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday"", ""summary"": ""With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson (NYSE: JNJ) to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell. Johnson & Johnson shares gained 0.3% to $158.00 in after-hours trading. NetScout Systems, Inc. (NASDAQ: NTCT) reported weak preliminary results for the second quarter and lowered its FY24 guidance. NetScout Systems""}, {""date"": ""2023-10-17"", ""headline"": ""U.S. stocks open lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Dividend Income Summary: Lanny's September 2023 Summary"", ""summary"": ""In September, we (my wife and I) received a dividend income total of $4,987.23. So close to $5,000 this month for our family.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson expects flat procedures in MedTech in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson says 'confident' in product pipeline for 2024/2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Unusually active option classes on open October 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""5 stocks to watch on Tuesday: J&J, Bank of America, United Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""U.S. stock futures lower amid earnings beats and strong retail sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Invest in millennials and these \u2018once-in-a-lifetime opportunity\u2019 stocks, says this fund manager"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson says continues to pursue four-pronged talc litigation strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson says continues to make progress on new product launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Morning Brew: Microsoft's Accelerated Growth, Lockheed Martin's Q3 Earnings Beat, and Apple ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains on Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""TOP NEWS: J&J raises full-year sales outlook after \""solid\"" quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""J&J\u2019s stock rallies after profit and sales rise above expectations, full-year outlook increased"", ""summary"": ""Shares of Johnson & Johnson rallied 0.8% in premarket trading Tuesday, after the drug maker and medical technology company reported third-quarter profit and...""}, {""date"": ""2023-10-17"", ""headline"": ""US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson in charts: Sales grow Y/Y for both major segments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson powers to Q3 beat as pharma outperforms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Earnings Scheduled For October 17, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains After Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson in charts: Segment sales continue to grow in Q3, while regional sales decline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson\u2019s stock climbs after company beats earnings estimates and raises profit guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Intuitive Surgical: When Paying A Premium Makes Sense"", ""summary"": ""Intuitive Surgical is launching new products to complement its flagship da Vinci product line, pointing to continued growth. Find out why ISRG stock is a Buy.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.66 beats by $0.14, revenue of $21.35B beats by $300M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Genmab reports Q3 worldwide net sales of DARZALEX $2.499B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson raises FY23 adjusted EPS to $10.07-$10.13 from $10.00-$10.10"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""As Q3 earnings season revs into high gear, here's what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Johnson & Johnson reports Q3 adjusted EPS $2.66, consensus $2.51"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""The 7 Best Forever Stocks To Buy Now: October 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""7 Healthcare Stocks That Can Cure a Lackluster Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""CVS removing certain cold medicines containing phenylephrine, CNBC reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson declares $1.19 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-18"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Why Johnson & Johnson Stock Flopped Today"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) stock had a bit of a hangover Wednesday.  Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%.  Before the market open Wednesday, a pair of pundits tracking Johnson & Johnson stock lowered their fair value estimations of the healthcare giant.""}, {""date"": ""2023-10-18"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-10-18"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.15% to $152.73 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-18"", ""headline"": ""JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus"", ""summary"": ""The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.""}, {""date"": ""2023-10-18"", ""headline"": ""1 Warren Buffett Stock to Buy Hand Over Fist Right Now"", ""summary"": ""Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is a defensive investor at heart.  As a result, Berkshire Hathaway's portfolio is heavily tilted toward dyed-in-the-wool value stocks \u2013 many of which pay generous and sustainable dividends.  Underscoring this point, a $1,000 investment in Berkshire Hathway stock at the start of Buffett's tenure as CEO would be worth an astonishing $1.82 million today.""}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson\u2019s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect [\u2026]""}, {""date"": ""2023-10-18"", ""headline"": ""Genmab hits 52-week low after Q3 Darzalex sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""FDA approves UCB's Bimzelx for plaque psoriasis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Is the \""New\"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?"", ""summary"": ""Some things are different about J&J. But other things remain the same as they've been for a long time.""}, {""date"": ""2023-10-18"", ""headline"": ""Dow remains lower with Treasury yields near 16 year highs, oil jumping and tech earnings ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""My Dividend Stock Portfolio: New September Dividend Record - 98 Holdings With 22 Buys"", ""summary"": ""The S&P 500 and Dow Jones Industrial Average saw sharp losses for the month and the quarter. Click here to read my analysis.""}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson price target lowered to $178 from $186 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson price target lowered to $171 from $174 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Johnson & Johnson (NYSE:JNJ)\u00a0to Boost MedTech Division\u2019s Margins"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Dividend Income Update September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""J&J considers third bankruptcy attempt over talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Q3 2023 Johnson & Johnson Earnings Call"", ""summary"": ""Q3 2023 Johnson & Johnson Earnings Call""}, {""date"": ""2023-10-19"", ""headline"": ""New Dengue Pill from Johnson & Johnson (NYSE:JNJ) Gives Shares a Boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023"", ""summary"": ""NEW BRUNSWICK, N.J., October 19, 2023--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2023 of $1.19 per share on the company\u2019s common stock. The dividend is payable on December 5, 2023 to shareholders of record at the close of business on November 21, 2023. The ex-dividend date is November 20, 2023.""}, {""date"": ""2023-10-19"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.27% to $152.32 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-19"", ""headline"": ""Kenvue: Very Profitable And Significantly Undervalued"", ""summary"": ""Kenvue is significantly undervalued vs. peers of similar size and with a similar product mix. Find out if now is a good time to buy KVUE stock.""}, {""date"": ""2023-10-19"", ""headline"": ""Big-Name Stock Spinoffs Are Going Mainstream. Here\u2019s Why."", ""summary"": ""Globalization and easier access to capital are encouraging prominent companies to consider spinoffs, writes Allan Sloan.""}, {""date"": ""2023-10-19"", ""headline"": ""ChatGPT Stock Advice: 15 Recent Stock Recommendations"", ""summary"": ""In this article, we will take a look at the ChatGPT stock advice: 15 recent stock recommendations. To see more such companies, go directly to ChatGPT Stock Advice: 5 Recent Stock Recommendations. More and more hedge funds are starting to deploy AI for stock picking and financial analysis. And the logic behind this practice is [\u2026]""}, {""date"": ""2023-10-19"", ""headline"": ""Is Johnson & Johnson Still a Good Dividend Stock to Buy?"", ""summary"": ""Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.""}, {""date"": ""2023-10-19"", ""headline"": ""Eli Lilly, Novo among notable decliners in pharma weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Johnson & Johnson Enters Oversold Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""'Things were way tougher': Charlie Munger gets blunt with whiners worried about 'hardship' \u2014 plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances in tough times"", ""summary"": ""The 99-year-old investing legend has spoken.""}, {""date"": ""2023-10-19"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""2023-10-19"", ""headline"": ""Video: Dow Movers: JNJ, MCD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Drug retailers, makers face mounting litigation over decongestant products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""AT&T Is Still A Mess, So Buy These 9%-Yielding Dividend Aristocrat Bargains"", ""summary"": ""AT&T stock has been a value trap for four decades. Find out two other 9%-yielding dividend aristocrat bargains capable of doubling in value every 5 years""}, {""date"": ""2023-10-19"", ""headline"": ""Johnson & Johnson\u2019s Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""GLOBAL BROKER RATINGS: DZ Bank cuts P&G, but raises PepsiCo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""7 Dividend Aristocrats That Are Built to Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Johnson & Johnson price target raised to $165 from $162 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Johnson & Johnson Considers Ditching Texas Two-Step for Third Talc Bankruptcy"", ""summary"": ""The healthcare giant is exploring another bankruptcy and a Supreme Court appeal to try to resolve its mass talc liabilities.""}, {""date"": ""2023-10-20"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $153.00 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-20"", ""headline"": ""Abbott Labs: Fear Is In The Air - That's Why I'm Bullish"", ""summary"": ""Abbott Laboratories reported solid growth across all segments in its third-quarter results, excluding its COVID diagnostics portfolio. Read more here.""}, {""date"": ""2023-10-20"", ""headline"": ""Medical device makers see limited hit from weight-loss drugs"", ""summary"": ""Intuitive, which makes a surgical robot used in several procedures including bariatrics, said on an earnings call that the U.S. growth rate for weight-loss surgery was slowing as patients consider using the new drugs instead.""}, {""date"": ""2023-10-20"", ""headline"": ""Buffett's 6 Dividend Buys For October"", ""summary"": ""The article discusses Warren Buffett's dividend stocks, highlighting the top performers and providing investment insights based on YCharts data. Click here for more.""}, {""date"": ""2023-10-20"", ""headline"": ""IN BRIEF: J&J's Tremfya shows positive results in psoriasis study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Johnson & Johnson shows antiviral effects of dengue pill in mid-stage trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Janssen announces Phase 3b Week 16 results from Cohort A of VISIBLE trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Alvotech upgraded at Citi citing FDA nod for biosimilars"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Johnson & Johnson: Q3 Earnings Unveils Life After Kenvue Spinoff"", ""summary"": ""Johnson & Johnson reported Q3 earnings with a 6.8% surge in sales, reaching $21.4 billion in revenue. Click here to read my earnings analysis of the JNJ stock.""}, {""date"": ""2023-10-20"", ""headline"": ""3 Mutual Funds to Invest in for Pro Management and Low Fees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""First pill for dengue shows promise in human challenge trial"", ""summary"": ""A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.  There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago.  \u201cIt is the first ever to show antiviral activity against dengue,\u201d Marnix Van Loock, who oversees emerging pathogens research for J&J\u2019s Janssen division, said of the drug.""}, {""date"": ""2023-10-20"", ""headline"": ""GLOBAL BROKER RATINGS: DZ likes Roche; Metzler likes Mercedes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Wall Street Breakfast Podcast: CVS Pulls Phenylephrine Amid Legal Woes"", ""summary"": ""Drug retailers, makers face mounting litigation over decongestant products. Toyota works out deal with Tesla to adopt NACS charging standard. Jazz Pharmaceutical exploring strategic options.""}, {""date"": ""2023-10-20"", ""headline"": ""IN BRIEF: J&J's Janssen notes \""promising\"" data for dengue antiviral"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-21"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-21"", ""headline"": ""Bank Bonds That Cut Risk Draw Ares and Blackstone: Credit Weekly"", ""summary"": ""(Bloomberg) -- Banks are reviving the sale of credit-linked notes, a type of synthetic securitization that\u2019s been relatively uncommon in the US since the financial crisis, ahead of new rules that will require them to hold more regulatory capital.Most Read from BloombergCar Owners Fall Behind on Payments at Highest Rate on RecordIsrael Latest: Gaza Air Strikes to Intensify Before \u2018Next Stage\u2019Web Summit CEO Cosgrave Quits After Israel ControversyModerna Shaves Off $7 Billion in Value After Pfizer""}, {""date"": ""2023-10-21"", ""headline"": ""Analysts find strength in consumer stocks Hershey, P&G, J&J"", ""summary"": ""Consumer staples is the third worst performing sector this year, but early earnings results show sentiment towards the sector may soon shift.""}, {""date"": ""2023-10-21"", ""headline"": ""2 Warren Buffett Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Famed investor Warren Buffett is known for several things, including his love for dividends and his penchant for companies whose shares he can hold forever.  It's not surprising, then, to find great dividend stocks worth holding on to for good among Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) holdings.  Two of the most attractive are Johnson & Johnson (NYSE: JNJ) and Visa (NYSE: V).""}, {""date"": ""2023-10-21"", ""headline"": ""2 Attractive High Dividend Yield Buys For Your Dividend Income Portfolio"", ""summary"": ""This week, two additional companies have been added to The Dividend Income Accelerator Portfolio.""}, {""date"": ""2023-10-21"", ""headline"": ""These 2 Dow Stocks Moved Markets This Week"", ""summary"": ""When any of the 30 companies that are in the Dow Jones Industrials report their latest financial results, it has the potential to move the entire market.  On Tuesday morning, both Johnson & Johnson (NYSE: JNJ) and Goldman Sachs (NYSE: GS) gave investors their quarterly reports for the third quarter.""}, {""date"": ""2023-10-21"", ""headline"": ""Intuitive Surgical's Revenue Dipped: Is It Time to Sell?"", ""summary"": ""A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.""}, {""date"": ""2023-10-22"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}, {""date"": ""2023-10-22"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""2023-10-22"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""2023-10-22"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}]","{""assetTurnoverTTM"": 0.4721, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0459, ""eps"": 10.2071, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.538, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.3818, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.2712, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.7006, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.125, ""salesPerShare"": 8.3729, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
41,2023-10-22,151.7845001220703,2023-10-29,144.44329833984375,-0.048365951571619714,D5,"[{""date"": ""2023-10-21"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-22"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}, {""date"": ""2023-10-22"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""2023-10-22"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""2023-10-22"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}, {""date"": ""2023-10-23"", ""headline"": ""Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech"", ""summary"": ""NEW BRUNSWICK, N.J., October 23, 2023--Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities. Ms. McEvoy will remain with the Company into Q1 2024 to support a successful transition. Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company\u2019s Executive""}, {""date"": ""2023-10-23"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.05% to $151.39 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-23"", ""headline"": ""Big name brand plans a new bankruptcy filing"", ""summary"": ""The company, which has tried to file Chapter 11 through its LTL Management affiliate but was denied by a bankruptcy court in New Jersey, has a new plan to resolve its massive liabilities.  This case has nothing to do with Johnson & Johnson's ongoing operations.""}, {""date"": ""2023-10-23"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-23"", ""headline"": ""Charles River (CRL) Offers Access to Preclinical Cancer Research"", ""summary"": ""Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.""}, {""date"": ""2023-10-23"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-10-23"", ""headline"": ""Janssen says Rybrevant combination study showed 30% risk reduction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""IN BRIEF: J&J sees positive results for Tremfya in ulcerative colitis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""Quanterix announces new agreement to advance blood-based Alzheimer's detection"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""J&J report slew of positive trial results focused on various cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""J&J MedTech head stepping down in wake of lower-than-expected sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Bond Yields May Have Peaked. Consider These Stocks."", ""summary"": ""Bond yields may have peaked, making a host of stocks look attractive.""}, {""date"": ""2023-10-24"", ""headline"": ""Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Dividend Capture Strategy: 10 High Yield Stocks To Buy in November"", ""summary"": ""In this article, we discuss dividend capture strategy and high yield stocks to buy in November. You can skip our detailed analysis of the dividend capture approach and the performance of dividend stocks, and go directly to read Dividend Capture Strategy: 5 High Yield Stocks To Buy in November. Investing in dividend stocks is easier [\u2026]""}, {""date"": ""2023-10-24"", ""headline"": ""Johnson & Johnson Stock Skirts a 52-Week Low. Here\u2019s What\u2019s Ailing Healthcare."", ""summary"": ""Shares of  Johnson & Johnson  approached a 52-week low Tuesday, just over a week after the drugmaker reported better than expected third-quarter financial results and raised its forecast for full-year earnings.  Johnson & Johnson  (ticker: JNJ) has entirely given up the gains it clocked in the first half of the year, when shares climbed from $150.11 in late March to $174.01 in late August.  More than one malady has struck the healthcare sector, and there\u2019s no panacea in sight.""}, {""date"": ""2023-10-24"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.11% to $151.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-24"", ""headline"": ""3 High-Yielding Dividend Stocks Near Their 52-Week Lows"", ""summary"": ""Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.""}, {""date"": ""2023-10-24"", ""headline"": ""The Best Stocks to Invest $5,000 In Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings you a solid track record of growth -- plus potential for more ahead.  The company is testing a new CF treatment in phase 3 studies that may even beat Trikafta, paving the way for Vertex to hold onto its leadership at least until the late 2030s.  Meanwhile, Vertex may be about to launch its first potential blockbuster beyond CF.""}, {""date"": ""2023-10-24"", ""headline"": ""2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking"", ""summary"": ""These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.""}, {""date"": ""2023-10-24"", ""headline"": ""VTV: A Must-Watch ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""VTV: A Great ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Johnson & Johnson\u2019s Stock: A Stable Transition and Promising Future Despite Leadership Change"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Johnson & Johnson inks licensing deal with Quanterix for Alzheimer's testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""Dow Jones Bear Market: 3 Cheap Stocks to Buy Now"", ""summary"": ""The stock market has entered a slump. The Federal Reserve continues its campaign to limit inflation. In doing so, interest rates have soared which is likely to hurt the housing market and consumer spending. Given the uncertainty, investors have been trimming positions in vulnerable stocks. The sell-off, however, is creating an opportunity. Particularly for these three cheap Dow Jones stocks to buy, the current economic headwinds are setting up an excellent buy-the-dip situation. Johnson & Johnso""}, {""date"": ""2023-10-25"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.22% higher to $151.57 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-10-25"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""Here's what Wall Street is saying about IBM ahead of earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""The 7 Best Forever Stocks to Buy for October 2023"", ""summary"": ""Navigating the thunderstorm of fluctuating markets, savvy investors anchor their portfolios with the best forever stocks. These stocks have proven resilient in the face of economic uncertainties and continue to flourish amid influential megatrends. These paragons of consistency boast tremendous histories of relentless expansion rooted in sectors indispensable to our daily grind. What sets them apart is a formidable moat, be it robust brand equity, cutting-edge technology, or potent network effec""}, {""date"": ""2023-10-25"", ""headline"": ""2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?"", ""summary"": ""This hasn't been a sensational year for the dividend stocks already in investors' portfolios, but you could hardly pick a better time to be a buyer.  The risk-free returns institutional investors can receive from long-term Treasuries have risen to levels we haven't seen since before the global financial crisis kicked off about 15 years ago.  While higher interest rates are wreaking havoc on stock prices, they won't unravel the competitive advantages that allow these companies to consistently outperform.""}, {""date"": ""2023-10-26"", ""headline"": ""Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""3 Stocks to Buy (and Never Ever Sell)"", ""summary"": ""Investors have seen it all in the past three years: a pandemic, lockdown, supply chain issues, inflation, war and high interest rates. The market has shown high volatility and put investors in a state where they are only looking to invest in stocks that have already proven themselves and can survive through market turmoil. The best way to do this is to find forever stocks that have strong fundamentals, proven track records and a solid history. This will ensure that they continue to grow, no matt""}, {""date"": ""2023-10-26"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.70% to $149.00 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-26"", ""headline"": ""2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income"", ""summary"": ""High-quality dividend stocks are always worth loading up on.  This is doubly true for companies that offer shareholders an attractive mix of reliable income and reasonable levels of growth.  With risk-free assets, like the 10-year Treasury note, offering a near 5% yield, dividend stocks have generally underperformed growth plays in 2023.""}, {""date"": ""2023-10-26"", ""headline"": ""3 Pharma Stocks That Are Screaming Buys in October"", ""summary"": ""It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD).  Continued uncertainty regarding talc lawsuits is weighing on Johnson & Johnson.  Amgen's huge pipeline hasn't been fully appreciated by the market, and Gilead's settlement of an antitrust lawsuit resulted in lowering yearly earnings per share guidance.""}, {""date"": ""2023-10-26"", ""headline"": ""UPDATE 2-Kenvue cuts annual profit forecast on soft demand for cold, flu medicines"", ""summary"": ""Kenvue on Thursday cut the higher end of its annual profit forecast, as Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impact from a stronger dollar.  The consumer health company said its third-quarter net sales were hurt by a slow start to the flu season and soft demand for its products in China.  Kenvue, the spun-off unit of Johnson & Johnson, said it expects full-year organic sales growth between 5.5% and 6%, compared with its prior forecast of 5.5% to 6.5% growth.""}, {""date"": ""2023-10-26"", ""headline"": ""Cantor biotech/biopharma analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""The Passive Income Snowball Path To Wealth: VYM Vs. DGRW"", ""summary"": ""WisdomTree US Quality Dividend Growth ETF and Vanguard High Dividend Yield ETF are 2 popular dividend growth ETFs. Read our take on which is the better buy right now.""}, {""date"": ""2023-10-26"", ""headline"": ""Kenvue\u2019s stock slides premarket as company reports slow start to flu and cold season"", ""summary"": ""Kenvue Inc.\u2019s stock fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after...""}, {""date"": ""2023-10-26"", ""headline"": ""ViiV Healthcare receives approval from NMPA of China for Vocabria with Rekambys"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""The Johnson & Johnson (JNJ) Company: A Short SWOT Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""UPDATE 1-J&J says DoJ seeking information related to eye products in civil investigation"", ""summary"": ""Johnson & Johnson disclosed on Friday that the U.S. Department of Justice (DOJ) in July had sought documents and information related to the drugmaker's free and discounted eye surgery products in connection with a civil investigation.  The company said it had begun complying with the DoJ's civil investigative demands.  J&J said it is in ongoing discussion with DOJ regarding the inquiry.""}, {""date"": ""2023-10-27"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.28% to $145.60 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-27"", ""headline"": ""AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View"", ""summary"": ""AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.""}, {""date"": ""2023-10-27"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Dow down nearly 200 points on losses for shares of Chevron, Verizon"", ""summary"": ""Shares of Chevron and Verizon are trading lower Friday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""2023-10-27"", ""headline"": ""Chevron, JPMorgan Chase share losses lead Dow's 100-point drop"", ""summary"": ""Behind negative returns for shares of Chevron and JPMorgan Chase, the Dow Jones Industrial Average is falling Friday morning. Shares of Chevron and JPMorgan...""}, {""date"": ""2023-10-27"", ""headline"": ""FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""10 High-Yield Dividend Aristocrats Perfect For What's Coming Next"", ""summary"": ""Investors are worried about soaring interest rates, a pending government shutdown, wars around the world, and a recession looming next year. Read more here.""}, {""date"": ""2023-10-28"", ""headline"": ""Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime"", ""summary"": ""The average holding period is less than a year.  This short-term mindset is unfortunate because frequently trading in and out of stocks can eat into investors' long-term returns by locking in losses and increasing taxes.  Holding a high-quality company long term enables investors to capitalize on its ability to compound shareholder value.""}, {""date"": ""2023-10-28"", ""headline"": ""Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now"", ""summary"": ""Coca-Cola (NYSE: KO) is the world's largest non-alcoholic beverage company, selling drinks in more than 200 countries, but this leader still is growing.  In the most recent quarter, Coca-Cola's case volume, total revenue, and earnings per share all advanced -- and the company now expects to deliver full-year revenue growth in the double digits.  History has shown you can count on Coca-Cola's brand strength to keep customers coming back to its eponymous drink and its other popular products, such as Minute Maid juices and Dasani water.""}, {""date"": ""2023-10-29"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}, {""date"": ""2023-10-29"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
42,2023-10-29,144.44329833984375,2023-11-05,150.13768005371094,0.03942295543867691,U4,"[{""date"": ""2023-10-29"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}, {""date"": ""2023-10-29"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances"", ""summary"": ""VanEck Pharmaceutical Fund has had the strongest one-year performance of four major pharmaceutical ETF competitors. Read why I rate PPH ETF a Buy.""}, {""date"": ""2023-10-30"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Western Digital Shares Soar as Company Splits Off Flash Memory Business"", ""summary"": ""Shares of Western Digital Corp. (WDC) surged more than 10% in early trading Monday before giving back gains, after the company said it would spin off its flash memory business into a separate company.""}, {""date"": ""2023-10-30"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $147.03 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-10-30"", ""headline"": ""13 Best Warren Buffett Stock Picks for Beginners"", ""summary"": ""In this article, we discuss the 13 best Warren Buffett stock picks for beginners. To skip reading Warren Buffett\u2019s investment strategy and Q2 bets of Berkshire Hathaway, go directly to the 5 Best Warren Buffett Stock Picks for Beginners. The Oracle of Omaha, Warren Buffett, might not be the wealthiest man in the world, but [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept Responsibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Is This Year-End Rally, Like Waiting For Godot?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best November Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 11 best November dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the past years, and go directly to read 5 Best November Dividend Stocks To Buy. Dividend-paying stocks have been a preferred choice among investors for quite some time. They offer [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks"", ""summary"": ""Warren Buffett thinks big.  It's not surprising that he has led Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) to put a lot of money into some of the biggest companies on the planet.  Nearly 70% of Buffett's $326 billion Berkshire portfolio is invested in these nine megacap stocks.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Pharma Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Pharma Stocks To Buy Now. Shortly following the onset of the COVID-19 pandemic, it became evident that the world [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks"", ""summary"": ""The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.""}, {""date"": ""2023-10-30"", ""headline"": ""The Litigation Joker In Johnson & Johnson's Deck"", ""summary"": ""Johnson & Johnson, America's oldest and bluest chip corporation, is facing significant recurring litigation troubles. Explore more details here.""}, {""date"": ""2023-10-30"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.89% higher to $148.34 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-10-31"", ""headline"": ""UPDATE 1-GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy"", ""summary"": ""GSK will pay about $1 billion for exclusive rights to further develop and commercialize Johnson & Johnson's hepatitis B therapy, the British drugmaker said on Tuesday.  JNJ-3989 was initially developed by Arrowhead Pharmaceuticals and licensed to Johnson & Johnson-owned Janssen in 2018.  Exclusive rights to the therapy will fuel the expansion of GSK's own hepatitis B treatment, bepirovirsen, which is currently in late-stage development, the company said.""}, {""date"": ""2023-10-31"", ""headline"": ""Ozempic, Wegovy, and other weight loss drugs\u2019 real business impact"", ""summary"": ""The potential of weight loss drugs is too appetizing for Wall Street to pass up. But they may not have the doomsday effect on food and health as some feared.""}, {""date"": ""2023-10-31"", ""headline"": ""Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""GSK inks $1B deal to obtain rights to hepatitis B drug from J&J"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""GSK, Arrowhead announce deal with Janssen for rights to JNJ-3989"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""Is Johnson & Johnson Stock Worth Buying Following Q3 2023 Earnings?"", ""summary"": ""Johnson & Johnson's management raised its financial guidance for full-year 2023. Read why we continue upgrading JNJ stock to Outperform from Hold for next 12 months.""}, {""date"": ""2023-11-01"", ""headline"": ""Amgen Wins Big With FDA, Analyst Sees Soaring Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-01"", ""headline"": ""EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-01"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $4,108.00K"", ""summary"": """"}, {""date"": ""2023-11-01"", ""headline"": ""Chart of the Day: Is This Bullpen Name Ready for a Call-Up?"", ""summary"": ""Johnson & Johnson  has been in the Action Alerts PLUS Bullpen for awhile now.  As one of the biggest pharmaceutical names in the world with great brand recognition, research/development and tremendous sales growth, Johnson & Johnson has our attention.  While the company still does tremendous business in drugs and medical devices, its famous consumer brands are now part of Kenvue  , a recent spinoff that includes the company's former consumer products.""}, {""date"": ""2023-11-01"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $148.69 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-11-01"", ""headline"": ""3 Dividend Kings Whose Growth Streaks Could Break Before 2030"", ""summary"": ""Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.""}, {""date"": ""2023-11-01"", ""headline"": ""Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?"", ""summary"": ""Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?""}, {""date"": ""2023-11-01"", ""headline"": ""Amgen cleared in U.S. to market biosimilar to J&J\u2019s Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Key Lawyer in Johnson & Johnson Talc Litigation Supports Call to Rethink Legal Strategies in Light of Failure of Texas Two-Step"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Johnson & Johnson's Long-Term Charts Got a Boo-boo"", ""summary"": ""Johnson & Johnson  is a household name and I used to live near its corporate headquarters.  The company is a major employer in New Jersey, and a member of the Dow Jones industrial average, with a 2.94% weight at the moment.  The Moving Average Convergence Divergence (MACD) oscillator has been correcting to the downside since early 2021 and is below the zero line.""}, {""date"": ""2023-11-02"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.04% to $150.24 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-02"", ""headline"": ""Smith+Nephew plays down concerns about weight-loss drugs"", ""summary"": ""British medical products maker Smith+Nephew said weight-loss drugs could help previously ineligible overweight patients get approval for joint replacement surgery, playing down concerns about the impact of the new therapies on its business.  that healthcare companies, including Smith+ Nephew that treat obese and overweight patients for knee-related issues, will be hurt by powerful new obesity drugs known as GLP-1s like Novo Nordisk's Wegovy.  \""As patients presumably benefit from GLP-1, you could actually see some of these patients who are previously ineligible for joint replacement become eligible for that surgery,\"" CEO Deepak Nath told Reuters in an interview.""}, {""date"": ""2023-11-02"", ""headline"": ""Looking Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Pfizer: Value Investment Opportunity After Recent Price Decline"", ""summary"": ""Pfizer still generates significant gross profit and has a strong revenue growth rate. Read why I feel PFE stock presents a value investment opportunity now.""}, {""date"": ""2023-11-02"", ""headline"": ""Vor Bio announces clinical data on treating AML to be presented at ASH meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""New Biosense Webster QDOT MICRO\u2122 Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.73% higher to $151.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-03"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-11-03"", ""headline"": ""The 3 Best Forever Stocks to Buy in November"", ""summary"": ""Anytime you bring up the concept of \u201cforever stocks,\u201d you\u2019re running the risk of incurring a serious tail risk. Obviously, forever is a long time \u2013 long enough for something to go wrong. Still, certain entities stand out because they basically command permanent relevance. To be sure, my ideas for forever stocks are boring \u2013 there\u2019s no way getting around that. And while I could elect some spicier enterprises, here\u2019s the problem: I just don\u2019t know if such entities would be around for the long haul""}, {""date"": ""2023-11-03"", ""headline"": ""3 Healthcare Stocks to Buy Hand Over Fist in November"", ""summary"": ""Biotech CRISPR Therapeutics (NASDAQ: CRSP) may soon score its first product approval.  Healthcare giants Johnson & Johnson (NYSE: JNJ) and Medtronic (NYSE: MDT) have increased earnings over time -- and they've both gone through recent transformations that should spur growth in the coming quarters.  CRISPR Therapeutics might soon reach a major milestone.""}, {""date"": ""2023-11-04"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-04"", ""headline"": ""Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Dividend stocks are great because they offer you payments no matter how they perform -- and no matter how the market performs.  High levels of free cash flow, paired with a reasonable cash dividend payout ratio, suggest the company can afford to make these payouts and even lift its dividend.  AbbVie (NYSE: ABBV) formed in 2013 when it split from healthcare giant Abbott Laboratories.""}, {""date"": ""2023-11-04"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - November 2023"", ""summary"": ""This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. Read more here.""}, {""date"": ""2023-11-05"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""2023-11-05"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""2023-11-05"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
43,2023-11-05,150.13768005371094,2023-11-12,146.08018493652344,-0.02702516194293103,D3,"[{""date"": ""2023-11-04"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-05"", ""headline"": ""The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman \u2013 and Martin Shkreli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-05"", ""headline"": ""J&J\u2019s patent win against Viatris referred back to lower court"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-05"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""2023-11-05"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""2023-11-05"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-06"", ""headline"": ""Controversial brand back, survives Chapter 11 bankruptcy"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""2023-11-06"", ""headline"": ""Long-Term Winners: Ray Dalio\u2019s Top 3 Stock Recommendations for a Prosperous Future"", ""summary"": ""Amid the intricacies in the investment realm, Ray Dalio stock picks continue to resonate with both budding and seasoned investors. Since he stepped down from active leadership at Bridgewater Associates, Dalio, with his wealth of experience and visionary outlook, has continued to guide its strategy from the boardroom. His recent warnings about an overbought U.S. stock market after its bull run in the first half of the year shouldn\u2019t be ignored. Citing political and economic risks, he paints a pic""}, {""date"": ""2023-11-06"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $151.70 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-06"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""2023-11-06"", ""headline"": ""IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This"", ""summary"": ""The iShares U.S. Pharmaceuticals ETF offers targeted exposure to the pharmaceutical industry with a concentrated portfolio. Read more about IHE here.""}, {""date"": ""2023-11-06"", ""headline"": ""Quanterix Corporation: Going For Three In A Row"", ""summary"": ""Learn about Quanterix Corporation, a life sciences company with strong financials, positive quarterly results, and insider buying. Click here for more on QTRX.""}, {""date"": ""2023-11-06"", ""headline"": ""J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study"", ""summary"": ""Scores on a quality-of-life scale improved and use of antiarrhythmic drugs fell after people underwent treatment with the device.""}, {""date"": ""2023-11-06"", ""headline"": ""Mind-altering ketamine becomes latest pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-06"", ""headline"": ""Mind-altering ketamine becomes new pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""5 Kings And Aristocrats Selling At Decade High Dividend Yields"", ""summary"": ""Long-duration US Treasuries may not be a good investment. Find out a better alternative to buying long duration government debt.""}, {""date"": ""2023-11-07"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""ESSA Pharma: Unique N-Terminal Domain Approach Might Hinder mCRPC Resistance"", ""summary"": ""ESSA's EPI-7386 shows promise in treating advanced prostate cancer, with positive PSA data presented. Read my analysis of EPIX stock here.""}, {""date"": ""2023-11-07"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.53% to $150.90 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-07"", ""headline"": ""High Yield Stock Watchlist - November 2023"", ""summary"": ""The majority of the 22 stocks on my high yield watchlist for November 2023 are undervalued based on dividend yield theory. Click here for the complete list.""}, {""date"": ""2023-11-07"", ""headline"": ""J&J targets 2024 for Ottava FDA filing"", ""summary"": ""The company expects to file a submission for an\u00a0investigational device exemption\u00a0in the second half of 2024 that will allow it to begin clinical trials for the robotic surgery system.""}, {""date"": ""2023-11-07"", ""headline"": ""2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade"", ""summary"": ""Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.""}, {""date"": ""2023-11-07"", ""headline"": ""Morning Brew: Johnson & Johnson's Ottava Delay, Uber's Q3 Miss, and Intel's Foundry Business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""Johnson & Johnson to seek FDA nod to trial general surgery robot in H2 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""15 Best American Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best American dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Best American Dividend Stocks To Buy Now. In the third quarter of this year, the U.S. economy expanded at a rate of 4.9% [\u2026]""}, {""date"": ""2023-11-08"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.36% to $150.35 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-08"", ""headline"": ""Pharma ETFs in Focus Post Q3 Earnings"", ""summary"": ""Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.""}, {""date"": ""2023-11-08"", ""headline"": ""3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever"", ""summary"": ""Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.""}, {""date"": ""2023-11-08"", ""headline"": ""Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""IN BRIEF: J&J reports positive data for arthritis treatment, Tremfya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Grab these 2 funds with rich 11%-12% yields while you can"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Johnson & Johnson\u2019s Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.95% to $147.42 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-09"", ""headline"": ""3 Dividend Stocks That Could Pay for Your Holiday Shopping"", ""summary"": ""The holiday season is here, and if you haven\u2019t budgeted for your shopping, now is the perfect time to do so. With inflation under control and consumer spending slowly improving, we will have a good holiday season. If you do not want to use your credit card for purchases or haven\u2019t set aside an amount, you might want to consider making your money work for you. Investing in dividend stocks allows you to enjoy passive income to help pay for your holiday shopping. Savvy investors know that certain s""}, {""date"": ""2023-11-09"", ""headline"": ""JNJ December 29th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""3 Dividend Stocks to Buy for Consistent Income"", ""summary"": ""In the dynamic world of investing, dividend stocks have always been a consistent way for investors to generate income. These stalwarts not only offer a steady income stream but also demonstrate the power of compounding returns. Imagine a scenario where your portfolio receives a consistent boost, safeguarding your investments against the unpredictable waves of market fluctuations. Moreover, the dividends from these stocks carry a positive connotation, often reflecting the underlying company\u2019s fin""}, {""date"": ""2023-11-09"", ""headline"": ""2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague"", ""summary"": ""Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business.""}, {""date"": ""2023-11-09"", ""headline"": ""Did Warren Buffett Trade Stocks Berkshire Hathaway Owned In His Private Stock Portfolio?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""11 Best S&P 500 Stocks To Buy According to Ray Dalio\u2019s Bridgewater Associates"", ""summary"": ""In this article, we discuss the 11 best S&P 500 stocks to buy according to Bridgewater Associates. To skip the details about the firm\u2019s performance and Q2 bets, go directly to the 5 Best S&P 500 Stocks To Buy according to Bridgewater Associates. Bridgewater Associates was founded by Ray Dalio in 1975, merely two years [\u2026]""}, {""date"": ""2023-11-09"", ""headline"": ""7 Safe Stocks to Buy if You Think Q3\u2019s Gangbuster Growth Won\u2019t Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.12% to $147.25 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-10"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The November 2023 Heat Map"", ""summary"": ""Discover our 3-step process for identifying attractive, undervalued stocks with wide economic moats - Morningstar approved. Click here to read more.""}, {""date"": ""2023-11-10"", ""headline"": ""13 Best DRIP Stocks To Own"", ""summary"": ""In this article, we discuss 13 best DRIP stocks to own. You can skip our detailed analysis of the dividend reinvestment plan and the overall performance of dividend stocks, and go directly to read 5 Best DRIP Stocks To Own. A dividend reinvestment plan, or DRIP, is a strategy where investors use the dividends earned [\u2026]""}, {""date"": ""2023-11-10"", ""headline"": ""12 Dogs of the Dow Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 Dogs of the Dow dividend stocks to buy. You can skip our detailed analysis of the dogs of the Dow strategy and its returns over the years, and go directly to read 5 Dogs of the Dow Dividend Stocks to Buy. Many investors who prioritize dividends find dividend yields [\u2026]""}, {""date"": ""2023-11-10"", ""headline"": ""Big Players' Recent Trades in JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-11"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of November 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the November 12 weekly update.""}, {""date"": ""2023-11-11"", ""headline"": ""Strategic Portfolio Allocation With Risk/Reward Optimization: A Deep Dive Into My Dividend Portfolio"", ""summary"": ""Exploring the concentration and risk levels of a financial writer's personal investment portfolio, and its deviation from a new investment approach.""}, {""date"": ""2023-11-11"", ""headline"": ""Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth"", ""summary"": ""Eli Lilly (NYSE: LLY) may be a big pharma company, but it's looking like a high-growth player with a lineup of products driving double-digit percentage revenue growth.  In Q3, new products accounted for $1.44 billion of sales, and growth products, most of which won't lose patent protection in the near future, represented nearly $5 billion in revenue.  Zepbound is the same molecule as Lilly's type 2 diabetes drug, Mounjaro -- which was already one of the blockbusters driving the company's growth.""}, {""date"": ""2023-11-11"", ""headline"": ""Why You Should Aim For $2 Million For Retirement"", ""summary"": ""Retirement goals should be set based on individual situations and factors like your pre-retirement earnings. Explore more details here.""}, {""date"": ""2023-11-12"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}, {""date"": ""2023-11-12"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""2023-11-12"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}]",{}
44,2023-11-12,146.08018493652344,2023-11-19,148.59999084472656,0.017249470962116265,U2,"[{""date"": ""2023-11-12"", ""headline"": ""LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-12"", ""headline"": ""Meta Platforms Inc Takes a Hit in Jeremy Grantham's Latest Portfolio Adjustments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-12"", ""headline"": ""FMC Corp Takes the Spotlight in Tweedy Browne's Latest 13F Filing with a 1.56% Portfolio Impact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-12"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}, {""date"": ""2023-11-12"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""2023-11-12"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""2023-11-13"", ""headline"": ""Addex Therapeutics completes recruitment of patients in ADX71149"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Johnson & Johnson's Monarch approved in China for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""UCB launches newly approved psoriasis drug Bimzelx in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Ray Dalio's Bridgewater Associates Adjusts Portfolio, Notably Reduces Johnson & Johnson Stake"", ""summary"": ""Insight into Bridgewater's Q3 Moves: Dalio's Strategy Reflects in Latest 13F Filings""}, {""date"": ""2023-11-13"", ""headline"": ""Dividend Kings Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss 25 dividend kings with the highest dividend yields. You can skip our detailed analysis of dividend-growing stocks and their performance over the years, and go directly to read Dividend Kings Ranked By Yield: Top 10. Dividend Kings are a select group of publicly traded companies that have consistently increased their [\u2026]""}, {""date"": ""2023-11-13"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.26% higher to $147.63 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-11-13"", ""headline"": ""4 Large Drug Stocks Likely to Sail Through Industry Woes"", ""summary"": ""Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.""}, {""date"": ""2023-11-13"", ""headline"": ""Investors seeking triple-A rated U.S. corporate debt only have these two choices \u2014 for now"", ""summary"": ""If Moody's downgrades the U.S. rating, it may not bode well for the two remaining triple-A corporate credits.""}, {""date"": ""2023-11-13"", ""headline"": ""MedTech stocks gain after Novo Nordisk data for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Unlocking Intrinsic Value: Analysis of Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Warren Buffett's Berkshire Hathaway exits GM, Activision bets in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Ray Dalio's Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Buffett's Berkshire Trimmed Chevron Stake While Cashing Out Of GM And This COVID Stock: Here's How The Sage Of Omaha Adjusted His Portfolio In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""A Quick Look At Berkshire Hathaway\u2019s Recent Moves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Buffett\u2019s Berkshire Sells JNJ and UPS Stocks; Should You Follow?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.02% higher to $147.66 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-11-14"", ""headline"": ""Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows"", ""summary"": ""Bonds issued by America's most valuable companies are steaming ahead after sinking to their lowest prices in about 20 years.""}, {""date"": ""2023-11-14"", ""headline"": ""All Dividend Companies Have One Big Problem In Common"", ""summary"": ""Dividend investing is struggling in the current macroeconomic environment due to high interest rates. Click here to read more.""}, {""date"": ""2023-11-14"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie"", ""summary"": ""Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.""}, {""date"": ""2023-11-14"", ""headline"": ""Merck: Tracking Well Above The Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing"", ""summary"": ""It's a great idea to include a bit of both in your portfolio to support performance through any market environment.  You can either keep these payments and enjoy the passive income or reinvest the dividends to further grow your position in a particular stock.  Now, the big question is: How should you choose a winning dividend player for your portfolio?""}, {""date"": ""2023-11-14"", ""headline"": ""Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""It\u2019s Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Turner Awarded $65 Million in Contracts to Expand Johnson & Johnson Vision Manufacturing Plant"", ""summary"": ""Turner Construction Company was chosen as the contractor for a $65 million expansion to the Johnson & Johnson disposable contact lens manufacturing plant in Jacksonville, Florida.The expansion is...""}, {""date"": ""2023-11-14"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Berkshire Hathaway buys Sirius XM, exits General Motors in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Thoughts For Thursday: The Market Is Firming Higher, Tread Carefully"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Kenvue initiated with a Neutral at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio"", ""summary"": ""With the possibility that the fourth quarter\u2019s economic results might disappoint given the stellar print of Q3, investors may want to consider dividend aristocrats. If you\u2019re looking for some of the best dividend stocks for income, you can\u2019t go wrong with this label. It refers to S&P 500 companies that have increased their payouts to shareholders for at least 25 years. Fundamentally, the major benefit of dividend aristocrats centers on incentivized performance. No one wants to lead the team that""}, {""date"": ""2023-11-15"", ""headline"": ""Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow."", ""summary"": ""Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.""}, {""date"": ""2023-11-15"", ""headline"": ""15 Developed Countries with Lowest Autism Rates"", ""summary"": ""In this article, we will discuss 15 developed countries with lowest autism rates. If you want to skip our discussion on the autism industry, you can go directly to the 5 Developed Countries with Lowest Autism Rates. According to Fortune Business Insights, the autism spectrum disorder market was assessed at $1.93 billion in 2022. The [\u2026]""}, {""date"": ""2023-11-15"", ""headline"": ""12 Monthly Dividend Stocks with Over 5% Yield"", ""summary"": ""In this article, we discuss 12 monthly dividend stocks with over 5% yield. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Monthly Dividend Stocks with Over 5% Yield. During periods of financial instability, investors often focus on stocks that generate consistent income [\u2026]""}, {""date"": ""2023-11-15"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.77% higher to $148.80 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-11-15"", ""headline"": ""2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever"", ""summary"": ""If size were directly correlated with stock market performance, CVS Health (NYSE: CVS) and Johnson & Johnson (NYSE: JNJ) would always perform well as they are among the largest healthcare stocks in the U.S. However, both corporations have faced company-specific issues that have held them back, and as of this writing, they aren't that far off from their 52-week lows.  Despite their struggles, CVS Health and Johnson & Johnson have some major redeeming qualities, especially for income-seeking and long-term investors.  Let's find out why these healthcare stocks are still worth buying and holding forever.""}, {""date"": ""2023-11-15"", ""headline"": ""Berkshire Hathaway exits GM, Johnson & Johnson positions"", ""summary"": ""Warren Buffett's Berkshire Hathaway (BRK-A, BRK-B) has exited positions and sold its stakes in several companies like General Motors (GM) and Johnson & Johnson (JNJ) that recently underwent or announced new business ventures. Meanwhile, Apple (APPL), Bank of America (BAC), and American Express (AXP) continue to stand as Berkshire's top holdings. Yahoo Finance's Rachelle Akuffo and Akiko Fujita analyze Berkshire Hathaway's portfolio adjustments. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-11-15"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-11-15"", ""headline"": ""Arcellx: A Strong Contender In The CAR-T Multiple Myeloma Market"", ""summary"": ""Arcellx's CART-ddBCMA reported strong and competitive data in late-line multiple myeloma patients. Read more to see our analysis on ACLX stock.""}, {""date"": ""2023-11-15"", ""headline"": ""Buffett's firm sells off several smaller investments, including GM and UPS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Greece fines local branches of J&J and Colgate-Palmolive for allegedly breaching a profit cap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""JNJ February 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Janssen Pharmaceutical - New VOYAGER PAD Analyses Reinforce Benefit of XARELTO plus Aspirin across High-Risk and Complex Patient Populations with Peripheral Artery Disease"", ""summary"": ""TITUSVILLE - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO over...""}, {""date"": ""2023-11-15"", ""headline"": ""My Dividend Stock Portfolio: New October Dividend Record - 98 Holdings With 23 Buys"", ""summary"": ""S&P 500 and Dow Jones dropped for the third straight month in October, just before staging a remarkable reversal in November. Click here to read more.""}, {""date"": ""2023-11-15"", ""headline"": ""Donville Kent Asset Management October 2023 Insights"", ""summary"": ""In Q3 newsletter, DKAM discusses the phenomenon of market cycles, the current cycle, the impact on stock valuations, and inflation implications. Click here to read more.""}, {""date"": ""2023-11-16"", ""headline"": ""Intuitive Surgical (NASDAQ:ISRG) Gains after Analyst Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Notable Friday Option Activity: JNJ, VRT, PLL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""The Buckle (NYSE:BKE) Blasts Up After a Mixed Earnings Report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""21 Analysts Have This to Say About Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""J&J settles first talc cases to go to trial after failed bankruptcies"", ""summary"": ""Johnson & Johnson on Thursday said it has settled two lawsuits claiming its talc products caused cancer, the first such cases to go to trial since a federal court rejected the company's plan to move its talc liabilities into bankruptcy court.  The settlements resolved lawsuits brought by two men, Rosalino Reyes and Marlin Eagles, who said they developed mesothelioma related to asbestos in J&J talc powder, and was part of a broader deal to settle all talc cases brought by the law firm representing them, Kazan, McClain, Satterley & Greenwood, the company said.""}, {""date"": ""2023-11-16"", ""headline"": ""3 Must-Buy Stocks on Every Market Dip"", ""summary"": ""The stock market is flying high in November, propelled by economic data showing that inflation and the U.S. economy are slowing. Another catalyst lies in expectations that the U.S. Federal Reserve is likely finished raising interest rates. After declining for three consecutive months, the benchmark S&P 500 index has risen 7% so far in November as a year-end Santa Claus rally appears to be taking hold. Investors welcome this news as stocks of many well-known companies climbing higher. Yet despite""}, {""date"": ""2023-11-16"", ""headline"": ""3 Strong-Buy Dividend Stocks That Analysts Love"", ""summary"": ""For much of 2022 and 2023, investors could take shelter in dividend stocks. They were, as the saying goes, the best houses in a bad neighborhood (the equity markets). It\u2019s not that the analysts loved these stocks, but they hated them less. That sentiment is changing which makes it a good time to look for strong buy dividend stocks. What are analysts seeing? For starters, they\u2019re noticing that interest rates may have peaked. That doesn\u2019t mean they\u2019ll come down anytime soon, but the Federal Reserv""}, {""date"": ""2023-11-16"", ""headline"": ""10 States With The Most Doctors Per Capita In 2023"", ""summary"": ""In this article, we will discuss the 10 states with the most doctors per capita in 2023. If you want to skip our discussion on the healthcare industry in the United States, you can go directly to the 5 States With The Most Doctors Per Capita In 2023. In the ever-changing healthcare landscape in the [\u2026]""}, {""date"": ""2023-11-16"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.87% higher to $150.10 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-11-16"", ""headline"": ""Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-11-16"", ""headline"": ""Johnson & Johnson to Host Enterprise Business Review"", ""summary"": ""NEW BRUNSWICK, N.J., November 16, 2023--Johnson & Johnson (NYSE: JNJ) (the \u2018Company\u2019) will hold an Enterprise Business Review for the investment community on Tuesday, December 5, 2023. During the event, Company leaders will share a detailed review of the Innovative Medicine and MedTech businesses and their respective pipelines as well as discuss the Company\u2019s long-term strategy to deliver sustained growth and value to shareholders.""}, {""date"": ""2023-11-16"", ""headline"": ""Buffett, Dalio, Einhorn, Ackman: The Masters Of Wall Street Shuffle Their Stock Decks In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""JNJ July 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Johnson & Johnson(JNJ) 2022 CEO Joaquin Duato's Shareholder Letter: Navigating Challenges ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On"", ""summary"": ""Maybe you could find out which stocks a well-known company that has been successful for a long time really likes -- a company such as Johnson & Johnson (NYSE: JNJ).  Here are the three stocks that J&J is betting the most on.  As of Sept. 30, 2023, Johnson & Johnson's biggest investment was in Legend Biotech (NASDAQ: LEGN).""}, {""date"": ""2023-11-16"", ""headline"": ""Ex-Dividend Reminder: Johnson & Johnson, STERIS and Prudential Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Pfizer: Undervalued At Peak Pessimism in the Post-COVID-19 Era"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""7 High-Yield Blue Chips Suitable for Any Retiree"", ""summary"": ""Before extolling the benefits of high-yield blue-chip stocks, it\u2019s important to acknowledge the reality that many investors are feeling. Long-term stock investors have had to muddle through challenging macroeconomic headwinds in 2023. High inflation, rising interest rates, bank failures, two government shutdowns averted, and a new war that is fueling concerns about a broader conflict. Have I missed anything? Probably. 2023 has been a year many investors would like to forget. It\u2019s times like thes""}, {""date"": ""2023-11-17"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.21% to $149.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-17"", ""headline"": ""Morning Brew: Market Eyes Late-Cycle Quality Stocks and Housing Gains"", ""summary"": ""Market Eyes Late-Cycle Quality Stocks and Housing Gains""}, {""date"": ""2023-11-17"", ""headline"": ""Talc Lawyer: Johnson & Johnson Settlements Undermine Bankruptcy Strategy, Serve as Acknowledgment That Baby Powder Contained Asbestos"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) won't be breathing down Intuitive Surgical's (NASDAQ: ISRG) neck anytime soon.  With J&J's plans to produce a robotic surgical unit in full swing, a competitive showdown is now inevitable, and it'll play out over the rest of the decade.  The stakes are quite high for Intuitive, so let's evaluate what's going on.""}, {""date"": ""2023-11-17"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""J&J settles first talc-related lawsuits since dismissal of bankruptcy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Why Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Dividend Roundup: General Mills, Nike, Johnson & Johnson, Marriott, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-18"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
45,2023-11-19,148.59999084472656,2023-11-26,152.5,0.026245016120819198,U3,"[{""date"": ""2023-11-18"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Merck: A Dividend Growth Stock Worth Considering"", ""summary"": ""Merck reports positive quarterly earnings and consistent dividend growth over 12 years. Read why MRK stock is well-positioned for potential future success.""}, {""date"": ""2023-11-20"", ""headline"": ""Intuitive Surgical: Monopoly Days May Be Over"", ""summary"": ""Intuitive Surgical's Da Vinci Surgical Systems excel in performing precise surgeries and are positioned in a growing market. See why ISRG stock is hold rated.""}, {""date"": ""2023-11-20"", ""headline"": ""Dividend Aristocrats In Focus: Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2023 Update"", ""summary"": ""Bridgewater Associates' 13F portfolio value increased by approximately 2% to $16.55 billion in Q3 2023. Click here for a detailed analysis.""}, {""date"": ""2023-11-20"", ""headline"": ""Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug"", ""summary"": ""Bristol-Myers Squibb and 2seventy bio shares dropped after the FDA said it would not make a decision on expanded use of the companies' cancer drug next month.""}, {""date"": ""2023-11-20"", ""headline"": ""Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug"", ""summary"": ""German drugmaker Bayer scrapped a late-stage trial of an experimental blood thinner that could have major implications for Bristol Myers.""}, {""date"": ""2023-11-20"", ""headline"": ""J&J's Janssen submits FDA application for Rybrevant for cancer form"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Bayer ends large blood thinner trial for \u2018inferior efficacy\u2019"", ""summary"": ""Company shares fell by one-fifth after study monitors called for halting a planned 18,000-person trial because Bayer\u2019s\u00a0experimental drug wasn\u2019t working as well as Eliquis.""}, {""date"": ""2023-11-20"", ""headline"": ""20 Most Valuable Healthcare Companies in the World"", ""summary"": ""In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare [\u2026]""}, {""date"": ""2023-11-20"", ""headline"": ""Behind the Scenes of Johnson & Johnson's Latest Options Trends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""25 States with the Highest Poverty Rates in the US"", ""summary"": ""In this article, we will be navigating through the poverty situation in the US, the disparity in state-level poverty, while covering the 25 states with the highest poverty rates in the country. If you wish to skip our detailed analysis, you can move directly to the 5 States with the Highest Poverty Rates in the [\u2026]""}, {""date"": ""2023-11-20"", ""headline"": ""Kenvue may be activist target amid recent 13-F filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Johnson & Johnson's Dividend Analysis"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) recently announced a dividend of $1.19 per share, payable on 2023-12-05, with the ex-dividend date set for 2023-11-20.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Johnson & Johnson's dividend performance and assess its sustainability.""}, {""date"": ""2023-11-20"", ""headline"": ""Suit says J&J, Kenvue failed to flag decongestant issue in IPO, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Thinking about trading options or stock in Meta Platforms, Johnson & Johnson, PENN Entertainment, Bristol-Myers Squibb, or Cadence Design Systems?"", ""summary"": ""NEW YORK, Nov. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for META, JNJ, PENN, BMY, and CDNS. ...""}, {""date"": ""2023-11-21"", ""headline"": ""Market Whales and Their Recent Bets on JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value declined by 2% to $21.17B in Q3 2023. Microsoft, UnitedHealth, Alphabet, J&J, and Meta Platforms are top holdings.""}, {""date"": ""2023-11-21"", ""headline"": ""Hormel Foods Corporation: Thankful For 57 Years Of Growing Dividends"", ""summary"": ""Hormel Foods stock offers potential for capital appreciation and a high yield on cost for long-term holders. Read here to know why we rate HRL stock a buy.""}, {""date"": ""2023-11-21"", ""headline"": ""Top Analyst Reports for Novo Nordisk, Bank of America & Netflix"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Bank of America Corporation (BAC) and Netflix, Inc. (NFLX).""}, {""date"": ""2023-11-21"", ""headline"": ""J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant"", ""summary"": ""J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib).""}, {""date"": ""2023-11-21"", ""headline"": ""17 Stocks Warren Buffett Just Bought and Sold"", ""summary"": ""In this article, we will take a look at the 17 stocks Warren Buffett just bought and sold. To see more such companies, go directly to 5 Stocks Warren Buffett Just Bought and Sold. Warren Buffett is one of the most successful investors of all time. His net worth stands at about $120 billion as [\u2026]""}, {""date"": ""2023-11-21"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.81% higher to $151.12 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...""}, {""date"": ""2023-11-21"", ""headline"": ""Pfizer (NYSE:PFE) Sued for Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""J&J, Merck, Bristol Myers CEOs asked to testify before Senate panel on drug prices"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""A Golden Age of Vaccines Is Here. What It Means for You."", ""summary"": ""Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.""}, {""date"": ""2023-11-22"", ""headline"": ""Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income"", ""summary"": ""While the stock market has been recovering since the pullback last year, market volatility remains high as geopolitical tensions persist. The recent crisis in the Middle East has sparked concerns regarding broader regional instability. The weakening economy has caused investors to cause the November rally to halt, with the Dow Jones Industrial Average index declining marginally intraday on Tuesday. The National Retail Federation expects retail sales to grow at the slowest pace in the last five y""}, {""date"": ""2023-11-22"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.20% to $150.82 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-22"", ""headline"": ""The Zacks Analyst Blog Highlights Novo Nordisk  Bank of America, Netflix, Johnson & Johnson and TotalEnergies"", ""summary"": ""Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.""}, {""date"": ""2023-11-22"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter"", ""summary"": ""These brand-name companies had been fixtures in Berkshire Hathaway's portfolio for the past 11 to 18 years.""}, {""date"": ""2023-11-22"", ""headline"": ""GSK: Undervalued At Peak Pessimism"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""15 Best Income Stocks To Invest In"", ""summary"": ""In this article, we discuss 15 best income stocks to invest in. You can skip our detailed analysis of income stocks and the performance of dividend stocks in the past, and go directly to read 5 Best Income Stocks To Invest In. On November 22, the U.S. stock market closed with gains, driven by the positive [\u2026]""}, {""date"": ""2023-11-23"", ""headline"": ""How To Build A Dividend Portfolio Allocating $100,000 Among November's Top 20 Dividend Companies"", ""summary"": ""I will show you how you can build a dividend portfolio by allocating $100,000 among November\u00e2\u0080\u0099s top 20 dividend companies as well as one ETF. Read more here.""}, {""date"": ""2023-11-23"", ""headline"": ""Thoughts On 35 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Decades"", ""summary"": ""Many high-profile stocks can come with risks and uncertainties that make them less than ideal for investors who prioritize reliable dividend income.  While it's impossible to know where a stock will be in 20 years, certain attributes in a company increase the likelihood that it will be able to maintain its dividends well into the future.  Emerson Electric (NYSE: EMR) is a diversified industrial company that offers a broad range of products, including electrical equipment, valves, control and measurement devices, regulators, welding equipment, and automation software.""}, {""date"": ""2023-11-24"", ""headline"": ""Pneumonia outbreak in China is no reason for alarm: WHO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""AVLV: Add A Quality Tilt To Your Broad Market Index Funds With This Active Large Cap ETF"", ""summary"": """"}, {""date"": ""2023-11-24"", ""headline"": ""Goldman Sachs Value Stocks: Top 12 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top value stock picks of the investment bank Goldman Sachs. If you want to skip our introduction to the investment bank, some relevant news, and a primer on value investing, then you can skip ahead to Goldman Sachs Value Stocks: Top 5 Stock Picks. Value investing [\u2026]""}, {""date"": ""2023-11-24"", ""headline"": ""South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs"", ""summary"": ""South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.  In the COVID-19 pandemic, rich countries bought most of the world\u2019s vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called \u201ca catastrophic moral failure.\u201d  Now, poorer countries are trying to become more self-reliant \u201cbecause they\u2019ve realized after COVID they can\u2019t count on anyone else,\u201d said Brook Baker, who studies treatment-access issues at Northeastern University.""}, {""date"": ""2023-11-25"", ""headline"": ""11 Best Fortune 500 Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best Fortune 500 dividend stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their performance in the past, and go directly to read 5 Best Fortune 500 Dividend Stocks To Buy Now. The Fortune 500 is an annual list compiled and published by [\u2026]""}, {""date"": ""2023-11-25"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-25"", ""headline"": ""3 Reasons You Should Stay The Course With Dividend Stocks"", ""summary"": ""With bond yields at levels last seen before the Great Recession, it is difficult to argue against the attractiveness of fixed-income investments. Read more here.""}, {""date"": ""2023-11-26"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}, {""date"": ""2023-11-26"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""2023-11-26"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""2023-11-26"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""2023-11-26"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}]",{}
46,2023-11-26,152.5,2023-12-03,158.3800048828125,0.03855740906762306,U4,"[{""date"": ""2023-11-26"", ""headline"": ""Biden Plans to Boost Drug Production Using Cold-War Era Law"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-26"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-26"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}, {""date"": ""2023-11-26"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""2023-11-26"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""2023-11-26"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""2023-11-26"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""2023-11-27"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""3 Robotics Stocks That Could Be Multibaggers in the Making"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson sank 0.80% to $151.28 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-27"", ""headline"": ""3 Biotech Stocks To Watch Before December 2023"", ""summary"": ""Biotech stocks to check out in the stock market today.""}, {""date"": ""2023-11-27"", ""headline"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls"", ""summary"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls""}, {""date"": ""2023-11-27"", ""headline"": ""President Biden to use 1950 law to boost essential drug production"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""5 Stocks You Can Confidently Invest $500 In Right Now"", ""summary"": ""Amazon (NASDAQ: AMZN) is the leader in two markets growing in the double-digits: e-commerce and cloud computing.  Amazon recently improved its cost structure, which should pay off over time.  The company's moves in e-commerce include making its fulfillment process more efficient, and in cloud computing include major investments in artificial intelligence (AI).""}, {""date"": ""2023-11-27"", ""headline"": ""J&J : applies for an extended indication for Rybrevant"", ""summary"": ""J&J announces that its Janssen pharmaceutical companies have applied to the European Medicines Agency for an extension of the indication for Rybrevant in combination with chemotherapy for the...""}, {""date"": ""2023-11-27"", ""headline"": ""The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Buy 6 December Dividend Kings, 4 More On Watch"", ""summary"": ""An analysis of the top Dividend Kings and their impressive long-term dividend payouts is presented. Click here to find out the six December Dividend Kings.""}, {""date"": ""2023-11-27"", ""headline"": ""Gracell initiated with an Outperform at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Alvotech stock gains on positive results for J&J arthritis drug biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""2023-11-28"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.23% higher to $151.63 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-11-28"", ""headline"": ""FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now"", ""summary"": ""With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.""}, {""date"": ""2023-11-28"", ""headline"": ""Cabaletta Bio, Gracell slide as FDA probes risk of CAR T cell immunotherapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""J&J : Wells Fargo remains positive, lowers target"", ""summary"": ""Wells Fargo reaffirms its 'overweight' recommendation on Johnson & Johnson despite a price target lowered from $178 to $170, based on a ratio of around 15 times its 2025 EPS assumption for the...""}, {""date"": ""2023-11-28"", ""headline"": ""FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""10 Dividend Growth Stocks For November 2023"", ""summary"": ""Discover the top 10 dividend growth stocks for potential investment, ranked by their defensiveness scores. Click here to read my analysis.""}, {""date"": ""2023-11-28"", ""headline"": ""Johnson & Johnson price target lowered to $170 from $178 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""J&J appoints Eugene Woods to its board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q3 2023 Update"", ""summary"": ""Tweedy, Browne's 13F portfolio value decreased by 2% to $1.87B this quarter. Click here to read more about its holdings and trades for Q3 2023.""}, {""date"": ""2023-11-29"", ""headline"": ""20 Countries With The Lowest Retirement Ages in The World"", ""summary"": ""This article takes a look at the 20 countries with the lowest retirement ages in the world. If you wish to skip our detailed analysis on navigating aging populations, you may go to 5 Countries with The Lowest Retirement Ages in The World. On Navigating Aging Populations According to the World Health Organization, the population [\u2026]""}, {""date"": ""2023-11-29"", ""headline"": ""Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.""}, {""date"": ""2023-11-29"", ""headline"": ""15 States with the Best Economy Right Now"", ""summary"": ""In this article, we will discuss the 15 states with the best economy right now. If you want to skip our detailed analysis, you can go directly to the 5 States with the Best Economy Right Now. According to a report by Goldman Sachs, the economy of the United States is on track to beat expectations [\u2026]""}, {""date"": ""2023-11-29"", ""headline"": ""Johnson & Johnson, Ben Graham, And Defensive Stocks"", ""summary"": ""Johnson & Johnson satisfies all the requirements that Benjamin Graham promoted for picking defensive stocks. Read more on JNJ stock here.""}, {""date"": ""2023-11-29"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.32% higher to $152.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-11-29"", ""headline"": ""Biogen: LAQEMBI's $10 Billion Potential"", ""summary"": ""Biogen's latest Alzheimer's drug, Aduhelm, faced challenges after FDA approval. Click here to read why we still rate the BIIB stock as a 'Strong Buy'.""}, {""date"": ""2023-11-29"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-11-29"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""2023-11-29"", ""headline"": ""J&J : to present its medical advances in San Diego"", ""summary"": ""Johnson & Johnson announced today that more than 85 abstracts from its hematology portfolio and pipeline will be presented at the 65th annual meeting of the American Society of Hematology , to be held...""}, {""date"": ""2023-11-29"", ""headline"": ""3 medtech spinoffs that reshaped the industry in 2023, and what to expect next"", ""summary"": ""GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.""}, {""date"": ""2023-11-29"", ""headline"": ""Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""The 7 Biggest Dividend Stocks in Warren Buffett\u2019s Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson upgraded to Buy from Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims"", ""summary"": ""Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.  In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95% effective because it offered a \""relative risk reduction\"" for people to who took it.  Paxton said the claim was based on only two months of clinical trial data, and vaccine recipients' \""absolute risk reduction\"" showed that the vaccine was just 0.85% effective.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors"", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson (NYSE: JNJ) announced today that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed to its Board of Directors.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson Names Eugene Woods as Board Member"", ""summary"": ""By Sabela Ojea Johnson &amp; Johnson added Eugene Woods, chief executive of Advocate Health, to the board of directors. The healthcare company's chief...""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.68% to $154.66 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat"", ""summary"": ""JNJ maintains a rock-solid balance sheet, which operationally shields it from the higher for longer rate narrative. Click here to read my analysis of the stock.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson MedTech Acquires Laminar, Inc."", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and regulatory milestone payments in 2024 and beyond. Lamin""}, {""date"": ""2023-11-30"", ""headline"": ""J&J heats up LAA closure competition with $400M Laminar buy"", ""summary"": ""Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.""}, {""date"": ""2023-11-30"", ""headline"": ""IN BRIEF: Johnson & Johnson MedTech business acquires Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Revised Earnings Don\u2019t Worry Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""7 Blue-Chip Stocks to Buy for 2024, According to AI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Revised Earnings Don\u2019t Balk Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Johnson & Johnson implies that they have significant influence over...""}, {""date"": ""2023-11-30"", ""headline"": ""J&J : EPS target lowered after Laminar acquisition"", ""summary"": ""Johnson & Johnson announced on Thursday that it had lowered its earnings per share target for 2023 to take into account the acquisition of Laminar, made official today.This transaction, valued at...""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson : By the numbers"", ""summary"": ""Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company's MedTech and...""}, {""date"": ""2023-11-30"", ""headline"": ""J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?"", ""summary"": ""The 137-year-old pharmaceutical and medical-device company is taking a new direction in its efforts to discover drugs""}, {""date"": ""2023-11-30"", ""headline"": ""Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson Buys Laminar For $400 Million, Trims Profit Outlook"", ""summary"": ""By Will Feuer Johnson & Johnson said it has bought Laminary, a privately held medical device company, for an upfront payment of $400 million. J&J also cut its full-year adjusted profit...""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson buys medical device maker Laminar, cuts full-year earnings guidance"", ""summary"": ""Johnson & Johnson said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a deal that will reduce its full-year...""}, {""date"": ""2023-11-30"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Texas Sues Pfizer For \""Misrepresenting COVID-19 Vaccine Efficacy\"" And \""Conspiring To Censor Public Discourse\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Johnson & Johnson highlights its preeminent leadership in hematology through differentiated blood cancer portfolio and pipeline with new clinical and real-world data at ASH"", ""summary"": ""RARITAN - Johnson & Johnson announced today that more than 85 presentations from the Company's robust hematology portfolio and pipeline will be presented at the 65th Annual American Society of...""}, {""date"": ""2023-11-30"", ""headline"": ""J&J revises EPS guide after $400M deal to buy Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""UBS Upgrades Johnson & Johnson (JNJ)"", ""summary"": """"}, {""date"": ""2023-12-01"", ""headline"": ""Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day"", ""summary"": ""Shares are lower this year, thanks to an ongoing legal situation, but UBS says those worries are factored into the stock.""}, {""date"": ""2023-12-01"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rallied 2.41% to $158.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-01"", ""headline"": ""My Dividend Growth Portfolio November Update - Thankful For Dividend Raises"", ""summary"": ""Don't miss out on potential bargains in a rising market.""}, {""date"": ""2023-12-01"", ""headline"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls"", ""summary"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls""}, {""date"": ""2023-12-01"", ""headline"": ""Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Johnson & Johnson : the stock benefits from a positive opinion from UBS"", ""summary"": ""Johnson & Johnson shares are bucking the downward trend on Wall Street on Friday, thanks to a recommendation upgrade from UBS, which sees the American healthcare giant exceeding market expectations.A...""}, {""date"": ""2023-12-01"", ""headline"": ""Investors Should Not Pay More Than A 15 P/E Ratio When Buying A Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""J&J : Eugene A. Woods joins the Board of Directors"", ""summary"": ""Johnson & Johnson has announced the appointment of Eugene A. Woods, CEO of Advocate Health, to its Board of Directors. Woods, CEO of Advocate Health, to the Board of Directors.'M. Woods has an...""}, {""date"": ""2023-12-01"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""J&J gets upgrade from UBS with 'high conviction' in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""J&J gets upgrade from UBS with \""high conviction\"" in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Johnson & Johnson upgraded to Buy at UBS ahead of analyst day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-02"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""2023-12-02"", ""headline"": ""Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-02"", ""headline"": ""JP Morgan\u2019s Top 15 Stock Picks for 2023 and Now"", ""summary"": ""In this piece, we will take a look at JP Morgan\u2019s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world\u2019s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan\u2019s Top 5 Stock Picks for 2023. [\u2026]""}, {""date"": ""2023-12-02"", ""headline"": ""How To Build A High-Potential Dividend Portfolio Combining Dividend Income With Dividend Growth"", ""summary"": ""Learn how to build a diversified dividend portfolio that combines income and growth for an attractive total return. Read the article for more details on the portfolio.""}, {""date"": ""2023-12-02"", ""headline"": ""Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson"", ""summary"": ""Stay informed on upcoming key events in the market with Seeking Alpha's Stocks to Watch newsletter, covering IPOs, earnings reports, and more.""}, {""date"": ""2023-12-02"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - December 2023"", ""summary"": ""Discover five large-cap dividend-paying companies with discounts to their historical norms, selected from over 7,500 U.S. traded companies. Click for our picks!""}, {""date"": ""2023-12-03"", ""headline"": ""Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""2023-12-03"", ""headline"": ""The Second-Largest U.S. Pension Slashed Its AMC Stock Stake"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""2023-12-03"", ""headline"": ""Warren Buffett sold a whopping $7B worth of stock in Q3 \u2014 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong"", ""summary"": ""It's surely a bad sign for the US economy, right? Not so fast.""}, {""date"": ""2023-12-03"", ""headline"": ""Warren Buffett Just Closed His Position in This Dividend Giant. Should You?"", ""summary"": ""Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil.  One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy.  Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.""}, {""date"": ""2023-12-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}]",{}
47,2023-12-03,158.3800048828125,2023-12-10,154.4199981689453,-0.02500319858429889,D3,"[{""date"": ""2023-12-02"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""2023-12-02"", ""headline"": ""Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-03"", ""headline"": ""J&J gets FDA breakthrough status for TAR-200 in bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-03"", ""headline"": ""Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""2023-12-03"", ""headline"": ""The Second-Largest U.S. Pension Slashed Its AMC Stock Stake"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""2023-12-03"", ""headline"": ""Warren Buffett sold a whopping $7B worth of stock in Q3 \u2014 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong"", ""summary"": ""It's surely a bad sign for the US economy, right? Not so fast.""}, {""date"": ""2023-12-03"", ""headline"": ""Warren Buffett Just Closed His Position in This Dividend Giant. Should You?"", ""summary"": ""Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil.  One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy.  Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.""}, {""date"": ""2023-12-03"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""2023-12-04"", ""headline"": ""Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Johnson & Johnson: Navigating Growth and Regulatory Challenges in Medical Technology"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Johnson & Johnson Vs. Pfizer: Better Pharma Stock?"", ""summary"": ""We compared Johnson & Johnson with Pfizer Inc., the two largest pharmaceutical companies in the US. Read why JNJ stock is a Buy and PFE stock is a Hold.""}, {""date"": ""2023-12-04"", ""headline"": ""GLOBAL BRIEFING: EU trade deal with South America hangs in the balance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024"", ""summary"": ""Read about Pfizer's challenges in 2023, including decreased demand for COVID-19 vaccines and antiviral products, a destructive tornado, and a weight-loss treatment.""}, {""date"": ""2023-12-04"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.32% higher to $158.88 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-04"", ""headline"": ""Buffett Just Sold Dividend Kings Johnson & Johnson And Procter & Gamble - Buy This One Instead"", ""summary"": ""Buffett recently sold 2 popular Dividend Kings. Read more to see a high yielding Dividend King that we think looks very attractively priced at the moment.""}, {""date"": ""2023-12-04"", ""headline"": ""J&J CFO, pharma head reportedly in running to be next CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""The past one-year earnings decline for Johnson & Johnson (NYSE:JNJ) likely explains shareholders long-term losses"", ""summary"": ""The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...""}, {""date"": ""2023-12-04"", ""headline"": ""The Executives Who Could Be Johnson & Johnson\u2019s Next CEO"", ""summary"": ""Leading contenders for the helm of one of the world\u2019s biggest healthcare companies are pharmaceuticals chief Jennifer Taubert and CFO Joseph Wolk.""}, {""date"": ""2023-12-04"", ""headline"": ""JNJ Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Thinking about buying stock in Johnson & Johnson, Fortress Biotech, MicroStrategy, Neximmune, or ShiftPixy?"", ""summary"": ""NEW YORK, Dec. 4, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JNJ, FBIO, MSTR, NEXI, and PIXY. ...""}, {""date"": ""2023-12-04"", ""headline"": ""The 7 Best Ways to Invest $1,000 in the Stock Market Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""December Dogs Of The Dow: 3 Buyable, 5 Watchable"", ""summary"": ""Some of these Dow Industrials are too pricey and reveals only skinny dividends. Read here about 3 of the 5 lowest-priced Dogs of the Dow which are ready to buy.""}, {""date"": ""2023-12-04"", ""headline"": ""Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Purdue Pharma bankruptcy settlement heads to Supreme Court review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Johnson & Johnson (JNJ) and IGM Biosciences (IGMS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Elliott Wave Technical Analysis: Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""J&J says it has settled some talc claims, will continue bankruptcy strategy"", ""summary"": ""Johnson & Johnson's worldwide vice president for litigation said on Tuesday that the company has recently reached settlements with several law firms over their clients' claims that J&J talc products caused cancer.  The settlements were reached \""with a goal to facilitate our pursuit of a consensual prepackaged bankruptcy resolution,\"" Erik Haas said on an investor call.  J&J said in October that it was considering a new bankruptcy filing to resolve talc claims.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $158.55, marking a -0.21% move from the previous day.""}, {""date"": ""2023-12-05"", ""headline"": ""Top Analyst Reports for Johnson & Johnson, T-Mobile & Caterpillar"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), T-Mobile US, Inc. (TMUS) and Caterpillar Inc. (CAT).""}, {""date"": ""2023-12-05"", ""headline"": ""UPDATE 1-Johnson & Johnson forecasts as much as 6% sales growth in 2024"", ""summary"": ""Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full year after hiving off its consumer health unit, on strong demand for cancer treatments Darzalex and Carvykti, and blockbuster psoriasis drug Stelara.  \""I think they can earn closer to $10.85 vs the $10.55-10.75 guidance,\"" said Jeff Jonas, portfolio manager at Gabelli Funds, adding the company's profit per share target is \""always very conservative.\""  Sales of Stelara in Europe are expected to come under pressure as a key patent on the drug expires next year.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.21% to $158.55 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-05"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks mixed as soft jobs data backs pivot view"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson Stock Edges Higher After Guidance Release"", ""summary"": ""Johnson & Johnson  stock was edging higher after the pharmaceutical and medical-device company shared its long-term financial outlook.  In a release before a meeting with the investment community at the New York Stock Exchange on Tuesday, the company said it expects operational sales growth in the range of 5% to 6% in 2024, which excludes revenue from the Covid-19 vaccine.  Analysts had called for sales growth of 3.3%, according to FactSet.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson Targets Sales Growth in Years Ahead"", ""summary"": ""Johnson & Johnson is targeting sales growth of as much as 7% a year in the coming years, driven by its innovative medicine and MedTech operations.""}, {""date"": ""2023-12-05"", ""headline"": ""J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag"", ""summary"": ""FDA grants Breakthrough Therapy Designation to J&J's (JNJ) TAR-200 for high-risk non-muscle-invasive bladder cancer based on data from the phase IIb SunRISe-1 study.""}, {""date"": ""2023-12-05"", ""headline"": ""Take-Two Interactive, Designer Brands fall premarket;  CVS, Autozone rise"", ""summary"": ""Investing.com -- U.S. futures traded lower Tuesday, with investors turning cautious ahead of the release of job opening data, as a precursor to Friday\u2019s official monthly payrolls number.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson forecasts as much as 6% sales growth in 2024"", ""summary"": ""(Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full year after hiving off its consumer health unit, on strong demand for cancer treatments Darzalex and Carvykti, and blockbuster psoriasis drug Stelara.  \""I think they can earn closer to $10.85 vs the $10.55-10.75 guidance,\"" said Jeff Jonas, portfolio manager at Gabelli Funds, adding the company's profit per share target is \""always very conservative.\""  Sales of Stelara in Europe are expected to come under pressure as a key patent on the drug expires next year.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review"", ""summary"": ""NEW BRUNSWICK, N.J., December 05, 2023--Johnson & Johnson (NYSE: JNJ) (the \u2018Company\u2019) is hosting a meeting today with the investment community at the New York Stock Exchange to present the Company\u2019s overarching strategy, its diverse and robust Innovative Medicine and MedTech pipelines and long-term financial outlook.""}, {""date"": ""2023-12-05"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""J&J pitches investors on sales growth from cancer, immune disease drugs"", ""summary"": ""The company expects its pharmaceutical division to deliver 20 new medicines through the end of the decade, including several it believes could earn peak annual sales of more than $5 billion.""}, {""date"": ""2023-12-05"", ""headline"": ""Publication in Bloomberg Law: \u2018A Third J&J Bankruptcy Attempt Won\u2019t Resolve Victims\u2019 Talc Claims\u2019 by Andy Birchfield"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Shares Its Key Long Term Growth Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Buy Rating Affirmed for Johnson & Johnson: Long-Term Growth and Strategic Positioning Underpin Optimistic Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson's Investigational TAR-200 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer"", ""summary"": ""RARITAN - Johnson & Johnson announced today that the U.S. Food and Drug Administration has granted TAR-200 Breakthrough Therapy Designation for the potential future treatment of patients with...""}, {""date"": ""2023-12-05"", ""headline"": ""Goldman Sachs: Top 30 mutual fund underweight holdings, including Apple and Tesla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson : long-term objectives unveiled"", ""summary"": ""Johnson & Johnson unveiled its long-term financial targets on Tuesday, saying it wanted to become a leader in the healthcare market as a result of the wave of innovation currently affecting the...""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Shares Key Long Term Growth Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""TOP NEWS: J&J expects strong long-term growth in three key drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson said to be pushing to settle talc lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""J&J\u2019s stock slightly higher as company offers guidance for 2024 and longer term"", ""summary"": ""Johnson & Johnson\u2019s stock was slightly higher premarket Tuesday, after the healthcare company set guidance for 2024 and for the longer term, ahead of an...""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson sets 2024 guidance impacted from Laminar buyout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""Johnson & Johnson sees FY24 adjusted EPS $10.55-$10.75, consensus $10.78"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Strong Growth Ahead: Buy Rating for Johnson & Johnson Amid Exceeding Long-Term Projections"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Johnson & Johnson says it's finally making 'progress' on disturbing cancer lawsuits"", ""summary"": ""Johnson & Johnson (J&J) has been under fire for a decade for a myriad of cases alleging that its talc-based baby powder has caused cancer.  In a meeting at the New York Stock Exchange on Tuesday, J&J  in-house lawyer Eric Haas told investors that the company has made \""progress\"" in the last few weeks by \""resolving\"" some of the cases it's facing, according to a report by Bloomberg.  J&J is facing over 50,000 cases that claim it hid the cancer risk that comes with using its baby powder.""}, {""date"": ""2023-12-06"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 1.22% to $156.62 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-06"", ""headline"": ""J&J (JNJ) Announces 2024 and Long-Term Financial Outlook"", ""summary"": ""J&J (JNJ) expects operational sales growth in the range of 5-6% in 2024, driven by both its Innovative Medicine and MedTech divisions.""}, {""date"": ""2023-12-06"", ""headline"": ""Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential"", ""summary"": ""With the S&P 500 index stunningly back to its winning ways, it may be time to get on the bandwagon but with bargain stocks with potential. In other words, these enterprises presently lag the benchmark on a year-to-date basis. However, they could offer better bang for the buck over the intermediate to long term. First, while the broader equities space has responded positively to strong holiday sales, it\u2019s not entirely clear that the underlying consumer base can keep up the spending. For example,""}, {""date"": ""2023-12-06"", ""headline"": ""His dad worked on the factory floor at Johnson & Johnson. Now he\u2019s the CFO"", ""summary"": ""Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.""}, {""date"": ""2023-12-06"", ""headline"": ""30 Stocks shunned by hedge and mutual funds - GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""5 takeaways from J&J\u2019s investor day"", ""summary"": ""The company outlined its long-term growth expectations and confirmed that it has no plans to separate its medtech and pharma segments.""}, {""date"": ""2023-12-06"", ""headline"": ""Top 30 stocks with highest hedge fund + mutual fund short positions \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Top stocks with highest hedge fund + mutual fund positions, according to GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks"", ""summary"": ""Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks are included in this Analyst Blog.""}, {""date"": ""2023-12-06"", ""headline"": ""Johnson & Johnson price target raised to $181 from $178 at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""How To Live Off Of Dividends For Potentially Life-Changing Passive Income"", ""summary"": ""Achieving financial independence through passive income can truly be life changing. Find out why and how to do this and some of our top picks.""}, {""date"": ""2023-12-06"", ""headline"": ""Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Pharma Stocks With Nice Dividends: The RX Investors Need"", ""summary"": ""Many healthcare stocks have been under the weather this year amid concerns about the advent of weight-loss drugs, weaker Covid-related sales, and the market\u2019s narrow focus on a handful of tech names.  \u201cThe demographics alone are a huge tailwind for this sector,\u201d says Stephanie Link, chief investment strategist at Hightower Advisors.  No doubt, 2023 has been a forgettable year for many healthcare stocks.""}, {""date"": ""2023-12-06"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Johnson & Johnson price target raised by $5 at Stifel, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""J&J hernia mesh settlement prompts judge to dismiss more than 200 cases"", ""summary"": ""The company and\u00a0claimants in Georgia\u00a0filed to dismiss cases related to Ethicon\u2019s Physiomesh\u00a0in late November.""}, {""date"": ""2023-12-06"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Ping An Healthcare and Technology Company (OtherPANHF), Healthequity (HQY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Citi opens 'positive catalyst watch' on Legend Biotech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""White House to back controversial patent ploy to fight drug costs, STAT says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Investing in the Aging Population: 3 Healthcare Stocks to Watch"", ""summary"": ""In 2016, there were 49 million Americans aged 65 or older. Analysts forecast that will grow to 73 million retirement-age Americans in 2030 and an eye-opening 95 million in the year 2060. Needless to say, America\u2019s aging population will be an investing megatrend in the years to come. Given America\u2019s prosperity, a ton of money will go into healthcare companies that can extend lifespans and give people more quality time in their golden years. These three healthcare stocks, in particular, are set to""}, {""date"": ""2023-12-07"", ""headline"": ""My Top 10 High Dividend Yield Companies For December 2023"", ""summary"": ""High dividend yield companies can provide investors with several benefits, such as generation of income and reduction of portfolio volatility. Read more here.""}, {""date"": ""2023-12-07"", ""headline"": ""20 Countries with Free Health Care"", ""summary"": ""In this article, we will be taking a look at the 20 countries with free health care. To skip our detailed analysis, you can go directly to see the 5 countries with free health care. The U.S. is one of the only advanced countries in the world to not have free healthcare, which is said [\u2026]""}, {""date"": ""2023-12-07"", ""headline"": ""15 Stocks ChatGPT Says Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will take a detailed look at the 15 Stocks ChatGPT Says Will Make Me Rich in 10 Years. For a quick overview of the 5 such stocks, read our article 5 Stocks ChatGPT Says Will Make Me Rich in 10 Years. Picking individual stocks to beat the market is getting harder by the [\u2026]""}, {""date"": ""2023-12-07"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.78% to $155.40 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-07"", ""headline"": ""Top 20 Most Valuable American Companies Today"", ""summary"": ""In this article, we will be taking a look at the top 20 most valuable American companies today. To skip our detailed analysis, you can go directly to see the top 5 most valuable American companies today. When the U.S. sneezes, the world catches a cold. This one saying illustrates the importance of the U.S. [\u2026]""}, {""date"": ""2023-12-07"", ""headline"": ""Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""Johnson & Johnson will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief...""}, {""date"": ""2023-12-07"", ""headline"": ""A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?"", ""summary"": ""The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.""}, {""date"": ""2023-12-07"", ""headline"": ""Walgreens\u2019 stock soars 8% to lead Dow gainers but is still on track for worst year since 1972"", ""summary"": ""Walgreens' stock rose ahead of a ruling on what scientific evidence can be cited in lawsuits alleging that use of Tylenol by pregnant women can lead to...""}, {""date"": ""2023-12-07"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to autism in children"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to austism in children"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Johnson & Johnson (JNJ) and Elanco Animal Health (ELAN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Vanda stock jumps on $100M license deal for MS drug from J&J unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Johnson & Johnson (JNJ) and Veeva Systems (VEEV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Vanda Pharmaceuticals acquires U.S. and Canadian rights to PONVORY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-08"", ""headline"": ""The 4 Key Qualities Of Dividend Stocks That You Can Retire On"", ""summary"": ""Four essential qualities are needed in a dividend stock to make it a worthy holding in your passive income portfolio. Click here to read our stock picks with these qualities.""}, {""date"": ""2023-12-08"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.63% to $154.42 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-08"", ""headline"": ""Insiders At Johnson & Johnson Sold US$5.6m In Stock, Alluding To Potential Weakness"", ""summary"": ""Over the past year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a significant stake in the company which may have...""}, {""date"": ""2023-12-08"", ""headline"": ""7 Tech Stocks to Light Up Your Portfolio This Holiday Season"", ""summary"": ""As the festive season rolls in, finding the best tech stocks to buy is exciting, lighting up various sectors with innovative energy. These industry giants are showing impressive resilience and growth across diverse fields, from groundbreaking pharmaceuticals and cloud services to AI-powered customer interactions, cutting-edge semiconductor technology, and the expanding world of streaming platforms. Pfizer (PFE) Source: photobyphm / Shutterstock.com One of Pfizer\u2019s (NYSE:PFE) significant strength""}, {""date"": ""2023-12-08"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-08"", ""headline"": ""New Jersey Appellate Court Reverses Plaintiff Jury Verdict In Talc Litigation Based On Improperly Admitted Plaintiff Expert Opinions"", ""summary"": ""On October 3, 2023, a three-judge panel from the Superior Court of New Jersey Appellate Division reversed a jury verdict against Johnson & Johnson over accusations its asbestos-tainted talcum powder...""}, {""date"": ""2023-12-08"", ""headline"": ""Nanobiotix initiated with an Outperform at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-09"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Decades"", ""summary"": ""Remember Montgomery Ward, Lehman Brothers, and Pan Am?  Investors who bought those stocks counting on receiving steady dividends throughout their lifetimes were sorely disappointed.  Here are three dividend stocks that you can safely hold for decades.""}, {""date"": ""2023-12-09"", ""headline"": ""How To Invest $100,000 Today In A Sleep Well Portfolio"", ""summary"": ""The economic cycles have always been with us. But the frequency of boom and bust cycles has certainly increased in the last couple of decades. Read more here.""}]",{}
48,2023-12-10,154.4199981689453,2023-12-17,155.16000366210938,0.004792161002064255,U1,"[{""date"": ""2023-12-10"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-10"", ""headline"": ""Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-10"", ""headline"": ""Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $155.06 in the latest trading session, marking a +0.41% move from the prior day.""}, {""date"": ""2023-12-11"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., December 11, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 23rd to review fourth-quarter results. Joaquin Duato, Chairman and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.""}, {""date"": ""2023-12-11"", ""headline"": ""The Cooper Companies: Not In My Sight Yet"", ""summary"": ""The Cooper Companies, Inc., with a growing medical device business and market share in CooperVision, offers better value. Click for my take on COO stock now.""}, {""date"": ""2023-12-11"", ""headline"": ""Should You Consider Adding Kenvue(KVUE) to Your Portfolio?"", ""summary"": ""Mayar Capital, an investment management firm, released its \u201cMayar Responsible Global Equity Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was down -5.26% net of all expenses and fees, while the MSCI World Index decreased by -4.31% in the same period. The fund has increased 168.57% [\u2026]""}, {""date"": ""2023-12-11"", ""headline"": ""Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""2 Top Dividend Stocks to Buy Now"", ""summary"": ""This is exactly what dividend stocks offer you: the promise of regular payments each year no matter what the market is doing.  The passive income can limit your losses during market downturns and boost your winnings when stocks are soaring.  Which dividend stocks should you choose?""}, {""date"": ""2023-12-11"", ""headline"": ""5 Phenomenal Stocks in Warren Buffett's \""Secret\"" Portfolio That Are Screaming Buys in 2024"", ""summary"": ""The Oracle of Omaha's $610 million hidden portfolio has five amazing bargains hiding in plain sight.""}, {""date"": ""2023-12-11"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Johnson & Johnson just downgraded at Wells Fargo, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Kenvue: A High-Quality Consumer Health Company on Sale"", ""summary"": ""This newly created health and beauty company is undervalued""}, {""date"": ""2023-12-12"", ""headline"": ""Secular Bull Market - Part III"", ""summary"": ""2024 should be another positive year for capital market returns, specifically the major equity and fixed income benchmark indices.""}, {""date"": ""2023-12-12"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.01% higher to $155.07 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-12-12"", ""headline"": ""10 A-Rated Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at the ten A-Rated stocks billionaires are loading up on. If you want to skip our overview of the stock market and the latest news, then you can take a look at 5 A-Rated Stocks Billionaires Are Loading Up On. The stock market is made of thousands [\u2026]""}, {""date"": ""2023-12-12"", ""headline"": ""JNJ multiple myeloma therapy outperforms standard of care by 58%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Eli Lilly: The Party Is Over"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""J&J: Data from Phase 3 PERSEUS study shows improvement in outcomes for patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Why heart device makers are investing in left atrial appendage closure"", ""summary"": ""Medtronic and Johnson & Johnson are pursuing\u00a0a market that leader Boston Scientific predicts could hit $6 billion by 2030.""}, {""date"": ""2023-12-12"", ""headline"": ""The biopharma stocks to own in 2024, according to Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Johnson & Johnson price target lowered by $1 at Morgan Stanley, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Johnson & Johnson Earnings to Be Hit by Loss of Stelara Exclusivity, Wells Fargo Says"", ""summary"": ""Johnson & Johnson  stock was trading lower Wednesday after a Wells Fargo analyst cited concerns over the company\u2019s future earnings growth.  The healthcare company stands to lose exclusive U.S. rights to a major drug, Stelara, in 2025.  Wells Fargo analyst Larry Biegelsen downgraded J&J shares to Equal Weight from Overweight and lowered his price target to $163 from $170.""}, {""date"": ""2023-12-13"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.46% higher to $155.79 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-12-13"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-12-13"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 5.3%. However, the company's...""}, {""date"": ""2023-12-13"", ""headline"": ""Wells Fargo lowers J&J to equal weight, cites Stelara patent cliff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Seeking Passive Income? 7 Dividend Stocks You Don\u2019t Want to Miss."", ""summary"": ""The quest for the passive income from a stable investment avenues beckons toward dividend stocks. Enter a realm where industry giants don their strategic armor, ready to navigate the tides of market dynamics and consumer demands. The stage is set for an enthralling exploration of seven passive income juggernauts. Each is an emblem of innovation and resilience in their respective domains. These passive income plays offer investors a panoramic view of the dividend stock landscape in the ever-evolv""}, {""date"": ""2023-12-13"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""20 Biggest Multinational Companies Headquartered in the US"", ""summary"": ""In this article, we will take a look at the 20 biggest multinational companies headquartered in the US. If you want to skip our detailed analysis, you can go directly to 5 Biggest Multinational Companies Headquartered in the US. The Future of Multinational Companies According to a report by Deloitte, a sweeping international tax policy [\u2026]""}, {""date"": ""2023-12-13"", ""headline"": ""J&J : shares fall behind Pfizer and an analyst downgrade"", ""summary"": ""On Wednesday, Johnson & Johnson posted the second biggest drop in the Dow Jones index, penalized by Pfizer's disappointing forecasts and a downgrading by Wells Fargo analysts.A little less than an...""}, {""date"": ""2023-12-13"", ""headline"": ""Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""J&J : new positive data in multiple myeloma"", ""summary"": ""Johnson & Johnson has announced that initial data from a Phase 3 study demonstrate significant clinical improvement in newly diagnosed multiple myeloma patients eligible for transplantation with a...""}, {""date"": ""2023-12-13"", ""headline"": ""J&J : promising results in multiple myeloma"", ""summary"": ""Johnson & Johnson has announced new results from a Phase III study of Carvykti in adults with relapsed lenalidomide-refractory multiple myeloma who have received one to three prior lines of therapy ....""}, {""date"": ""2023-12-13"", ""headline"": ""Key Talc Lawyers: Planned \u201cPrepack\u201d J&J Bankruptcy is \u201cFarce\u201d and Improper Litigation Tactic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Video: Dow Movers: JNJ, AAPL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Microsoft initiated, Hertz downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Ford cut to Neutral on dwindling F-150 EV truck demand outlook: 4 big analyst cuts"", ""summary"": ""Reports from earlier this week indicated that Ford plans to halve the production of its F-150 Lightning electric pickup truck in 2024, citing \""changing market demand\"" as the reason. This move reflects a broader industry trend of reducing electric vehicle investments due to slower-than-expected sales growth.""}, {""date"": ""2023-12-13"", ""headline"": ""Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Protagonist earns $10M payment for milestone in Phase 2b ANTHEM-UC study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""GLOBAL BROKER RATINGS: UBS raises BASF; JPMorgan cuts LVMH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Integra to acquire Acclarent from Johnson & Johnson for $275M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""The Dogs of the Dow May Pay Big Dividends in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""3 Dow Stocks I Wouldn\u2019t Touch With a 10-Foot Pole"", ""summary"": ""The Dow Jones Industrial Average, or Dow 30, is an index of 30 blue-chip stocks that, taken together, is supposed to serve as a bellwether for the American economy. But that doesn\u2019t mean that every stock in the Dow is a strong performer. Quite the opposite. Many of the stocks in the Dow are of companies that have grown long in the tooth and are now considered to be value traps. Critics of the Dow point to the current crop of underperforming stocks and claim that the index is outdated and no long""}, {""date"": ""2023-12-14"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.69% higher to $156.87 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-12-14"", ""headline"": ""Wells Fargo Downgrades Johnson & Johnson (JNJ)"", ""summary"": """"}, {""date"": ""2023-12-14"", ""headline"": ""Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Vertex Pharmaceuticals: Growth Is Still a Better Choice"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy in December"", ""summary"": ""2023 has been mixed for growth stocks but I believe the worst is over. There is high optimism in the stock market as we end the year on a high note. However, if you want to secure your portfolio from such ups and downs and are looking for ways to generate passive income, considering top dividend stocks to buy is the best way forward. But, all dividend stocks aren\u2019t the same and some are more promising than many others. You need to look for companies that have shown steady growth, and resilience""}, {""date"": ""2023-12-15"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.09% to $155.16 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-12-15"", ""headline"": ""IXJ: Healthcare Dashboard For December"", ""summary"": ""iShares Global Healthcare is a global alternative to Healthcare Select Sector SPDR Fund. Click here to read an analysis on IXJ ETF here.""}, {""date"": ""2023-12-15"", ""headline"": ""AC Immune Alzheimer's drug advanced into Phase 2b testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""AC Immune reports ACI-35.030 advances into Phase 2b trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""BTIG makes top medtech stock picks for 2024, sees sector stabilizing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""12 Best Slow Growth Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a detailed look at the 12 Best Slow Growth Stocks To Buy According To Hedge Funds. For a quick overview of such stocks, read our article 5 Best Slow Growth Stocks To Buy According To Hedge Funds. It would be interesting to see how markets react to the latest events after a statement [\u2026]""}, {""date"": ""2023-12-17"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}, {""date"": ""2023-12-17"", ""headline"": ""3 of the Most Attractive Dividend Stocks in the Pharma Space"", ""summary"": ""In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportunities for long-term investors. Moreover, given the evergreen nature of healthcare demand which remains sturdy across economic cycles, pharma businesses exhibit remarkable resilience. They channel substantial investments into research and development. And, they effectively pave the way for innovative""}, {""date"": ""2023-12-17"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) Using Too Much Debt?"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""2023-12-17"", ""headline"": ""\u2018You'll be a millionaire when you're 65': Kevin O'Leary says you must save this percentage of your income for a healthy retirement \u2014 and even gives his 3 top stocks for new investors"", ""summary"": ""'You can't assume someone will be there for you,' says the Shark Tank star.""}]",{}
49,2023-12-17,155.16000366210938,2023-12-24,155.4600067138672,0.0019335076351965075,U1,"[{""date"": ""2023-12-16"", ""headline"": ""BTIG makes top medtech stock picks for 2024, sees sector stabilizing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}, {""date"": ""2023-12-17"", ""headline"": ""3 of the Most Attractive Dividend Stocks in the Pharma Space"", ""summary"": ""In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportunities for long-term investors. Moreover, given the evergreen nature of healthcare demand which remains sturdy across economic cycles, pharma businesses exhibit remarkable resilience. They channel substantial investments into research and development. And, they effectively pave the way for innovative""}, {""date"": ""2023-12-17"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) Using Too Much Debt?"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""2023-12-17"", ""headline"": ""\u2018You'll be a millionaire when you're 65': Kevin O'Leary says you must save this percentage of your income for a healthy retirement \u2014 and even gives his 3 top stocks for new investors"", ""summary"": ""'You can't assume someone will be there for you,' says the Shark Tank star.""}, {""date"": ""2023-12-18"", ""headline"": ""Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $155.44, marking a +0.18% move from the previous day.""}, {""date"": ""2023-12-18"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.18% higher to $155.44 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-12-18"", ""headline"": ""XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector"", ""summary"": ""XLV comprises major healthcare industry players and offers a convenient and cost-effective way to invest in the sector. Find out my analysis of XLV ETF.""}, {""date"": ""2023-12-18"", ""headline"": ""The Zacks Analyst Blog Highlights JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP"", ""summary"": ""JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP are included in this Analyst Blog.""}, {""date"": ""2023-12-18"", ""headline"": ""13 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device [\u2026]""}, {""date"": ""2023-12-18"", ""headline"": ""Janssen treatment of ADPKD granted FDA orphan designation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Sanofi: The Current Price Makes No Sense"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Forever Favorites: 7 Dividend Stocks to Buy and Never Sell"", ""summary"": ""Some investments just look after themselves. They are \u201cset it and forget it\u201d kind of stocks. Typically they pay dividends because dividend stocks tend to be profitable businesses that have been through the mill a time or two. They want to share their success with their investors. The asset managers at Hartford Funds looked at the performance of the benchmark S&P 500 going all the way back to 1930. They found dividends contributed 40% to the total return of the index over that 93-year period. Mor""}, {""date"": ""2023-12-19"", ""headline"": ""Lawsuits claiming Tylenol causes autism lack scientific support, judge finds"", ""summary"": ""A judge has barred expert witnesses from testifying that Johnson & Johnson spin-off Kenvue's painkiller Tylenol can cause autism if mothers take it during pregnancy, finding that they failed to support their conclusions with scientific evidence.  The ruling on Monday by U.S. District Judge Denise Cote in Manhattan federal court likely means the end of a consolidated mass tort litigation of about 500 lawsuits over the popular over-the-counter drug, unless plaintiffs get it reversed on appeal.  Cote, in a 148-page ruling, found that none of the five expert witnesses proposed by the plaintiffs had offered a sound scientific methodology to support their opinion that Tylenol's active ingredient, acetaminophen, could cause autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).""}, {""date"": ""2023-12-19"", ""headline"": ""Kenvue Shares Are Rising. Tylenol Litigation Fades Into the Rearview."", ""summary"": ""A ruling hurts litigation against Kenvue that alleges a link between prenatal exposure to the company\u2019s Tylenol and autism spectrum disorder or ADHD.""}, {""date"": ""2023-12-19"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.66% higher to $156.46 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-12-19"", ""headline"": ""7 New Year\u2019s Stocks to Buy to Get 2024 Off to a Bright Start"", ""summary"": ""With another year in the global markets coming to a close, now is a great time to consider stocks to buy for 2024. Part of the reason is to establish a framework for navigating the myriad uncertainties that could lie ahead. For example, there\u2019s a lot of talk about the Federal Reserve\u2019s monetary policy these days. With the central bank broadcasting the acknowledgment of a possible policy pivot, the development sparked considerable enthusiasm of what could lie ahead. That helps fuel motivation for""}, {""date"": ""2023-12-19"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Kenvue\u2019s stock rises after favorable court ruling in Tylenol litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""3 Healthcare Stocks That Could Help Make You a Millionaire"", ""summary"": ""These stocks each have reached an important turning point that could signal growth ahead.""}, {""date"": ""2023-12-19"", ""headline"": ""Kenvue gains as ruling in Tylenol case likely collapses plaintiffs case - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""J&J spinoff rises following favorable Tylenol court ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Kenvue's stock rises after favorable court ruling in Tylenol litigation"", ""summary"": ""Kenvue shares gained nearly 5% Tuesday morning after a federal court's ruling in a product-liability case appeared to work in the Tylenol maker's favor.""}, {""date"": ""2023-12-19"", ""headline"": ""Kenvue shares rise after favorable court ruling in Tylenol litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""J&J submits sBLA and NDA to FDA for approval of Rybrevant combo in NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""J&J submits sBLA to FDA for Rybrevant combo in non-small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Noteworthy Thursday Option Activity: JNJ, CTAS, AON"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""11 Best Fundamental Stocks to Buy"", ""summary"": ""In this article, we discuss the 11 best fundamental stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Fundamental Stocks to Buy. The United States economy is one of the most resilient in the world. This is aptly illustrated by the fact that the [\u2026]""}, {""date"": ""2023-12-20"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 2.04% to $153.27 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-20"", ""headline"": ""COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""11 Best Roth IRA Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 11 best Roth IRA stocks to buy according to hedge funds. If you want to read about some more Roth IRA stocks, go directly to 5 Best Roth IRA Stocks To Buy According To Hedge Funds. In 2022, recession fears had clouded the marketplace as the Federal Reserve in [\u2026]""}, {""date"": ""2023-12-20"", ""headline"": ""Lantheus Holdings Is Charting a Path to Sustainable Growth and Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""IUSV: An Old Value ETF Beating Most Competitors"", ""summary"": ""iShares Core S&P U.S. Value ETF is a well-diversified and consistently outperforming fund for long-term investors and tactical traders. Find out more on IUSV.""}, {""date"": ""2023-12-21"", ""headline"": ""Legend Biotech, J&J's Carvykti drug gets label update to include warning on blood cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-21"", ""headline"": ""Build Your Future Portfolio: 3 Generous Dividend Stocks"", ""summary"": ""You heard it here: 2024 could be an excellent year for stocks. The economy is improving, and specifically the third-quarter results were better than expected. This means we could see a significant upside in stocks in the coming months. However, if you are looking to make a steady income in 2024, it is advisable to invest in dividend stocks. Look for stocks that show capital appreciation and continue to generate steady income for you in the coming years. You\u2019ll need to identify companies that hav""}, {""date"": ""2023-12-21"", ""headline"": ""15 Stocks That Will Make You Rich in 5 Years According to ChatGPT"", ""summary"": ""In this article, we will take a detailed look at the 15 Stocks That Will Make You Rich in 5 Years According to ChatGPT. For a quick overview of such stocks, read our article 5 Stocks That Will Make You Rich in 5 Years According to ChatGPT. All anyone in the Wall Street could talk about [\u2026]""}, {""date"": ""2023-12-21"", ""headline"": ""35 Best Countries For Raising Kids"", ""summary"": ""In this article, we are going to discuss the 35 Best Countries For Raising Kids. You can skip our detailed analysis based on Reddit threads and go directly to 10 Best Countries For Raising Kids. When choosing the best place to raise kids, there are many factors to consider, such as the cost of living, education [\u2026]""}, {""date"": ""2023-12-21"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.02% to $154.84 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-21"", ""headline"": ""7 Stocks That Might Win on Election Year Uncertainty"", ""summary"": ""Soon, it will be that favorite time of the quadrennial cycle where American citizens will decide the future of this great nation, subsequently necessitating a discussion about election year stocks. On surface level, you might think that such periods would be rather disastrous for equities, especially with the vituperative environment. However, the hard numbers suggest otherwise. According to Morningstar, \u201chistorical data suggests that elections are not synonymous with market selloffs. A deeper l""}, {""date"": ""2023-12-21"", ""headline"": ""J&J bets bigger on\u00a0MeiraGTx\u2019s eye gene therapy"", ""summary"": ""Ahead of a Phase 3 readout that could come next year, the pharma is paying $130 million in upfront and near-term cash for rights to the retinitis pigmentosa treatment that it didn\u2019t already own.""}, {""date"": ""2023-12-21"", ""headline"": ""Got $1,000? 5 of the Safest Stocks to Buy for 2024"", ""summary"": ""Regardless of what's thrown Wall Street's way in the new year, these tried-and-true companies can deliver for their shareholders.""}, {""date"": ""2023-12-21"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-21"", ""headline"": ""Johnson & Johnson : Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT\u00ae\u25bc (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""News Release Media Contacts: Zayn Qureshi +44 7760 334666 Email: zqureshi@its.jnj.com Investor...""}, {""date"": ""2023-12-21"", ""headline"": ""Warren Buffett's Wealth-Building Formula: Consider VIG Instead Of Berkshire Hathaway"", ""summary"": ""We examine several Buffett quotes that encapsulate his wealth-building formula and look at why VIG could be a better option than Berkshire Hathaway.""}, {""date"": ""2023-12-21"", ""headline"": ""MeiraGTx announces asset purchase agreement with Janssen for bota-vec"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""Johnson & Johnson: Ottava Surgical Robot Is A Growth Tailwind"", ""summary"": ""Johnson & Johnson enters surgical robotics market with Ottava system, offering competitive advantages over da Vinci. Read about the buy thesis for JNJ stock.""}, {""date"": ""2023-12-22"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.40% higher to $155.46 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-12-22"", ""headline"": ""14 Cheap DRIP Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 cheap DRIP stocks to buy now. You can skip our detailed analysis of dividend reinvestment plans and performance of dividend stocks in the past, and go directly to read 5 Cheap DRIP Stocks To Buy Now. Investing in dividend stocks is often seen as a game for patient investors [\u2026]""}, {""date"": ""2023-12-22"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""J&J : EU marketing authorization application for Rybrevant"", ""summary"": ""Johnson & Johnson announces that it has submitted a marketing authorization application to the European Medicines Agency seeking approval of lazertinib + Rybrevant for the first-line treatment of...""}, {""date"": ""2023-12-22"", ""headline"": ""29 Undervalued Dividend Aristocrats: December 2023"", ""summary"": ""The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats. Click here to read more.""}, {""date"": ""2023-12-22"", ""headline"": ""J&J : seeks FDA approval for Rybrevant"", ""summary"": ""Johnson & Johnson announced that it has applied to the FDA for approval of Rybrevant in combination with lazertinib as a first-line treatment for adult patients with EGFR-mutated locally advanced or...""}, {""date"": ""2023-12-22"", ""headline"": ""Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""New Jersey - Johnson & Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration together with a New Drug Application seeking...""}, {""date"": ""2023-12-22"", ""headline"": ""Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT, for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""BELGIUM - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a marketing authorisation application to the European Medicines Agency seeking approval of...""}, {""date"": ""2023-12-23"", ""headline"": ""3 Worst Performing Dow Jones Stocks In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-23"", ""headline"": ""Dividend Contenders List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend contenders according to yields. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read Dividend Contenders List Ranked By Yield: Top 10. Dividend contenders typically refer to companies that have consistently increased their dividends for at least 10 consecutive [\u2026]""}, {""date"": ""2023-12-23"", ""headline"": ""Strategically Building A $50,000 Dividend Portfolio With Only 3 ETFs And 3 Stocks"", ""summary"": ""This dividend portfolio serves as a buy-and-hold portfolio. It provides investors with an extensive diversification across companies. Read more here.""}, {""date"": ""2023-12-23"", ""headline"": ""5 Top Stocks to Buy With Your End-of-the-Year Bonus"", ""summary"": ""Your bonus could become the gift that keeps on giving.""}, {""date"": ""2023-12-23"", ""headline"": ""What To Do With High-Flying Tech At The Start Of 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-24"", ""headline"": ""25 Happiest States In The US"", ""summary"": ""In this article, we will take a look at the 25 happiest states in the US in 2023. If you want to skip our discussion on the happiness measurement metrics, you can go directly to the 5 Happiest States In The US. For the longest time, people have believed that happiness is not quantifiable; it [\u2026]""}, {""date"": ""2023-12-24"", ""headline"": ""2 Top Dividend Stocks You Can Buy and Hold Forever"", ""summary"": ""These companies pay very durable dividends.""}, {""date"": ""2023-12-24"", ""headline"": ""6 Reasons to Avoid Johnson & Johnson (JNJ) At All Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
50,2023-12-24,155.4600067138672,2023-12-31,156.74000549316406,0.008233621021596749,U1,"[{""date"": ""2023-12-23"", ""headline"": ""3 Worst Performing Dow Jones Stocks In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-23"", ""headline"": ""Dividend Contenders List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend contenders according to yields. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read Dividend Contenders List Ranked By Yield: Top 10. Dividend contenders typically refer to companies that have consistently increased their dividends for at least 10 consecutive [\u2026]""}, {""date"": ""2023-12-24"", ""headline"": ""25 Happiest States In The US"", ""summary"": ""In this article, we will take a look at the 25 happiest states in the US in 2023. If you want to skip our discussion on the happiness measurement metrics, you can go directly to the 5 Happiest States In The US. For the longest time, people have believed that happiness is not quantifiable; it [\u2026]""}, {""date"": ""2023-12-24"", ""headline"": ""2 Top Dividend Stocks You Can Buy and Hold Forever"", ""summary"": ""These companies pay very durable dividends.""}, {""date"": ""2023-12-24"", ""headline"": ""6 Reasons to Avoid Johnson & Johnson (JNJ) At All Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-25"", ""headline"": ""Nanobiotix says LianBio enters NBTXR3 development pact with Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-25"", ""headline"": ""7 Rock-Solid Dividend Stocks to Trust in Difficult Times"", ""summary"": ""While the upcoming new year generally brings optimistic sentiment to the market, investors should be prepared for anything, which is why solid dividend stocks represent an incredibly relevant topic. Much like playing the hot corner, you\u2019ve got to be ready for anything. In baseball, hard-hit balls can end up anywhere on the field. However, they generally tend to scream toward third base. That\u2019s why you\u2019ve got to have some quick hands to play this position. As well, you\u2019ve got to be smart because""}, {""date"": ""2023-12-25"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-25"", ""headline"": ""Capital Gain/Loss On Holdings And Trading Gain/Loss With Cash Cows"", ""summary"": ""I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. Read more here.""}, {""date"": ""2023-12-25"", ""headline"": ""The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.44% higher to $156.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-12-26"", ""headline"": ""Best Stocks To Buy In 2024? 2 Blue Chip Stocks In Focus"", ""summary"": ""2 blue chip stocks for your 2024 watchlist.""}, {""date"": ""2023-12-26"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 57% Above Its Share Price"", ""summary"": ""Key Insights Johnson & Johnson's estimated fair value is US$245 based on 2 Stage Free Cash Flow to Equity Current share...""}, {""date"": ""2023-12-26"", ""headline"": ""Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""Johnson & Johnson inks licensing deal with LianBio (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""Thinking about trading options or stock in NVIDIA, Marvell Technology, Johnson & Johnson, Stratasys, or Digital World Acquisition Corp?"", ""summary"": ""NEW YORK, Dec. 26, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, MRVL, JNJ, SSYS, and DWAC. ...""}, {""date"": ""2023-12-26"", ""headline"": ""Integra LifeSciences: M&A Masks Operational Struggles"", ""summary"": ""Integra LifeSciences is a leader in neurosurgical solutions, regenerative technologies, and surgical instrumentation. Find out my analysis of IART stock.""}, {""date"": ""2023-12-27"", ""headline"": ""Contagious Opportunities: Norovirus Cases Are On The Rise, These Are The Stocks That May Be Impacted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""11 Hot Healthcare Stocks To Buy Now"", ""summary"": ""In this article, we will be taking a look at 11 hot healthcare stocks to buy now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Hot Healthcare Stocks To Buy Now. Healthcare is a vital part of daily living for everyone, whether it be to cure [\u2026]""}, {""date"": ""2023-12-27"", ""headline"": ""20 Most Expensive Drugs in the World"", ""summary"": ""In this article, we will take a look at the 20 most expensive drugs in the world. If you want to skip our discussion on the pharmaceutical industry, you can go directly to the 5 Most Expensive Drugs in the World. The health of the global population is being adversely affected due to numerous factors, [\u2026]""}, {""date"": ""2023-12-27"", ""headline"": ""Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness"", ""summary"": ""The United States leads globally in the healthcare sector, with its innovative healthcare stocks drawing attention from an impressive $4.3 trillion in spending. As the American Medical Association highlights, this expenditure equals nearly $13,000 per person, contributing 18.3% to the nation\u2019s GDP. This level of investment showcases its commitment to health and underscores its role as a frontrunner in medical advancements and innovations. Amidst this landscape, the U.S. emerges as a powerhouse i""}, {""date"": ""2023-12-27"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.13% higher to $156.35 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-12-27"", ""headline"": ""A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?"", ""summary"": ""In pharma, a company can take a larger slice of the healthcare pie than peers, but it is still constrained by the size of the pie.""}, {""date"": ""2023-12-27"", ""headline"": ""Can JNJ reverse loss in 2024 on EPS growth, eyes on talc litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""FDA\u2019s new drug approvals for 2023 rise 51% from last year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?"", ""summary"": ""These stocks have significantly underperformed the market. But are they really \""cheap\""?""}, {""date"": ""2023-12-27"", ""headline"": ""J&J : licensing agreement with Korea's LegoChem in ADCs"", ""summary"": ""LegoChem Biosciences announced yesterday the conclusion of an exclusive licensing agreement with Janssen Biotech, under which the South Korean laboratory will grant the J&J subsidiary the rights to...""}, {""date"": ""2023-12-27"", ""headline"": ""3 No-Brainer Stocks to Buy With $200 Right Now"", ""summary"": ""A reasonably modest amount of money can go a long way when it's invested in innovation-driven businesses.""}, {""date"": ""2023-12-27"", ""headline"": ""J&J's Janssen signs licensing deal worth up to $1.7B with LegoChem"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Johnson & Johnson holders allowed to sue as a class over talc disclosures, judge rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why"", ""summary"": ""In the most recent trading session, Johnson & Johnson (JNJ) closed at $156.58, indicating a +0.15% shift from the previous trading day.""}, {""date"": ""2023-12-28"", ""headline"": ""Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024"", ""summary"": ""Although next year looks to be a good time to invest in risk assets like Bitcoin (BTC-USD), investors with a lower risk tolerance look toward safe havens to grow their income. Some of these haven assets provide diversification benefits for investors who engage in risky positions elsewhere. Bonds and other instruments are inversely correlated to broader indices like the S&P 500. This article will explore three types of safe-haven assets that investors can tap into for reliable income. I\u2019ve select""}, {""date"": ""2023-12-28"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.15% higher to $156.58 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-12-28"", ""headline"": ""11 Set-It-and-Forget-It Stocks to Buy According to Financial Media"", ""summary"": ""In this article, we discuss the 11 set-it-and-forget-it stocks to buy according to financial media. To skip the overview of set-it-and-forget-it stocks and portfolios, go directly to the 5 Set-It-and-Forget-It Stocks to Buy According to Financial Media. Some stocks are meant to be kept forever according to financial media and investors. The set-it-and-forget-it stock portfolio [\u2026]""}, {""date"": ""2023-12-28"", ""headline"": ""Top 15 Value Stocks to Buy for 2024"", ""summary"": ""In this article, we discuss top 15 value stocks to buy for 2024 picked by Joel Greenblatt. To skip the details about Mr. Greenblatt\u2019s life, portfolio performance, and investment strategy, go directly to Top 5 Value Stocks to Buy for 2024. Investing offers an exciting and effective way of growing wealth over time. Value investing is [\u2026]""}, {""date"": ""2023-12-28"", ""headline"": ""February 2024 Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?"", ""summary"": ""Buffett didn't say why he closed positions in two stocks with underlying businesses that are doing well at the moment.""}, {""date"": ""2023-12-28"", ""headline"": ""Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""Dow Dogs Gain Some Respect In Q4 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""UPDATE 1-Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013, to Dec. 13, 2018, to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""2023-12-29"", ""headline"": ""Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013 to Dec. 13, 2018 to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""2023-12-29"", ""headline"": ""REFILE-Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013 to Dec. 13, 2018 to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""2023-12-29"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.10% higher to $156.74 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-29"", ""headline"": ""There Are Only 5 Dow Stocks I Wouldn't Buy in 2024"", ""summary"": ""There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.""}, {""date"": ""2023-12-29"", ""headline"": ""Your New Year's Resolution For 2024: Invest $10,000 In These 5 Stocks"", ""summary"": ""Discover five world-class companies that offer strong dividend growth potential in this article on long-term investing strategies. Click here to read more.""}, {""date"": ""2023-12-29"", ""headline"": ""11 Best Psychedelic Stocks to Buy in 2024"", ""summary"": ""In this article, we discuss 11 of the best psychedelic stocks to buy in 2024. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy. Unlike substances like marijuana or cocaine, psychedelics are potent and serve as a form of gateway to an \u2018alternate reality\u2019 for those [\u2026]""}, {""date"": ""2023-12-29"", ""headline"": ""15 Best Dow Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 15 best Dow stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Dow Stocks To Buy Now. The Dow Jones Industrial Average, also known as Dow Jones or Dow, is one of the oldest and most followed equity [\u2026]""}, {""date"": ""2023-12-29"", ""headline"": ""Unpacking the Latest Options Trading Trends in Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times"", ""summary"": ""Whether you are a beginner or a professional investor, a small amount can go a long way. Investing in dividend stocks can not only help build a strong portfolio, but also generate steady passive income for you. Several companies have raised their payouts in the third quarter, and as the economy improves, we could see better numbers in the coming years. This is great for investors, but the trick is to look for companies that steadily pay dividends and are generous with their payout. Reinvestment""}, {""date"": ""2023-12-29"", ""headline"": ""From \u2018Putin\u2019s chef\u2019 to Henry Kissinger, Jim Brown to Bobby Knight, and Harry Belafonte to Tina Turner \u2014 plus Charlie Munger \u2014 these were the notable deaths of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-30"", ""headline"": ""Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation"", ""summary"": ""Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Read why I'm rating BMY stock a Buy at this point.""}, {""date"": ""2023-12-30"", ""headline"": ""These are the largest publicly-traded companies in each US state"", ""summary"": ""Yahoo Finance compiled a list of the biggest publicly traded companies in each state and Washington, D.C. based on market cap.""}, {""date"": ""2023-12-30"", ""headline"": ""2 Best Warren Buffett Stocks to Buy for the Long Haul"", ""summary"": ""These companies need no introduction.""}, {""date"": ""2023-12-30"", ""headline"": ""Dividend Stock Watch List: January 2024 Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-31"", ""headline"": ""3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024"", ""summary"": ""These \""Dogs of the Dow\"" offer attractive dividend yields and upside potential.""}, {""date"": ""2023-12-31"", ""headline"": ""January's 54 Dividend Kings: Buy 8, Watch 5"", ""summary"": ""Discover the top Dividend Kings for January, including Altria Group, with high yields and potential for net-gains according to brokers.""}, {""date"": ""2023-12-31"", ""headline"": ""Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
51,2023-12-31,156.74000549316406,2024-01-07,161.1300048828125,0.02800816151457841,U3,"[{""date"": ""2023-12-30"", ""headline"": ""Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation"", ""summary"": ""Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Read why I'm rating BMY stock a Buy at this point.""}, {""date"": ""2023-12-31"", ""headline"": ""Dow Dogs Gain Some Respect In Q4 2023"", ""summary"": ""In the fourth quarter, the Dow Dogs generated mid-teens growth that resulted in the 2023 total return equaling 14.5% for the year and almost matching the Dow's return of 16.0%.""}, {""date"": ""2023-12-31"", ""headline"": ""Johnson & Johnson Is A Trending Stock: Facts To Know Before Betting On It"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-31"", ""headline"": ""Dividend Stock Watch List: Lanny's January 2024 Edition"", ""summary"": ""It\u00e2\u0080\u0099s difficult to find undervalued dividend stocks right now, due to the market surging over 25% this year. Check out three dividend stocks on my watch list.""}, {""date"": ""2023-12-31"", ""headline"": ""3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024"", ""summary"": ""These \""Dogs of the Dow\"" offer attractive dividend yields and upside potential.""}, {""date"": ""2023-12-31"", ""headline"": ""January's 54 Dividend Kings: Buy 8, Watch 5"", ""summary"": ""Discover the top Dividend Kings for January, including Altria Group, with high yields and potential for net-gains according to brokers.""}, {""date"": ""2023-12-31"", ""headline"": ""Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Johnson & Johnson Shareholders' Class Action Lawsuit Gets Nod from Federal Judge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""2024\u2019s Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns"", ""summary"": ""Blue-chip stocks act as a portfolio anchor that prevents steep losses. And, they often pay substantial dividends that can keep returns ticking over amid market volatility. These stocks strategically offer an appealing hedge while investors take on more risk elsewhere. Also, they are often names that bounce back the fastest after recovering from a market downturn. In fact, these companies can potentially deliver strong gains in their own right. Let\u2019s explore three blue-chip stocks capable of outp""}, {""date"": ""2024-01-01"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2024-01-01"", ""headline"": ""Meet the 2024 Dogs of the Dow"", ""summary"": ""2023 was another tough year for this popular investing strategy, but fans are hoping for better results in the coming year.""}, {""date"": ""2024-01-01"", ""headline"": ""IGA: Trading At A Discount For A Very Good Reason"", ""summary"": ""Voya Global Advantage and Premium Opportunity Fund offers high level income through its equities and dividend-paying stock portfolios. Read my analysis of IGA.""}, {""date"": ""2024-01-01"", ""headline"": ""Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why"", ""summary"": ""MeiraGTx's (MGTX) shares surge on the sale of rights for a rare ocular disease gene therapy for up to $ 415 million. This funding helps MGTX extend its cash runway into mid-2026.""}, {""date"": ""2024-01-02"", ""headline"": ""Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024"", ""summary"": ""NEW BRUNSWICK, N.J., January 02, 2024--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2024 of $1.19 per share on the company\u2019s common stock. The dividend is payable on March 5, 2024 to shareholders of record at the close of business on February 20, 2024. The ex-dividend date is February 16, 2024.""}, {""date"": ""2024-01-02"", ""headline"": ""Amgen, Merck share gains lead Dow's 100-point jump"", ""summary"": ""Behind strong returns for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday afternoon. The Dow was most recently trading 100...""}, {""date"": ""2024-01-02"", ""headline"": ""Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise, Tuesday, 1/2/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Johnson & Johnson (JNJ) Shares Cross Above 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Johnson & Johnson call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""J&J : 1st quarter dividend set"", ""summary"": ""Johnson & Johnson announces that its Board of Directors has approved a dividend of $1.19 per share for the first quarter. The dividend is payable on March 5, 2024 to shareholders of record at the...""}, {""date"": ""2024-01-02"", ""headline"": ""Johnson & Johnson declares $1.19 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""December 2023 Passive Income Update"", ""summary"": ""There are three sources of passive income, and we had $1,259.83 from dividends in December 2023. Check out the companies that paid us in December.""}, {""date"": ""2024-01-03"", ""headline"": ""Johnson & Johnson (JNJ) Gets a Buy from Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts"", ""summary"": ""In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $160.97, denoting a +0.63% change from the preceding trading day.""}, {""date"": ""2024-01-03"", ""headline"": ""Revenge of the Boring Stocks! Dividends Are Sexy Again."", ""summary"": ""It\u2019s a new year and apparently there\u2019s a new theme on Wall Street for investors. Many of the Magnificent Seven stocks and their high-flying tech peers are off to a difficult start in 2024. But stodgy, dividend-paying consumer staples, telecom, and healthcare stocks are surging. Coca-Cola (NYSE:KO) was in the green on Tuesday and Wednesday while the broader market fell both days. Coke, a Dow Jones stock, is already up 2% after tumbling about 5% in 2023, missing the big market rally. The soft drin""}, {""date"": ""2024-01-03"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.63% higher to $160.97 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the...""}, {""date"": ""2024-01-03"", ""headline"": ""This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year"", ""summary"": ""A modest amount of money can go a long way when it's put to work in industry-leading, time-tested businesses with well-defined catalysts.""}, {""date"": ""2024-01-03"", ""headline"": ""The biopharmaceuticals stocks to own in 2024, according to BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""4 stocks to watch on Wednesday: Apple, Moderna and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Johnson & Johnson inks multi-million dollar deal for cancer drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Elektrofi, Janssen Biotech enter collaboration, license agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Neumora Therapeutics price target raised by $2 at BofA, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Johnson & Johnson price target lowered by $5 at Barclays, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Dogs of the Dow 2024: Cheap Dividends, But Are They Values?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Catalyst Watch: CES lights up tech, retail's ICR conference and bank earnings blitz"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Johnson & Johnson: One Of The World's Safest Stocks Could Return +10% Per Year"", ""summary"": ""Johnson & Johnson is a safe investment option with a history of consistent income and extreme financial safety. Find out why JNJ stock is a Buy.""}, {""date"": ""2024-01-04"", ""headline"": ""Johnson & Johnson stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 0.21% to $160.63 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2024-01-04"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Return Potential (Rating Upgrade)"", ""summary"": ""Johnson & Johnson offers a safe and attractive investment opportunity with solid growth, a strong balance sheet, and a +3% dividend yield. Learn more on JNJ stock here.""}, {""date"": ""2024-01-04"", ""headline"": ""Johnson & Johnson: Rock Solid 3% Yield With Over 10% Annual Return Potential (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""January Dogs Of The Dow: 2 Buyable, 6 Watchable"", ""summary"": ""Discover criteria for stocks to be added to the Dow, find the highest-yield stocks in December, and see stocks with most potential. Click here for our list!""}, {""date"": ""2024-01-04"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Interesting JNJ Put And Call Options For February 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Still Worried About a 2024 Recession? 7 Stocks to Watch."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Johnson & Johnson - One Of The World's Safest Stocks Could Return +10% Per Year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Dow Darlings: Top 3 Stocks That Will Lead the Charge in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""15 States With The Highest Drug Overdose Death Rates In The US"", ""summary"": ""In this article, we will take a look at the 15 states with the highest drug overdose death rates in the US. If you want to skip our discussion on the drug crisis, you can go directly to the 5 States With The Highest Drug Overdose Death Rates In The US. In the 12-month period [\u2026]""}, {""date"": ""2024-01-05"", ""headline"": ""How I Beat The Market Again In 2023"", ""summary"": ""I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. Click here to read more.""}, {""date"": ""2024-01-05"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.31% higher to $161.13 Friday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2024-01-05"", ""headline"": ""Johnson & Johnson: A Defensive Dividend King Set To Outperform The S&P 500"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina expands collaboration with Janssen on cancer test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Florida wins FDA nod for mass drug imports from Canada (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""10 Best January Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 10 best January dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best January Dividend Stocks To Buy. During 2023, dividends didn\u2019t hold much appeal for investors as compared to previous times. Instead, the [\u2026]""}, {""date"": ""2024-01-05"", ""headline"": ""Illumina expands collaboration with Janssen R&D"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Florida to become first state to win FDA nod for mass drug imports from Canada: NYT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Mersana Therapeutics announces business updates, expected 2024 milestones"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Dividend Roundup: Johnson & Johnson, AT&T, Mastercard, PNC Financial, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-06"", ""headline"": ""LVHD: Valuation And Quality Look Good, Performance Is Disappointing"", ""summary"": ""The Franklin U.S. Low Volatility High Dividend ETF utilizes a yield-focused strategy with investments in defensive sectors. Explore more details here.""}, {""date"": ""2024-01-06"", ""headline"": ""These Dow Stocks Will Boost Their Dividends Soon"", ""summary"": ""In this article, we discuss 10 Dow stocks that will boost their dividends soon. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read These 5 Dow Stocks Will Boost Their Dividends Soon. The Dow Jones Industrial Average, known as the Dow, is a famous [\u2026]""}, {""date"": ""2024-01-06"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - January 2024"", ""summary"": ""Discover five large-cap dividend-paying companies offering significant discounts.""}, {""date"": ""2024-01-06"", ""headline"": ""Johnson & Johnson's Bullish Outlook: Surprising Strength You Shouldn't Overlook"", ""summary"": ""Johnson & Johnson is a Dividend King focused on the creation and manufacturing of medical devices, vaccines, and medicines. Read more about JNJ stock here.""}, {""date"": ""2024-01-06"", ""headline"": ""Up To 10% Yields: My Top 10 High Dividend Yield Companies For January 2024"", ""summary"": ""High dividend yield companies are essential components within a well-balanced and diversified dividend portfolio. Read more here.""}, {""date"": ""2024-01-07"", ""headline"": ""Johnson & Johnson: Overblown Stelara Concerns Distract From Value"", ""summary"": ""Johnson & Johnson's Stelara is nearing the end of its exclusivity, which will likely slow down the growth of EPS. Click here to read why JNJ stock is a Buy.""}, {""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
52,2024-01-07,161.1300048828125,2024-01-14,162.38999938964844,0.007819738525747022,U1,"[{""date"": ""2024-01-06"", ""headline"": ""LVHD: Valuation And Quality Look Good, Performance Is Disappointing"", ""summary"": ""The Franklin U.S. Low Volatility High Dividend ETF utilizes a yield-focused strategy with investments in defensive sectors. Explore more details here.""}, {""date"": ""2024-01-07"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""UniFirst Corporation declares $0.33 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""Johnson & Johnson: Overblown Stelara Concerns Distract From Value"", ""summary"": ""Johnson & Johnson's Stelara is nearing the end of its exclusivity, which will likely slow down the growth of EPS. Click here to read why JNJ stock is a Buy.""}, {""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Ambrx Biopharma just downgraded at JMP Securities, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson: A Steady Hold Amidst Strategic Expansion and Pipeline Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Dividend Income Summary: Lanny's December 2023 Summary"", ""summary"": ""In December, we (my wife and I) received a dividend income total of $10,193.04. Crossed the $10k threshold, again.""}, {""date"": ""2024-01-08"", ""headline"": ""Asia Stocks Set to Track Wall Street Tech Rebound: Markets Wrap"", ""summary"": ""(Bloomberg) -- Asian stocks are poised to track Wall Street gains following a big tech rally which buoyed US stocks at the start of a week that brings key inflation data and bank earnings.Most Read from BloombergBoeing Slumps After Panel Blowout Leads to Partial 737 GroundingMusk\u2019s Drug Use Concerns Tesla, SpaceX Leaders, WSJ SaysIPhone Survives 16,000-Foot Fall, Helps Steer Jet-Panel HuntChina Says It Caught Foreign Consultant Spying for UK\u2019s MI6Australian stocks climbed in early trading, while""}, {""date"": ""2024-01-08"", ""headline"": ""Barclays sheds 5,000 jobs amid cost-cutting drive"", ""summary"": ""Barclays cut its workforce by around 5,000 last year as part of an ongoing push to strip costs from the lender.""}, {""date"": ""2024-01-08"", ""headline"": ""Merck and J&J\u2019s Biotech Deals Are More Good News for a Troubled Sector"", ""summary"": ""Merck and Johnson & Johnson are paying big premiums to acquire companies with promising biotech targets.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.25% higher to $161.53 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson (JNJ) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)"", ""summary"": ""Johnson &amp; Johnson. (NYSE:NYSE:JNJ) J.P.""}, {""date"": ""2024-01-08"", ""headline"": ""NEW YORK MARKET CLOSE: Boeing nosedives but stocks jump as tech shines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'"", ""summary"": ""Cancer-focused biotech companies Ambrx and Harpoon snapped up a pair of takeover deals. AMAM stock and HARP stock soared.""}, {""date"": ""2024-01-08"", ""headline"": ""UPDATE 1-J&J to pay $700 mln to settle states' talc-marketing probe - Bloomberg News"", ""summary"": ""Johnson & Johnson has come to a tentative agreement to pay about $700 million for settling claims by over 40 U.S. states that it wrongfully marketed its talc-based baby powder, Bloomberg News reported on Monday.  The settlement would avert potential lawsuits alleging J&J hid any links between the talc in its powder and various cancers, the report said citing people familiar with the deal.  J&J and representatives for state attorneys general are still working out the specific terms of the deal but have agreed on the total amount, Bloomberg News reported.""}, {""date"": ""2024-01-08"", ""headline"": ""My Dividend Growth Portfolio: Final 2023 Recap"", ""summary"": ""An analysis of sales and purchases made throughout the year, portfolio goals and history, and impressive income growth of 11.1%. Click here to read more.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion"", ""summary"": ""Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson: EPS Growth Returns In 2024, JPM Healthcare Conference On Tap"", ""summary"": ""Investors are showing interest in Johnson & Johnson as they move away from glamour growth stocks. Read more to see our analysis on JNJ stock.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer"", ""summary"": ""NEW BRUNSWICK, N.J., January 08, 2024--Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement to acquire Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody drug conjugates (ADCs), in an all-cash merger transaction for a total equity value of approximately $2.0 billion, or $1.9 billion net of estimated cash acquired.""}, {""date"": ""2024-01-08"", ""headline"": ""M & A News: Johnson & Johnson (NYSE:JNJ) to Acquire Ambrx Biopharma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise, Monday, 1/8/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Interesting June 2025 Stock Options for JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to Settle States' Talc Probe for $700 Million, Bloomberg Reports"", ""summary"": ""By Dean Seal --Johnson & Johnson has reached a tentative $700 million agreement with more than 40 states to settle an investigation into claims that it failed to warn of possible health risks...""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Latest Acquisition Does it Few Favors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""J&J's Tentative $700M Agreement To Resolve Talc Powder-Related Lawsuits Across US States"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""J&J to pay $700 million to settle states' talc-marketing probe - Bloomberg News"", ""summary"": ""Johnson & Johnson hastentatively agreed to pay about $700 million to resolve aninvestigation by over 40 U.S. states into claims it wrongfullymarketed its talc-based baby powder, Bloomberg News...""}, {""date"": ""2024-01-08"", ""headline"": ""Ambrx Biopharma Shares Double on $2B Acquisition by Johnson & Johnson"", ""summary"": ""By Ben Glickman Shares of Ambrx Biopharma surged Monday after the company agreed to be acquired by Johnson &amp; Johnson for $2 billion in cash. The stock...""}, {""date"": ""2024-01-08"", ""headline"": ""J&J to acquire ADC drug developer Ambrx for $2B"", ""summary"": ""The proposed takeout follows a spate of dealmaking around antibody-drug conjugates, targeted cancer medicines that have lured AbbVie, Pfizer, Merck and Gilead.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson eyes $700M deal to settle states\u2019 talc-marketing probe: Bloomberg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""J&J agrees to settle talc marketing probe for $700M, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Biggest stock movers today: Boeing, American Eagle Outfitters, Harpoon Therapeutics, Ambrx, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Morning Brew: Apple Unveils Vision Pro Amid Mixed Market Signals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""J&J : acquisition of Ambrx for $2 billion"", ""summary"": ""Johnson & Johnson announced on Monday that it had reached an agreement to acquire Ambrx Biopharma, a specialist in antibody conjugates, for approximately $2 billion in cash.In a press release, J&J...""}, {""date"": ""2024-01-08"", ""headline"": ""J&J agrees to buy Ambrx for USD2.0 billion to advance cancer treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""4 stocks to watch on Monday: Boeing, J&J and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to acquire Ambrx in $2 billion deal"", ""summary"": ""Johnson & Johnson said Monday it has entered into a definitive agreement to acquire Ambrx Biopharma Inc. The all-cash merger transaction has a total equity...""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to acquire ADC developer Ambrx Biopharma for $2B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson to acquire Ambrx Biopharma for $2B in cash"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Ambrx Biopharma to be acquired by Johnson & Johnson for $28.00 per share"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""7 Stable Stocks to Buy No Matter What Happens to Interest Rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""The latest trading day saw Johnson & Johnson (JNJ) settling at $161.63, representing a +0.06% change from its previous close.""}, {""date"": ""2024-01-09"", ""headline"": ""Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J"", ""summary"": ""J&J (JNJ) is set to acquire Ambrx Biopharma (AMAM) in an all-cash transaction for $2.0 billion. The transaction will likely close in first-half 2024.""}, {""date"": ""2024-01-09"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.06% higher to $161.63 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2024-01-09"", ""headline"": ""Ambrx Holders Who Bought for Pennies See 6,700% Gain on J&J Bid"", ""summary"": ""(Bloomberg) -- Longtime believers in Ambrx Biopharma Inc. are being rewarded with juicy returns as Johnson & Johnson\u2019s buyout offer values the biotech stock at more than 6,700% of its all-time low.Most Read from BloombergIPhone Survives 16,000-Foot Fall, Helps Steer Jet-Panel HuntChinese Billionaire Is Second-Biggest Foreign Owner of US LandMusk\u2019s Drug Use Concerns Tesla, SpaceX Leaders, WSJ SaysBoeing Slumps After Panel Blowout Leads to Partial 737 GroundingXi, Biden and the $10 Trillion Cost o""}, {""date"": ""2024-01-09"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Sell Alert: The Slaughter Of Office REITs Is Just Beginning"", ""summary"": ""Major companies like Charles Schwab, Johnson & Johnson, Dropbox, and Microsoft have already downsized their office spaces. Learn more about the challenges office REITs are facing.""}, {""date"": ""2024-01-09"", ""headline"": ""J&J MedTech gets Japanese regulatory approval for Varipulse PFA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""This Dividend Stock Has a $13 Billion Secret Weapon"", ""summary"": ""Johnson & Johnson made a key decision last year.""}, {""date"": ""2024-01-09"", ""headline"": ""Biosense Webster Announces Regulatory Approval of VARIPULSE\u2122 Pulsed Field Ablation (PFA) Platform in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Prothena (PRTA), Johnson & Johnson (JNJ) and Zimmer Biomet Holdings (ZBH)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Johnson & Johnson: $2 Billion Buyout Of Antibody Drug Conjugate Specialist Ambrx Is Good Business"", ""summary"": ""Johnson & Johnson (JNJ) has announced plans to acquire Ambrx (AMAM) for ~$2.0 billion. Read more to see my thoughts on this acquisition.""}, {""date"": ""2024-01-10"", ""headline"": ""Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Coca-Cola and Other Dividend Kings That Have Raised Their Payouts for 60 Years or More"", ""summary"": ""Investing in companies that have raised their payouts annually for six decades or more has paid off over the long haul.""}, {""date"": ""2024-01-10"", ""headline"": ""Johnson & Johnson's Acquisition Of Ambrx Biopharma: Hold Through It"", ""summary"": ""The recent acquisition announcement by JNJ shifted Ambrx Biopharma's investment profile to an M&A arbitrage play. Read the article for more on AMAM stock.""}, {""date"": ""2024-01-10"", ""headline"": ""3 Unshakeable Dividend Stocks for Lifelong Wealth"", ""summary"": ""While many, if not most investors, appear bullish about the market\u2019s prospects this year, it\u2019s never a bad time to consider long-term dividend stocks. By that, we\u2019re talking about profitable, relevant enterprises that you can trust. These aren\u2019t necessarily sexy securities but they should help you ride out any turbulence or even outright storms. Indeed, one of the main benefits of so-called unshakeable long-term dividend stocks centers on the psychological factor. So long as you\u2019re targeting rel""}, {""date"": ""2024-01-10"", ""headline"": ""Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Micron Technology, Inc. (MU) and The Southern Company (SO).""}, {""date"": ""2024-01-10"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.15% higher to $161.87 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2024-01-10"", ""headline"": ""Will Q4 Earnings Push Dow ETF Higher?"", ""summary"": ""Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.""}, {""date"": ""2024-01-10"", ""headline"": ""3 Dividend Aristocrats Signal Buy In January With 7 To Watch"", ""summary"": ""66 Aristocrats screened as of January 8, 2024 represented all 11 Morningstar Sectors. By yield, MMM topped-all Aristocrats. Read more here.""}, {""date"": ""2024-01-10"", ""headline"": ""IN BRIEF: J&J's Varipulse platform receives approval in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""J&J : green light for Varipulse platform in Japan"", ""summary"": ""J&J announces that Biosense Webster, a global specialist in the treatment of cardiac arrhythmia and part of Johnson & Johnson MedTech, has received approval from Japan's Ministry of Health, Labor and...""}, {""date"": ""2024-01-10"", ""headline"": ""Is Johnson & Johnson Stock a Buy Now?"", ""summary"": ""The pharmaceutical giant recently announced another acquisition.""}, {""date"": ""2024-01-10"", ""headline"": ""A Closer Look at Johnson & Johnson's Options Market Dynamics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Johnson & Johnson reports regulatory approval of Varipulse PFA platform in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""My Dividend Stock Portfolio: New December Dividend Record - 98 Holdings With 18 Buys"", ""summary"": """"}, {""date"": ""2024-01-10"", ""headline"": ""Alvotech-Stada biosimilar to J&J's Stelara wins Europe marketing authorization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2023 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2023 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2022 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2022 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2022 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2022 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2021 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2021 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2021 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2021 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2020 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2020 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2020 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2020 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2019 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2019 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2019 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2019 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2018 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2023 Johnson & Johnson Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation"", ""summary"": ""For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the \u201cDividend Dynasty.\u201d Here, seven high-yield stocks stand as pillars of long-term wealth accumulation. Picture a treasure trove of stocks offering substantial dividends and strategic blueprints for sustainable growth. The article reveals the investment potential of the stalwarts listed in the article. Each stock embodies a unique narrative of resilience, strategic prowess, and dividend consis""}, {""date"": ""2024-01-11"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slumped 0.44% to $161.15 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2024-01-11"", ""headline"": ""Sana Biotechnology: Finally Rewarding Investors, But Not Sufficiently Derisked"", ""summary"": ""If I were an investor, I'd be prepared to hold my Sana Biotechnology shares and wait for more data. Read more to see our analysis on SANA stock.""}, {""date"": ""2024-01-11"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR"", ""summary"": ""Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR are part of the Zacks top Analyst Blog.""}, {""date"": ""2024-01-11"", ""headline"": ""JNJ March 1st Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Buy Rating on Johnson & Johnson: Strategic Oncology Acquisition Promises Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""2023 Year-End Sector Review - Part 2"", ""summary"": ""While most renewables face a challenging environment, not all renewable energy utilities are such precarious positions.""}, {""date"": ""2024-01-11"", ""headline"": ""Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January"", ""summary"": ""Businesses with efficient operations and growth potential open the door to dividend raises for years to come.""}, {""date"": ""2024-01-11"", ""headline"": ""Johnson & Johnson Insiders Sold US$5.6m Of Shares Suggesting Hesitancy"", ""summary"": ""In the last year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""2024-01-11"", ""headline"": ""2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague"", ""summary"": ""Among the Dow Jones Industrial Average's 30 time-tested components, there are two that are historically cheap and ripe for the picking, while another outperformer is riddled with issues.""}, {""date"": ""2024-01-12"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.77% higher to $162.39 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2024-01-12"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2024-01-12"", ""headline"": ""2024 Dividend Growth Portfolio Review And Look Ahead"", ""summary"": ""My dividend growth portfolio has consistently grown income in excess of 10% annually. Read more to see a review of the portfolio's positions.""}, {""date"": ""2024-01-13"", ""headline"": ""Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week"", ""summary"": ""Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2B. Click here to read more biotech news.""}, {""date"": ""2024-01-13"", ""headline"": ""2 Average Stocks That Could Make You Rich"", ""summary"": ""You don't always have to pick a game-changing company to win in the stock market.""}, {""date"": ""2024-01-13"", ""headline"": ""Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-13"", ""headline"": ""Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Idexx Laboratories (IDXX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends"", ""summary"": ""If you\u2019re a growth investor, an article about overlooked high-yield dividend stocks is not for you. However, with the recent numbers showing that inflation is that dinner party guest that is overstaying its welcome, you may not want to dismiss income-generating stocks too quickly. Now, if you\u2019re still with me, I\u2019ll also say that this I\u2019m not recommending that you find the dividend stocks with the highest dividend yields and be done with it. While high-yield dividend stocks are attractive, they\u2019r""}, {""date"": ""2024-01-14"", ""headline"": ""First RSV shots, groundbreaking gene therapy among 2024 drugs to watch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now"", ""summary"": ""You shouldn't lose any sleep worrying about these great dividends.""}, {""date"": ""2024-01-14"", ""headline"": ""2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024"", ""summary"": ""Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors.""}]",{}
53,2024-01-14,162.38999938964844,2024-01-21,160.42999267578125,-0.012069750115364153,D2,"[{""date"": ""2024-01-13"", ""headline"": ""Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week"", ""summary"": ""Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2B. Click here to read more biotech news.""}, {""date"": ""2024-01-14"", ""headline"": ""Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends"", ""summary"": ""If you\u2019re a growth investor, an article about overlooked high-yield dividend stocks is not for you. However, with the recent numbers showing that inflation is that dinner party guest that is overstaying its welcome, you may not want to dismiss income-generating stocks too quickly. Now, if you\u2019re still with me, I\u2019ll also say that this I\u2019m not recommending that you find the dividend stocks with the highest dividend yields and be done with it. While high-yield dividend stocks are attractive, they\u2019r""}, {""date"": ""2024-01-14"", ""headline"": ""First RSV shots, groundbreaking gene therapy among 2024 drugs to watch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now"", ""summary"": ""You shouldn't lose any sleep worrying about these great dividends.""}, {""date"": ""2024-01-14"", ""headline"": ""2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024"", ""summary"": ""Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors.""}, {""date"": ""2024-01-15"", ""headline"": ""Bert's December Dividend Income Summary"", ""summary"": ""In December 2023, we received $6,884.70 in dividend income. Johnson & Johnson, Target, and T. Rowe Price were clearly the top 3 individual stock payers.""}, {""date"": ""2024-01-15"", ""headline"": ""Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-15"", ""headline"": ""The 3 Most Undervalued Value Stocks to Buy in January"", ""summary"": ""With Wall Street jubilant about avoiding a recession last year, investors may want to continue betting on the same horse, although here\u2019s the thing: targeting undervalued value stocks may offer a more sensible approach. You don\u2019t necessarily want to abandon your winners outright. However, it\u2019s also risky to assume lightning will strike twice. I\u2019m not going to list all the heavily hyped names of 2023 \u2013 you already know them. But because these enterprises have performed surprisingly well, a possib""}, {""date"": ""2024-01-15"", ""headline"": ""2023 Was A Big Year For The Growth & Income Portfolio"", ""summary"": ""Most market analysts made inaccurate forecasts a year ago, once again demonstrating that short-term predictions usually aren't all that useful in building a long-term portfolio.""}, {""date"": ""2024-01-15"", ""headline"": ""Johnson & Johnson: One Penny, Per Hour, Forever"", ""summary"": ""Johnson & Johnson is a powerhouse with an amazing quality rating and very long, and successful track record. Click here to read my analysis of JNJ.""}, {""date"": ""2024-01-15"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), GoodRx Holdings (GDRX) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-15"", ""headline"": ""Johnson & Johnson Partners with Captain Jason to Share his ACUVUE Contact Lens Journey"", ""summary"": ""Johnson & Johnson announced a partnership with one of the world's most talked about boat captains, Captain Jason Chambers to share his ACUVUE contact lens journey with his social followers.Known not...""}, {""date"": ""2024-01-15"", ""headline"": ""Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition"", ""summary"": ""Johnson & Johnson's moderate returns seem relatively safe, even taking the recent developments into consideration. Learn why I rate JNJ stock a hold.""}, {""date"": ""2024-01-15"", ""headline"": ""Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Dividend Income Update December 2023"", ""summary"": ""The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated.""}, {""date"": ""2024-01-16"", ""headline"": ""20 Worst States for Dividend Income Investors"", ""summary"": ""In this article, we will take a look at the 20 worst states for dividend income investors. If you want to skip our detailed analysis, you can go directly to 5 Worst States for Dividend Income Investors. Why Should Investors Consider Dividend Aristocrats? On December 30, 2023, Dave Mazza, Chief Strategy Officer at Roundhill Investments, [\u2026]""}, {""date"": ""2024-01-16"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.15% to $160.52 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-16"", ""headline"": ""Global company events calendar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off?"", ""summary"": ""A fresh look at Johnson & Johnson is warranted, especially in light of split-off of its Consumer Health segment and amid ongoing talc litigation. Learn more on JNJ stock here.""}, {""date"": ""2024-01-17"", ""headline"": ""3 Reasons to Rely on Dividend Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""3 Dividend Stocks For A Steady Drip Of Income"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""7 Must-Have Stocks for Serious Wealth Accumulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.06%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) concluded the recent trading session at $160.43, signifying a -0.06% move from its prior day's close.""}, {""date"": ""2024-01-17"", ""headline"": ""Johnson & Johnson stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson dropped 0.06% to $160.43 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-17"", ""headline"": ""Investing in Johnson & Johnson (NYSE:JNJ) five years ago would have delivered you a 43% gain"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}, {""date"": ""2024-01-17"", ""headline"": ""Financial Freedom With VIG Vs. DGRW: Only One Is A Worthy Compounder"", ""summary"": ""We compared VIG and DGRW side-by-side to see which one is a worthy long-term compounding vehicle. Click here to read more.""}, {""date"": ""2024-01-18"", ""headline"": ""Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""J&J says FDA grants full approval for Balversa for mUC with genetic alterations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson (JNJ) Q4 Earnings"", ""summary"": ""Get a deeper insight into the potential performance of Johnson & Johnson (JNJ) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.""}, {""date"": ""2024-01-18"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.49% higher to $161.21 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2024-01-18"", ""headline"": ""11 Best Global Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best global dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Global Dividend Stocks To Buy Now. Investors across the globe are increasingly drawn to stocks that provide regular dividends as a [\u2026]""}, {""date"": ""2024-01-18"", ""headline"": ""Eli Lilly\u2019s Jaypirca to lead BTK inhibitor market for leukemia"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Senate Health, Education, Labor & Pensions Committee holds an executive session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""My Dividend Growth Portfolio - Q4 2023 Summary"", ""summary"": ""As we wrap up Q4 2023, it's clear that while the market will continue to present challenges, it will also provide valuable investment opportunities. Click here to read more.""}, {""date"": ""2024-01-19"", ""headline"": ""Tesla, Netflix earnings, econ. data: What to Watch Next Week"", ""summary"": ""Yahoo Finance Live anchors Josh Lipton and Jared Blikre look ahead to the top earnings results and economic data expected out next week, including earnings from companies like United Air Lines (UAL), Netflix (NFLX), and Tesla (TSLA), as well as Personal Consumption Expenditures (PCE) index and preliminary fourth-quarter GDP prints. Yahoo Finance is also kicking off its \""AI Revolution\"" special coverage all of next week. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.""}, {""date"": ""2024-01-19"", ""headline"": ""2 Dividend Kings For A Potentially Comfortable Retirement"", ""summary"": ""Procter & Gamble and Johnson & Johnson are Dividend Kings with impressive dividend growth track records. Click here to read more.""}, {""date"": ""2024-01-19"", ""headline"": ""IN BRIEF: J&J gets US FDA approval for cancer treatment Balversa"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.29% higher to $161.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2024-01-19"", ""headline"": ""Wall Street Lunch: Spirit Not Giving Up On Merger"", ""summary"": ""Spirit Airlines confirms commitment to merger along with upbeat guidance. Consumer sentiment hits a 2-1/2 year high. Meta buying up Nvidia AI chips.""}, {""date"": ""2024-01-19"", ""headline"": ""J&J (JNJ) Gears Up to Report Q4 Earnings: What's in Store?"", ""summary"": ""J&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex and Stelara. Surgical procedure recovery and new products are likely to have driven MedTech sales.""}, {""date"": ""2024-01-19"", ""headline"": ""Sanders threatens to subpoena J&J, Merck CEOs over drug prices"", ""summary"": ""The Senate HELP committee, which is seeking testimony from J&J's Joaquin Duato and Merck's Robert Davis, hasn't issued a subpoena since 1981.""}, {""date"": ""2024-01-19"", ""headline"": ""Alvotech stock jumps 15% on Stelara, Humira biosimilars updates (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""FDA flags possible violation at Alvotech biosimilars plant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Trump and Biden Both Hate Pharma\u2014Investors Shouldn\u2019t"", ""summary"": ""The drug sector just had one of its worst years ever relative to the S&P 500 and now faces political attacks, but investors should focus on the value.""}, {""date"": ""2024-01-19"", ""headline"": ""Eli Lilly production plant said to be under renewed FDA scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Q4 Earnings Results Reflect Stability"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""IYH: Healthcare Dashboard For January"", ""summary"": ""The healthcare sector is overvalued currenty, but with promising value scores. Click for my review of iShares U.S. Healthcare ETF (IYH).""}, {""date"": ""2024-01-19"", ""headline"": ""Senate panel to consider subpoenas for J&J and Merck CEOs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Too Much Optimism Is Baked Into Intuitive Surgical"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-20"", ""headline"": ""The 2024 Dogs of the Dow: Which Ones Are Buys Right Now?"", ""summary"": ""A few of these Dogs of the Dow can probably hunt in the new year.""}, {""date"": ""2024-01-20"", ""headline"": ""Retirement Stock Portfolio: 12 Healthcare Stocks To Consider"", ""summary"": ""In this article, we discuss the 12 healthcare stock options to add to your retirement portfolio. If you wish to see more such stocks within our list, you can go directly to read the Retirement Stock Portfolio: 5 Healthcare Stocks To Consider. Globally, retirees are exploring investment opportunities to supplement their income, driven by the [\u2026]""}, {""date"": ""2024-01-21"", ""headline"": ""Nearing Retirement? These Stocks Are as Safe as They Come"", ""summary"": ""These stocks should provide solid income with little drama.""}, {""date"": ""2024-01-21"", ""headline"": ""Prediction: This Will Be the First Trillion-Dollar Healthcare Stock"", ""summary"": ""This company is currently firing on all cylinders.""}, {""date"": ""2024-01-21"", ""headline"": ""Walgreens Boots Alliance Just Cut Its Dividend: Here Are 2 Companies That Won't"", ""summary"": ""Not every dividend stock is created equal, and these two far exceed Walgreens Boots Alliance.""}, {""date"": ""2024-01-21"", ""headline"": ""Mayar Capital Q4 2023 Letter To Partners"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-21"", ""headline"": ""New ADHD drugs could pay off for pharmaceutical companies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-21"", ""headline"": ""Do Fundamentals Have Any Role To Play In Driving Johnson & Johnson's (NYSE:JNJ) Stock Up Recently?"", ""summary"": ""Most readers would already know that Johnson & Johnson's (NYSE:JNJ) stock increased by 6.8% over the past three months...""}, {""date"": ""2024-01-21"", ""headline"": ""My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024"", ""summary"": ""These stocks may help you win in 2024 -- no matter what the market does.""}, {""date"": ""2024-01-21"", ""headline"": ""Anti-obesity meds can expand the market for weight loss surgery: Bernstein"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-21"", ""headline"": ""2 Ideal Barron's/Fortune New-Year 2024 Dividend Buys"", ""summary"": ""Discover the top stock picks for 2024 according to Barron's and Fortune, including Microsoft, Nvidia, and Google.""}, {""date"": ""2024-01-21"", ""headline"": ""Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-21"", ""headline"": ""Our U.S. Stock Portfolio Performance For 2023 And Longer-Term Market Beat"", ""summary"": ""The U.S. market exceeded expectations in 2023, delivering a 26% return for the S&P 500. Click here to read more about the portfolio and our stock picks.""}]",{}
